FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Benvenuto, D
   Giovanetti, M
   Salemi, M
   Prosperi, M
   De Flora, C
   Alcantara, LC
   Angeletti, S
   Ciccozzi, M
AF Benvenuto, Domenico
   Giovanetti, Marta
   Salemi, Marco
   Prosperi, Mattia
   De Flora, Cecilia
   Junior Alcantara, Luiz Carlos
   Angeletti, Silvia
   Ciccozzi, Massimo
TI The global spread of 2019-nCoV: a molecular evolutionary analysis
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article
DE 2019-nCoV; molecular Epidemiology; phylogeny; SARS
ID CORONAVIRUS
AB The global spread of the 2019-nCoV is continuing and is fast moving, as indicated by the WHO raising the risk assessment to high. In this article, we provide a preliminary phylodynamic and phylogeographic analysis of this new virus. A Maximum Clade Credibility tree has been built using the 29 available whole genome sequences of 2019-nCoV and two whole genome sequences that are highly similar sequences from Bat SARS-like Coronavirus available in GeneBank. We are able to clarify the mechanism of transmission among the countries which have provided the 2019-nCoV sequence isolates from their patients. The Bayesian phylogeographic reconstruction shows that the 2019-2020 nCoV most probably originated from the Bat SARS-like Coronavirus circulating in the Rhinolophus bat family. In agreement with epidemiological observations, the most likely geographic origin of the new outbreak was the city of Wuhan, China, where 2019-nCoV time of the most recent common ancestor emerged, according to molecular clock analysis, around November 25(th), 2019. These results, together with previously recorded epidemics, suggest a recurring pattern of periodical epizootic outbreaks due to Betacoronavirus. Moreover, our study describes the same population genetic dynamic underlying the SARS 2003 epidemic, and suggests the urgent need for the development of effective molecular surveillance strategies of Betacoronavirus among animals and Rhinolophus of the bat family.
C1 [Benvenuto, Domenico; De Flora, Cecilia] Univ Campus Biomed Rome, Unit Med Stat & Mol Epidemiol, Rome, Italy.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos; Ciccozzi, Massimo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Salemi, Marco; Prosperi, Mattia] Univ Florida, Dept Epidemiol, Gainesville, FL USA.
   [Salemi, Marco; Prosperi, Mattia] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Angeletti, Silvia] Univ Campus Biomed Rome, Unit Clin Lab Sci, Rome, Italy.
RP Angeletti, S (corresponding author), Univ Campus Biomed Rome, Unit Clin Lab Sci, Rome, Italy.
EM s.angeletti@unicampus.it
RI Benvenuto, Domenico/AAO-5576-2020; Giovanetti, Marta/AAK-7408-2020;
   Ribeiro, Nuno/AAH-2299-2020
OI Benvenuto, Domenico/0000-0003-3833-2927; Alcantara,
   Luiz/0000-0002-6769-9931
CR [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Salemi M, 2004, J VIROL, V78, P1602, DOI 10.1128/JVI.78.3.1602-1603.2004
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 16
TC 28
Z9 30
U1 4
U2 39
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PD FEB 17
PY 2020
VL 114
IS 2
BP 64
EP 67
DI 10.1080/20477724.2020.1725339
EA FEB 2020
PG 4
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA KY8MH
UT WOS:000513613400001
PM 32048560
OA Green Published, Bronze
DA 2020-11-24
ER

PT J
AU Giovanetti, M
   Benvenuto, D
   Angeletti, S
   Ciccozzi, M
AF Giovanetti, Marta
   Benvenuto, Domenico
   Angeletti, Silvia
   Ciccozzi, Massimo
TI The first two cases of 2019-nCoV in Italy: Where they come from?
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE epidemiology; engineering and technology; infection; macromolecular
   design
AB A novel Coronavirus, 2019-nCoV, has been identified as the causal pathogen of an ongoing epidemic, with the first cases reported in Wuhan, China, last December 2019, and has since spread to other countries worldwide, included Europe and very recently Italy. In this short report, phylogenetic reconstruction was used to better understand the transmission dynamics of the virus from its first introduction in China focusing on the more recent evidence of infection in a couple of Chinese tourists arrived in Italy on 23rd January 2020 and labeled as Coronavirus Italian cases. A maximum clade credibility tree has been built using a dataset of 54 genome sequences of 2019-nCoV plus two closely related bat strains (SARS-like CoV) available in GenBank. Bayesian time-scaled phylogenetic analysis was implemented in BEAST 1.10.4. The Bayesian phylogenetic reconstruction showed that 2019-2020 nCoV firstly introduced in Wuhan on 25 November 2019, started epidemic transmission reaching many countries worldwide, including Europe and Italy where the two strains isolated dated back 19 January 2020, the same that the Chinese tourists arrived in Italy. Strains isolated outside China were intermixed with strains isolated in China as evidence of likely imported cases in Rome, Italy, and Europe, as well. In conclusion, this report suggests that further spread of 2019-nCoV epidemic was supported by human mobility and that quarantine of suspected or diagnosed cases is useful to prevent further transmission. Viral genome phylogenetic analysis represents a useful tool for the evaluation of transmission dynamics and preventive action.
C1 [Giovanetti, Marta] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Benvenuto, Domenico; Ciccozzi, Massimo] Univ Campus Biomed Rome, Unit Med Stat & Mol Epidemiol, Rome, Italy.
   [Angeletti, Silvia] Univ Campus Biomed Rome, Unit Clin Lab Sci, I-00128 Rome, Italy.
RP Angeletti, S (corresponding author), Univ Campus Biomed Rome, Unit Clin Lab Sci, I-00128 Rome, Italy.
EM s.angeletti@unicampus.it
RI Ribeiro, Nuno/AAH-2299-2020; Benvenuto, Domenico/AAO-5576-2020;
   Giovanetti, Marta/AAK-7408-2020; Ulatan, Jeffrey/AAM-5560-2020;
   ciccozzi, massimo/C-6484-2016
OI Benvenuto, Domenico/0000-0003-3833-2927; Ulatan,
   Jeffrey/0000-0002-3756-0568; ciccozzi, massimo/0000-0003-3866-9239
CR [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Benvenuto D, 2020, J MED VIROL, V92, P455, DOI 10.1002/jmv.25688
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 13
TC 78
Z9 79
U1 5
U2 59
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2020
VL 92
IS 5
BP 518
EP 521
DI 10.1002/jmv.25699
EA FEB 2020
PG 4
WC Virology
SC Virology
GA KU3AY
UT WOS:000512724700001
PM 32022275
OA Green Published, Bronze
DA 2020-11-24
ER

PT J
AU Benvenuto, D
   Giovanetti, M
   Ciccozzi, A
   Spoto, S
   Angeletti, S
   Ciccozzi, M
AF Benvenuto, Domenico
   Giovanetti, Marta
   Ciccozzi, Alessandra
   Spoto, Silvia
   Angeletti, Silvia
   Ciccozzi, Massimo
TI The 2019-new coronavirus epidemic: Evidence for virus evolution
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE coronavirus; epidemiology; macromolecular design; SARS coronavirus
AB There is a worldwide concern about the new coronavirus 2019-nCoV as a global public health threat. In this article, we provide a preliminary evolutionary and molecular epidemiological analysis of this new virus. A phylogenetic tree has been built using the 15 available whole genome sequences of 2019-nCoV, 12 whole genome sequences of 2019-nCoV, and 12 highly similar whole genome sequences available in gene bank (five from the severe acute respiratory syndrome, two from Middle East respiratory syndrome, and five from bat SARS-like coronavirus). Fast unconstrained Bayesian approximation analysis shows that the nucleocapsid and the spike glycoprotein have some sites under positive pressure, whereas homology modeling revealed some molecular and structural differences between the viruses. The phylogenetic tree showed that 2019-nCoV significantly clustered with bat SARS-like coronavirus sequence isolated in 2015, whereas structural analysis revealed mutation in Spike Glycoprotein and nucleocapsid protein. From these results, the new 2019-nCoV is distinct from SARS virus, probably trasmitted from bats after mutation conferring ability to infect humans.
C1 [Benvenuto, Domenico; Ciccozzi, Alessandra] Univ Campus Biomed Rome, Unit Med Stat & Mol Epidemiol, Rome, Italy.
   [Giovanetti, Marta; Ciccozzi, Massimo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Spoto, Silvia] Univ Campus Biomed Rome, Internal Med Unit, Rome, Italy.
   [Angeletti, Silvia] Univ Campus Biomed Rome, Unit Clin Lab Sci, I-00128 Rome, Italy.
RP Angeletti, S (corresponding author), Univ Campus Biomed Rome, Unit Clin Lab Sci, I-00128 Rome, Italy.
EM s.angeletti@unicampus.it
RI Benvenuto, Domenico/AAO-5576-2020; Giovanetti, Marta/AAK-7408-2020;
   ciccozzi, massimo/C-6484-2016
OI Benvenuto, Domenico/0000-0003-3833-2927; ciccozzi,
   massimo/0000-0003-3866-9239
CR Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322
   Chakraborty S, 2017, GENE, V604, P48, DOI 10.1016/j.gene.2016.11.023
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764
   Schrodinger LLC, 2015, PYMOL MOL GRAPH SYST
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007
NR 19
TC 122
Z9 140
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD APR
PY 2020
VL 92
IS 4
SI SI
BP 455
EP 459
DI 10.1002/jmv.25688
EA FEB 2020
PG 5
WC Virology
SC Virology
GA KM6QU
UT WOS:000511536300001
PM 31994738
OA Green Published, Bronze
DA 2020-11-24
ER

PT J
AU Tosta, SFD
   Passos, MS
   Kato, R
   Salgado, A
   Xavier, J
   Jaiswal, AK
   Soares, SC
   Azevedo, V
   Giovanetti, M
   Tiwari, S
   Alcantara, LC
AF de Oliveira Tosta, Stephane Fraga
   Passos, Mariana Santana
   Kato, Rodrigo
   Salgado, Alvaro
   Xavier, Joilson
   Jaiswal, Arun Kumar
   Soares, Siomar C.
   Azevedo, Vasco
   Giovanetti, Marta
   Tiwari, Sandeep
   Junior Alcantara, Luiz Carlos, Jr.
TI Multi-epitope based vaccine against yellow fever virus applying
   immunoinformatics approaches
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE Immunoinformatics; flavivirus; multi-epitope vaccine; vaccine; Yellow
   fever virus
ID PEPTIDE VACCINE; NUCLEOTIDE-SEQUENCE; PROTEIN; DESIGN; PREDICTION;
   RESPONSES; STRATEGY; GENOME; ALPHA; IMMUNOGENICITY
AB Yellow fever disease is considered a re-emerging major health issue which has caused recent outbreaks with a high number of deaths. Tropical countries, mainly African and South American, are the most affected by Yellow fever outbreaks. Despite the availability of an attenuated vaccine, its use is limited for some groups such as pregnant and nursing women, immunocompromised and immunosuppressed patients, elderly people >65 years, infants <6 months and patients with biological disorders like thymus disorders. In order to achieve new preventive measures, we applied immunoinformatics approaches to develop a multi-epitope-based subunit vaccine for Yellow fever virus. Different epitopes, related to humoral and cell-mediated immunity, were predicted for complete polyproteins of two Yellow fever strains (Asibi and 17 D vaccine). Those epitopes common for both strains were mapped into a set of 137 sequences of Yellow fever virus, including 77 sequences from a recent outbreak at the state of Minas Gerais, southeast Brazil. Therefore, the present work uses robust bioinformatics approaches for the identification of a multi-epitope vaccine against the Yellow fever virus. Our results indicate that the identified multi-epitope vaccine might stimulate humoral and cellular immune responses and could be a potential vaccine candidate against Yellow fever virus infection. Hence, it should be subjected to further experimental validations. Communicated by Ramaswamy H. Sarma
C1 [de Oliveira Tosta, Stephane Fraga; Kato, Rodrigo; Salgado, Alvaro; Jaiswal, Arun Kumar; Azevedo, Vasco; Tiwari, Sandeep] Fed Univ Minas Gerais UFMG, Inst Biol Sci, Postgrad Program Bioinformat, BR-31270901 Belo Horizonte, MG, Brazil.
   [Passos, Mariana Santana; Xavier, Joilson; Giovanetti, Marta; Junior Alcantara, Luiz Carlos, Jr.] Fed Univ Minas Gerais UFMG, Inst Biol Sci, Dept Genet, Belo Horizonte, MG, Brazil.
   [Jaiswal, Arun Kumar; Soares, Siomar C.] Fed Univ Triangulo Mineiro UFTM, Inst Biol & Nat Sci, Dept Immunol Microbiol & Parasitol, Uberaba, MG, Brazil.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos, Jr.] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Manguinho, RJ, Brazil.
RP Tiwari, S (corresponding author), Fed Univ Minas Gerais UFMG, Inst Biol Sci, Postgrad Program Bioinformat, BR-31270901 Belo Horizonte, MG, Brazil.; Giovanetti, M; Alcantara, LC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Manguinho, RJ, Brazil.
EM giovanetti.marta@gmail.com; sandip_sbtbi@yahoo.com;
   luiz.alcantara@ioc.fiocruz.br
RI Azevedo, Vasco A/B-1556-2019; Giovanetti, Marta/AAK-7408-2020
OI Azevedo, Vasco A/0000-0002-4775-2280; jaiswal, A run
   kumar/0000-0002-0558-483X; Kato, Rodrigo/0000-0002-9046-1702; Xavier,
   Joilson/0000-0003-3916-2018; Alcantara, Luiz/0000-0002-6769-9931
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior,
   Brasil)CAPES; CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq)
FX We acknowledge the collaboration and assistance of all team members and
   the Brazilian funding agencies CAPES (Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior, Brasil) and CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico).
CR Ali M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09199-w
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   [Anonymous], 2013, Wkly Epidemiol Rec, V88, P269
   Backert L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0245-0
   Barh D, 2010, BIOINFORMATION, V5, P77, DOI 10.6026/97320630005077
   Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Biscayart C, 2014, VACCINE, V32, P1266, DOI 10.1016/j.vaccine.2014.01.015
   Breugelmans JG, 2013, VACCINE, V31, P1819, DOI 10.1016/j.vaccine.2013.01.054
   Campi-Azevedo AC, 2016, HUM VACC IMMUNOTHER, V12, P491, DOI 10.1080/21645515.2015.1082693
   Chauhan V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39299-8
   Chen HY, 2017, J MOL MICROB BIOTECH, V27, P64, DOI 10.1159/000454813
   Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291
   Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039
   Cole GT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003768
   Couto A. Mallmann, 2010, Morbidity and Mortality Weekly Report, V59, P130
   DALGARNO L, 1986, J MOL BIOL, V187, P309, DOI 10.1016/0022-2836(86)90435-3
   Dar HA, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030088
   de Melo AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001938
   Dhanda SK, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-30
   Dorosti H, 2019, J BIOMOL STRUCT DYN, V37, P3524, DOI 10.1080/07391102.2018.1519460
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107
   Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Giovanetti M, 2020, J VIROL, V94, DOI 10.1128/JVI.01623-19
   Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0
   Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376
   Gu Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01475
   GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155
   HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019
   Hajighahramani N, 2017, INFECT GENET EVOL, V48, P83, DOI 10.1016/j.meegid.2016.12.010
   Hall T., 2013, BIOEDIT VERSION 7 2, DOI [10.1016/j.ifset.2004.06.001, DOI 10.1016/J.IFSET.2004.06.001]
   Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458
   Jenik M, 2012, NUCLEIC ACIDS RES, V40, pW348, DOI 10.1093/nar/gks447
   JENNINGS AD, 1994, J INFECT DIS, V169, P512, DOI 10.1093/infdis/169.3.512
   Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008
   Johansson MA, 2010, AM J TROP MED HYG, V83, P183, DOI 10.4269/ajtmh.2010.09-0782
   Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646
   Khan M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49354-z
   Khromava AY, 2005, VACCINE, V23, P3256, DOI 10.1016/j.vaccine.2005.01.089
   Kwok SC, 2002, PROTEIN SCI, V11, P1519, DOI 10.1110/ps.4170102
   Lang J, 1999, AM J TROP MED HYG, V60, P1045, DOI 10.4269/ajtmh.1999.60.1045
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   Lawrence GL, 2005, COMMUN DIS INTELL, V29, P248
   Li XY, 2015, INTERVIROLOGY, V58, P403, DOI 10.1159/000445059
   LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993
   Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499
   Lohia N, 2014, VIRAL IMMUNOL, V27, P225, DOI 10.1089/vim.2013.0135
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Maciel M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003693
   Magnan CN, 2010, BIOINFORMATICS, V26, P2936, DOI 10.1093/bioinformatics/btq551
   Marfin AA, 2005, INFECT DIS CLIN N AM, V19, P151, DOI 10.1016/j.idc.2004.11.004
   Minor PD, 2015, VIROLOGY, V479, P379, DOI 10.1016/j.virol.2015.03.032
   Mohan T, 2013, VACCINE, V31, P1707, DOI 10.1016/j.vaccine.2013.01.041
   Monath TP, 2007, NEW ENGL J MED, V357, P2222, DOI 10.1056/NEJMp0707161
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023
   Murphy D, 2019, CHEM BIOL DRUG DES, V93, P21, DOI 10.1111/cbdd.13357
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   Narula A, 2018, INFECT GENET EVOL, V61, P4, DOI 10.1016/j.meegid.2018.03.007
   Naz K, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2713-9
   Nezafat N, 2016, COMPUT BIOL CHEM, V62, P82, DOI 10.1016/j.compbiolchem.2016.04.006
   Nezafat N, 2014, J THEOR BIOL, V349, P121, DOI 10.1016/j.jtbi.2014.01.018
   Nishioka SD, 1998, TROP MED INT HEALTH, V3, P29, DOI 10.1046/j.1365-3156.1998.00164.x
   Ode H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00258
   Paho, 2018, EP UPD YELL FEV SIT
   Pandey RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19456-1
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   Porudominsky R, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/RPSP.2018.75, 10.26633/rpsp.2018.75]
   Pritam M, 2019, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2482-x
   Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Rana A, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00572
   Rana A, 2016, IMMUNOBIOLOGY, V221, P544, DOI 10.1016/j.imbio.2015.12.004
   Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   RUIZLINARES A, 1989, J VIROL, V63, P4199, DOI 10.1128/JVI.63.10.4199-4209.1989
   Rutkowski K, 2013, INT ARCH ALLERGY IMM, V161, P274, DOI 10.1159/000346350
   Saadi M, 2017, INFECT GENET EVOL, V51, P227, DOI 10.1016/j.meegid.2017.04.009
   Sabetian S, 2019, J BIOMOL STRUCT DYN, V37, P2546, DOI 10.1080/07391102.2018.1491890
   Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Shey RA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40833-x
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Smith H. H., 1938, AM J TROP MED HYG, Vs1-18, P437, DOI [10.4269/ajtmh.1938.s1-18.437, DOI 10.4269/AJTMH.1938.S1-18.437]
   Staples J. E., 2018, 63 YELLOW FEVER VACC, DOI [10.1016/B978-0-323-35761-6.00063-8, DOI 10.1016/B978-0-323-35761-6.00063-8]
   TAKAHASHI H, 1989, J IMMUNOL, V142, P2221
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8
   Torchala M, 2013, BIOINFORMATICS, V29, P807, DOI 10.1093/bioinformatics/btt038
   Traiber C, 2011, J PEDIAT-BRAZIL, V87, P269, DOI [10.2223/JPED.2067, 10.1590/S0021-75572011000300015]
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   Ul-Rahman A, 2020, J BIOMOL STRUCT DYN, V38, P3110, DOI 10.1080/07391102.2019.1651673
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Velders MP, 2001, J IMMUNOL, V166, P5366, DOI 10.4049/jimmunol.166.9.5366
   Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006
   von Lindern JJ, 2006, J GEN VIROL, V87, P895, DOI 10.1099/vir.0.81236-0
   Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601
   Wang LF, 2016, J INFECTION, V73, P377, DOI 10.1016/j.jinf.2016.07.003
   Wang S, 2016, NUCLEIC ACIDS RES, V44, pW430, DOI 10.1093/nar/gkw306
   Ward JJ, 2003, BIOINFORMATICS, V19, P1650, DOI 10.1093/bioinformatics/btg223
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   WHO, 2014, LIST COUNTR TERR AR
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P248, DOI 10.1016/S1473-3099(16)30588-6
   Yano A, 2005, VACCINE, V23, P2322, DOI 10.1016/j.vaccine.2005.01.031
   Zhang LF, 2018, CELL MOL IMMUNOL, V15, P182, DOI 10.1038/cmi.2017.92
NR 113
TC 7
Z9 7
U1 3
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2019.1707120
EA JAN 2020
PG 17
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA KA6EL
UT WOS:000505890000001
PM 31854239
DA 2020-11-24
ER

PT J
AU Oliveira, JV
   Carvalho, TCX
   Giovanetti, M
   de Jesus, JG
   Santos, CS
   Pessoa, LB
   Magalhaes, CFQ
   Lima, JGS
   Carvalho, DAX
   Figueiredo, EM
   Biron, AC
   dos Santos, DC
   Viana, P
   Duarte, AO
   Pessoa, R
   Souza, GB
   Calcagno, JI
   Lima, FWM
   Alcantara, LCJ
   de Siqueira, IC
AF Oliveira, Joao, V
   Carvalho, Tereza C. X.
   Giovanetti, Marta
   de Jesus, Jaqueline G.
   Santos, Cleiton S.
   Pessoa, Lorena B.
   Magalhaes Filho, Claudio F. Q.
   Lima, Jessica G. S.
   Carvalho, Daniel A. X.
   Figueiredo, Eduardo M.
   Biron, Ana Carolina
   dos Santos, Daiana C.
   Viana, Paloma
   Duarte, Alan O.
   Pessoa, Rosana
   Souza, Gloryane B.
   Calcagno, Juan, I
   Lima, Fernanda W. M.
   Alcantara, Luiz C. J.
   de Siqueira, Isadora C.
TI Neonatal surveillance for congenital Zika infection during the 2016
   microcephaly outbreak in Salvador, Brazil: Zika virus detection in
   asymptomatic newborns
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Brazil; Congenital infection; Microcephaly; Neonatal surveillance; Zika
   virus
AB Objective To identify newborns with congenital Zika infection (CZI) at a maternity hospital in Salvador, Brazil, during the 2016 microcephaly outbreak. Methods A prospective study enrolled microcephalic and normocephalic newborns with suspected CZI between January and December 2016. Serology (immunoglobulins IgM and IgG) and quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) for the Zika virus were performed. Demographic and clinical characteristics of newborns with and without microcephaly were compared. Results Of the 151 newborns enrolled, 32 (21.2%) were classified as microcephalic. The majority of these cases were born between January and May 2016. IgM and IgG Zika virus antibodies were detected in 5 (23.8%) and 17 (80.9%) microcephalic newborn blood samples, respectively. Six (24%) microcephalic newborns tested positive for Zika virus by RT-qPCR in urine or placenta samples. Thirteen (11.8%) normocephalic newborns also tested positive for Zika virus by PCR in urine, plasma, or placenta samples, while IgM antibodies against Zika were detected in 4 (4.2%) others. Conclusions Identification of 17 normocephalic CZI cases, confirmed by IgM serology or RT-qPCR for Zika virus, provides evidence that CZI can present asymptomatically at birth. This finding highlights the need for prenatal and neonatal screening for Zika virus in endemic regions.
C1 [Oliveira, Joao, V; de Jesus, Jaqueline G.; Santos, Cleiton S.; Pessoa, Lorena B.; Magalhaes Filho, Claudio F. Q.; Lima, Jessica G. S.; Carvalho, Daniel A. X.; dos Santos, Daiana C.; Viana, Paloma; de Siqueira, Isadora C.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Minist Hlth, Salvador, BA, Brazil.
   [Carvalho, Tereza C. X.; Figueiredo, Eduardo M.; Biron, Ana Carolina; Pessoa, Rosana; Souza, Gloryane B.; Calcagno, Juan, I] Jose Maria de Magalhaes Netto Matern Hosp, Salvador, BA, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz C. J.] Fiocruz MS, Flavivirus Lab, Oswald Cruz Inst, Rio De Janeiro, RJ, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz C. J.] Univ Fed Minas Gerais, ICB, Cell & Mol Genet Lab, Belo Horizonte, MG, Brazil.
   [Duarte, Alan O.; Lima, Fernanda W. M.] Univ Fed Bahia, Fac Pharm, Immunol Infect Dis Lab, Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
EM isadora.siqueira@fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016; Giovanetti,
   Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Alcantara,
   Luiz/0000-0002-6769-9931
FU HRP Alliance, part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization; National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq) [425380/2016, 440685/2016-8, 443875/2018];
   Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES [88887.130716/2016-00, 88881.130825/2016-00]
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation.
   Financial support was also provided by the National Council for
   Scientific and Technological Development (CNPq) (425380/2016,
   440685/2016-8, and 443875/2018) and by Coordination for the Improvement
   of Higher Education Personnel (CAPES) (88887.130716/2016-00 and
   88881.130825/2016-00). The authors are grateful to the physicians and
   nurses charged with the patients' clinical care and would also like to
   thank the Arboviral Diseases Branch Diagnostic and Reference Team
   (Vector-Borne Diseases Division of the Centers for Disease Control and
   Prevention) for kindly providing the reagents necessary for MAC-ELISA
   serological testing. Andris K. Walter provided English language revision
   and manuscript copyediting assistance.
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carvalho AL, 2019, CLIN MICROBIOL INFEC, V25, P524, DOI 10.1016/j.cmi.2018.12.021
   Centers for Disease Control and Prevention C, 2018, ZIK MAC ELISA INSTR, P101
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Onis M, 1996, ZIK MAC ELISA INSTR, V64, P650
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Giovanetti M, 2018, CLIN MICROBIOL INFEC, V24, P1111, DOI 10.1016/j.cmi.2018.06.008
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministry of Health, 2015, SURV RESP PROT OCC M
   Ministry of Health, 2016, EP B MON MICR CAS BR, V47
   Ministry of Health, 2018, EP B INT MON GROWTH, V49
   Ministry of Health, 2017, INT SURV HLTH CAR GU, P158
   Ministry of Health, 2015, PROT VIG RESP OC MIC, P55
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2015, EP AL INCR MICR NE B
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 26
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 9
EP 14
DI 10.1002/ijgo.13042
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700003
PM 31975394
OA Other Gold, Green Published
DA 2020-11-24
ER

PT J
AU Maia, ZPG
   Pereira, FM
   Said, RFD
   Fonseca, V
   Graf, T
   Nogueira, FD
   Nardy, VB
   Xavier, J
   Maia, ML
   Abreu, AL
   de Albuquerque, CFC
   Oliveira, WK
   Croda, J
   de Filippis, AMB
   Cunha, RV
   Lourenco, J
   de Oliveira, T
   Faria, NR
   Alcantara, LCJ
   Giovanetti, M
AF Pereira Gusmao Maia, Zuinara
   Mota Pereira, Felicidade
   do Carmo Said, Rodrigo Fabiano
   Fonseca, Vagner
   Graef, Tiago
   de Bruycker Nogueira, Fernanda
   Brandao Nardy, Vanessa
   Xavier, Joilson
   Lima Maia, Maricelia
   Abreu, Andre L.
   Campelo de Albuquerque, Carlos F.
   Kleber Oliveira, Wanderson
   Croda, Julio
   de Filippis, Ana Maria Bispo
   Venancio Cunha, Rivaldo
   Lourenco, Jose
   de Oliveira, Tulio
   Faria, Nuno Rodrigues
   Junior Alcantara, Luiz Carlos
   Giovanetti, Marta
TI Return of the founder Chikungunya virus to its place of introduction
   into Brazil is revealed by genomic characterization of exanthematic
   disease cases
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Chikungunya; East-Central-South-African genotype; Northeast Brazil;
   surveillance; portable genome sequencing
ID ZIKA
AB Between June 2017 and August 2018, several municipalities located in Bahia state (Brazil) reported a large increase in the number of patients presenting with febrile illness similar to that of arboviral infections. Using a combination of portable whole genome sequencing, molecular clock and epidemiological analyses, we revealed the return of the CHIKV-ECSA genotype into Bahia. Our results show local persistence of lineages in some municipalities and the re-introduction of new epidemiological strains from different Brazilian regions, highlighting a complex dynamic of transmission between epidemic seasons and sampled locations. Estimated climate-driven transmission potential of CHIKV remained at similar levels throughout the years, such that large reductions in the total number of confirmed cases suggests a slow, but gradual accumulation of herd-immunity over the 4 years of the epidemic in Bahia after its introduction in 2014. Bahia remains a reservoir of the genetic diversity of CHIKV in the Americas, and genomic surveillance strategies are essential to assist in monitoring and understanding arboviral transmission and persistence both locally and over large distances.
C1 [Pereira Gusmao Maia, Zuinara; Mota Pereira, Felicidade; Brandao Nardy, Vanessa] Dept Virol, Lab Cent Saude Publ, Salvador, BH, Brazil.
   [do Carmo Said, Rodrigo Fabiano; Giovanetti, Marta] Univ Fed Minas Gerais, Inst Ciencias Biol, Coordenacao Geral Vigilancia Arboviroses CGARB, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Graef, Tiago] Fiocruz MS, Lab Patol Expt, Inst Goncalo Moniz, Salvador, BH, Brazil.
   [de Bruycker Nogueira, Fernanda; de Filippis, Ana Maria Bispo; Junior Alcantara, Luiz Carlos; Giovanetti, Marta] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Lima Maia, Maricelia] Univ Estadual Feira de Santana, Feira De Santana, BA, Brazil.
   [Lima Maia, Maricelia] Secretaria Saude Feira de Santana, Feira De Santana, BA, Brazil.
   [Abreu, Andre L.] Minist Saude, Secretaria Vigilancia Saude, Coordenacao Geral Lab Saude Publ, CGLAB SVS MS, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] Org Mundial Saude, Org Panamer Saude, Brasilia, DF, Brazil.
   [Kleber Oliveira, Wanderson] Minist Saude SVS MS, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Croda, Julio] Minist Saude DEVIT SVS MS, Secretaria Vigilancia Saude, Dept Vigilancia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Venancio Cunha, Rivaldo] Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil.
   [Venancio Cunha, Rivaldo] Fundacao Oswaldo Cruz, Coordinat Hlth Surveillance & Reference Labs, Rio De Janeiro, RJ, Brazil.
   [Lourenco, Jose; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
RP Giovanetti, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Coordenacao Geral Vigilancia Arboviroses CGARB, Belo Horizonte, MG, Brazil.; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.; Alcantara, LC; Giovanetti, M (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
EM luiz.alcantara@ioc.fiocruz.br; giovanetti.marta@gmail.com
RI Faria, Nuno R/I-2975-2012; Giovanetti, Marta/AAK-7408-2020; Maia,
   Zuinara Pereira Gusmao/AAA-6737-2020; Fonseca, Vagner/R-5813-2019; Graf,
   Tiago/S-8535-2019; Maia, Zuinara/M-7713-2019
OI Faria, Nuno R/0000-0001-8839-2798; Maia, Zuinara Pereira
   Gusmao/0000-0003-0224-4335; Fonseca, Vagner/0000-0001-5521-6448; Graf,
   Tiago/0000-0003-4921-7975; Xavier, Joilson/0000-0003-3916-2018;
   Alcantara, Luiz/0000-0002-6769-9931
FU ZiBRA2 project - Brazilian Ministry of Health (SVS-MS); Pan American
   Organization (OPAS); CNPqNational Council for Scientific and
   Technological Development (CNPq) [440685/2016-8, 440856/2016-7];
   CAPESCAPES [88887.130716/2016-00, 88881.130825/2016-00,
   88887.130823/2016-00]; Horizon 2020 Framework Programme
   [PRES-005-FEX-17-4-2-33]; Faperj (Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/2002.930/2016]; International Development Research Centre (IDRC)
   Canada [108411-001]; EU's Horizon 2020 Framework Programme through
   ZikaPlan [734584, 734857]; EU's Horizon 2020 Framework Programme through
   ZikAction [734584, 734857]; Department of Zoology, University of Oxford;
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
FX This work was supported by the ZiBRA2 project, supported by the
   Brazilian Ministry of Health (SVS-MS) and the Pan American Organization
   (OPAS) and founded by CNPq [grant number 440685/2016-8 and
   440856/2016-7]; by CAPES [grant number 88887.130716/2016-00,
   88881.130825/2016-00 and 88887.130823/2016-00]; by Horizon 2020
   Framework Programme [grant number PRES-005-FEX-17-4-2-33]. The
   Flavivirus Laboratory activities were also supported by Faperj (Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)
   under the [grant number E-26/2002.930/2016], by the International
   Development Research Centre (IDRC) Canada over the [grant number
   108411-001] and EU's Horizon 2020 Framework Programme through ZikaPlan
   and ZikAction under the [grant number 734584 and 734857]. JL was
   supported by a lectureship from the Department of Zoology, University of
   Oxford. MG is supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro - FAPERJ; Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior.
CR Brasil, 2019, B EPIDEMIOLOGICO MON
   Fonseca V, 2019, PLOS NEGLECT TROP D, V8, P13
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lourenco J, 2017, ELIFE, V9, P6
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Naveca FG, 2019, PLOS NEGLECT TROP D, V7, P13
   Obolski U., 2019, METHODS ECOL EVOL, V1, P1
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Xavier J, 2019, PLOS ONE, V11, P14
NR 14
TC 0
Z9 1
U1 1
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 53
EP 57
DI 10.1080/22221751.2019.1701954
PG 5
WC Immunology; Microbiology
SC Immunology; Microbiology
GA JZ6DG
UT WOS:000505191100001
PM 31880218
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Giovanetti, M
   de Mendonca, MCL
   Fonseca, V
   Mares-Guia, MA
   Fabri, A
   Xavier, J
   de Jesus, JG
   Graf, T
   Rodrigues, CDD
   dos Santos, CC
   Sampaio, SA
   Chalhoub, FLL
   Nogueira, FD
   Theze, J
   Romano, APM
   Ramos, DG
   de Abreu, AL
   Oliveira, WK
   Said, RFD
   de Alburque, CFC
   de Oliveira, T
   Fernandes, CA
   Aguiar, SF
   Chieppe, A
   Sequeira, PC
   Faria, NR
   Cunha, RV
   Alcantara, LCJ
   de Filippis, AMB
AF Giovanetti, Marta
   Lima de Mendonca, Marcos Cesar
   Fonseca, Vagner
   Mares-Guia, Maria Angelica
   Fabri, Allison
   Xavier, Joilson
   de Jesus, Jaqueline Goes
   Graf, Tiago
   dos Santos Rodrigues, Cintia Damasceno
   dos Santos, Carolina Cardoso
   Sampaio, Simone Alves
   Levy Chalhoub, Flavia Lowen
   Nogueira, Fernanda de Bruycker
   Theze, Julien
   Martins Romano, Alessandro Pecego
   Ramos, Daniel Garkauskas
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   do Carmo Said, Rodrigo Fabiano
   Campelo de Alburque, Carlos F.
   de Oliveira, Tulio
   Fernandes, Carlos Augusto
   Aguiar, Shirlei Ferreira
   Chieppe, Alexandre
   Sequeira, Patricia Carvalho
   Faria, Nuno Rodrigues
   Cunha, Rivaldo Venancio
   Junior Alcantara, Luiz Carlos
   Bispo de Filippis, Ana Maria
TI Yellow Fever Virus Reemergence and Spread in Southeast Brazil, 2016-2019
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE yellow fever; outbreak; Southeast Brazil; genomic surveillance; outbreak
   response
ID PHYLOGENETIC ANALYSIS; DENGUE; ZIKA
AB The recent reemergence of yellow fever virus (YFV) in Brazil has raised serious concerns due to the rapid dissemination of the virus in the southeastern region. To better understand YFV genetic diversity and dynamics during the recent outbreak in southeastern Brazil, we generated 18 complete and nearly complete genomes from the peak of the epidemic curve from nonhuman primates (NHPs) and human infected cases across the Espirito Santo and Rio de Janeiro states. Genomic sequencing of 18 YFV genomes revealed the estimated timing, source, and likely routes of yellow fever virus transmission and dispersion during one of the largest outbreaks ever registered in Brazil. We showed that during the recent epidemic, YFV was reintroduced from Minas Gerais to the Espirito Santo and Rio de Janeiro states multiple times between 2016 and 2019. The analysis of data from portable sequencing could identify the corridor of spread of YFV. These findings reinforce the idea that continued genomic surveillance strategies can provide information on virus genetic diversity and transmission dynamics that might assist in understanding arbovirus epidemics.
   IMPORTANCE Arbovirus infections in Brazil, including yellow fever, dengue, zika, and chikungunya, result in considerable morbidity and mortality and are pressing public health concerns. However, our understanding of these outbreaks is hampered by the limited availability of genomic data. In this study, we investigated the genetic diversity and spatial distribution of YFV during the current outbreak by analyzing genomic data from areas in southeastern Brazil not covered by other previous studies. To gain insights into the routes of YFV introduction and dispersion, we tracked the virus by sequencing YFV genomes sampled from nonhuman primates and infected patients from the southeastern region. Our study provides an understanding of how YFV initiates transmission in new Brazilian regions and illustrates that genomics in the field can augment traditional approaches to infectious disease surveillance and control.
C1 [Giovanetti, Marta; Lima de Mendonca, Marcos Cesar; Mares-Guia, Maria Angelica; Fabri, Allison; dos Santos Rodrigues, Cintia Damasceno; dos Santos, Carolina Cardoso; Sampaio, Simone Alves; Levy Chalhoub, Flavia Lowen; Nogueira, Fernanda de Bruycker; Sequeira, Patricia Carvalho; Junior Alcantara, Luiz Carlos; Bispo de Filippis, Ana Maria] Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Fonseca, Vagner; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [de Jesus, Jaqueline Goes; Graf, Tiago] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
   [Theze, Julien] Univ Oxford, Dept Zool, Oxford, England.
   [Martins Romano, Alessandro Pecego; Ramos, Daniel Garkauskas] Minist Saude, Coordenacao Geral Vigilancia Arboviroses CGARB, CGLAB SVS MS, Brasilia, DF, Brazil.
   [de Abreu, Andre Luiz] Minist Saude, Coordenacao Geral Lab Saude Publ, Secretaria Vigilancia Saude, Minist Saude,CGLAB SVS MS, Brasilia, DF, Brazil.
   [Oliveira, Wanderson Kleber] Minist Saude, SVS, Brasilia, DF, Brazil.
   [Campelo de Alburque, Carlos F.] Lab Cent Saude Publ Noel Nutels LACEN RJ, Rio De Janeiro, Brazil.
   [Fernandes, Carlos Augusto] Superintendencia Vigilancia Estado, Rio De Janeiro, Brazil.
   [Chieppe, Alexandre] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Cunha, Rivaldo Venancio] Univ Fed Mato Grosso, Fac Med, Campo Grande, MS, Brazil.
RP Giovanetti, M (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Giovanetti, M (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.
EM giovanetti.marta@gmail.com
RI Faria, Nuno R/I-2975-2012; Graf, Tiago/S-8535-2019; Giovanetti,
   Marta/AAK-7408-2020; Fonseca, Vagner/R-5813-2019
OI Faria, Nuno R/0000-0001-8839-2798; Graf, Tiago/0000-0003-4921-7975;
   Fonseca, Vagner/0000-0001-5521-6448; Theze, Julien/0000-0001-8188-9494;
   Xavier, Joilson/0000-0003-3916-2018; Alcantara,
   Luiz/0000-0002-6769-9931; Garkauskas Ramos, Daniel/0000-0002-7404-2209
FU ZiBRA2 project - Brazilian Ministry of Health (SVS-MS); Pan American
   Organization (OPAS); CNPqNational Council for Scientific and
   Technological Development (CNPq) [440685/2016-8, 440856/2016-7];
   CAPESCAPES [88887.130716/2016-00, 88881.130825/2016-00,
   88887.130823/2016-00]; EU's Horizon 2020 program through ZIKAlliance
   [PRES-005-FEX-17-4-2-33]; Faperj (Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/2002.930/2016]; International Development Research Centre (IDRC)
   Canada [108411-001]; Horizon 2020 through ZikaPlan [734584, 734857];
   Horizon 2020 through ZikAction [734584, 734857]; Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX We thank all personnel from Health Surveillance System in Rio de Janeiro
   that coordinated surveillance and helped with data collection and
   assembly. We also thank Ronaldo Lapa e Solange Regina Conceicao from the
   Instituto Oswaldo Cruz (Fiocruz, Rio de Janeiro) for their support.;
   This work was supported by the ZiBRA2 project supported by the Brazilian
   Ministry of Health (SVS-MS) and the Pan American Organization (OPAS) and
   founded by Decit/SCTIE/MoH and CNPq (440685/2016-8 and 440856/2016-7);
   by CAPES (88887.130716/2016-00, 88881.130825/2016-00, and
   88887.130823/2016-00); and by EU's Horizon 2020 program through
   ZIKAlliance (PRES-005-FEX-17-4-2-33). The Flavivirus Laboratory
   activities was also supported by Faperj (Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro) under grant number
   E-26/2002.930/2016, by the International Development Research Centre
   (IDRC) Canada over the grant 108411-001 and Horizon 2020 through
   ZikaPlan and ZikAction under the grant's agreement numbers 734584 and
   734857. M.G. is supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ).
CR Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Brazilian Ministry of Health, 2017, EP UPD YELL FEV
   Brazilian Ministry of Health, 2018, EP UPD YELL FEV
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   CHANG GJJ, 1995, J VIROL, V69, P5773, DOI 10.1128/JVI.69.9.5773-5780.1995
   Cunha MS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41950-3
   de Souza R. P., 2019, BIORXIV, DOI [10.1101/645341, DOI 10.1101/645341]
   Degallier Nicolas, 1992, Ciencia e Cultura (Sao Paulo), V44, P143
   Delatorre E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01079
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Giovanetti M, 2019, BIORXIV, DOI [10.1101/711994, DOI 10.1101/711994]
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Mondet B, 1996, B SOC PATHOL EXOT, V89, P107
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Ribeiro AF, 2019, AM J TROP MED HYG, V101, P180, DOI 10.4269/ajtmh.18-0882
   de Abreu FVS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190076
   Secretaria de Vigilancia em Saude, 2019, MON PER SAZ FEBR AM
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Souza Renato Pereira de, 2011, Rev. Inst. Med. trop. S. Paulo, V53, P133, DOI 10.1590/S0036-46652011000300004
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
NR 36
TC 4
Z9 4
U1 4
U2 15
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2020
VL 94
IS 1
AR e01623-19
DI 10.1128/JVI.01623-19
PG 12
WC Virology
SC Virology
GA JX6LP
UT WOS:000503844300009
PM 31597773
OA Green Published, Bronze
DA 2020-11-24
ER

PT J
AU Giovanetti, M
   de Jesus, JG
   Joshua, Q
   Claro, IM
   Xavier, J
   Hill, SC
   Renato, S
   Paz, P
   Lourenco, J
   Dellicour, S
   Sabino, E
   Loman, NJ
   Naveca, F
   Pybus, OG
   Faria, NR
   Alcantara, LCJ
AF Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Joshua, Quick
   Claro, Ingra Morales
   Xavier Junior, Joilson
   Hill, Sarah C.
   Renato, Souza
   Paz, Paola
   Lourenco, Jose
   Dellicour, Simon
   Sabino, Esther
   Loman, Nicholas J.
   Naveca, Felipe
   Pybus, Oliver G.
   Faria, Nuno Rodrigues
   Junior Alcantara, Luiz Carlos
TI Genomic surveillance of Zika virus transmission in the Amazonas State,
   Brazil
SO VIRUS EVOLUTION
LA English
DT Meeting Abstract
C1 [Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier Junior, Joilson; Junior Alcantara, Luiz Carlos] Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Joshua, Quick; Loman, Nicholas J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Claro, Ingra Morales; Sabino, Esther] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Hill, Sarah C.; Lourenco, Jose; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Renato, Souza; Paz, Paola] Univ Fed Rio de Janeiro, Inst Pasteur, Lab Clin & Epidemiol Virol, Rio De Janeiro, Brazil.
   [Dellicour, Simon] Univ Leuven, KU Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium.
   [Naveca, Felipe] Fiocruz MS, Fundacao Oswaldo Cruz, Manaus, Amazonas, Brazil.
RI Giovanetti, Marta/AAK-7408-2020; Dellicour, Simon/AAE-9054-2020; Faria,
   Nuno R/I-2975-2012; Pybus, Oliver G/B-2640-2012
OI Dellicour, Simon/0000-0001-9558-1052; Faria, Nuno R/0000-0001-8839-2798;
   Pybus, Oliver G/0000-0002-8797-2667
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD AUG
PY 2019
VL 5
SU 1
MA A32
BP S10
EP S10
DI 10.1093/ve/vez002.031
PG 1
WC Virology
SC Virology
GA JX6ZN
UT WOS:000503880600033
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU De Jesus, JG
   Giovanetti, M
   Faria, NR
   Alcantara, LC
AF De Jesus, Jaqueline Goes
   Giovanetti, Marta
   Faria, Nuno Rodrigues
   Alcantara, Luiz Carlos Junior
TI Acute Vector-Borne Viral Infection:Zika and MinION Surveillance
SO MICROBIOLOGY SPECTRUM
LA English
DT Article
ID ZIKA VIRUS-INFECTIONS; YELLOW-FEVER; ARBOVIRUS INFECTIONS;
   NUCLEOTIDE-SEQUENCE; EPIDEMIC; OUTBREAK; TRANSMISSION; CHIKUNGUNYA;
   ANTIBODIES; MOSQUITOS
AB The MinION sequencer was launched by the Oxford Nanopore Technologies start-up as a disruptive technology for genome sequencing based on single-molecule synthesis. Its characteristics as a portable device, low cost, and simple library preparation have made it a good candidate for field researchers. MinION has been used to sequence a number of microorganisms, such as bacteria, viruses, and fungi. Based on the experience that characterized the Ebola virus genetic diversity in Guinea during the 2014-2015 outbreak, the ZiBRA (Zika in Brazil Real-time Analysis) project aimed to sequence a large number of Zika virus genomes during a mobile laboratory trip in northeast Brazil to provide important epidemiological information about the spread of this disease in this country. In response to the positive and rapid results obtained by the ZiBRA project, the Brazilian Ministry of Health and many leading institutions, such as the Pan American Health Organization and WHO, have shown interest in expanding the strategy used in this project to other countries dealing with arbovirus infection.
C1 [De Jesus, Jaqueline Goes] Fundacao Oswaldo Cruz, Lab Expt Pathol, Goncalo Moniz Inst, BR-40296710 Salvador, BA, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz Carlos Junior] Fundacao Oswaldo Cruz, Lab Flaviviruses, Oswaldo Cruz Inst, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz Carlos Junior] Univ Fed Minas Gerais, Lab Cellular & Mol Genet, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3SZ, England.
RP Alcantara, LC (corresponding author), Fundacao Oswaldo Cruz, Lab Flaviviruses, Oswaldo Cruz Inst, BR-21040900 Rio De Janeiro, RJ, Brazil.; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Lab Cellular & Mol Genet, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
EM alcantaraluiz42@gmail.com
RI Giovanetti, Marta/AAK-7408-2020; Faria, Nuno R/I-2975-2012
OI Faria, Nuno R/0000-0001-8839-2798; Alcantara, Luiz/0000-0002-6769-9931
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Ambardar S, 2016, INDIAN J MICROBIOL, V56, P394, DOI 10.1007/s12088-016-0606-4
   Antwerpen MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123298
   Balasubramanian S, 2011, CHEM COMMUN, V47, P7281, DOI 10.1039/c1cc11078k
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOWEN ETW, 1973, T ROY SOC TROP MED H, V67, P702, DOI 10.1016/0035-9203(73)90041-2
   BRASIL Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V21, P27
   BRASIL Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V6, P47
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FIERS W, 1976, NATURE, V260, P500, DOI 10.1038/260500a0
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Heather JM, 2016, GENOMICS, V107, P1, DOI 10.1016/j.ygeno.2015.11.003
   HOLLEY RW, 1965, SCIENCE, V147, P1462, DOI 10.1126/science.147.3664.1462
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P553, DOI 10.1016/0035-9203(65)90158-6
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laver T, 2015, Biomol Detect Quantif, V3, P1
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700
   Lu HY, 2016, GENOM PROTEOM BIOINF, V14, P265, DOI 10.1016/j.gpb.2016.05.004
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P192, DOI 10.1016/0035-9203(61)90025-6
   Meinel DM, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.08.010
   Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751
   Mikheyev AS, 2014, MOL ECOL RESOUR, V14, P1097, DOI 10.1111/1755-0998.12324
   Min Jou W, 1972, Nature, V237, P82
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nilakanta Haema, 2014, BMC Res Notes, V7, P830, DOI 10.1186/1756-0500-7-830
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003
   Plesivkova D, 2019, WIRES FORENSIC SCI, V1, pe1323, DOI [10.1002/wfs2.1323, DOI 10.1002/wfs2.1323]
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0
   SANGER F., 1965, J MOL BIOL, V13, P373
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P376
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   Vogel G, 2016, SCIENCE, V352, P1152, DOI 10.1126/science.352.6290.1152
   Walter MC, 2017, J BIOTECHNOL, V250, P16, DOI 10.1016/j.jbiotec.2016.12.006
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Webb JLA, 2016, LANCET, V388, P556, DOI 10.1016/S0140-6736(16)31225-9
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO World Health Organization, 2016, ZIK VIR MICR GUILL B
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, WHO DIRECTOR GENERAL
   WU R, 1968, J MOL BIOL, V35, P523, DOI 10.1016/S0022-2836(68)80012-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 80
TC 2
Z9 2
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2165-0497
J9 MICROBIOL SPECTR
JI Microbiol. Spectr.
PD JUL
PY 2019
VL 7
IS 4
AR AME-0008-2019
DI 10.1128/microbiolspec.AME-0008-2019
PG 11
WC Microbiology
SC Microbiology
GA IT2VO
UT WOS:000482711900003
PM 31400093
DA 2020-11-24
ER

PT J
AU Xavier, J
   Giovanetti, M
   Fonseca, V
   Theze, J
   Graf, T
   Fabri, A
   de Jesus, JG
   de Mendonca, MCL
   Rodrigues, CDD
   Mares-Guia, MA
   dos Santos, CC
   Tosta, SFD
   Candido, D
   Nogueira, RMR
   de Abreu, AL
   Oliveira, WK
   de Albuquerque, CFC
   Chieppe, A
   de Oliveira, T
   Brasil, P
   Calvet, G
   Sequeira, PC
   Faria, NR
   de Filippis, AMB
   Alcantara, LCJ
AF Xavier, Joilson
   Giovanetti, Marta
   Fonseca, Vagner
   Theze, Julien
   Graf, Tiago
   Fabri, Allison
   de Jesus, Jaqueline Goes
   Lima de Mendonca, Marcos Cesar
   dos Santos Rodrigues, Cintia Damasceno
   Mares-Guia, Maria Angelica
   dos Santos, Carolina Cardoso
   de Oliveira Tosta, Stephane Fraga
   Candido, Darlan
   Ribeiro Nogueira, Rita Maria
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   Campelo de Albuquerque, Carlos F.
   Chieppe, Alexandre
   de Oliveira, Tulio
   Brasil, Patricia
   Calvet, Guilherme
   Sequeira, Patricia Carvalho
   Faria, Nuno Rodrigues
   Bispo de Filippis, Ana Maria
   Junior Alcantara, Luiz Carlos
TI Circulation of chikungunya virus East/Central/South African lineage in
   Rio de Janeiro, Brazil
SO PLOS ONE
LA English
DT Article
ID TRANSMISSION; POPULATION; MODEL; ZIKA
AB The emergence of chikungunya virus (CHIKV) has raised serious concerns due to the virus' rapid dissemination into new geographic areas and the clinical features associated with infection. To better understand CHIKV dynamics in Rio de Janeiro, we generated 11 near-complete genomes by means of real-time portable nanopore sequencing of virus isolates obtained directly from clinical samples. To better understand CHIKV dynamics in Rio de Janeiro, we generated 11 near-complete genomes by means of real-time portable nanopore sequencing of virus isolates obtained directly from clinical samples. Our phylogenetic reconstructions indicated the circulation of the East-Central-South-African (ECSA) lineage in Rio de Janeiro. Time-measured phylogenetic analysis combined with CHIKV notified case numbers revealed the ECSA lineage was introduced in Rio de Janeiro around June 2015 (95% Bayesian credible interval: May to July 2015) indicating the virus was circulating unnoticed for 5 months before the first reports of CHIKV autochthonous transmissions in Rio de Janeiro, in November 2015. These findings reinforce that continued genomic surveillance strategies are needed to assist in the monitoring and understanding of arbovirus epidemics, which might help to attenuate public health impact of infectious diseases.
C1 [Xavier, Joilson; de Jesus, Jaqueline Goes] Fiocruz MS, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Xavier, Joilson; Giovanetti, Marta; Fabri, Allison; Lima de Mendonca, Marcos Cesar; dos Santos Rodrigues, Cintia Damasceno; Mares-Guia, Maria Angelica; dos Santos, Carolina Cardoso; Ribeiro Nogueira, Rita Maria; Sequeira, Patricia Carvalho; Bispo de Filippis, Ana Maria; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Fonseca, Vagner; de Oliveira Tosta, Stephane Fraga; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Theze, Julien; Candido, Darlan; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Graf, Tiago; Fabri, Allison] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [de Abreu, Andre Luiz; Oliveira, Wanderson Kleber] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] Org Mundial Saude, Org Panamer Saude, Brasilia, DF, Brazil.
   [Chieppe, Alexandre] Superintendencia Vigilancia Estado, Rio De Janeiro, Brazil.
   [Brasil, Patricia; Calvet, Guilherme] Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP de Filippis, AMB; Alcantara, LC (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
EM abispo@ioc.fiocruz.br; luiz.alcantara@ioc.fiocruz.br
RI Oliveira, Wanderson/AAF-5182-2019; Giovanetti, Marta/AAK-7408-2020;
   Fonseca, Vagner/R-5813-2019; Calvet, GA/G-6959-2013; Faria, Nuno
   R/I-2975-2012; Graf, Tiago/S-8535-2019
OI Oliveira, Wanderson/0000-0002-9662-1930; Fonseca,
   Vagner/0000-0001-5521-6448; Calvet, GA/0000-0002-3545-5238; Faria, Nuno
   R/0000-0001-8839-2798; Graf, Tiago/0000-0003-4921-7975; De Jesus,
   Jaqueline/0000-0002-5404-272X; Theze, Julien/0000-0001-8188-9494;
   Xavier, Joilson/0000-0003-3916-2018; Alcantara, Luiz/0000-0002-6769-9931
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440685/2016-8]; CAPESCAPES [88887.130716/2016-00]; Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro /FaperjCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.930/2016]; Coordenacao de Vigilancia em Saude e Laboratorios
   de Referencia da Fundacao Oswaldo Cruz
FX This research was funded by CNPq grant number (440685/2016-8); CAPES
   grant number (88887.130716/2016-00). Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro /Faperj over the grant number E-26/202.930/2016
   and by the Coordenacao de Vigilancia em Saude e Laboratorios de
   Referencia da Fundacao Oswaldo Cruz.
CR Bastos MLA, 2018, BRAZ J INFECT DIS, V22, P248, DOI 10.1016/j.bjid.2018.05.002
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Brasil, 2018, B EP MON CAS DENG FE
   Brasil, 2016, B EP ARB CEN EP DENG
   Brasil, 2019, B EP MON CAS DENG FE
   Brasil, 2015, B EP MON CAS DED FEB
   Brasil. Boletim Epidemiologico, 2017, B EP MON CAS DENG FE
   de Albuquerque IGC, 2012, REV SOC BRAS MED TRO, V45, P128, DOI 10.1590/S0037-86822012000100026
   Collado D, 2018, J VIROL
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860019, 10.1590/s1678-9946201860019]
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Katoh K, 2017, BRIEF BIOINFORM
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lessa-Aquino C, 2018, EPIDEMIOL INFECT, V146, P2056, DOI 10.1017/S0950268818002467
   Mascarenhas M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207554
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   PAHO/WHO, 2017, NUM CAS REP CHIK PAI
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Powers AM, 2011, EXP BIOL MED, V236, P909, DOI 10.1258/ebm.2011.011078
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262
   Souza TML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39406-9
   Souza TMA, 2017, PLOS CURR, V9
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 46
TC 4
Z9 4
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 11
PY 2019
VL 14
IS 6
AR e0217871
DI 10.1371/journal.pone.0217871
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IC4XB
UT WOS:000470970000023
PM 31185030
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Fonseca, V
   Libin, PJK
   Theys, K
   Faria, NR
   Nunes, MRT
   Restovic, MI
   Freire, M
   Giovanetti, M
   Cuypers, L
   Nowe, A
   Abecasis, A
   Deforche, K
   Santiago, GA
   de Siqueira, IC
   San, EJ
   Machado, KCB
   Azevedo, V
   Bispo-de Filippis, AM
   da Cunha, RV
   Pybus, OG
   Vandamme, AM
   Alcantara, LCJ
   de Oliveira, T
AF Fonseca, Vagner
   Libin, Pieter J. K.
   Theys, Kristof
   Faria, Nuno R.
   Nunes, Marcio R. T.
   Restovic, Maria I.
   Freire, Murilo
   Giovanetti, Marta
   Cuypers, Lize
   Nowe, Ann
   Abecasis, Ana
   Deforche, Koen
   Santiago, Gilberto A.
   de Siqueira, Isadora C.
   San, Emmanuel J.
   Machado, Kaliane C. B.
   Azevedo, Vasco
   Bispo-de Filippis, Ana Maria
   da Cunha, Rivaldo Venancio
   Pybus, Oliver G.
   Vandamme, Anne-Mieke
   Alcantara, Luiz C. J.
   de Oliveira, Tulio
TI A computational method for the identification of Dengue, Zika and
   Chikungunya virus species and genotypes
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MOLECULAR EPIDEMIOLOGY; LARGE PHYLOGENIES; PERFORMANCE; ACCURATE;
   BURDEN; SYSTEM; HIV-1
AB In recent years, an increasing number of outbreaks of Dengue, Chikungunya and Zika viruses have been reported in Asia and the Americas. Monitoring virus genotype diversity is crucial to understand the emergence and spread of outbreaks, both aspects that are vital to develop effective prevention and treatment strategies. Hence, we developed an efficient method to classify virus sequences with respect to their species and sub-species (i.e. serotype and/or genotype). This tool provides an easy-to-use software implementation of this new method and was validated on a large dataset assessing the classification performance with respect to whole-genome sequences and partial-genome sequences. Available online: http://krisp.org.za/tools.php.
   Author summary Dengue (DENV), Chikungunya (CHIKV) and Zika (ZIKV) are considered major public health challenges. In addition to the epidemic caused by DENV, which has been described in many tropical countries, the introduction of CHIKV and ZIKV in these countries is a major public health concern. These arboviruses are primarily transmitted by mosquitoes of the species Ae. Aegypti and its related diseases result in increased financial costs associated with diagnosis and treatment. To support the design of efficient diagnosis, prevention and treatment strategies, a bioinformatics tool has been developed for the genotyping of these viruses based on appropriate evolutionary models in an automatic, accurate and rapid manner. A set of virus reference sequences was obtained from GenBank and used for the development of the tools. This process involved the alignment of the reference sequences followed by phylogenetic tree reconstructions. To assign the genotypes uploaded by the user, the tool analyses the sequences one by one, genotypes through identification, alignment and phylogenetic reconstruction. This computational method allows the high-throughput classification of these virus species and genotypes in seconds. As shown experimentally, genotypes are classified most confidently using the envelope gene or complete genome sequences.
C1 [Fonseca, Vagner; Giovanetti, Marta; Bispo-de Filippis, Ana Maria; Alcantara, Luiz C. J.] Fundacao Oswaldo Cruz, IOC, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Fonseca, Vagner; San, Emmanuel J.; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Fonseca, Vagner; Azevedo, Vasco; Alcantara, Luiz C. J.] Univ Fed Minas Gerais, ICB, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Libin, Pieter J. K.; Nowe, Ann] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Lab, Brussels, Belgium.
   [Libin, Pieter J. K.; Theys, Kristof; Cuypers, Lize; Vandamme, Anne-Mieke] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium.
   [Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Restovic, Maria I.; Freire, Murilo; de Siqueira, Isadora C.; Machado, Kaliane C. B.] Fundacao Oswaldo Cruz, Lab Patol Expt, Salvador, BA, Brazil.
   [Abecasis, Ana; Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol, Ctr Global Hlth & Trop Med, Lisbon, Portugal.
   [Deforche, Koen] EMWEB Private Co, Herent, Belgium.
   [Santiago, Gilberto A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [da Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Coordenacao Vigilancia Saude & Lab Referencias, Rio De Janeiro, Brazil.
RP Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, IOC, Lab Flavivirus, Rio De Janeiro, Brazil.; de Oliveira, T (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, ICB, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
EM alcantaraluiz42@gmail.com; tuliodna@gmail.com
RI Pybus, Oliver G/B-2640-2012; de Siqueira, Isadora Cristina/R-9953-2016;
   Giovanetti, Marta/AAK-7408-2020; Faria, Nuno R/I-2975-2012; Fonseca,
   Vagner/R-5813-2019; Azevedo, Vasco A/B-1556-2019; Abecasis,
   Ana/B-6295-2009
OI Pybus, Oliver G/0000-0002-8797-2667; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Faria, Nuno R/0000-0001-8839-2798;
   Fonseca, Vagner/0000-0001-5521-6448; Azevedo, Vasco
   A/0000-0002-4775-2280; Alcantara, Luiz/0000-0002-6769-9931; Abecasis,
   Ana/0000-0002-3903-5265; Nowe, Ann/0000-0001-6346-4564
FU South African Medical Re-search Council [MRC-RFA-UFSP-01-2013/UKZN
   HIVEPI]; Royal Society Newton Advanced Fellowship; VIROGENESIS project -
   European Union's Horizon 2020 Research and Innovation Programme
   [634650]; National Institutes of Health Common FundUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U24HG006941]; FWO (Fonds Wetenschappelijk Onderzoek
   Vlaanderen)FWO; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440685/2016-8, 440856/2016-7]; CAPESCAPES
   [88887.130716/201600, 88881.130825/2016-00, 88887.130823/2016-00]; EU's
   Horizon 2020 Programme through ZIKAlliance [PRES-005-FEX-17-4-2-33];
   Fundacao para a Ciencia e Tecnologia (FCT)Portuguese Foundation for
   Science and Technology [GHTM-UID/Multi/04413/2013]; Decit/SCTIE/MoH;
   NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Human Genome Research Institute (NHGRI) [U24HG006941,
   U24HG006941, U24HG006941, U24HG006941, U24HG006941] Funding Source: NIH
   RePORTER
FX Supported by a research Flagship grant from the South African Medical
   Re-search Council (MRC-RFA-UFSP-01-2013/UKZN HIVEPI), a Royal Society
   Newton Advanced Fellowship (TdO), the VIROGENESIS project receives
   funding from the European Union's Horizon 2020 Research and Innovation
   Programme (under Grant Agreement no. 634650) and the National Institutes
   of Health Common Fund, grant number U24HG006941. Pieter Libin was
   supported by a PhD grant of the FWO (Fonds Wetenschappelijk Onderzoek
   Vlaanderen). This work was supported by Decit/SCTIE/MoH and CNPq
   (440685/2016-8 and 440856/2016-7); by CAPES (88887.130716/201600,
   88881.130825/2016-00 and 88887.130823/2016-00); and by EU's Horizon 2020
   Programme through ZIKAlliance (PRES-005-FEX-17-4-2-33). Ana Abecasis was
   supported by Fundacao para a Ciencia e Tecnologia (FCT) through funds to
   GHTM-UID/Multi/04413/2013. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Altschul SF, 1990, BASIC LOCAL ALIGNMEN
   [Anonymous], 2018, STROKE, V49, pe233
   Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmicro1523, 10.1038/nrmico1523]
   Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkr1202]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CHUNGUE E, 1993, J GEN VIROL, V74, P2765, DOI 10.1099/0022-1317-74-12-2765
   Cuypers L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100569
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Ha Schmidt, 2002, BIOINFORMATICS, V18, P502, DOI [10.1093/bioinformatics/18.3.502, DOI 10.1093/BIOINFORMATICS/18.3.502]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.16.171082
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Libin P., 2018, BIOINFORMATICS OXFOR
   Libin P, 2017, BIOINFORMATICS, V33, P3993, DOI 10.1093/bioinformatics/btx535
   Libin P, 2013, BIOINFORMATICS, V29, P1477, DOI 10.1093/bioinformatics/btt162
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Morens DM, 2016, J INFECT DIS, V214, pS434, DOI 10.1093/infdis/jiw291
   Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388
   Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Salemi M., 2003, PHYLOGENETIC HDB PRA
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theys K, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006528
   Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447
   Vilsker M, 2019, BIOINFORMATICS, V35, P871, DOI 10.1093/bioinformatics/bty695
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 45
TC 6
Z9 6
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2019
VL 13
IS 5
AR e0007231
DI 10.1371/journal.pntd.0007231
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IB3ST
UT WOS:000470188100009
PM 31067235
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Queiroz, A
   Pinto, IFD
   Lima, M
   Giovanetti, M
   de Jesus, JG
   Xavier, J
   Barreto, FK
   Canuto, GAB
   do Amaral, HR
   de Filippis, AMB
   Mascarenhas, DL
   Falcao, MB
   Santos, NP
   Azevedo, VAD
   Yoshinaga, MY
   Miyamoto, S
   Alcantara, LC
AF Queiroz, Adriano
   Dantas Pinto, Isabella Fernanda
   Lima, Maricelia
   Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   Barreto, Fernanda Khouri
   Baptista Canuto, Gisele Andre
   do Amaral, Helineide Ramos
   Bispo de Filippis, Ana Maria
   Mascarenhas, Denise Lima
   Falcao, Melissa Barreto
   Santos, Normeide Pedreira
   de Carvalho Azevedo, Vasco Ariston
   Yoshinaga, Marcos Yukio
   Miyamoto, Sayuri
   Alcantara, Luiz Carlos Junior
TI Lipidomic Analysis Reveals Serum Alteration of Plasmalogens in Patients
   Infected With ZIKA Virus
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; serum lipidomics; plasmalogens; phosphatidylethanolamine;
   arbovirus
ID DENGUE VIRUS; REPLICATION; PHOSPHATIDYLSERINE; PEROXISOMES; MEMBRANES
AB Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) in the Flavivirus genus of the Flaviviridae family. Since the large outbreaks in French Polynesia in 2013-2014 and in Brazil in 2015, ZIKV has been considered a new public health threat. Similar to other related flavivirus, ZIKV is associated with mild and self-limiting symptoms such as rash, pruritus, prostration, headache, arthralgia, myalgia, conjunctivitis, lower back pain and, when present, a short-term low grade fever. In addition, ZIKV has been implicated in neurological complications such as neonatal microcephaly and Guillain-Barre syndrome in adults. Herein, serum lipidomic analysis was used to identify possible alterations in lipid metabolism triggered by ZIKV infection. Patients who presented virus-like symptoms such as fever, arthralgia, headache, exanthema, myalgia and pruritus were selected as the control group. Our study reveals increased levels of several phosphatidylethanolamine (PE) lipid species in the serum of ZIKV patients, the majority of them plasmenyl-phosphatidylethanolamine (pPE) (or plasmalogens) linked to polyunsaturated fatty acids. Constituting up to 20% of total phospholipids in humans, plasmalogens linked to polyunsaturated fatty acids are particularly enriched in neural membranes of the brain. The biosynthesis of plasmalogens requires functional peroxisomes, which are important sites for viral replication, including ZIKV. Thus, increased levels of plasmalogens in serum of ZIKV infected subjects suggest a link between ZIKV life cycle and peroxisomes. Our data provide important insights into specific host cellular lipids that are likely associated with ZIKV replication and may serve as platform for antiviral strategy against ZIKV.
C1 [Queiroz, Adriano; Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier, Joilson; Alcantara, Luiz Carlos Junior] Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Dantas Pinto, Isabella Fernanda; Yoshinaga, Marcos Yukio; Miyamoto, Sayuri] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.
   [Lima, Maricelia] Univ Estadual Feira de Santana, Dept Saude, Feira De Santana, Brazil.
   [Giovanetti, Marta; Bispo de Filippis, Ana Maria; Alcantara, Luiz Carlos Junior] Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Barreto, Fernanda Khouri] Univ Fed Bahia, Inst Multidisciplinar Saude, Vitoria Da Conquista, Brazil.
   [Baptista Canuto, Gisele Andre] Univ Fed Bahia, Dept Quim Analit, Inst Quim, Salvador, BA, Brazil.
   [do Amaral, Helineide Ramos] Univ Estadual Feira de Santana, Nucleo Pesquisa Vigilancia Saude, Feira De Santana, Brazil.
   [Mascarenhas, Denise Lima; Falcao, Melissa Barreto; Santos, Normeide Pedreira] Secretaria Municipal Saude Municipio Feira de San, Feira De Santana, Brazil.
   [de Carvalho Azevedo, Vasco Ariston] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Alcantara, Luiz Carlos Junior] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, Brazil.
RP Alcantara, LC (corresponding author), Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.; Yoshinaga, MY (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.; Alcantara, LC (corresponding author), Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, Brazil.
EM marcosyukio@gmail.com; luiz.alcantara@ioc.fiocruz.br
RI Queiroz, Adriano/AAQ-1164-2020; Giovanetti, Marta/AAK-7408-2020; Canuto,
   Gisele A B/N-7338-2015; Miyamoto, Sayuri/A-2144-2008; Azevedo, Vasco
   A/B-1556-2019
OI Queiroz, Adriano/0000-0003-0080-6509; Canuto, Gisele A
   B/0000-0002-6616-3705; Miyamoto, Sayuri/0000-0002-5714-8984; Azevedo,
   Vasco A/0000-0002-4775-2280; Yoshinaga, Marcos
   Yukio/0000-0002-5533-5348; Alcantara, Luiz/0000-0002-6769-9931; Xavier,
   Joilson/0000-0003-3916-2018
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq) [CNPq
   440685/20168, CNPq 424094/2016-9]; CAPESCAPES [88887.130716/2016-00];
   Financiadora de Estudos e ProjetosCiencia Tecnologia e Inovacao (FINEP)
   [FINEP 04.16.0060.00]; EU's Horizon 2020 Program through ZIKAlliance
   [734548]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [13/07937-8]; International Development Research Centre (IDRC)
   over the Grant [108411-001]; European UnionEuropean Union (EU) [734857];
   CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate
   Education within the Ministry of Education of Brazil); Fundacao de
   Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [FAPESP 2014/11556-2]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq 440685/20168, CNPq 424094/2016-9), CAPES
   (88887.130716/2016-00), Financiadora de Estudos e Projetos (FINEP
   04.16.0060.00) and EU's Horizon 2020 Program through ZIKAlliance (Grant
   734548). The activities ofMY, IP, and SMwere funded by FAPESP
   (CEPID-Redoxoma grant 13/07937-8). And the activities of AF was
   supported by the International Development Research Centre (IDRC) over
   the Grant 108411-001 and by the European Union's Horizon 2020 grant
   agreement ZikAction no. 734857. AQ, MG, FB, and MY were funded by a post
   doc fellowship from CAPES (Brazilian Federal Agency for Support and
   Evaluation of Graduate Education within the Ministry of Education of
   Brazil) and IP by a Ph.D fellowship from Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP 2014/11556-2).
CR Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Berger J, 2016, BBA-MOL CELL RES, V1863, P934, DOI 10.1016/j.bbamcr.2015.12.005
   Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008
   Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Cui L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002373
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018
   Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Farooqui AA, 2001, NEUROSCIENTIST, V7, P232, DOI 10.1177/107385840100700308
   GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harak C, 2015, VIROLOGY, V479, P418, DOI 10.1016/j.virol.2015.02.029
   Jordan TX, 2016, CURR OPIN VIROL, V19, P7, DOI 10.1016/j.coviro.2016.05.007
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Liu STH, 2011, P NATL ACAD SCI USA, V108, P12869, DOI 10.1073/pnas.1109796108
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Odendall Charlotte, 2013, Subcell Biochem, V69, P67, DOI 10.1007/978-94-007-6889-5_4
   Melo CFOR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30385-x
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rog T, 2016, BBA-BIOMEMBRANES, V1858, P97, DOI 10.1016/j.bbamem.2015.10.023
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   SATOH O, 1990, J LIPID RES, V31, P1293
   Schoeman JC, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0318-8
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052
   Tanner LB, 2014, J LIPID RES, V55, P1357, DOI 10.1194/jlr.M049148
   Wewer CR, 2018, SOFT MATTER, V14, P5615, DOI 10.1039/c8sm00223a
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   You J, 2015, J VIROL, V89, P12349, DOI 10.1128/JVI.01365-15
NR 45
TC 6
Z9 6
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 12
PY 2019
VL 10
AR 753
DI 10.3389/fmicb.2019.00753
PG 10
WC Microbiology
SC Microbiology
GA HT1IR
UT WOS:000464317800001
PM 31031729
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Naveca, FG
   Claro, I
   Giovanetti, M
   de Jesus, JG
   Xavier, J
   Iani, FCD
   do Nascimento, VA
   de Souza, VC
   Silveira, PP
   Lourenco, J
   Santillana, M
   Kraemer, MUG
   Quick, J
   Hill, SC
   Theze, J
   Carvalho, RDD
   Azevedo, V
   Salles, FCD
   Nunes, MRT
   Lemos, PD
   Candido, DD
   Pereira, GD
   Oliveira, MAA
   Meneses, CAR
   Maito, RM
   Cunha, CRS
   Campos, DPD
   Castilho, MD
   Siqueira, TCD
   Terra, TM
   de Albuquerque, CFC
   da Cruz, LN
   de Abreu, AL
   Martins, DV
   Simoes, DSDV
   de Aguiar, RS
   Luz, SLB
   Loman, N
   Pybus, OG
   Sabino, EC
   Okumoto, O
   Alcantara, LCJ
   Faria, NR
AF Naveca, Felipe Gomes
   Claro, Ingra
   Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   de Melo Iani, Felipe Campos
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   Silveira, Paola Paz
   Lourenco, Jose
   Santillana, Mauricio
   Kraemer, Moritz U. G.
   Quick, Josh
   Hill, Sarah C.
   Theze, Julien
   de Oliveira Carvalho, Rodrigo Dias
   Azevedo, Vasco
   da Silva Salles, Flavia Cristina
   Teixeira Nunes, Marcio Roberto
   Lemos, Poliana da Silva
   Candido, Darlan da Silva
   Pereira, Glauco de Carvalho
   Assuncao Oliveira, Marluce Aparecida
   Ribeiro Meneses, Catia Alexandra
   Maito, Rodrigo Melo
   Santa Brigida Cunha, Claudeth Rocha
   de Sousa Campos, Daniela Palha
   Castilho, Marcia da Costa
   da Silva Siqueira, Thalita Caroline
   Terra, Tiza Matos
   Campelo de Albuquerque, Carlos F.
   da Cruz, Laura Nogueira
   de Abreu, Andre Luis
   Martins, Divino Valerio
   de Moraes Vanlume Simoes, Daniele Silva
   de Aguiar, Renato Santana
   Bessa Luz, Sergio Luiz
   Loman, Nicholas
   Pybus, Oliver G.
   Sabino, Ester C.
   Okumoto, Osnei
   Junior Alcantara, Luiz Carlos
   Faria, Nuno Rodrigues
TI Genomic, epidemiological and digital surveillance of Chikungunya virus
   in the Brazilian Amazon
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MAYARO VIRUS; POPULATION-DYNAMICS; MATO-GROSSO; ZIKA VIRUS; OUTBREAK;
   INFERENCE; EMERGENCE; OROPOUCHE; DISEASE; ILLNESS
AB Background Since its first detection in the Caribbean in late 2013, chikungunya virus (CHIKV) has affected 51 countries in the Americas. The CHIKV epidemic in the Americas was caused by the CHIKV-Asian genotype. In August 2014, local transmission of the CHIKV-Asian genotype was detected in the Brazilian Amazon region. However, a distinct lineage, the CHIKV-East-Central-South-America (ECSA)-genotype, was detected nearly simultaneously in Feira de Santana, Bahia state, northeast Brazil. The genomic diversity and the dynamics of CHIKV in the Brazilian Amazon region remains poorly understood despite its importance to better understand the epidemiological spread and public health impact of CHIKV in the country.
   Methodology/Principal findings We report a large CHIKV outbreak (5,928 notified cases between August 2014 and August 2018) in Boa vista municipality, capital city of Roraima's state, located in the Brazilian Amazon region. We generated 20 novel CHIKV-ECSA genomes from the Brazilian Amazon region using MinION portable genome sequencing. Phylogenetic analyses revealed that despite an early introduction of the Asian genotype in 2015 in Roraima, the large CHIKV outbreak in 2017 in Boa Vista was caused by an ECSA-lineage most likely introduced from northeastern Brazil. Epidemiological analyses suggest a basic reproductive number of R-0 of 1.66, which translates in an estimated 39 (95% CI: 36 to 45) % of Roraima's population infected with CHIKV-ECSA. Finally, we find a strong association between Google search activity and the local laboratory-confirmed CHIKV cases in Roraima.
   Conclusions/Significance This study highlights the potential of combining traditional surveillance with portable genome sequencing technologies and digital epidemiology to inform public health surveillance in the Amazon region. Our data reveal a large CHIKV-ECSA outbreak in Boa Vista, limited potential for future CHIKV outbreaks, and indicate a replacement of the Asian genotype by the ECSA genotype in the Amazon region.
C1 [Naveca, Felipe Gomes; do Nascimento, Valdinete Alves; de Souza, Victor Costa; Bessa Luz, Sergio Luiz] Fiocruz MS, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [Claro, Ingra; da Silva Salles, Flavia Cristina; Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Claro, Ingra; da Silva Salles, Flavia Cristina; Sabino, Ester C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; de Melo Iani, Felipe Campos; de Oliveira Carvalho, Rodrigo Dias; Azevedo, Vasco; Pereira, Glauco de Carvalho; Assuncao Oliveira, Marluce Aparecida; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [de Jesus, Jaqueline Goes; Xavier, Joilson] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [de Melo Iani, Felipe Campos] FUNED, Inst Octavio Magalhaes, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Silveira, Paola Paz; de Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil.
   [Lourenco, Jose; Kraemer, Moritz U. G.; Hill, Sarah C.; Theze, Julien; Candido, Darlan da Silva; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.
   [Santillana, Mauricio] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.
   [Santillana, Mauricio] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Quick, Josh; Loman, Nicholas] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Teixeira Nunes, Marcio Roberto; Lemos, Poliana da Silva] Brazilian Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Ribeiro Meneses, Catia Alexandra; Maito, Rodrigo Melo; Santa Brigida Cunha, Claudeth Rocha] Lab Cent Saude Publ, Boa Vista, Roraima, Brazil.
   [de Sousa Campos, Daniela Palha; da Silva Siqueira, Thalita Caroline] Secretaria Municipal Saude Boa Vista, Superintendencia Vigilancia Saude, Roraima, Brazil.
   [Castilho, Marcia da Costa] Fundacao Med Trop Doutor Heitor Vieira Dourado, Dept Virol, Manaus, Amazonas, Brazil.
   [Terra, Tiza Matos] Lab Cent Saude Publ Amazonas, Manaus, Amazonas, Brazil.
   [Campelo de Albuquerque, Carlos F.] OMS, OPAS, Brasilia, DF, Brazil.
   [da Cruz, Laura Nogueira; de Abreu, Andre Luis; Martins, Divino Valerio; de Moraes Vanlume Simoes, Daniele Silva; Okumoto, Osnei] MS, SVS, Brasilia, DF, Brazil.
RP Alcantara, LC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.; Faria, NR (corresponding author), Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.
EM luiz.alcantara@ioc.fiocruz.br; nuno.faria@zoo.ox.ac.uk
RI Nascimento, Valdinete Alves do/AAV-1879-2020; Pybus, Oliver
   G/B-2640-2012; Aguiar, Renato S/G-3542-2015; Loman,
   Nicholas/Z-1573-2019; Giovanetti, Marta/AAK-7408-2020; Faria, Nuno
   R/I-2975-2012; Sabino, Ester Cerdeira/F-7750-2010; Azevedo, Vasco
   A/B-1556-2019
OI Nascimento, Valdinete Alves do/0000-0002-7786-4718; Pybus, Oliver
   G/0000-0002-8797-2667; Aguiar, Renato S/0000-0001-5180-3717; Faria, Nuno
   R/0000-0001-8839-2798; Sabino, Ester Cerdeira/0000-0003-2623-5126;
   Azevedo, Vasco A/0000-0002-4775-2280; Theze, Julien/0000-0001-8188-9494;
   Lourenco, Jose/0000-0002-9318-2581; da Silva Candido,
   Darlan/0000-0002-5080-3130; Souza, Victor Costa de/0000-0002-3869-1519;
   Carvalho, Rodrigo/0000-0003-0216-7173; Hill, Sarah/0000-0002-2995-2596;
   Luz, Sergio Luiz Bessa/0000-0001-5887-7372; da Silva Sales, Flavia
   Cristina/0000-0002-9048-0030; Iani, Felipe/0000-0002-3629-8529;
   /0000-0002-8529-4022; Xavier, Joilson/0000-0003-3916-2018; Alcantara,
   Luiz/0000-0002-6769-9931
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [440685/2016-8, 440856/2016-7]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES [88887.130716/2016-00,
   88881.130825/2016-00, 88887.130823/2016-00]; EU's Horizon 2020 Programme
   through ZIKAlliance [PRES-005-FEX-17-4-2-33]; Royal SocietyRoyal Society
   of London; Wellcome Trust Sir Henry Dale Fellowship [204311/Z/16/Z];
   John Fell Research Fund [005166]; ERCEuropean Research Council (ERC)
   [614725-PATHPHYLODYN]; National Institute of General Medical Sciences of
   the NIH (USA) [R01GM130668]; internal GCRF grant [005073]; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM130668] Funding
   Source: NIH RePORTER
FX The ZIBRA-2 project is funded by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (grant 440685/2016-8) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (grant
   88887.130716/2016-00). FGN is funded by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br, grant
   440856/2016-7) and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (http://www.capes.gov.br, grants 88881.130825/2016-00 and
   88887.130823/2016-00). L.C.J.A. is supported by the EU's Horizon 2020
   Programme through ZIKAlliance (grant PRES-005-FEX-17-4-2-33). N.R.F. is
   funded by a Royal Society and Wellcome Trust Sir Henry Dale Fellowship
   (204311/Z/16/Z), internal GCRF grant 005073, and John Fell Research Fund
   grant 005166. This research received funding from the ERC (grant
   agreement 614725-PATHPHYLODYN). MS was partially supported by the
   National Institute of General Medical Sciences of the NIH (USA) under
   award number R01GM130668. The funders had no role in study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript.
CR [Anonymous], 2015, PUBMED, V7, pe141
   [Anonymous], 2017, EMERGING INFECTIOUS, V23, ps6
   [Anonymous], 2015, PUBMED, V31, P43
   [Anonymous], 2016, PLOS CURRENTS OUTBRE, V39, pS1, DOI 10.2337/dc16-S001
   [Anonymous], 2015, PUBMED, V4, pA1
   [Anonymous], 2010, EURO SURVEILLANCE, V15, pe1936
   [Anonymous], 2016, PUBMED, V44, pD7
   [Anonymous], 2016, EVOLUTION, V2, pA49
   [Anonymous], 2016, PUBMED, V21, piii
   de Brito CAA, 2017, MEM I OSWALDO CRUZ, V112, P650, DOI 10.1590/0074-02760170124
   Aragao CF, 2018, ACTA TROP, V186, P1, DOI 10.1016/j.actatropica.2018.06.022
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Brunini S, 2017, EMERG INFECT DIS, V23, P1025, DOI 10.3201/eid2306.160929
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carrillo FB, 2019, J VIROL, V93, DOI 10.1128/JVI.01622-18
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   da Costa VG, 2017, INT J INFECT DIS, V62, P84, DOI 10.1016/j.ijid.2017.07.016
   da Silva NM, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000300003, 10.5123/s1679-49742018000300003]
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860019, 10.1590/s1678-9946201860019]
   Del Valle SY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3124-7
   Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Freitas Andre Ricardo Ribas, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.14608e586cd321d8d5088652d7a0d884
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LEDUC JW, 1981, AM J TROP MED HYG, V30, P682, DOI 10.4269/ajtmh.1981.30.682
   Lourenco Jose, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.19433b1e4d007451c691f138e1e67e8c
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Figueiredo LTM, 2017, REV SOC BRAS MED TRO, V50, P583, DOI 10.1590/0037-8682-0397-2017
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Obolski U, 2018, MVSE R PACKAGE ESTIM, DOI [10.1101/360701, DOI 10.1101/360701]
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Organization PAWH, 2017, NUMB REP CAS CHIK FE
   Pauvolid-Correa A, 2015, MEM I OSWALDO CRUZ, V110, P125, DOI 10.1590/0074-02760140383
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Receveur M. C., 2010, EUROSURVEILLANCE, V15, P18
   Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Souza TM, 2017, PLOS CURRENTS, V9, DOI [10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727, DOI 10.1371/CURRENTS.OUTBREAKS.4200119978D62CCAA454599CD27357]
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Team RC, 2014, R LANG ENV COMP
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
   Vasconcelos PFC, 1992, CIENC CULT-SAO PAULO, V43, P117
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181
   White SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196857
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 79
TC 16
Z9 16
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2019
VL 13
IS 3
AR e0007065
DI 10.1371/journal.pntd.0007065
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3YU
UT WOS:000463799300007
PM 30845267
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU de Almeida, BL
   Giovanetti, M
   Oliveira, JV
   Xavier, TC
   Figueiredo, EM
   Goes, JJ
   Alcantara, LC
   de Siqueira, IC
AF de Almeida, Breno L.
   Giovanetti, Marta
   Oliveira, Joao V.
   Xavier, Tereza C.
   Figueiredo, Eduardo M.
   Goes, Jaqueline J.
   Alcantara, Luiz C.
   de Siqueira, Isadora C.
TI DETECTION AND SEQUENCING OF ZIKA VIRUS IN NORMOCEPHALIC NEWBORNS WITH
   CONGENITAL ZIKA IN FECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [de Almeida, Breno L.; Giovanetti, Marta; Oliveira, Joao V.; Goes, Jaqueline J.; Alcantara, Luiz C.; de Siqueira, Isadora C.] Fundacao Oswaldo Cruz Fiocruz, Salvador, BA, Brazil.
   [Xavier, Tereza C.] Maternidade Referencia Prof Jose Maria de Maglhae, Salvador, BA, Brazil.
   [Figueiredo, Eduardo M.] Maternidade Referencia Prof Jose Maria de Magalha, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; Giovanetti,
   Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 209
BP 63
EP 63
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502209
DA 2020-11-24
ER

PT J
AU do Rosario, MS
   Giovanetti, M
   de Jesus, PAP
   Farias, DS
   Faria, NR
   de Lima, CPS
   da Silva, SP
   Nunes, MR
   Alcantara, LC
   de Siqueira, IC
AF do Rosario, Mateus Santana
   Giovanetti, Marta
   Pereira de Jesus, Pedro Antonio
   Farias, Daniel Santana
   Faria, Nuno R.
   de Lima, Clayton Pereira S.
   da Silva, Sandro Patroca
   Nunes, Marcio Roberto
   Junior Alcantara, Luiz Carlos
   de Siqueira, Isadora Cristina
TI Opsoclonus-myoclonus-ataxia syndrome associated with chikungunya and
   dengue virus co-infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Opsoclonus; Chikungunya; Dengue
ID NEUROLOGICAL MANIFESTATIONS; INFECTION; DIAGNOSIS
AB Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare neurological disorder characterized by irregular multidirectional eye movements, myoclonus, cerebellar ataxia, sleep disturbances, and cognitive dysfunction. Although most commonly related to paraneoplastic syndrome, this condition has occasionally been described following infectious illnesses. This article reports the first case of OMAS in association with chikungunya and dengue virus co-infection. The genetic analysis identified chikungunya virus of East/Central/South African genotype and dengue serotype 4 virus of genotype II. This report represents an unusual clinical syndrome associated with viral co-infection and reinforces the need for clinical vigilance with regard to neurological syndromes in the context of emergent arboviruses. (c) 2018 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [do Rosario, Mateus Santana; Giovanetti, Marta; Junior Alcantara, Luiz Carlos; de Siqueira, Isadora Cristina] Fundacao Oswaldo Cruz, Minist Saude, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana; Pereira de Jesus, Pedro Antonio; Farias, Daniel Santana] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Pereira de Jesus, Pedro Antonio] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford, England.
   [de Lima, Clayton Pereira S.; da Silva, Sandro Patroca; Nunes, Marcio Roberto] Inst Evandro Chagas, Ctr Tecnol & Inovacao, Ananindeua, Para, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@bahia.fiocruz.br
RI Giovanetti, Marta/AAK-7408-2020; de Siqueira, Isadora
   Cristina/R-9953-2016; Faria, Nuno R/I-2975-2012
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Faria, Nuno
   R/0000-0001-8839-2798; Alcantara, Luiz/0000-0002-6769-9931; Jesus, Pedro
   Antonio/0000-0003-1211-2272; do Rosario, Mateus/0000-0001-7404-6392
FU CNPq-National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [302584/2015-3]; MCTI-Ministry of Science, Technology,
   Innovation/FINEP-Funding Authority for Studies and
   Projects/FNDCT-National Fund for the Development of Science and
   Technology [04160060-00/2016]
FX CNPq-National Council for Scientific and Technological Development
   (302584/2015-3) and MCTI-Ministry of Science, Technology,
   Innovation/FINEP-Funding Authority for Studies and
   Projects/FNDCT-National Fund for the Development of Science and
   Technology (04160060-00/2016)
CR Bintner M, 2015, NEUROLOGY, P2005
   Blaes F, 2008, J NEUROIMMUNOL, V201, P221, DOI 10.1016/j.jneuroim.2008.05.033
   Cao-Lormeau V. M., 2016, LANCET
   Chiam CW, 2013, DIAGN MICR INFEC DIS, V77, P133, DOI 10.1016/j.diagmicrobio.2013.06.018
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Gorman MP, 2010, CURR OPIN PEDIATR, V22, P745, DOI 10.1097/MOP.0b013e32833fde3f
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Tan AH, 2014, PARKINSONISM RELAT D, V20, P1309, DOI 10.1016/j.parkreldis.2014.09.002
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
NR 15
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD OCT
PY 2018
VL 75
BP 11
EP 14
DI 10.1016/j.ijid.2018.07.019
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA GV6IS
UT WOS:000446213000003
PM 30076990
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Giovanetti, M
   de Jesus, JG
   de Maia, ML
   Junior, JX
   Amarante, MFC
   Viana, P
   Barreto, FK
   de Cerqueira, EM
   Santos, NP
   Falcao, MB
   Costa, MCM
   Faical, AVB
   de Melo, ALA
   Amorim, LS
   de Siqueira, IC
   Macarenhas, DL
   de Filippis, AMB
   Faria, NR
   Acosta, AX
   Alcantara, LCJ
AF Giovanetti, M.
   Goes de Jesus, J.
   Lima de Maia, M.
   Junior, J. X.
   Castro Amarante, M. F.
   Viana, P.
   Khouri Barreto, F.
   de Cerqueira, E. M.
   Pedreira Santos, N.
   Barreto Falcao, M.
   Machado Costa, M. C.
   Barros Faical, A. V.
   Andrade de Melo, A. L.
   Santos Amorim, L.
   de Siqueira, I. C.
   Macarenhas, D. L.
   Bispo de Filippis, A. M.
   Faria, N. Rodrigues
   Xavier Acosta, A.
   Junior Alcantara, L. C.
TI Genetic evidence of Zika virus in mother's breast milk and body fluids
   of a newborn with severe congenital defects
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Letter
C1 [Giovanetti, M.; Goes de Jesus, J.; Junior, J. X.; Castro Amarante, M. F.; Viana, P.; Khouri Barreto, F.; Santos Amorim, L.; Junior Alcantara, L. C.] Inst Goncalo Moniz Salvador, Lab Patol Expt, Salvador, BA, Brazil.
   [Giovanetti, M.; Bispo de Filippis, A. M.; Junior Alcantara, L. C.] Fiocruz MS, Lab Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Lima de Maia, M.; de Cerqueira, E. M.] Univ Estadual Feira de Santana, Salvador, BA, Brazil.
   [Lima de Maia, M.; Pedreira Santos, N.; Barreto Falcao, M.; Machado Costa, M. C.; Andrade de Melo, A. L.; Macarenhas, D. L.] Secretaria Saude Feira Santana, Salvador, BA, Brazil.
   [Barreto Falcao, M.; Xavier Acosta, A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Faria, N. Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, Fundac Oswaldo Cruz, Rio De Janeiro, Brazil.
EM lalcan@bahia.fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016; Faria, Nuno R/I-2975-2012;
   Giovanetti, Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Faria, Nuno
   R/0000-0001-8839-2798; Xavier, Joilson/0000-0003-3916-2018; Castro
   Amarante, Maria Fernanda/0000-0003-2162-9505; Alcantara,
   Luiz/0000-0002-6769-9931
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES
FX Supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES). All authors report no conflicts of interest
   relevant to this article.
CR de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dupont-Rouzeyrol M, 2016, LANCET LOND ENGL, V387, P1051
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 5
TC 8
Z9 8
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD OCT
PY 2018
VL 24
IS 10
BP 1111
EP 1112
DI 10.1016/j.cmi.2018.06.008
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GU0EY
UT WOS:000444923000026
PM 29906587
OA Bronze
DA 2020-11-24
ER

PT J
AU Faria, NR
   Kraemer, MUG
   Hill, SC
   de Jesus, JG
   Aguiar, RS
   Iani, FCM
   Xavier, J
   Quick, J
   du Plessis, L
   Dellicour, S
   Theze, J
   Carvalho, RDO
   Baele, G
   Wu, CH
   Silveira, PP
   Arruda, MB
   Pereira, MA
   Pereira, GC
   Lourenco, J
   Obolski, U
   Abade, L
   Vasylyeva, TI
   Giovanetti, M
   Yi, D
   Weiss, DJ
   Wint, GRW
   Shearer, FM
   Funk, S
   Nikolay, B
   Fonseca, V
   Adelino, TER
   Oliveira, MAA
   Silva, MVF
   Sacchetto, L
   Figueiredo, PO
   Rezende, IM
   Mello, EM
   Said, RFC
   Santos, DA
   Ferraz, ML
   Brito, MG
   Santana, LF
   Menezes, MT
   Brindeiro, RM
   Tanuri, A
   dos Santos, FCP
   Cunha, MS
   Nogueira, JS
   Rocco, IM
   da Costa, AC
   Komninakis, SCV
   Azevedo, V
   Chieppe, AO
   Araujo, ESM
   Mendonca, MCL
   dos Santos, CC
   dos Santos, CD
   Mares-Guia, AM
   Nogueira, RMR
   Sequeira, PC
   Abreu, RG
   Garcia, MHO
   Abreu, AL
   Okumoto, O
   Kroon, EG
   de Albuquerque, CFC
   Lewandowski, K
   Pullan, ST
   Carroll, M
   de Oliveira, T
   Sabino, EC
   Souza, RP
   Suchard, MA
   Lemey, P
   Trindade, GS
   Drumond, BP
   Filippis, AMB
   Loman, NJ
   Cauchemez, S
   Alcantara, LCJ
   Pybus, OG
AF Faria, N. R.
   Kraemer, M. U. G.
   Hill, S. C.
   de Jesus, J. Goes
   Aguiar, R. S.
   Iani, F. C. M.
   Xavier, J.
   Quick, J.
   du Plessis, L.
   Dellicour, S.
   Theze, J.
   Carvalho, R. D. O.
   Baele, G.
   Wu, C. -H.
   Silveira, P. P.
   Arruda, M. B.
   Pereira, M. A.
   Pereira, G. C.
   Lourenco, J.
   Obolski, U.
   Abade, L.
   Vasylyeva, T. I.
   Giovanetti, M.
   Yi, D.
   Weiss, D. J.
   Wint, G. R. W.
   Shearer, F. M.
   Funk, S.
   Nikolay, B.
   Fonseca, V.
   Adelino, T. E. R.
   Oliveira, M. A. A.
   Silva, M. V. F.
   Sacchetto, L.
   Figueiredo, P. O.
   Rezende, I. M.
   Mello, E. M.
   Said, R. F. C.
   Santos, D. A.
   Ferraz, M. L.
   Brito, M. G.
   Santana, L. F.
   Menezes, M. T.
   Brindeiro, R. M.
   Tanuri, A.
   dos Santos, F. C. P.
   Cunha, M. S.
   Nogueira, J. S.
   Rocco, I. M.
   da Costa, A. C.
   Komninakis, S. C. V.
   Azevedo, V.
   Chieppe, A. O.
   Araujo, E. S. M.
   Mendonca, M. C. L.
   dos Santos, C. C.
   dos Santos, C. D.
   Mares-Guia, A. M.
   Nogueira, R. M. R.
   Sequeira, P. C.
   Abreu, R. G.
   Garcia, M. H. O.
   Abreu, A. L.
   Okumoto, O.
   Kroon, E. G.
   de Albuquerque, C. F. C.
   Lewandowski, K.
   Pullan, S. T.
   Carroll, M.
   de Oliveira, T.
   Sabino, E. C.
   Souza, R. P.
   Suchard, M. A.
   Lemey, P.
   Trindade, G. S.
   Drumond, B. P.
   Filippis, A. M. B.
   Loman, N. J.
   Cauchemez, S.
   Alcantara, L. C. J.
   Pybus, O. G.
TI Genomic and epidemiological monitoring of yellow fever virus
   transmission potential
SO SCIENCE
LA English
DT Article
ID SPREAD; BRAZIL; ANGOLA
AB The yellow fever virus (YFV) epidemic in Brazil is the largest in decades. The recent discovery of YFV in Brazilian Aedes species mosquitos highlights a need to monitor the risk of reestablishment of urban YFV transmission in the Americas. We use a suite of epidemiological, spatial, and genomic approaches to characterize YFV transmission. We show that the age and sex distribution of human cases is characteristic of sylvatic transmission. Analysis of YFV cases combined with genomes generated locally reveals an early phase of sylvatic YFV transmission and spatial expansion toward previously YFV-free areas, followed by a rise in viral spillover to humans in late 2016. Our results establish a framework for monitoring YFV transmission in real time that will contribute to a global strategy to eliminate future YFV epidemics.
C1 [Faria, N. R.; Kraemer, M. U. G.; Hill, S. C.; du Plessis, L.; Theze, J.; Lourenco, J.; Obolski, U.; Abade, L.; Vasylyeva, T. I.; Wint, G. R. W.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Kraemer, M. U. G.] Harvard Med Sch, Dept Pediat, Boston, MA USA.
   [de Jesus, J. Goes; Xavier, J.; Giovanetti, M.; Araujo, E. S. M.; Mendonca, M. C. L.; dos Santos, C. C.; dos Santos, C. D.; Mares-Guia, A. M.; Nogueira, R. M. R.; Sequeira, P. C.; de Oliveira, T.; Filippis, A. M. B.; Alcantara, L. C. J.] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Aguiar, R. S.; Silveira, P. P.; Arruda, M. B.; Menezes, M. T.; Brindeiro, R. M.; Tanuri, A.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Mol Virol Lab, Rio De Janeiro, Brazil.
   [Iani, F. C. M.; Pereira, M. A.; Pereira, G. C.; Adelino, T. E. R.; Oliveira, M. A. A.; Silva, M. V. F.] FUNED, Inst Octavio Magalhaes, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Iani, F. C. M.; Carvalho, R. D. O.; Giovanetti, M.; Fonseca, V.; Sacchetto, L.; Figueiredo, P. O.; Rezende, I. M.; Mello, E. M.; Azevedo, V.; Kroon, E. G.; Trindade, G. S.; Drumond, B. P.; Alcantara, L. C. J.] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Quick, J.; Loman, N. J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Dellicour, S.; Baele, G.; Lemey, P.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium.
   [Wu, C. -H.] Univ Oxford, Dept Stat, Oxford, England.
   [Abade, L.] Univ Oxford, Global Hlth Network, Oxford, England.
   [Yi, D.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.
   [Weiss, D. J.; Shearer, F. M.] Univ Oxford, Nuffield Dept Med, Big Data Inst, Malaria Atlas Project, Oxford, England.
   [Funk, S.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, Ctr Bioinformat, Paris, France.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, CNRS, Genom Evolut Modelisat & Sante UMR2000, Paris, France.
   [Fonseca, V.; de Oliveira, T.] Univ KwaZulu Natal, KwaZulu Natal Res Innovat & Sequencing Platform K, Sch Lab Med & Med Sci, Durban, South Africa.
   [Said, R. F. C.; Santos, D. A.; Ferraz, M. L.; Brito, M. G.; Santana, L. F.] Secretaria Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   [dos Santos, F. C. P.; Cunha, M. S.; Nogueira, J. S.; Rocco, I. M.; Souza, R. P.] Adolfo Lutz Inst, Nucleo Doencas Transmissao Vetorial, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Komninakis, S. C. V.] Univ Fed Sao Paulo, Retrovirol Lab, Sao Paulo, Brazil.
   [Komninakis, S. C. V.] Sch Med ABC FMABC, Clin Immunol Lab, Santo Andre, SP, Brazil.
   [Chieppe, A. O.] Coordenacao Vigilancia Epidemiol Estado Rio de Ja, Rio De Janeiro, Brazil.
   [Abreu, R. G.; Garcia, M. H. O.] Minist Saude, Dept Vigilancia Doencas Transmissiveis, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Abreu, A. L.; Okumoto, O.] Minist Saude, Secretaria Vigilancia Saude, Coordenacao Geral Labs Saude Publ, Brasilia, DF, Brazil.
   [de Albuquerque, C. F. C.] OMS, OPAS, Brasilia, DF, Brazil.
   [Lewandowski, K.; Pullan, S. T.] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Carroll, M.] Publ Hlth England, NIHR HPRU Emerging & Zoonot Infect, London, England.
   [de Oliveira, T.] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.
   [Suchard, M. A.] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA USA.
   [Suchard, M. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath & Human Genet, Los Angeles, CA 90095 USA.
RP Faria, NR; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Alcantara, LCJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
EM nuno.faria@zoo.ox.ac.uk; luiz.alcantara@ioc.fiocruz.br;
   oliver.pybus@zoo.ox.ac.uk
RI Kroon, Erna/V-5444-2019; Faria, Nuno R/I-2975-2012; Komninakis, Shirley
   V/B-2915-2010; Dellicour, Simon/AAE-9054-2020; Giovanetti,
   Marta/AAK-7408-2020; Loman, Nicholas/Z-1573-2019; Azevedo, Vasco
   A/B-1556-2019; da-Costa, Antonio Charlys/G-1548-2010; Sabino, Ester
   Cerdeira/F-7750-2010; Fonseca, Vagner/R-5813-2019; Azevedo, Vasco
   A.C/F-4315-2011; Rezende, Izabela Mauricio/AAL-5766-2020; Sacchetto,
   Livia/B-8841-2019; Pybus, Oliver G/B-2640-2012; Funk,
   Stefan/B-7629-2015; Aguiar, Renato S/G-3542-2015; Baele,
   Guy/R-8157-2017; du Plessis, Louis/K-1667-2013
OI Faria, Nuno R/0000-0001-8839-2798; Komninakis, Shirley
   V/0000-0001-7784-3418; Dellicour, Simon/0000-0001-9558-1052; Azevedo,
   Vasco A/0000-0002-4775-2280; da-Costa, Antonio
   Charlys/0000-0001-5516-5177; Sabino, Ester Cerdeira/0000-0003-2623-5126;
   Fonseca, Vagner/0000-0001-5521-6448; Azevedo, Vasco
   A.C/0000-0002-4775-2280; Rezende, Izabela Mauricio/0000-0003-2616-6300;
   Sacchetto, Livia/0000-0001-9716-6899; Pybus, Oliver
   G/0000-0002-8797-2667; Funk, Stefan/0000-0002-2012-0080; Aguiar, Renato
   S/0000-0001-5180-3717; Baele, Guy/0000-0002-1915-7732; Carvalho,
   Rodrigo/0000-0003-0216-7173; Pereira de Souza,
   Renato/0000-0003-1315-7085; Funk, Sebastian/0000-0002-2842-3406;
   Vasylyeva, Tetyana/0000-0002-9736-7022; Iani,
   Felipe/0000-0002-3629-8529; Alcantara, Luiz/0000-0002-6769-9931; Hill,
   Sarah/0000-0002-2995-2596; Theze, Julien/0000-0001-8188-9494; Wu,
   Chieh-Hsi/0000-0001-9386-725X; Pullan, Steven/0000-0002-8983-599X; du
   Plessis, Louis/0000-0003-0352-6289; De Jesus,
   Jaqueline/0000-0002-5404-272X; Xavier, Joilson/0000-0003-3916-2018
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [400354/2016-0]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2016/01735-2, 2017/00021-9]; Sir Henry Dale Fellowship
   [204311/Z/16/Z]; internal GCRF grant [005073]; John Fell Research Fund
   [005166]; ERCEuropean Research Council (ERC) [614725-PATHPHYLODYN];
   Oxford Martin School; Branco Weiss Fellowship; National Institute of
   Child Health and Human DevelopmentUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Eunice
   Kennedy Shriver National Institute of Child Health & Human Development
   (NICHD) [T32HD040128]; National Library of Medicine of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Library of
   Medicine (NLM) [R01LM010812, R01LM011965]; Fonds Wetenschappelijk
   Onderzoek (FWO, Flanders, Belgium)FWO; Interne Fondsen KU
   Leuven/Internal Funds KU Leuven; EU's Horizon 2020 Programme through
   ZIKAlliance [734548]; Investissement d'Avenir programFrench National
   Research Agency (ANR); Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program [ANR-10-LABX-62-IBEID]; Models of
   Infectious Disease Agent Study of the National Institute of General
   Medical Sciences; AXA Research Fund; Association Robert Debre; European
   Research CouncilEuropean Research Council (ERC) [725422-ReservoirDOCS];
   Wellcome TrustWellcome Trust [206298/Z/17/Z]; Research Foundation,
   Flanders (Fonds voor Wetenschappelijk Onderzoek, Vlaanderen)FWO
   [G066215N, G0D5117N, G0B9317N]; EUNICE KENNEDY SHRIVER NATIONAL
   INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [T32HD040128, T32HD040128, T32HD040128, T32HD040128,
   T32HD040128, T32HD040128, T32HD040128] Funding Source: NIH RePORTER;
   EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32HD040128,
   T32HD040128, T32HD040128, T32HD040128, T32HD040128, T32HD040128,
   T32HD040128, T32HD040128, T32HD040128] Funding Source: NIH RePORTER;
   NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Library of
   Medicine (NLM) [R01LM011965, R01LM010812, R01LM010812, R01LM010812,
   R01LM010812, R01LM011965, R01LM010812, R01LM010812, R01LM010812,
   R01LM011965, R01LM011965, R01LM010812] Funding Source: NIH RePORTER
FX This work was supported in part by CNPq 400354/2016-0 and FAPESP
   2016/01735-2. N.R.F. is supported by a Sir Henry Dale Fellowship
   (204311/Z/16/Z), internal GCRF grant 005073, and John Fell Research Fund
   grant 005166. This research received funding from the ERC (grant
   agreement 614725-PATHPHYLODYN) and from the Oxford Martin School.
   M.U.G.K. acknowledges funding from a Branco Weiss Fellowship,
   administered by ETH Zurich, a Training Grant from the National Institute
   of Child Health and Human Development (T32HD040128), and the National
   Library of Medicine of the National Institutes of Health (R01LM010812
   and R01LM011965). S.D. is funded by the Fonds Wetenschappelijk Onderzoek
   (FWO, Flanders, Belgium). G.B. acknowledges support from the Interne
   Fondsen KU Leuven/Internal Funds KU Leuven. A.C.d.C. is funded by FAPESP
   2017/00021-9. B.B.N. and S.C. are supported by the EU's Horizon 2020
   Programme through ZIKAlliance (grant 734548), the Investissement
   d'Avenir program, the Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program (grant ANR-10-LABX-62-IBEID), the
   Models of Infectious Disease Agent Study of the National Institute of
   General Medical Sciences, the AXA Research Fund, and the Association
   Robert Debre. P.L. and M.A.S. acknowledge funding from the European
   Research Council (grant agreement 725422-ReservoirDOCS) and from the
   Wellcome Trust Collaborative Award 206298/Z/17/Z. P.L. acknowledges
   support from the Research Foundation, Flanders (Fonds voor
   Wetenschappelijk Onderzoek, Vlaanderen, G066215N, G0D5117N, and
   G0B9317N).
CR Auguste AJ, 2015, EMERG INFECT DIS, V21, P99, DOI 10.3201/eid2101.140814
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Brasil, 2017, B EPIDEMIOLOGICO, V48
   Camara FP, 2011, REV SOC BRAS MED TRO, V44, P297, DOI [10.1590/S0037-86822011005000024, 10.1590/s0037-86822011005000024]
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   CHANG GJJ, 1995, J VIROL, V69, P5773, DOI 10.1128/JVI.69.9.5773-5780.1995
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   do Nascimento Rafaela Almeida, 2013, Neotropical Biology and Conservation, V8, P79, DOI 10.4013/nbc.2013.82.03
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.31257, 10.7554/eLife.37324, 10.7554/elife.37324]
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Flacio E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1577-3
   FRANCO Odair, 1969, HIST FEBRE AMARELA B
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gill MS, 2016, SYST BIOL, V65, P1041, DOI 10.1093/sysbio/syw050
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Jung L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129789
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/s1473-3099(16)30513-8, 10.1016/S1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   PAHO, 2009, OUTBR YELL FEV PAR
   Pan American Health Organization/World Health Organization, 2018, EP UPD YELL FEV 16 F
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Ribeiro M, 2009, REV SOC BRAS MED TRO, V42, P523, DOI 10.1590/S0037-86822009000500009
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46
   Segura M. N. O., 2007, ATLAS CULICIDEOS AMA, V167
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Stephens PR, 2017, ECOLOGY, V98, P1476, DOI 10.1002/ecy.1799
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   Vainio J., 1998, YELLOW FEVER
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Vasconcelos PFC, 2001, J MED VIROL, V65, P598, DOI 10.1002/jmv.2078
   Vaughan TG, 2014, BIOINFORMATICS, V30, P2272, DOI 10.1093/bioinformatics/btu201
   von Lindern JJ, 2006, J GEN VIROL, V87, P895, DOI 10.1099/vir.0.81236-0
   Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601
NR 49
TC 79
Z9 80
U1 0
U2 14
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 31
PY 2018
VL 361
IS 6405
BP 894
EP +
DI 10.1126/science.aat7115
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS3UB
UT WOS:000443547000033
PM 30139911
OA Green Accepted, Bronze
DA 2020-11-24
ER

PT J
AU do Rosario, M
   Jesus, P
   Farias, D
   Novaes, MA
   Moura, D
   Lima, F
   Santos, C
   Giovanetti, M
   Alcantara, LC
   Siqueira, I
AF do Rosario, M.
   Jesus, P.
   Farias, D.
   Novaes, M. A.
   Moura, D.
   Lima, F.
   Santos, C.
   Giovanetti, M.
   Alcantara, L. C.
   Siqueira, I.
TI Neurological complications associated with arboviruses during Zika
   outbreak in Salvador, Bahia-Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [do Rosario, M.; Santos, C.; Giovanetti, M.; Alcantara, L. C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Jesus, P.] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Farias, D.] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Novaes, M. A.] Hosp Sao Rafael, Salvador, BA, Brazil.
   [Moura, D.; Lima, F.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; Giovanetti,
   Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 22.004
BP 49
EP 49
DI 10.1016/j.ijid.2018.04.3534
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100100
OA DOAJ Gold
DA 2020-11-24
ER

PT J
AU Oliveira, JV
   Duarte, A
   Santos, C
   Pessoa, L
   Magalhaes, C
   Lima, J
   Carvalho, D
   Xavier, T
   Figueiredo, E
   Giovanetti, M
   Almeida, B
   Goes, J
   Lima, F
   Alcantara, LC
   Siqueira, I
AF Oliveira, J. V.
   Duarte, A.
   Santos, C.
   Pessoa, L.
   Magalhaes Filho, C.
   Lima, J.
   Carvalho, D.
   Xavier, T.
   Figueiredo, E.
   Giovanetti, M.
   Almeida, B.
   Goes, J.
   Lima, F.
   Alcantara, L. C.
   Siqueira, I.
TI Prevalence of Zika, dengue and Chikungunya virus infection in pregnant
   women and surveillance of congenital Zika infection in Salvador, Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Oliveira, J. V.; Santos, C.; Pessoa, L.; Magalhaes Filho, C.; Lima, J.; Carvalho, D.; Giovanetti, M.; Almeida, B.; Goes, J.; Alcantara, L. C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvdor, Brazil.
   [Duarte, A.; Lima, F.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
   [Xavier, T.; Figueiredo, E.] Maternidade Referencia Prof Jose Maria Magalhaes, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; amsalu, ribka/G-8780-2019;
   Giovanetti, Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 202
BP 182
EP 182
DI 10.1016/j.ijid.2018.04.3826
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100392
OA DOAJ Gold
DA 2020-11-24
ER

PT J
AU Scognamiglio, P
   Chiaradia, G
   Giovanetti, M
   Albertini, E
   Camposeragna, A
   Farinella, M
   Lorenzetti, D
   Oldrini, M
   Rancilio, L
   Caraglia, A
   Maraglino, FP
   Ippolito, G
   Girardi, E
AF Scognamiglio, Paola
   Chiaradia, Giacomina
   Giovanetti, Marta
   Albertini, Emidio
   Camposeragna, Antonella
   Farinella, Massimo
   Lorenzetti, Daniela
   Oldrini, Massimo
   Rancilio, Laura
   Caraglia, Anna
   Maraglino, Francesco Paolo
   Ippolito, Giuseppe
   Girardi, Enrico
TI HIV rapid testing in community and outreach sites: results of a
   nationwide demonstration project in Italy
SO BMC PUBLIC HEALTH
LA English
DT Article
DE HIV rapid test; Community-based services; Counseling and testing;
   Acceptability
ID UNITED-STATES; SETTINGS; CARE; TRANSMISSION; PREFERENCES; PREVENTION;
   STRATEGIES; CONTINUUM; BARRIERS; MEN
AB Background: Globally the access to HIV testing has greatly increased over the past 30 years. Nonetheless, a high proportion of people living with HIV remains undiagnosed, even in resource rich countries. To increase the proportion of people aware of their HIV serostatus and their access to medical care, several strategies have been proposed including HIV rapid test programs offered outside health facilities. The aim of this project was to evaluate the feasibility and efficacy of the HIV rapid testing offered in community and outreach settings in Italy.
   Methods: We conducted a national demonstration project on HIV rapid tests offered in community and outreach settings, including nongovernmental organization (NGO) facilities, primary care services for migrants and low-threshold services or mobile units for drug users (DU services). HIV rapid test on oral fluid (OraQuick (R); Orasure Technologies) was anonymously offered to eligible people who presented themselves at the selected sites. Those with reactive results were referred to a specialized outpatient unit for confirmatory testing and medical care.
   Results: Over a period of six months a total of 2949 tests were performed and 45.2% of individuals tested had not been previously tested. Overall 0.9% (27/2949) of tested people had a preliminary positive test. In NGO facilities the positivity rate was 1%. All subjects who performed their confirmatory test were confirmed as positive. In services for migrants the positivity rate was 0.5 and 80% were referred to care (with 1 false positive test). In DU services we observed the highest positivity rate (1.4%) but the lowest linkage to care (67%), with 1 false positive test.
   Conclusion: Our project showed that the offering of an HIV rapid testing program in community and outreach settings in Italy is feasible and that it may reach people who have never been tested before, while having a significant yield in terms of new HIV diagnoses as well.
C1 [Scognamiglio, Paola; Chiaradia, Giacomina; Giovanetti, Marta; Ippolito, Giuseppe; Girardi, Enrico] IRCCS, Natl Inst Infect Dis L Spallanzani, Clin Epidemiol Unit, Dept Epidemiol & Preclin Res, Via Portuense 292, I-00149 Rome, Italy.
   [Albertini, Emidio] Onphalos LGBTI Lesbian Gay Bisexual Transgender T, Perugia, Italy.
   [Camposeragna, Antonella] CNCA Natl Coordinat Care Communities, Rome, Italy.
   [Farinella, Massimo] Mario Mieli Homosexual Cultural Circle, Rome, Italy.
   [Lorenzetti, Daniela] ANLAIDS Onlus Italian Natl Assoc Fight Aids, Rome, Italy.
   [Oldrini, Massimo] Lila Onlus Italian League Fight AIDS, Milan, Italy.
   [Rancilio, Laura] Caritas Ambrosiana, AIDS Addict & Mental Hlth Area, Milan, Italy.
   [Caraglia, Anna; Maraglino, Francesco Paolo] Minist Hlth, Directorate Gen Hlth Prevent, Infect Dis Off, Rome, Italy.
RP Chiaradia, G (corresponding author), IRCCS, Natl Inst Infect Dis L Spallanzani, Clin Epidemiol Unit, Dept Epidemiol & Preclin Res, Via Portuense 292, I-00149 Rome, Italy.
EM giacomina.chiaradia@inmi.it
RI Giovanetti, Marta/AAK-7408-2020
OI Albertini, Emidio/0000-0003-2585-5649; Ippolito,
   Giuseppe/0000-0002-1076-2979; Camposeragna,
   Antonella/0000-0002-7571-1216; PERNO, CARLO FEDERICO/0000-0002-0825-5388
FU Italian Ministry of HealthMinistry of Health, Italy; NGOs working in the
   field of HIV/AIDS; Ricerca CorrenteMinistry of Health, ItalyMinistry of
   Health Italy - Ricerca Corrente (MOH-RC)
FX This study was supported by grants from the Italian Ministry of Health
   for Projects conducted in collaboration with NGOs working in the field
   of HIV/AIDS, and Ricerca Corrente to INMI "L. Spallanzani" IRCCS, Rome
   Italy.
CR Bowles KE, 2008, PUBLIC HEALTH REP, V123, P78, DOI 10.1177/00333549081230S310
   Colucci A, 2011, 1141 ISTISAN, Vvi
   Conway DP, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20221
   de la Fuente L, 2009, AIDS PATIENT CARE ST, V23, P625, DOI 10.1089/apc.2009.0019
   Easterbrook P, 2016, AIDS REV, V18, P3
   ECDC, 2010, HIV TEST INCR UPT EF
   Fernandez-Balbuena S, 2014, SEX TRANSM INFECT, V90, P112, DOI 10.1136/sextrans-2013-051234
   Fernandez-Lopez L, 2016, AIDS CARE
   Fernandez-Lopez L, 2016, AIDS CARE, V28, P712, DOI 10.1080/09540121.2016.1164290
   Gourlay AJ, 2017, AIDS, V31, P2053, DOI 10.1097/QAD.0000000000001597
   Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f
   HIV-COBATEST Project Cross-national survey on the implementation of CBVCT programmes, PROJ CROSS NAT SURV
   Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8
   Kakalou E, 2014, J INT AIDS SOC, V17, P86, DOI 10.7448/IAS.17.4.19619
   Laforgerie E, 2010, J VIROL METHODS, V165, P105, DOI 10.1016/j.jviromet.2009.12.007
   Louie B, 2008, J CLIN MICROBIOL, V46, P1494, DOI 10.1128/JCM.01945-07
   Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9
   Organization WH, 2010, SCAL HIV TEST COUNS
   Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1
   Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581
   Peralta L, 2001, ARCH PEDIAT ADOL MED, V155, P838, DOI 10.1001/archpedi.155.7.838
   Ratmann O, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad1863
   Skarbinski J, 2015, JAMA INTERN MED, V175, P588, DOI 10.1001/jamainternmed.2014.8180
   Song RG, 2017, JAIDS-J ACQ IMM DEF, V74, P3, DOI 10.1097/QAI.0000000000001151
   Spielberg F, 2005, JAIDS-J ACQ IMM DEF, V38, P348
   Spielberg F, 2003, JAIDS-J ACQ IMM DEF, V32, P318, DOI 10.1097/00126334-200303010-00012
   Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496
   Thornton AC, 2012, HIV MED, V13, P416, DOI 10.1111/j.1468-1293.2012.00992.x
   UNAIDS, 2014, 90 90 90 AMB TREATM
   WHO, 2013, CONGUID UANT DRU
NR 30
TC 2
Z9 2
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUN 18
PY 2018
VL 18
AR 748
DI 10.1186/s12889-018-5680-6
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GK1QX
UT WOS:000435894600002
PM 29914449
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Cella, E
   Giovanetti, M
   Milano, T
   Fogolari, M
   Garilli, F
   Alexiev, I
   Bazzardi, R
   Salemi, M
   Alcantara, LCJ
   Angeletti, S
   Pascarella, S
   Ciccozzi, M
AF Cella, Eleonora
   Giovanetti, Marta
   Milano, Teresa
   Fogolari, Marta
   Garilli, Francesco
   Alexiev, Ivailo
   Bazzardi, Riccardo
   Salemi, Marco
   Alcantara, Luiz Carlos Junior
   Angeletti, Silvia
   Pascarella, Stefano
   Ciccozzi, Massimo
TI Mayaro virus infection, the next epidemic wave after Zika? Evolutionary
   and structural analysis
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Mayaro virus; Proteins; Evolutionary analysis
ID B-CELL EPITOPES; CHIKUNGUNYA VIRUS; PREDICTION; SEQUENCE; EMERGENCE;
   OUTBREAK; AMERICA; DISEASE; SURFACE; BRAZIL
AB Objective: To evaluate the evolution of the pathogen Mayaro virus, causing Mayaro fever (a mosquito-borne disease) and to perform selective pressure analysis and homology modelling. Methods: Nine different datasets were built, one for each protein (from protein C to non-structural protein 4) and the last one for the complete genome. Selective pressure and homology modelling analyses were applied. Results: Two main clades (A and B) were pointed in the maximum likelihood tree. The clade A included five Brazilian sequences sampled from 1955 to 2015. The Brazilian sequence sampled in 2014 significantly clustered with the Haitian sequence sampled in 2015. The clade B included the remaining 27 sequences sampled in the Central and Southern America from 1957 to 2013. Selective pressure analysis revealed several sites under episodic diversifying selection in envelope surface glycoprotein E1, non-structural protein 1 and nonstructural protein 3 with a posterior probability P <= 0.01. Homology modelling showed different sites modified by selective pressure and some protein-protein interaction sites at high interaction propensity. Conclusion: Maximum likelihood analysis confirmed the Mayaro virus previous circulation in Haiti and the successful spread to the Caribbean and USA. Selective pressure analysis revealed a strong presence of negatively selected sites, suggesting a probable purging of deleterious polymorphisms in functional genes. Homology model showed the position 31, under selective pressure, located in the edge of the ADP-ribose binding site predicting to possess a high potential of protein-protein interaction and suggesting the possible chance for a protective vaccine, thus preventing Mayaro virus urbanization as with Chikungunya virus.
C1 [Cella, Eleonora] Sapienza Univ, Publ Hlth & Infect Dis, Rome, Italy.
   [Cella, Eleonora; Fogolari, Marta; Angeletti, Silvia; Ciccozzi, Massimo] Univ Campus Biomed Rome, Unit Clin Lab Sci, Via Alvaro del Portillo 200, I-00125 Rome, Italy.
   [Giovanetti, Marta; Alcantara, Luiz Carlos Junior] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Milano, Teresa; Pascarella, Stefano] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy.
   [Garilli, Francesco] Univ Campus Biomed Rome, Dept Med, Rome, Italy.
   [Alexiev, Ivailo] Natl Ctr Infect & Parasit Dis, Natl Reference Lab HIV, Sofia, Bulgaria.
   [Bazzardi, Riccardo] Expt Zooprophylact Inst Sardinia, Dept Food Hyg, Sassari, Italy.
   [Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
RP Cella, E; Angeletti, S; Ciccozzi, M (corresponding author), Univ Campus Biomed Rome, Unit Clin Lab Sci, Via Alvaro del Portillo 200, I-00125 Rome, Italy.
EM Eleonora.cella@yahoo.it; s.angeletti@unicampus.it; ciccozzi@iss.it
RI Cella, Eleonora/ABA-8333-2020; BAZZARDI, RICCARDO/M-2103-2019; Cella,
   Eleonora/J-9961-2016; Giovanetti, Marta/AAK-7408-2020; Bazzardi,
   Riccardo/G-3191-2019; Fogolari, Marta/X-1945-2019
OI Cella, Eleonora/0000-0002-7870-9744; BAZZARDI,
   RICCARDO/0000-0001-5528-6892; Cella, Eleonora/0000-0002-7870-9744;
   Bazzardi, Riccardo/0000-0001-5528-6892; Alcantara,
   Luiz/0000-0002-6769-9931; Alexiev, Ivailo/0000-0002-3186-1124
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Mota MTD, 2015, FUTURE VIROL, V10, P1109, DOI 10.2217/fvl.15.76
   Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471250953.bi0506s15, 10.1002/cpbi.3, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Gouandijka-Vasilache I, 2014, EMERG INFECT DIS, V20, P1254, DOI 10.3201/eid2007.131839
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829
   Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lavergne A, 2006, VIRUS RES, V117, P283, DOI 10.1016/j.virusres.2005.11.006
   Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381
   Liang SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-302
   Lo Presti A, 2016, INFECT GENET EVOL, V41, P270, DOI 10.1016/j.meegid.2016.04.006
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   McPherson RL, 2017, P NATL ACAD SCI USA, V114, P1666, DOI 10.1073/pnas.1621485114
   MEYER WJ, 1993, J VIROL, V67, P5117, DOI 10.1128/JVI.67.9.5117-5125.1993
   Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Potocnakova L, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6760830
   Powers A, 2011, VIRUS TAXONOMY, P1103
   Rack JGM, 2016, ANNU REV BIOCHEM, V85, P431, DOI 10.1146/annurev-biochem-060815-014935
   ROBINSON DM, 1976, MIL MED, V141, P163
   Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014
   Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Schroedinger LLC, 2015, PYMOL MOL GRAPH SYST
   SIEVERS F, 2014, CURR PROTOC BIOINFOR, V48, P3, DOI DOI 10.1002/0471250953.BI0313S48
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199
   Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Yao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045152
NR 57
TC 1
Z9 1
U1 0
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD MAR
PY 2018
VL 11
IS 3
BP 194
EP 201
DI 10.4103/1995-7645.228433
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GB1VD
UT WOS:000428837700003
OA DOAJ Gold
DA 2020-11-24
ER

PT J
AU Wadoum, REG
   Samin, A
   Mafopa, NG
   Giovanetti, M
   Russo, G
   Turay, P
   Turay, J
   Kargbo, M
   Kanu, MT
   Kargbo, B
   Akpablie, J
   Cain, CJ
   Pasin, P
   Batwala, V
   Sobze, MS
   Potesta, M
   Minutolo, A
   Colizzi, V
   Montesano, C
AF Wadoum, R. E. Guetiya
   Samin, A.
   Mafopa, N. G.
   Giovanetti, M.
   Russo, G.
   Turay, P.
   Turay, J.
   Kargbo, M.
   Kanu, M. T.
   Kargbo, B.
   Akpablie, J.
   Cain, C. J.
   Pasin, P.
   Batwala, V.
   Sobze, M. S.
   Potesta, M.
   Minutolo, A.
   Colizzi, V.
   Montesano, C.
TI Mobile health clinic for the medical management of clinical sequelae
   experienced by survivors of the 2013-2016 Ebola virus disease outbreak
   in Sierra Leone, West Africa
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Article
ID UGANDA
AB An Ebola survivor Mobile Health Clinic (MHC) was established to implement lasting changes in communities it operates by providing effective and efficient mobile healthcare. After months of development, the MHC solution was operationalised in February 2015, aiming to provide integrated primary healthcare services to address the medical and psychosocial needs of Ebola virus (EBOV) survivors living in areas with low medical coverage. A total of 910 medical consultations for 246 EBOV survivors were performed between 7 February 2015 and 10 June 2016. Females constituted 148 (60.2%) whereas 6 (2.44%) were children under 5 years of age. The most common complication was arthralgia 185 (75.2%), headache 98 (39.8%), abdominal pain 167 (68%), myalgia 182 (73.6%), and skin disease 25 (10%). Moreover, ocular problems were diagnosed in 84 survivors (34.1%), and 60 (24.4%) suffered from psycho-trauma. Some 16 female survivors (10.8%) had miscarriages, whereas 9 (6.1%) had complaints of oligomenorrhea, 7 (4.7%) loss of sexual desire and 4 (2.7%) premature menopause. Five male survivors (5.1%) reported erectile dysfunction and 10 (10.2%) loss of sexual desire. At least 221 (89.8%) reported more than one complication. Other infectious diseases were common and no clinically relevant differences were established from haematology and clinical biochemistry laboratory results. Ibuprofen, paracetamol, anti-malaria drugs and antibiotics were the most common medicines prescribed. Community participation is critical for implantation of MHC among EBOV survivors. Future strategies for the mobile clinics should include enrolment of survivors at discharge from treatment centres with close monitoring follow-up activities, to address sequelae as they arise, to reduce the potential for development of long-term disabilities.
C1 [Wadoum, R. E. Guetiya; Giovanetti, M.; Potesta, M.; Minutolo, A.; Colizzi, V.; Montesano, C.] Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, I-00133 Rome, Italy.
   [Wadoum, R. E. Guetiya; Turay, P.; Turay, J.; Colizzi, V.; Montesano, C.] Univ Makeni, Dept Publ Hlth, Makeni, Sierra Leone.
   [Wadoum, R. E. Guetiya; Mafopa, N. G.; Giovanetti, M.; Russo, G.; Potesta, M.; Minutolo, A.; Colizzi, V.; Montesano, C.] Holy Spirit Hosp, MBIL, Makeni, Sierra Leone.
   [Wadoum, R. E. Guetiya; Mafopa, N. G.] Univ Dschang, Dept Biochem, Dschang, Cameroon.
   [Samin, A.; Cain, C. J.] World Hope Int, Freetown, Sierra Leone.
   [Giovanetti, M.] Natl Inst Hlth ISS, Rome, Italy.
   [Russo, G.] Univ Rome 1 La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Turay, P.; Turay, J.] Holy Spirit Hosp, Makeni, Sierra Leone.
   [Kargbo, M.] Partner Relief Dev, Freetown, Sierra Leone.
   [Kanu, M. T.] Sierra Leone Assoc Ebola Survivors Bombali Branch, Bombali, Sierra Leone.
   [Kargbo, B.] Sierra Leone Minist Hlth & Sanitat MoHS, Freetown, Sierra Leone.
   [Akpablie, J.] WHO, Freetown, Sierra Leone.
   [Pasin, P.] ENGIM Italian Cooperat, Vicenza, Italy.
   [Batwala, V.] African Union Support Ebola Outbreak West Africa, Freetown, Freetown, Sierra Leone.
   [Batwala, V.] Mbarara Univ Sci & Technol, Mbarara, Uganda.
   [Sobze, M. S.] Univ Dschang, Dept Biomed Sci, Dschang, Cameroon.
RP Wadoum, REG; Colizzi, V; Montesano, C (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, I-00133 Rome, Italy.; Wadoum, REG; Colizzi, V; Montesano, C (corresponding author), Univ Makeni, Dept Publ Hlth, Makeni, Sierra Leone.; Wadoum, REG; Colizzi, V; Montesano, C (corresponding author), Holy Spirit Hosp, MBIL, Makeni, Sierra Leone.; Wadoum, REG (corresponding author), Univ Dschang, Dept Biochem, Dschang, Cameroon.
EM raoulemeric@gmail.com; colizzi@bio.uniroma2.it; montesano@uniroma2.it
RI MINUTOLO, ANTONELLA/AAA-1788-2020; Giovanetti, Marta/AAK-7408-2020;
   Russo, Gianluca/N-4362-2019
OI Russo, Gianluca/0000-0002-8764-7389; Montesano,
   Carla/0000-0002-9865-6619; Guetiya Wadoum, Raoul
   Emeric/0000-0002-1031-0649; minutolo, antonella/0000-0003-4784-4297;
   Giovanetti, Marta/0000-0002-5849-7326
FU Makeni diocese; World Hope International, Italian Episcopal Conference
   (Caritas-Camillian); Italian Cooperation; Italian Geographic Society
   (Nando Peretti Foundation); University of Rome "Tor Vergata"; Partner
   Relief Development (PaRD), Sierra Leone
FX This study received funding from the Makeni diocese (personnel and
   equipment), World Hope International, Italian Episcopal Conference
   (Caritas-Camillian), Italian Cooperation (Dokita 1, Dokita 2, Engim),
   Italian Geographic Society (Nando Peretti Foundation), University of
   Rome "Tor Vergata," and Partner Relief Development (PaRD), Sierra Leone.
CR [Anonymous], 2012, MOB HLTH CLIN PLAN
   Arwady MA, 2014, MMWR-MORBID MORTAL W, V63, P1207
   Chughtai AA, 2016, EPIDEMIOL INFECT, V144, P1652, DOI 10.1017/S0950268816000054
   Clark DV, 2015, LANCET INFECT DIS, V15, P905, DOI 10.1016/S1473-3099(15)70152-0
   De Roo A, 1998, TROP MED INT HEALTH, V3, P883, DOI 10.1046/j.1365-3156.1998.00322.x
   Gidado Saheed, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.0b805cac244d700a47d6a3713ef2d6db
   Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017
   Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242
   Hugo M, 2015, EMERG MED LOS ANGEL, V5, P285, DOI DOI 10.4172/2165-7548.1000285
   Lindgren TG, 2011, RURAL REMOTE HEALTH, V11
   Mattia JG, 2016, LANCET INFECT DIS, V16, P331, DOI 10.1016/S1473-3099(15)00489-2
   Ministry of Health and Sanitation, 2015, SIERR LEON BAS PACK
   Mohammed H, 2017, EMERG INFECT DIS, V23, P66, DOI 10.3201/eid2301.160631
   Nabena EP, 2015, OPEN MED J, V2, P53
   Nanyonga M, 2016, CLIN INFECT DIS, V62, P125, DOI 10.1093/cid/civ795
   Scott JT, 2016, EMERG INFECT DIS, V22, P641, DOI 10.3201/eid2204.151302
   Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158
   UNDP, 2013, HUM DEV REP RIS S HU
   WHO-EVD, 2016, WHOEVDOHEPED16
NR 19
TC 6
Z9 6
U1 2
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD NOV
PY 2017
VL 36
IS 11
BP 2193
EP 2200
DI 10.1007/s10096-017-3045-1
PG 8
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FK6NH
UT WOS:000413620200024
PM 28695354
DA 2020-11-24
ER

PT J
AU Faria, NR
   Quick, J
   Claro, IM
   Theze, J
   de Jesus, JG
   Giovanetti, M
   Kraemer, MUG
   Hill, SC
   Black, A
   da Costa, AC
   Franco, LC
   Silva, SP
   Wu, CH
   Raghwani, J
   Cauchemez, S
   du Plessis, L
   Verotti, MP
   de Oliveira, WK
   Carmo, EH
   Coelho, GE
   Santelli, ACFS
   Vinhal, LC
   Henriques, CM
   Simpson, JT
   Loose, M
   Andersen, KG
   Grubaugh, ND
   Somasekar, S
   Chiu, CY
   Munoz-Medina, JE
   Gonzalez-Bonilla, CR
   Arias, CF
   Lewis-Ximenez, LL
   Baylis, SA
   Chieppe, AO
   Aguiar, SF
   Fernandes, CA
   Lemos, PS
   Nascimento, BLS
   Monteiro, HAO
   Siqueira, IC
   de Queiroz, MG
   de Souza, TR
   Bezerra, JF
   Lemos, MR
   Pereira, GF
   Loudal, D
   Moura, LC
   Dhalia, R
   Franca, RF
   Magalhaes, T
   Marques, ET
   Jaenisch, T
   Wallau, GL
   de Lima, MC
   Nascimento, V
   de Cerqueira, EM
   de Lima, MM
   Mascarenhas, DL
   Neto, JPM
   Levin, AS
   Tozetto-Mendoza, TR
   Fonseca, SN
   Mendes-Correa, MC
   Milagres, FP
   Segurado, A
   Holmes, EC
   Rambaut, A
   Bedford, T
   Nunes, MRT
   Sabino, EC
   Alcantara, LCJ
   Loman, NJ
   Pybus, OG
AF Faria, N. R.
   Quick, J.
   Claro, I. M.
   Theze, J.
   de Jesus, J. G.
   Giovanetti, M.
   Kraemer, M. U. G.
   Hill, S. C.
   Black, A.
   da Costa, A. C.
   Franco, L. C.
   Silva, S. P.
   Wu, C. -H.
   Raghwani, J.
   Cauchemez, S.
   du Plessis, L.
   Verotti, M. P.
   de Oliveira, W. K.
   Carmo, E. H.
   Coelho, G. E.
   Santelli, A. C. F. S.
   Vinhal, L. C.
   Henriques, C. M.
   Simpson, J. T.
   Loose, M.
   Andersen, K. G.
   Grubaugh, N. D.
   Somasekar, S.
   Chiu, C. Y.
   Munoz-Medina, J. E.
   Gonzalez-Bonilla, C. R.
   Arias, C. F.
   Lewis-Ximenez, L. L.
   Baylis, S. A.
   Chieppe, A. O.
   Aguiar, S. F.
   Fernandes, C. A.
   Lemos, P. S.
   Nascimento, B. L. S.
   Monteiro, H. A. O.
   Siqueira, I. C.
   de Queiroz, M. G.
   de Souza, T. R.
   Bezerra, J. F.
   Lemos, M. R.
   Pereira, G. F.
   Loudal, D.
   Moura, L. C.
   Dhalia, R.
   Franca, R. F.
   Magalhaes, T.
   Marques, E. T., Jr.
   Jaenisch, T.
   Wallau, G. L.
   de Lima, M. C.
   Nascimento, V.
   de Cerqueira, E. M.
   de Lima, M. M.
   Mascarenhas, D. L.
   Moura Neto, J. P.
   Levin, A. S.
   Tozetto-Mendoza, T. R.
   Fonseca, S. N.
   Mendes-Correa, M. C.
   Milagres, F. P.
   Segurado, A.
   Holmes, E. C.
   Rambaut, A.
   Bedford, T.
   Nunes, M. R. T.
   Sabino, E. C.
   Alcantara, L. C. J.
   Loman, N. J.
   Pybus, O. G.
TI Establishment and cryptic transmission of Zika virus in Brazil and the
   Americas
SO NATURE
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; EVOLUTION; TIME; EMERGENCE; MODELS; DENGUE;
   BAHIA; RECOMBINATION; SEQUENCES; SELECTION
AB Transmission of Zika virus (ZIKV) in the Americas was first confirmed in May 2015 in northeast Brazil(1). Brazil has had the highest number of reported ZIKV cases worldwide (more than 200,000 by 24 December 20162) and the most cases associated with microcephaly and other birth defects (2,366 confirmed by 31 December 20162). Since the initial detection of ZIKV in Brazil, more than 45 countries in the Americas have reported local ZIKV transmission, with 24 of these reporting severe ZIKV-associated disease(3). However, the origin and epidemic history of ZIKV in Brazil and the Americas remain poorly understood, despite the value of this information for interpreting observed trends in reported microcephaly. Here we address this issue by generating 54 complete or partial ZIKV genomes, mostly from Brazil, and reporting data generated by a mobile genomics laboratory that travelled across northeast Brazil in 2016. One sequence represents the earliest confirmed ZIKV infection in Brazil. Analyses of viral genomes with ecological and epidemiological data yield an estimate that ZIKV was present in northeast Brazil by February 2014 and is likely to have disseminated from there, nationally and internationally, before the first detection of ZIKV in the Americas. Estimated dates for the international spread of ZIKV from Brazil indicate the duration of pre-detection cryptic transmission in recipient regions. The role of northeast Brazil in the establishment of ZIKV in the Americas is further supported by geographic analysis of ZIKV transmission potential and by estimates of the basic reproduction number of the virus.
C1 [Faria, N. R.; Theze, J.; Kraemer, M. U. G.; Hill, S. C.; Raghwani, J.; du Plessis, L.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford OX1 3SY, England.
   [Faria, N. R.; Franco, L. C.; Silva, S. P.; Lemos, P. S.; Nascimento, B. L. S.; Monteiro, H. A. O.; Nunes, M. R. T.] Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Quick, J.; Loman, N. J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Claro, I. M.; da Costa, A. C.; Levin, A. S.; Tozetto-Mendoza, T. R.; Mendes-Correa, M. C.; Segurado, A.; Sabino, E. C.] Univ Sao Paulo, Sch Med, Dept Infect Dis, Sao Paulo, Brazil.
   [Claro, I. M.; da Costa, A. C.; Levin, A. S.; Tozetto-Mendoza, T. R.; Mendes-Correa, M. C.; Segurado, A.; Sabino, E. C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [de Jesus, J. G.; Giovanetti, M.; Siqueira, I. C.; Alcantara, L. C. J.] Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, M.] Univ Roma Tor Vergata, Rome, Italy.
   [Kraemer, M. U. G.] Harvard Med Sch, Boston, MA USA.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Black, A.; Bedford, T.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Black, A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Wu, C. -H.] Univ Oxford, Dept Stat, Oxford OX1 3LB, England.
   [Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Cauchemez, S.] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
   [Cauchemez, S.] Ctr Natl Rech Sci, URA3012, Paris, France.
   [Verotti, M. P.] Minist Hlth, Coordena Lab Saude CGLAB DEVIT SVS, Brasilia, DF, Brazil.
   [de Oliveira, W. K.] Minist Hlth, Coordena Geral Vigilincia & Resposta Emergencias, Brasilia, DF, Brazil.
   [de Oliveira, W. K.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Data & Knowledge Integrat Hlth CIDACS, Salvador, BA, Brazil.
   [Carmo, E. H.; Henriques, C. M.] Minist Hlth, Dept Vigilincia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Coelho, G. E.; Santelli, A. C. F. S.; Vinhal, L. C.] Minist Hlth, Coordena Geral Programas Controle & Preven Malari, Brasilia, DF, Brazil.
   [Coelho, G. E.] PAHO, Buenos Aires, DF, Argentina.
   [Santelli, A. C. F. S.] Fundacao Oswaldo Cruz FIOCRUZ, Rio De Janeiro, Brazil.
   [Simpson, J. T.] Ontario Inst Canc Res, Toronto, ON, Canada.
   [Loose, M.] Univ Nottingham, Nottingham, England.
   [Andersen, K. G.; Grubaugh, N. D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Somasekar, S.; Chiu, C. Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Somasekar, S.; Chiu, C. Y.] Univ Calif San Francisco, Dept Med Infect & Dis, San Francisco, CA 94143 USA.
   [Munoz-Medina, J. E.; Gonzalez-Bonilla, C. R.] Inst Mexicano Seguro Social, Div Labs Vigilancia & Invest Epidemiol, Mexico City, DF, Mexico.
   [Arias, C. F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.
   [Lewis-Ximenez, L. L.] Inst Oswaldo Cruz FIOCRUZ, Rio De Janeiro, Brazil.
   [Baylis, S. A.] Paul Ehrlich Inst, Langen, Germany.
   [Chieppe, A. O.; Aguiar, S. F.; Fernandes, C. A.] Lab Cent Saude Publ Noel Nutels, Rio De Janeiro, Brazil.
   [de Queiroz, M. G.; de Souza, T. R.; Bezerra, J. F.] Labo Cent Saude Publ Estado Rio Grande Norte, Natal, RN, Brazil.
   [de Souza, T. R.] Univ Potiguar Rio Grande Norte, Natal, RN, Brazil.
   [Bezerra, J. F.] Fundacao Natalense Ensino & Cultura, Natal, RN, Brazil.
   [Lemos, M. R.; Pereira, G. F.; Loudal, D.; Moura, L. C.] Lab Cent Saude Publ Estado Paraiba, Joao Pessoa, Paraiba, Brazil.
   [Dhalia, R.; Franca, R. F.; Magalhaes, T.; Marques, E. T., Jr.; Wallau, G. L.] Fundacao Oswaldo Cruz FIOCRUZ, Recife, PE, Brazil.
   [Magalhaes, T.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   Univ Pittsburgh, Grad Sch Publ Hlth, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Jaenisch, T.] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [de Lima, M. C.; Nascimento, V.; de Cerqueira, E. M.] Lab Cent Saude Publ Estado Alagoas, Maceio, Brazil.
   [de Lima, M. M.] Univ Estadual Feira de Santana, Feira Santana, Bahia, Argentina.
   [Mascarenhas, D. L.] Secretaria Saude Feira Santana, Feira De Santana, Bahia, Brazil.
   [Moura Neto, J. P.] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Fonseca, S. N.] Hosp Sao Francisco, Ribeirao Preto, Brazil.
   [Milagres, F. P.] Univ Fed Tocantins, Palmas, Brazil.
   [Holmes, E. C.] Univ Sydney, Sydney, NSW, Australia.
   [Rambaut, A.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Rambaut, A.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Nunes, M. R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Pybus, O. G.] Metabiota, San Francisco, CA 94104 USA.
RP Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3SY, England.; Loman, NJ (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.; Sabino, EC (corresponding author), Univ Sao Paulo, Sch Med, Dept Infect Dis, Sao Paulo, Brazil.; Sabino, EC (corresponding author), Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.; Alcantara, LCJ (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.; Pybus, OG (corresponding author), Metabiota, San Francisco, CA 94104 USA.
EM sabinoec@usp.br; lalcan@bahia.fiocruz.br; n.j.loman@bham.ac.uk;
   oliver.pybus@zoo.ox.ac.uk
RI Marques, Ernesto T. A/L-4967-2013; Pybus, Oliver G/B-2640-2012; Bezerra,
   Joao Felipe/AAE-2500-2020; Dhalia, Rafael/AAD-5432-2020; Segurado,
   Aluisio C/K-2229-2012; da-Costa, Antonio Charlys/G-1548-2010;
   Giovanetti, Marta/AAK-7408-2020; Arias, Carlos/O-4036-2019; Magalhaes,
   Tereza/V-6632-2019; de Siqueira, Isadora Cristina/R-9953-2016; Rambaut,
   Andrew/B-2481-2009; Wallau, Gabriel Luz/B-5911-2008; Levin, Anna
   S/C-8831-2012; Faria, Nuno R/I-2975-2012; Esteban, Munoz Medina
   Jose/B-6186-2015; Bezerrra, Joao/C-8867-2017; Sabino, Ester
   Cerdeira/F-7750-2010; milagres, flavio/Q-2403-2019; Oliveira, Claudia
   DL/G-8618-2011; Loman, Nicholas/Z-1573-2019
OI Marques, Ernesto T. A/0000-0003-3826-9358; Pybus, Oliver
   G/0000-0002-8797-2667; Segurado, Aluisio C/0000-0002-6311-8036;
   da-Costa, Antonio Charlys/0000-0001-5516-5177; Arias,
   Carlos/0000-0003-3130-4501; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Rambaut, Andrew/0000-0003-4337-3707;
   Wallau, Gabriel Luz/0000-0002-1419-5713; Levin, Anna
   S/0000-0003-2427-8368; Faria, Nuno R/0000-0001-8839-2798; Esteban, Munoz
   Medina Jose/0000-0002-1289-4457; Bezerrra, Joao/0000-0002-9978-628X;
   Sabino, Ester Cerdeira/0000-0003-2623-5126; Loman,
   Nicholas/0000-0002-9843-8988; Hill, Sarah/0000-0002-2995-2596;
   Alcantara, Luiz/0000-0002-6769-9931; Theze, Julien/0000-0001-8188-9494;
   Holmes, Edward/0000-0001-9596-3552; Vinhal Frutuoso, Livia
   Carla/0000-0001-7926-1075; Grubaugh, Nathan/0000-0003-2031-1933; Wu,
   Chieh-Hsi/0000-0001-9386-725X; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; Giovanetti, Marta/0000-0002-5849-7326;
   Raghwani, Jayna/0000-0001-8538-4995; Loose, Matthew/0000-0002-5264-0929;
   Black, Allison/0000-0002-6618-4127
FU MRC/Wellcome Trust/Newton Fund Zika Rapid Response grant
   [MC_PC_15100/ZK/16-078]; USAID Emerging Pandemic Threats Program-2
   PREDICT-2United States Agency for International Development (USAID)
   [AID-OAA-A-14-00102]; MRC Bioinformatics Fellowship; Sir Henry Dale
   Fellowship [204311/Z/16/Z]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [457480/2014-9, 302584/2015-3,
   439975/2016-6]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2012/03417-7]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R35 GM119774,
   R01 HL105704]; NSFNational Science Foundation (NSF) [DGE-1256082];
   Abbott Laboratories, Inc.Abbott Laboratories; National Health and
   Medical Research CouncilNational Health and Medical Research Council of
   Australia [GNT1037231]; MRCMedical Research Council UK (MRC); CRUKCancer
   Research UK [ANR00310]; Wellcome TrustWellcome Trust; Royal SocietyRoyal
   Society of London [101237/Z/13/Z]; ERCEuropean Research Council (ERC)
   [614725-PATHPHYLODYN, 278433-PREDEMICS]; EUEuropean Union (EU)
   [643476-COMPARE, 734548-ZIKAlliance]; IDAMS; DENFREE; DengueTools;
   PPSUSFACEPE [APQ-0302-4.01/13]; FACEPE [APQ-0044.2.11/16,
   APQ-0055.2.11/16]; German Ministry of Health; Medical Research
   CouncilMedical Research Council UK (MRC) [MR/L015080/1, MR/M501621/1,
   MC_PC_15100] Funding Source: researchfish; NATIONAL HEART, LUNG, AND
   BLOOD INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [R01HL105704, R01HL105704, R01HL105704,
   R01HL105704, R01HL105704, R01HL105704, R01HL105704, R01HL105704,
   R01HL105704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   R33AI120977, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, R21AI120977, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   R33AI120977, T32AI007244, R21AI120977, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R35GM119774,
   R35GM119774, R35GM119774, R35GM119774, R35GM119774] Funding Source: NIH
   RePORTER
FX We thank Fundacao Oswaldo Cruz in Bahia and Pernambuco states,
   University of Sao Paulo, Instituto Evandro Chagas, and the Brazilian
   Zika virus surveillance network for their essential contributions. We
   thank the following for giving us permission to use their unpublished
   genomes available on GenBank: R. Lanciotti, J. Lednicky, A. Enfissi, F.
   Baldanti, R. Shabman, B. Picket, R. Schinazi, M. Bonaldo, M. Gale, M.
   Capobianchi and C. Concetta, M. Leguia, J. Alberto Diaz, E.
   Sevilla-Reyes, A. Franz, M. GarciaBlanco and M. J. van Hemert. We thank
   P. Fernando da Costa Vasconcelos, S. Guerreiro Rodrigues, J. Cardoso, J.
   Vasconcelos, J. Vianez Jr, J. Gil Melgaco, J. Blumel, M. C. Brito
   Lobato, L. Nunes Fava, C. Ayres, L. Abade and F. Campos. L. C. J. A.
   thanks QIAGEN for reagents and equipment and M. R. T. N. thanks FERPEL
   for consumables. We thank Oxford Nanopore for technical support,
   particularly R. Dokos, Z. McDougall, S. Cowan, G. Sanghera, and O.
   Hartwell. This work was supported by an MRC/Wellcome Trust/Newton Fund
   Zika Rapid Response grant (MC_PC_15100/ZK/16-078) and by the USAID
   Emerging Pandemic Threats Program-2 PREDICT-2 (Cooperative Agreement
   AID-OAA-A-14-00102). N. J. L. is supported by an MRC Bioinformatics
   Fellowship. N. R. F. is funded by a Sir Henry Dale Fellowship (grant
   204311/Z/16/Z). CNPq contributed to trip expenses (grant 457480/2014-9).
   A.C.d.C. was supported by FAPESP # 2012/03417-7 and M. R. T. N. by CNPq
   grant no. 302584/2015-3. A. B. and T. B. were supported by NIH award R35
   GM119774. A. B. is supported by the NSF Graduate Research Fellowship
   Program (grant DGE-1256082). T. B. is a Pew Biomedical Scholar. C.Y.C.
   is partially supported by NIH grant R01 HL105704 and an award from
   Abbott Laboratories, Inc. E. C. H. is supported by a National Health and
   Medical Research Council Australia Fellowship (GNT1037231). C.- H. W. is
   supported by the MRC and CRUK (ANR00310) and by the Wellcome Trust and
   Royal Society (grant 101237/Z/13/Z). S. C. H. is supported by the
   Wellcome Trust. This research received funding from the ERC under grant
   agreements 614725-PATHPHYLODYN and 278433-PREDEMICS, and from EU Horizon
   2020 under agreements 643476-COMPARE and 734548-ZIKAlliance. T. J. and
   E. T. M. acknowledge funding from IDAMS, DENFREE, DengueTools, and
   PPSUSFACEPE (project APQ-0302-4.01/13). R. F. F. received funding from
   FACEPE (APQ-0044.2.11/16 and APQ-0055.2.11/16) and from CNPq
   (439975/2016-6). S. A. B. was supported by the Sicherheit von Blut und
   Geweben hinsichtlich der Abwesenheit von Zikaviren from the German
   Ministry of Health.
CR [Anonymous], 2014, R LANG ENV COMP
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   De Maio N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005421
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Grubaugh N. D., 2017, NATURE
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kozlov AM, 2015, BIOINFORMATICS, V31, P2577, DOI 10.1093/bioinformatics/btv184
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Liu H, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.109
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Metsky HC, 2017, NATURE
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Ministerio da Saade, 2017, B EP SECR VIG SAUD
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Pacheco O., 2016, NEW ENGL J MED
   PAHO/WHO, 2016, PAHO WHO ZIK EP UPD
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Quick J., 2017, NAT PROTOCOLS
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Schierup MH, 2000, GENETICS, V156, P879
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 62
TC 226
Z9 230
U1 6
U2 80
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 15
PY 2017
VL 546
IS 7658
BP 406
EP +
DI 10.1038/nature22401
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX5BK
UT WOS:000403250900035
PM 28538727
OA Green Published, Green Accepted
DA 2020-11-24
ER

PT J
AU Quick, J
   Grubaugh, ND
   Pullan, ST
   Claro, IM
   Smith, AD
   Gangavarapu, K
   Oliveira, G
   Robles-Sikisaka, R
   Rogers, TF
   Beutler, NA
   Burton, DR
   Lewis-Ximenez, LL
   de Jesus, JG
   Giovanetti, M
   Hill, SC
   Black, A
   Bedford, T
   Carroll, MW
   Nunes, M
   Alcantara, LC
   Sabino, EC
   Baylis, SA
   Faria, NR
   Loose, M
   Simpson, JT
   Pybus, OG
   Andersen, KG
   Loman, NJ
AF Quick, Joshua
   Grubaugh, Nathan D.
   Pullan, Steven T.
   Claro, Ingra M.
   Smith, Andrew D.
   Gangavarapu, Karthik
   Oliveira, Glenn
   Robles-Sikisaka, Refugio
   Rogers, Thomas F.
   Beutler, Nathan A.
   Burton, Dennis R.
   Lewis-Ximenez, Lia Laura
   de Jesus, Jaqueline Goes
   Giovanetti, Marta
   Hill, Sarah C.
   Black, Allison
   Bedford, Trevor
   Carroll, Miles W.
   Nunes, Marcio
   Alcantara, Luiz Carlos, Jr.
   Sabino, Ester C.
   Baylis, Sally A.
   Faria, Nuno R.
   Loose, Matthew
   Simpson, Jared T.
   Pybus, Oliver G.
   Andersen, Kristian G.
   Loman, Nicholas J.
TI Multiplex PCR method for MinION and Illumina sequencing of Zika and
   other virus genomes directly from clinical samples
SO NATURE PROTOCOLS
LA English
DT Article
ID SURESELECT TARGET ENRICHMENT; REAL-TIME; EBOLA; SURVEILLANCE;
   AMPLIFICATION; EVOLUTION; INSIGHTS; PASSAGES; ROBUST; LASSA
AB Genome sequencing has become a powerful tool for studying emerging infectious diseases; however, genome sequencing directly from clinical samples (i.e., without isolation and culture) remains challenging for viruses such as Zika, for which metagenomic sequencing methods may generate insufficient numbers of viral reads. Here we present a protocol for generating coding-sequence-complete genomes, comprising an online primer design tool, a novel multiplex PCR enrichment protocol, optimized library preparation methods for the portable MinION sequencer (Oxford Nanopore Technologies) and the Illumina range of instruments, and a bioinformatics pipeline for generating consensus sequences. The MinION protocol does not require an Internet connection for analysis, making it suitable for field applications with limited connectivity. Our method relies on multiplex PCR for targeted enrichment of viral genomes from samples containing as few as 50 genome copies per reaction. Viral consensus sequences can be achieved in 1-2 d by starting with clinical samples and following a simple laboratory workflow. This method has been successfully used by several groups studying Zika virus evolution and is facilitating an understanding of the spread of the virus in the Americas. The protocol can be used to sequence other viral genomes using the online Primal Scheme primer designer software. It is suitable for sequencing either RNA or DNA viruses in the field during outbreaks or as an inexpensive, convenient method for use in the lab.
C1 [Quick, Joshua; Smith, Andrew D.; Loman, Nicholas J.] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Grubaugh, Nathan D.; Gangavarapu, Karthik; Robles-Sikisaka, Refugio; Rogers, Thomas F.; Beutler, Nathan A.; Burton, Dennis R.; Andersen, Kristian G.] Scripps Res Inst, La Jolla, CA 92037 USA.
   [Pullan, Steven T.; Carroll, Miles W.; Andersen, Kristian G.] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [Oliveira, Glenn; Andersen, Kristian G.] Scripps Translat Sci Inst, La Jolla, CA USA.
   [Rogers, Thomas F.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Lewis-Ximenez, Lia Laura] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [de Jesus, Jaqueline Goes; Giovanetti, Marta; Alcantara, Luiz Carlos, Jr.] Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Rome, Tor Vergata, Italy.
   [Hill, Sarah C.; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Black, Allison; Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Black, Allison] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Carroll, Miles W.] Univ Southampton, South Gen Hosp, Southampton, Hants, England.
   [Nunes, Marcio] Inst Evandro Chagas, Belem, Para, Brazil.
   [Baylis, Sally A.] Paul Ehrlich Inst, Langen, Germany.
   [Loose, Matthew] Univ Nottingham, Sch Life Sci, DeepSeq, Nottingham, England.
   [Simpson, Jared T.] OICR, Toronto, ON, Canada.
RP Loman, NJ (corresponding author), Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.
EM n.j.loman@bham.ac.uk
RI Faria, Nuno R/I-2975-2012; Loman, Nicholas/Z-1573-2019; Pybus, Oliver
   G/B-2640-2012; Sabino, Ester Cerdeira/F-7750-2010; Giovanetti,
   Marta/AAK-7408-2020
OI Faria, Nuno R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667;
   Sabino, Ester Cerdeira/0000-0003-2623-5126; Hill,
   Sarah/0000-0002-2995-2596; Grubaugh, Nathan/0000-0003-2031-1933; Loman,
   Nicholas/0000-0002-9843-8988; Beutler, Nathan/0000-0003-3240-9524;
   Alcantara, Luiz/0000-0002-6769-9931; Loose, Matthew/0000-0002-5264-0929;
   Pullan, Steven/0000-0002-8983-599X; Black, Allison/0000-0002-6618-4127;
   Giovanetti, Marta/0000-0002-5849-7326
FU Brazilian Ministry of Health and the Latin American Community Engagement
   Networks (LACENs); Medical Research Council/Wellcome Trust/Newton Fund
   Zika Rapid Response Initiative [ZK/16-078]; Medical Research Council
   Bioinformatics Fellowship as part of the Cloud Infrastructure for
   Microbial Bioinformatics (CLIMB) project; National Institutes of Health
   (NIH)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5T32AI007244-33]; NIH National Center
   for Advancing Translational Studies Clinical and Translational Science
   Award [UL1TR001114]; National Institute of Allergy and Infectious
   Diseases (NIAID)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [HHSN272201400048C]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R35 GM119774, U54 GM111274]; National Science
   Foundation Graduate Research Fellowship ProgramNational Science
   Foundation (NSF) [DGE-1256082]; Sir Henry Dale Fellowship (Wellcome
   Trust/Royal Society) [204311/Z/16/Z]; grant ('Sicherheit von
   Blut(produkten) und Geweben hinsichtlich der Abwesenheit von Zikaviren')
   from the German Ministry of Health; USAID Emerging Pandemic Threats
   Program-2 PREDICT-2United States Agency for International Development
   (USAID) [AID-OAA-A-14-00102]; Medical Research CouncilMedical Research
   Council UK (MRC) [MR/L015080/1, MC_PC_15100, MR/M501621/1] Funding
   Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244, T32AI007244,
   T32AI007244, T32AI007244, T32AI007244, T32AI007244] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [U54GM111274, U54GM111274, U54GM111274, U54GM111274, U54GM111274,
   U54GM111274, U54GM111274, U54GM111274, U54GM111274, U54GM111274,
   U54GM111274, U54GM111274, U54GM111274, U54GM111274, R35GM119774,
   U54GM111274, U54GM111274, U54GM111274, R35GM119774, U54GM111274,
   U54GM111274, U54GM111274, R35GM119774, U54GM111274, U54GM111274,
   U54GM111274, U54GM111274, U54GM111274, U54GM111274, U54GM111274,
   U54GM111274, U54GM111274, U54GM111274, R35GM119774] Funding Source: NIH
   RePORTER
FX The authors thank the Brazilian Ministry of Health and the Latin
   American Community Engagement Networks (LACENs) of Natal, Joao Pessoa,
   Recife, Maceio and Salvador for their support. We thank T. Fredeking
   from Antibody Systems for providing the Zika virus samples from
   Colombia. We thank K. Brunker for testing the Primal Scheme software.
   The Zika in Brazil Real-time Analysis (ZiBRA) project
   (http://www.zibraproject.org) is supported by the Medical Research
   Council/Wellcome Trust/Newton Fund Zika Rapid Response Initiative (grant
   no, ZK/16-078), which also provides J.Q.'s salary. N.J.L. is supported
   by a Medical Research Council Bioinformatics Fellowship as part of the
   Cloud Infrastructure for Microbial Bioinformatics (CLIMB) project.
   Primal Scheme is hosted on the CLIMB platform, where pipeline
   development and MinION data analysis was performed<SUP>59</SUP>. N.D.G.
   is supported by National Institutes of Health (NIH) training grant
   5T32AI007244-33. K.G.A. is a PEW Biomedical Scholar, and his work is
   supported by NIH National Center for Advancing Translational Studies
   Clinical and Translational Science Award UL1TR001114 and National
   Institute of Allergy and Infectious Diseases (NIAID) contract
   HHSN272201400048C. A.B. and T.B. were supported by NIH awards R35
   GM119774 and U54 GM111274. T.B. is a Pew Biomedical Scholar. A.B. is
   supported by the National Science Foundation Graduate Research
   Fellowship Program under Grant no. DGE-1256082. N.R.F. was funded by a
   Sir Henry Dale Fellowship (Wellcome Trust/Royal Society grant
   204311/Z/16/Z). Work at the Paul-Ehrlich-Institut was supported by a
   grant ('Sicherheit von Blut(produkten) und Geweben hinsichtlich der
   Abwesenheit von Zikaviren') from the German Ministry of Health. This
   study was supported by USAID Emerging Pandemic Threats Program-2
   PREDICT-2 (cooperative agreement AID-OAA-A-14-00102). The contents of
   this article are the responsibility of the authors and do not
   necessarily reflect the views of USAID or the US government.
CR Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020
   Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016
   Atkinson B, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01116-16
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Batty EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066129
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brown JR, 2015, J CLIN VIROL, V70, pS12, DOI 10.1016/j.jcv.2015.07.037
   Brown JR, 2016, J CLIN MICROBIOL, V54, P2530, DOI 10.1128/JCM.01052-16
   Carrillo C, 2007, J VIROL, V81, P11341, DOI 10.1128/JVI.00930-07
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Chan M, 2016, J APPL LAB MED, V1, P25, DOI 10.1373/jalm.2016.020131
   Connor TR, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000086
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Eckert SE, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000087
   Faria N. R., 2017, NATURE
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Gardner Shea N., 2014, Advances in Bioinformatics, V2014, P101894, DOI 10.1155/2014/101894
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Grubaugh N. D., 2017, NATURE
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182
   Hysom DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034560
   Kilianski A, 2016, EMERG INFECT DIS, V22, P1448, DOI 10.3201/eid2208.160270
   Kilianski A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0051-z
   Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480
   KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999
   KWOK S, 1994, PCR METH APPL, V3, pS39
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-261
   Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198
   Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419
   Marquez S, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomea.01673-16, 10.1128/genomeA.01673-16]
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   Metsky HC, 2017, NATURE
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666
   Misencik MJ, 2016, VECTOR-BORNE ZOONOT, V16, P181, DOI 10.1089/vbz.2015.1889
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219
   Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013
   Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480
   Sipos B., 2016, BIORXIV
   Thomson E, 2016, J CLIN MICROBIOL, V54, P2470, DOI 10.1128/JCM.00330-16
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Wang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00766
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Worobey M, 2016, NATURE, V539, P98, DOI 10.1038/nature19827
   Yu Q, 2011, BIOINFORMATICS, V27, P266, DOI 10.1093/bioinformatics/btq624
   Yuste E, 2000, J VIROL, V74, P9546, DOI 10.1128/JVI.74.20.9546-9552.2000
NR 59
TC 190
Z9 193
U1 8
U2 105
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-2189
EI 1750-2799
J9 NAT PROTOC
JI Nat. Protoc.
PD JUN
PY 2017
VL 12
IS 6
BP 1261
EP 1276
DI 10.1038/nprot.2017.066
PG 16
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA EV9RK
UT WOS:000402122900001
PM 28538739
OA Green Published, Bronze, Green Accepted
DA 2020-11-24
ER

PT J
AU Amoussa, AER
   Wilkinson, E
   Giovanetti, M
   Rego, FFD
   Araujo, THA
   Goncalves, MD
   de Oliveira, T
   Alcantara, LC
AF Roukiyath Amoussa, Adjile Edjide
   Wilkinson, Eduan
   Giovanetti, Marta
   de Almeida Rego, Filipe Ferreira
   Araujo, Thessika Hialla A.
   Goncalves, Marilda de Souza
   de Oliveira, Tulio
   Junior Alcantara, Luiz Carlos
TI HTLV-1aA introduction into Brazil and its association with the
   trans-Atlantic slave trade
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE HTLV; Brazil; Southern Africa; Trans-Atlantic slave trade
ID VIRUS TYPE-I; CELL LYMPHOTROPIC VIRUS; POST-COLUMBIAN INTRODUCTION;
   MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC SUBTYPES; INFECTED INDIVIDUALS;
   AFRICAN ORIGIN; TYPE-1 HTLV-1; LEUKEMIA; STRAINS
AB Introduction: Human T-lymphotropic virus (HTLV) is an endemic virus in some parts of the world, with Africa being home to most of the viral genetic diversity. In Brazil, HTLV-1 is endemic amongst Japanese and African immigrant populations. Multiple introductions of the virus in Brazil from other epidemic foci were hypothesized. The long terminal repeat (LTR) region of HTLV-1 was used to infer the origin of the virus in Brazil, using phylo-genetic analysis.
   Methods: LTR sequences were obtained from the HTLV-1 database (http://htlv1db.bahia.fiocruz.br). Sequences were aligned and maximum-likelihood and Bayesian tree topologies were inferred. Brazilian specific clusters were identified and molecular-clock and coalescent models were used to estimate each cluster's time to the most recent common ancestor (tMRCA).
   Results: Three Brazilian clusters were identified with a posterior probability ranged from 0.61 to 0.99. Molecular clock analysis of these three clusters dated back their respective tMRCAs between the year 1499 and the year 1668. Additional analysis also identified a close association between Brazilian sequences and new sequences from South Africa.
   Conclusion: Our results support the hypothesis of a multiple introductions of HTLV-1 into Brazil, with the majority of introductions occurring in the post-Colombian period. Our results further suggest that HTLV-1 introduction into Brazil was facilitated by the trans-Atlantic slave trade from endemic areas of Africa. The close association between southern African and Brazilian sequences also suggested that greater numbers of the southern African Bantu population might also have been part of the slave trade than previously thought. (C) 2016 Published by Elsevier B.V.
C1 [Roukiyath Amoussa, Adjile Edjide; Giovanetti, Marta; de Almeida Rego, Filipe Ferreira; Araujo, Thessika Hialla A.; Goncalves, Marilda de Souza; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Lab Hematol Genet & Computat Biol, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Wilkinson, Eduan; de Oliveira, Tulio] Univ Kwazulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [de Almeida Rego, Filipe Ferreira] Univ Catolica Salvador, Salvador, BA, Brazil.
   [Araujo, Thessika Hialla A.] Bahia Fdn Dev Sci, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
RP Alcantara, LC (corresponding author), Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
EM amoussaroukiyath@yahoo.fr; ewilkinson83@gmail.com;
   lalcan@bahia.fiocruz.br
RI Giovanetti, Marta/AAK-7408-2020
OI Alcantara, Luiz/0000-0002-6769-9931; Giovanetti,
   Marta/0000-0002-5849-7326
FU CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   BrasilNational Council for Scientific and Technological Development
   (CNPq) [200328/2015-8]; Medical Research Council flagship grant of the
   Republic of South Africa [MRC-RFA-UFSP-01-2013/UKZNHIVEPI]
FX This work was supported by CNPq (200328/2015-8) Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - Brasil. E.W. and T.d.O are
   funded by a Medical Research Council flagship grant of the Republic of
   South Africa (MRC-RFA-UFSP-01-2013/UKZNHIVEPI).
CR Alcantara LC, 2003, JAIDS-J ACQ IMM DEF, V33, P536, DOI 10.1097/00126334-200308010-00016
   Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13
   Aleluia M. M., 2015, VIROL REP, V5, P63
   Araujo THA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042123
   ANDERSON CW, 1975, COMMUN STAT, V4, P437, DOI 10.1080/03610917508548402
   Mota ACA, 2007, AIDS RES HUM RETROV, V23, P503, DOI 10.1089/aid.2006.0203
   Bacelar J. A., 1994, GALEGOS PARAISO RACI
   Bandeira LM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003691
   Berini CA, 2013, SEX TRANSM INFECT, V89, P333, DOI 10.1136/sextrans-2012-050594
   Bhatt NB, 2009, INT J STD AIDS, V20, P863, DOI 10.1258/ijsa.2008.008401
   Chen JL, 1995, AIDS RES HUM RETROV, V11, P1529, DOI 10.1089/aid.1995.11.1529
   CURTIN PD, 1969, SLAVE ATLANTIC TRADE
   Rego FFD, 2008, AIDS RES HUM RETROV, V24, P673, DOI 10.1089/aid.2007.0290
   Desrames A, 2014, J VIROL, V88, P9782, DOI 10.1128/JVI.01591-14
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Gallo RC, 2011, BEST PRACT RES CL HA, V24, P559, DOI 10.1016/j.beha.2011.09.012
   Gastaldello R, 2008, AIDS RES HUM RETROV, V24, P1139, DOI 10.1089/aid.2007.0299
   GESSAIN A, 1985, LANCET, V2, P407
   GESSAIN A, 1991, P NATL ACAD SCI USA, V88, P7694, DOI 10.1073/pnas.88.17.7694
   Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
   Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   KITAGAWA T, 1986, JAMA-J AM MED ASSOC, V256, P2342, DOI 10.1001/jama.1986.03380170058009
   LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990
   Leira L. P., 2002, GALEGOS BAHIA TODOS, P5
   Li HC, 1999, NAT MED, V5, P1428
   Magalhaes T, 2008, J MED VIROL, V80, P2040, DOI 10.1002/jmv.21278
   Mahieux R, 1997, J VIROL, V71, P1317, DOI 10.1128/JVI.71.2.1317-1333.1997
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124
   Padua E, 2011, AIDS RES HUM RETROV, V27, P317, DOI 10.1089/aid.2010.0195
   Paiva A, 2015, REV INST MED TROP SP, V57, P1, DOI 10.1590/S0036-46652015000100001
   Pineda M, 2015, RETROVIROLOGY, V12, DOI 10.1186/1742-4690-12-S1-P85
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Rego F. F. A., 2013, HIV HTLV 1 COI UNPUB
   RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3
   Salemi M, 1998, VIROLOGY, V246, P277, DOI 10.1006/viro.1998.9215
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Trevino A, 2014, AIDS RES HUM RETROV, V30, P856, DOI [10.1089/aid.2013.0128, 10.1089/AID.2013.0128]
   Vallejo A, 2003, AIDS RES HUM RETROV, V19, P609, DOI 10.1089/088922203322230978
   Van Dooren S, 2001, MOL BIOL EVOL, V18, P661, DOI 10.1093/oxfordjournals.molbev.a003846
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   van Tienen C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001690
   VANDAMME AM, 1994, VIROLOGY, V202, P212, DOI 10.1006/viro.1994.1337
   Verger P., 1976, TRADE RELATIONS BIGH, p[12, 24]
   Vicente ACP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001038
   Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102
   Yamashita M, 1998, J MED VIROL, V55, P152, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;152::AID-JMV12&gt;3.0.CO;2-K
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
   Zehender G, 2008, JAIDS-J ACQ IMM DEF, V47, P269, DOI 10.1097/QAI.0b013e31816649a4
NR 53
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD MAR
PY 2017
VL 48
BP 95
EP 101
DI 10.1016/j.meegid.2016.12.005
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA EM6ZQ
UT WOS:000395461600015
PM 27940215
DA 2020-11-24
ER

PT J
AU Mafopa, NG
   Russo, G
   Wadoum, REG
   Iwerima, E
   Batwala, V
   Giovanetti, M
   Minutolo, A
   Turay, P
   Turay, TB
   Kargbo, B
   Amicosante, M
   Mattei, M
   Montesano, C
AF Mafopa, Nadege Goumkwa
   Russo, Gianluca
   Wadoum, Raoul Emeric Guetiya
   Iwerima, Emmanuel
   Batwala, Vincent
   Giovanetti, Marta
   Minutolo, Antonella
   Turay, Patrick
   Turay, Thomas B.
   Kargbo, Brima
   Amicosante, Massimo
   Mattei, Maurizio
   Montesano, Carla
CA Ebola Study Grp
TI Seroprevalence of Ebola virus infection in Bombali District, Sierra
   Leone
SO JOURNAL OF PUBLIC HEALTH IN AFRICA
LA English
DT Article
DE Ebola virus infection; Sierra Leone; seroprevalence
ID HEMORRHAGIC-FEVER; DISEASE; KIKWIT; CONGO
AB A serosurvey of anti-Ebola Zaire virus nucleoprotein IgG prevalence was carried out among Ebola virus disease survivors and their Community Contacts in Bombali District, Sierra Leone. Our data suggest that the specie of Ebola virus (Zaire) responsible of the 2013-2016 epidemic in West Africa may cause mild or asymptomatic infection in a proportion of cases, possibly due to an efficient immune response.
C1 [Mafopa, Nadege Goumkwa; Wadoum, Raoul Emeric Guetiya] Univ Dschang, Dschang, Cameroon.
   [Mafopa, Nadege Goumkwa; Wadoum, Raoul Emeric Guetiya; Montesano, Carla] Univ Makeni, Makeni, Sierra Leone.
   [Mafopa, Nadege Goumkwa; Russo, Gianluca; Wadoum, Raoul Emeric Guetiya; Giovanetti, Marta; Minutolo, Antonella; Turay, Patrick; Montesano, Carla] Holy Spirit Hosp, Makeni, Sierra Leone.
   [Russo, Gianluca] Univ Roma La Sapienza, Rome, Italy.
   [Wadoum, Raoul Emeric Guetiya; Giovanetti, Marta; Minutolo, Antonella; Amicosante, Massimo; Mattei, Maurizio; Montesano, Carla] Univ Roma Tor Vergata, Via Ric Sci 1, I-00133 Rome, Italy.
   [Batwala, Vincent] Mbarara Univ Sci & Technol, Directorate Res & Grad Training, Mbarara, Uganda.
   [Turay, Thomas B.] Partner Relief Dev, Freetown, Sierra Leone.
   [Kargbo, Brima] Minist Hlth & Sanitat, Freetown, Sierra Leone.
RP Montesano, C (corresponding author), Univ Roma Tor Vergata, Via Ric Sci 1, I-00133 Rome, Italy.
EM montesano@uniroma2.it
RI MINUTOLO, ANTONELLA/AAA-1788-2020; Russo, Gianluca/N-4362-2019;
   Giovanetti, Marta/AAK-7408-2020; Dorfman, Jeffrey R/B-4854-2011;
   Dorfman, Jeffrey R/M-4218-2017; Mattei, Maurizio/AAC-1303-2019
OI Russo, Gianluca/0000-0002-8764-7389; Dorfman, Jeffrey
   R/0000-0001-9938-8911; Dorfman, Jeffrey R/0000-0001-9938-8911; Mattei,
   Maurizio/0000-0002-0814-8873; Guetiya Wadoum, Raoul
   Emeric/0000-0002-1031-0649; Montesano, Carla/0000-0002-9865-6619;
   minutolo, antonella/0000-0003-4784-4297
FU Italian Cooperation (Dokita ONG); Italian Geographical Society (Centro
   Relazioni con l'Africa); Italian Episcopal Conference (Camillian Task
   Force)
FX the data presented here were obtained with the financial support of the
   Italian Episcopal Conference (Camillian Task Force), the Italian
   Cooperation (Dokita ONG) and the Italian Geographical Society (Centro
   Relazioni con l'Africa). Authors wish to thank C.D. Pauza (Institute of
   Human Virology, University of Maryland School of Medicine, Baltimore,
   USA) for helpful discussions and language revision.
CR Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422
   Becquart P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009126
   Clark DV, 2015, LANCET INFECT DIS, V15, P905, DOI 10.1016/S1473-3099(15)70152-0
   Fhogartaigh CN, 2015, CLIN MED, V15, P61, DOI 10.7861/clinmedicine.15-1-61
   Glynn JR, 2017, LANCET INFECT DIS, V17, P645, DOI 10.1016/S1473-3099(17)30111-1
   Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321
   Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3
   Ministry of Health and Sanitation Sierra Leone, 2015, EB VIR DIS SIT REP
   Richardson ET, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005087
   Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318
   Schoepp RJ, 2014, EMERG INFECT DIS, V20, P1176, DOI 10.3201/eid2007.131265
   Sobarzo A, 2013, J INFECT DIS, V208, P299, DOI 10.1093/infdis/jit162
   Wadoum REG, 2017, EUR J CLIN MICROBIOL, V36, P2193, DOI 10.1007/s10096-017-3045-1
   Wauquier N, 2009, EMERG INFECT DIS
   World Health Organization, 2014, EB SIT REP
NR 15
TC 5
Z9 5
U1 0
U2 2
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 2038-9922
EI 2038-9930
J9 J PUBLIC HEALTH AFR
JI J. Public Health Africa
PY 2017
VL 8
IS 2
BP 132
EP 134
AR 732
DI 10.4081/jphia.2017.732
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GY6JU
UT WOS:000448694700002
PM 29456826
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Faria, NR
   Quick, J
   Morales, I
   Theze, J
   Jesus, J
   Giovanetti, M
   Nunes, MR
   Sabino, EC
   Alcantara, LC
   Loman, N
   Pybus, OG
AF Faria, Nuno R.
   Quick, Josh
   Morales, Ingra
   Theze, Julien
   Jesus, Jaqueline
   Giovanetti, Marta
   Nunes, Marcio R.
   Sabino, Ester C.
   Alcantara, Luis C.
   Loman, Nick
   Pybus, Oliver G.
TI PORTABLE GENOMIC SURVEILLANCE OF ZIKA VIRUS IN BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Faria, Nuno R.; Theze, Julien; Pybus, Oliver G.] Univ Oxford, Oxford, England.
   [Quick, Josh; Loman, Nick] Univ Birmingham, Birmingham, W Midlands, England.
   [Morales, Ingra; Sabino, Ester C.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Jesus, Jaqueline; Giovanetti, Marta; Alcantara, Luis C.] FioCruz Bahia, Salvador, BA, Brazil.
   [Nunes, Marcio R.] Evandro Chagas Inst, Ananindeua, Brazil.
RI Giovanetti, Marta/AAK-7408-2020; Sabino, Ester Cerdeira/F-7750-2010;
   Pybus, Oliver G/B-2640-2012; Loman, Nicholas/Z-1573-2019
OI Sabino, Ester Cerdeira/0000-0003-2623-5126; Pybus, Oliver
   G/0000-0002-8797-2667; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 142
BP 45
EP 45
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202142
DA 2020-11-24
ER

PT J
AU Oliveira, JV
   Pessoa, L
   Magalhaes, C
   Lima, JG
   Carvalho, DA
   Xavier, TC
   Pellegrini, R
   Bessa, G
   Figueiredo, EM
   Calgano, JI
   Romero, F
   dos Santos, D
   Oliveira, A
   Silva, P
   Giovanetti, M
   Goes, J
   Lima, B
   Carneiro, MW
   Duarte, A
   Lima, FW
   Alcantara, LC
   de Siqueira, IC
AF Oliveira, Joao V.
   Pessoa, Lorena
   Magalhaes, Claudio
   Lima, Jessica G.
   Carvalho, Daniel A.
   Xavier, Tereza C.
   Pellegrini, Rosana
   Bessa, Gloryane
   Figueiredo, Eduardo M.
   Calgano, Juan I.
   Romero, Fernando
   dos Santos, Daiana
   Oliveira, Aline
   Silva, Paloma
   Giovanetti, Marta
   Goes, Jaqueline
   Lima, Breno
   Carneiro, Marcia W.
   Duarte, Alan
   Lima, Fernanda W.
   Alcantara, Luiz C.
   de Siqueira, Isadora C.
TI PREVALENCE OF PREVIOUS AND RECENT INFECTIONS BY ZIKA VIRUS, DENGUE VIRUS
   AND CHIKUNGUNYA VIRUS IN PREGNANT WOMEN AND SURVEILLANCE FOR CONGENITAL
   ZIKA INFECTIONS IN SALVADOR, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Oliveira, Joao V.; Pessoa, Lorena; Magalhaes, Claudio; Lima, Jessica G.; Carvalho, Daniel A.; dos Santos, Daiana; Oliveira, Aline; Silva, Paloma; Giovanetti, Marta; Goes, Jaqueline; Lima, Breno; Carneiro, Marcia W.; Alcantara, Luiz C.; de Siqueira, Isadora C.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Xavier, Tereza C.; Pellegrini, Rosana; Bessa, Gloryane; Figueiredo, Eduardo M.; Calgano, Juan I.; Romero, Fernando] Secretaria Saude Estado Bahia, Salvador, BA, Brazil.
   [Duarte, Alan; Lima, Fernanda W.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; amsalu, ribka/G-8780-2019;
   Giovanetti, Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1426
BP 443
EP 443
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204142
DA 2020-11-24
ER

PT J
AU Fiscon, G
   Weitschek, E
   Cella, E
   Lo Presti, A
   Giovanetti, M
   Babakir-Mina, M
   Ciotti, M
   Ciccozzi, M
   Pierangeli, A
   Bertolazzi, P
   Felici, G
AF Fiscon, Giulia
   Weitschek, Emanuel
   Cella, Eleonora
   Lo Presti, Alessandra
   Giovanetti, Marta
   Babakir-Mina, Muhammed
   Ciotti, Marco
   Ciccozzi, Massimo
   Pierangeli, Alessandra
   Bertolazzi, Paola
   Felici, Giovanni
TI MISSEL: a method to identify a large number of small species-specific
   genomic subsequences and its application to viruses classification
SO BIODATA MINING
LA English
DT Article
DE Classification of genomic sequences; Genetic algorithms; Supervised
   learning; Extraction of multiple classification models
ID GENETIC DIVERSITY; MITOCHONDRIAL COI; DNA; RHINOVIRUSES; OPTIMIZATION;
   PROPOSALS; SEQUENCES; SELECTION; TAXONOMY; SYSTEM
AB Background: Continuous improvements in next generation sequencing technologies led to ever-increasing collections of genomic sequences, which have not been easily characterized by biologists, and whose analysis requires huge computational effort. The classification of species emerged as one of the main applications of DNA analysis and has been addressed with several approaches, e.g., multiple alignments-, phylogenetic trees-, statistical-and character-based methods.
   Results: We propose a supervised method based on a genetic algorithm to identify small genomic subsequences that discriminate among different species. The method identifies multiple subsequences of bounded length with the same information power in a given genomic region. The algorithm has been successfully evaluated through its integration into a rule-based classification framework and applied to three different biological data sets: Influenza, Polyoma, and Rhino virus sequences.
   Conclusions: We discover a large number of small subsequences that can be used to identify each virus type with high accuracy and low computational time, and moreover help to characterize different genomic regions. Bounding their length to 20, our method found 1164 characterizing subsequences for all the Influenza virus subtypes, 194 for all the Polyoma viruses, and 11 for Rhino viruses. The abundance of small separating subsequences extracted for each genomic region may be an important support for quick and robust virus identification.
   Finally, useful biological information can be derived by the relative location and abundance of such subsequences along the different regions.
C1 [Ciccozzi, Massimo; Bertolazzi, Paola; Felici, Giovanni] CNR, Inst Syst Anal & Comp Sci A Ruberti IASI, Via Taurini 19, I-00185 Rome, Italy.
   [Weitschek, Emanuel] Uninettuno Int Univ, Dept Engn, Corso Vittorio Emanuele 2 39, I-00186 Rome, Italy.
   [Cella, Eleonora; Lo Presti, Alessandra; Giovanetti, Marta; Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Dis, Viale Regina Margherita 299, I-00161 Rome, Italy.
   [Cella, Eleonora] Sapienza Univ, Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, I-00133 Rome, Italy.
   [Babakir-Mina, Muhammed] Fdn Tech Educ, Sulaimaniyah, Kurdistan Regio, Iraq.
   [Ciotti, Marco] Polyclin Tor Vergata Fdn, Lab Mol Virol, Viale Oxford 81, I-00133 Rome, Italy.
   [Pierangeli, Alessandra] Sapienza Univ, Dept Mol Med, Virol Lab, Viale Porta Tiburtina 2, I-00185 Rome, Italy.
RP Fiscon, G (corresponding author), CNR, Inst Syst Anal & Comp Sci A Ruberti IASI, Via Taurini 19, I-00185 Rome, Italy.
EM giulia.fiscon@iasi.cnr.it
RI Cella, Eleonora/ABA-8333-2020; Cella, Eleonora/J-9961-2016; Giovanetti,
   Marta/AAK-7408-2020; Weitschek, Emanuel/U-7158-2019; Pierangeli,
   Alessandra/A-6368-2008; FISCON, GIULIA/J-3442-2019; Lo Presti,
   Alessandra/K-1451-2016; ciccozzi, massimo/C-6484-2016
OI Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Weitschek, Emanuel/0000-0002-8045-2925;
   Pierangeli, Alessandra/0000-0003-0633-360X; FISCON,
   GIULIA/0000-0002-3354-8203; Giovanetti, Marta/0000-0002-5849-7326; Lo
   Presti, Alessandra/0000-0001-7611-5021; ciccozzi,
   massimo/0000-0003-3866-9239
FU FLAGSHIP "InterOmics" project [PB.P05]; Epigenomics Flagship Project
   (Progetto Bandiera Epigenomica) "EPIGEN" - Italian Ministry of
   Education, University and Research (MIUR) [PB.P01]; National Research
   Council of Italy (CNR)
FX The research is supported by the FLAGSHIP "InterOmics" project [PB.P05]
   and The Epigenomics Flagship Project (Progetto Bandiera Epigenomica)
   "EPIGEN" [PB.P01] funded by Italian Ministry of Education, University
   and Research (MIUR) and the National Research Council of Italy (CNR).
CR Albu M, 2011, MOL ECOL RESOUR, V11, P84, DOI 10.1111/j.1755-0998.2010.02901.x
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10
   Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261
   Bao YM, 2012, VIRUSES-BASEL, V4, P1318, DOI 10.3390/v4081318
   Bertolazzi P, 2008, COMPUT MATH APPL, V55, P889, DOI 10.1016/j.camwa.2006.12.093
   Bertolazzi P, 2016, EUR J OPER RES, V250, P389, DOI 10.1016/j.ejor.2015.09.051
   Broberg E, 2011, J CLIN VIROL, V51, P79, DOI 10.1016/j.jcv.2011.01.018
   Brown B, 1999, B ENTOMOL RES, V89, P287, DOI 10.1017/S0007485399000437
   Browne WJ, 2001, STAT MODEL, V1, P103, DOI 10.1177/1471082X0100100202
   Bucklin A, 1999, HYDROBIOLOGIA, V401, P239, DOI 10.1023/A:1003790411424
   Carstens EB, 2010, ARCH VIROL, V155, P133, DOI 10.1007/s00705-009-0547-x
   Colorni Alberto, 1992, P PAR PROBL SOLV NAT, V92, P509
   DasGupa B, 2005, BIOINFORMATICS, V21, P3424, DOI 10.1093/bioinformatics/bti547
   Deb K, 2003, BIOSYSTEMS, V72, P111, DOI 10.1016/S0303-2647(03)00138-2
   Dulli S, 2009, DATA MINING
   FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802
   Festa P, 2011, TELECOMMUN SYST, V46, P253, DOI 10.1007/s11235-010-9289-z
   Festa P, 2009, STUD COMPUT INTELL, V203, P75
   Glover F., 1989, ORSA Journal on Computing, V1, P190
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   HAMPARIAN VV, 1987, VIROLOGY, V159, P191
   Handl J, 2007, IEEE ACM T COMPUT BI, V4, P279, DOI 10.1109/TCBB.2007.070203
   Hara K, 2014, J INFECT DIS, V209, P38, DOI 10.1093/infdis/jit541
   Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312
   Holland J., 1975, ADAPTATION NATURAL A
   Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355
   Jackson JL, 2000, J NUTR, V130, p1512S, DOI 10.1093/jn/130.5.1512S
   Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC
   Kaji M, 2003, RESPIROLOGY, V8, P231, DOI 10.1046/j.1440-1843.2003.00457.x
   Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968
   KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671
   Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X
   Kotsiantis SB, 2007, FRONT ARTIF INTEL AP, V160, P3
   Kuksa P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S9
   Lavigne R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-224
   Li XD, 2003, LECT NOTES COMPUT SC, V2723, P37
   Little DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020552
   Liu C, 2011, BMC BIOINFORMA S13, V12, P4
   Liu J, 2002, IEEE C EVOL COMPUTAT, P297, DOI 10.1109/CEC.2002.1006250
   Maris E, 1999, PSYCHOMETRIKA, V64, P187, DOI 10.1007/BF02294535
   McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0
   McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10
   Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864
   Michailides C, 2015, ENG STRUCT, V85, P249, DOI 10.1016/j.engstruct.2014.12.031
   Midulla F, 2012, EUR RESPIR J, V39, P396, DOI 10.1183/09031936.00188210
   Miettinen K., 1999, NONLINEAR MULTIOBJEC, V12
   Muhire B, 2013, ARCH VIROL, V158, P1411, DOI 10.1007/s00705-012-1601-7
   Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316
   NANNEY DL, 1982, BIOSCIENCE, V32, P783, DOI 10.2307/1308971
   Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734
   Pierangeli A, 2013, MED MICROBIOL IMMUN, V202, P303, DOI 10.1007/s00430-013-0296-z
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sarkar IN, 2008, MOL ECOL RES, V8
   Tan P, 2005, INTRO DATA MINING
   Tapparel C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-224
   van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490
   Weitschek E., 2012, VIROL J, V9, P1
   Weitschek E, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0073-1
   Weitschek E, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-4
   Weitschek E, 2013, MOL ECOL RESOUR, V13, P1043, DOI 10.1111/1755-0998.12073
   Wisdom A, 2009, J CLIN MICROBIOL, V47, P3958, DOI 10.1128/JCM.00993-09
   WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088
NR 64
TC 6
Z9 6
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-0381
J9 BIODATA MIN
JI BioData Min.
PD DEC 6
PY 2016
VL 9
AR 38
DI 10.1186/s13040-016-0116-2
PG 24
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA EE3MK
UT WOS:000389493000001
PM 27980679
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Mugosa, B
   Vujosevic, D
   Ciccozzi, M
   Valli, MB
   Capobianchi, MR
   Lo Presti, A
   Cella, E
   Giovanetti, M
   Lai, A
   Angeletti, S
   Scarpa, F
   Terzic, D
   Vratnica, Z
AF Mugosa, Boban
   Vujosevic, Danijela
   Ciccozzi, Massimo
   Valli, Maria Beatrice
   Capobianchi, Maria Rosaria
   Lo Presti, Alessandra
   Cella, Eleonora
   Giovanetti, Marta
   Lai, Alessia
   Angeletti, Silvia
   Scarpa, Fabio
   Terzic, Dragica
   Vratnica, Zoran
TI Genetic Diversity of the Haemagglutinin (HA) of Human Influenza A (H1N1)
   Virus in Montenegro: Focus on its Origin and Evolution
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE influenza virus; genetic variability; epidemiology
ID DYNAMICS
AB In 2009 an influenza A epidemic caused by a swine origin H1N1strain, unusual in human hosts, has been described. The present research is aimed to perform the first phylogenetic investigation on the influenza virus A (H1N1) strains circulating in Montenegro, from December 1, 2009, when the first case of death due to H1N1 was confirmed, and the epidemic began causing a total of four fatalities. The phylogenetic analysis of the strains circulating showed the absence of a pure Montenegrin cluster, suggesting the occurrence of multiple re-introductions in that population from different areas till as far as the early 2010. The time to most recent common ancestor (TMRCA) for the complete dataset has been dated in early 2008, pre-dating the first Montenegrin identification of H1N1 infection. These data suggest that virus was spreading undetected, may be as a consequence of unidentified infections in returning travelers. Anyhow, the estimated TMRCA of Montenegrin strains is fully consistent to that found in different areas. Compatibly with the time coverage of the study period here analyzed, molecular dynamic of Montenegrin strains follows similar trend as in other countries. (C) 2016 Wiley Periodicals, Inc.
C1 [Mugosa, Boban; Vujosevic, Danijela; Vratnica, Zoran] Inst Publ Hlth, Podgorica, Montenegro.
   [Ciccozzi, Massimo; Lo Presti, Alessandra; Cella, Eleonora; Giovanetti, Marta] Natl Inst Hlth, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Dept Infect Parasit & Immunomediated Dis, Epidemiol Unit, Rome, Italy.
   [Ciccozzi, Massimo] Univ Hosp Campus Biomed, Rome, Italy.
   [Valli, Maria Beatrice; Capobianchi, Maria Rosaria] Natl Inst Infect Dis L Spallanzani, Virol, Rome, Italy.
   [Cella, Eleonora] Sapienza Univ, Publ Hlth & Infect Dis, Rome, Italy.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Dept Biol, Rome, Italy.
   [Lai, Alessia] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Sect Infect Dis & Immonupathol, Milan, Italy.
   [Angeletti, Silvia] Univ Hosp Campus Biomed Rome, Clin Pathol & Microbiol Lab, Rome, Italy.
   [Scarpa, Fabio] Univ Sassari, Dept Sci Nat & Environm Resources, Sassari, Italy.
   [Terzic, Dragica] Clin Ctr Montenegro, Podgorica, Montenegro.
RP Ciccozzi, M (corresponding author), Ist Super, Epidemiol Unit, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
EM massimo.ciccozzi@iss.it
RI Cella, Eleonora/J-9961-2016; Valli, Maria Beatrice/B-4687-2017;
   Giovanetti, Marta/AAK-7408-2020; Cella, Eleonora/ABA-8333-2020;
   ciccozzi, massimo/C-6484-2016; Lo Presti, Alessandra/K-1451-2016
OI Cella, Eleonora/0000-0002-7870-9744; Valli, Maria
   Beatrice/0000-0001-5022-5388; Cella, Eleonora/0000-0002-7870-9744;
   ciccozzi, massimo/0000-0003-3866-9239; Capobianchi, Maria
   Rosaria/0000-0003-3465-0071; Lo Presti, Alessandra/0000-0001-7611-5021
CR Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11
   Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4
   Butler D, 2009, NATURE, V458, P1082, DOI 10.1038/4581082a
   Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467
   Centers for Disease Control and Prevention (CDC), 2005, FLUVIEW WEEKL INFL S
   Ciccozzi Massimo, 2011, Open Virol J, V5, P22, DOI 10.2174/1874357901105010022
   Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30
   Cohen J, 2009, SCIENCE, V324, P700, DOI 10.1126/science.324_700
   Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006
   Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Khandaker I, 2013, VIRUS GENES, V47, P456, DOI 10.1007/s11262-013-0980-5
   KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6
   LAZAROWITZ SG, 1975, VIROLOGY, V68, P440, DOI 10.1016/0042-6822(75)90285-8
   Miller MA, 2010, GAT COMP ENV WORKSH, P1, DOI [10.1109/GCE.2010.5676129, DOI 10.1109/GCE.2010.5676129]
   Mullick J, 2011, INFECT GENET EVOL, V11, P997, DOI 10.1016/j.meegid.2011.03.015
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rambaut A, 2009, TRACER VERSION 1 5 0
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Salemi M, 2008, AIDS RES HUM RETROV, V24, P771, DOI 10.1089/aid.2007.0181
   Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399
   Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392
   WRIGHT PF, 2007, FIELDS VIROLOGY, P1691
   Zaraket H, 2009, ARCH VIROL, V154, P285, DOI 10.1007/s00705-009-0309-9
   Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047517
NR 31
TC 4
Z9 4
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD NOV
PY 2016
VL 88
IS 11
BP 1905
EP 1913
DI 10.1002/jmv.24552
PG 9
WC Virology
SC Virology
GA DZ3CX
UT WOS:000385723000010
PM 27088433
DA 2020-11-24
ER

PT J
AU Cella, E
   Lo Presti, A
   Giovanetti, M
   Veo, C
   Lai, A
   Dicuonzo, G
   Angeletti, S
   Ciotti, M
   Zehender, G
   Ciccozzi, M
AF Cella, Eleonora
   Lo Presti, Alessandra
   Giovanetti, Marta
   Veo, Carla
   Lai, Alessia
   Dicuonzo, Giordano
   Angeletti, Silvia
   Ciotti, Marco
   Zehender, Gianguglielmo
   Ciccozzi, Massimo
TI Phylogenetic Analysis of Human Immunodeficiency Virus Type 2 Group B
SO JOURNAL OF GLOBAL INFECTIOUS DISEASES
LA English
DT Article
DE Evolution; Group B; human immunodeficiency virus type 2; phylogeny;
   phylogeographic analysis
ID HIV-2 INFECTION; WEST-AFRICA; EPIDEMIOLOGY; TRANSMISSION; RETROVIRUS;
   SEQUENCES; DYNAMICS; HISTORY; SPREAD; BISSAU
AB Context: Human immunodeficiency virus type 2 (HIV-2) infections are mainly restricted to West Africa; however, in the recent years, the prevalence of HIV-2 is a growing concern in some European countries and the Southwestern region of India. Despite the presence of different HIV-2 groups, only A and B Groups have established human-to-human transmission chains. Aims: This work aimed to evaluate the phylogeographic inference of HIV-2 Group B worldwide to estimate their data of origin and the population dynamics. Materials and Methods: The evolutionary rates, the demographic history for HIV-2 Group B dataset, and the phylogeographic analysis were estimated using a Bayesian approach. The viral gene flow analysis was used to count viral gene out/in flow among different locations. Results: The root of the Bayesian maximum clade credibility tree of HIV-2 Group B dated back to 1957. The demographic history of HIV-2 Group B showed that the epidemic remained constant up to 1970 when started an exponential growth. From 1985 to early 2000s, the epidemic reached a plateau, and then it was characterized by two bottlenecks and a new plateau at the end of 2000s. Phylogeographic reconstruction showed that the most probable location for the root of the tree was Ghana. Regarding the viral gene flow of HIV-2 Group B, the only observed viral gene flow was from Africa to France, Belgium, and Luxembourg. Conclusions: The study gives insights into the origin, history, and phylogeography of HIV-2 Group B epidemic. The growing number of infections of HIV-2 worldwide indicates the need for strengthening surveillance.
C1 [Cella, Eleonora; Lo Presti, Alessandra; Giovanetti, Marta; Ciccozzi, Massimo] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [Cella, Eleonora] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Dept Biol, Gen Pathol Lab, Rome, Italy.
   [Veo, Carla; Lai, Alessia; Zehender, Gianguglielmo] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy.
   [Dicuonzo, Giordano; Angeletti, Silvia] Univ Hosp Campus Biomed Rome, Clin Pathol & Microbiol Lab, Rome, Italy.
   [Ciotti, Marco] Tor Vergata Fdn Hosp, Lab Mol Virol, Rome, Italy.
   [Ciccozzi, Massimo] Univ Hosp Campus Biomed, Clin Pathol & Microbiol Lab, Rome, Italy.
RP Ciccozzi, M (corresponding author), Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.; Ciccozzi, M (corresponding author), Univ Hosp Campus Biomed, Clin Pathol & Microbiol Lab, Rome, Italy.
EM ciccozzi@iss.it
RI Giovanetti, Marta/AAK-7408-2020; Cella, Eleonora/J-9961-2016; Cella,
   Eleonora/ABA-8333-2020; Lo Presti, Alessandra/K-1451-2016; ciccozzi,
   massimo/C-6484-2016
OI Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Lo Presti, Alessandra/0000-0001-7611-5021;
   ciccozzi, massimo/0000-0003-3866-9239
CR BABU PG, 1993, INDIAN J MED RES-A, V97, P49
   BARIN F, 1985, LANCET, V2, P1387
   CAZEIN F, 2008, B EPIDEMIOL HEBD, V45, P434
   Ciccozzi M, 2014, J MED VIROL, V86, P109, DOI 10.1002/jmv.23740
   Ciccozzi M, 2013, NEW MICROBIOL, V36, P93
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P1333, DOI 10.1089/aid.2011.0055
   Cilla G, 2001, AIDS RES HUM RETROV, V17, P417, DOI 10.1089/088922201750102481
   CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430
   DECOCK KM, 1993, JAMA-J AM MED ASSOC, V270, P2083, DOI 10.1001/jama.270.17.2083
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0
   KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   KULKARNI S, 1992, INDIAN J MED RES-A, V95, P213
   Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Nyamweya S, 2013, REV MED VIROL, V23, P221, DOI 10.1002/rmv.1739
   Peeters M, 2001, AIDS REV, V3, P3
   Pepin J, 2013, J EPIDEMIOL COMMUN H, V67, P473, DOI 10.1136/jech-2012-201423
   Piedade J, 2000, ACTA TROP, V76, P119, DOI 10.1016/S0001-706X(00)00096-6
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   POULSEN AG, 1989, LANCET, V1, P827, DOI 10.1016/S0140-6736(89)92281-2
   RUBSAMENWAIGMANN H, 1991, LANCET, V337, P550, DOI 10.1016/0140-6736(91)91333-P
   SLATKIN M, 1989, GENETICS, V123, P603
   Valadas E, 2009, CLIN INFECT DIS, V48, P1166, DOI 10.1086/597504
   van der Loeff MFS, 1999, AIDS, V13, pS69
   Wertheim JO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000377
   Yusim K, 2001, PHILOS T R SOC B, V356, P855, DOI 10.1098/rstb.2001.0859
NR 29
TC 4
Z9 5
U1 0
U2 6
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0974-777X
EI 0974-8245
J9 J GLOB INFECT DIS
JI J. Glob. Insect. Dis.
PD JUL-SEP
PY 2016
VL 8
IS 3
BP 108
EP +
DI 10.4103/0974-777X.188592
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DW6YS
UT WOS:000383797900004
PM 27621561
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Giovanetti, M
   Faria, NR
   Nunes, MRT
   de Vasconcelos, JM
   Lourenco, J
   Rodrigues, SG
   Vianez, JL
   da Silva, SP
   Lemos, PS
   Tavares, FN
   Martin, DP
   do Rosario, MS
   Siqueira, IC
   Ciccozzi, M
   Pybus, OG
   de Oliveira, T
   Alcantara, LC
AF Giovanetti, Marta
   Faria, Nuno Rodrigues
   Teixeira Nunes, Marcio Roberto
   de Vasconcelos, Janaina Mota
   Lourenco, Jose
   Rodrigues, Sueli Guerreiro
   Vianez, Joao Lidio, Jr.
   da Silva, Sandro Patroca
   Lemos, Poliana Silva
   Tavares, Fernando Neto
   Martin, Darren Patrick
   do Rosario, Mateus Santana
   Siqueira, Isadora Cristina
   Ciccozzi, Massimo
   Pybus, Oliver G.
   de Oliveira, Tulio
   Alcantara Junior, Luiz Carlos
TI Zika virus complete genome from Salvador, Bahia, Brazil
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Zika virus; Full-length sequence; Phylogeny
AB In May 2015 the first autochthonous Zika virus infection was reported in Brazil. Rapid and urgent measures are needed to contain the ongoing outbreak. Here we report the full-length ZIKV coding sequence from Bahia. Genetic analysis of outbreak sequences will be essential for characterizing the diversity of circulating strains, identifying hotspots of virus transmission and guiding public health control. Rapid and urgent measures are needed to contain the ongoing outbreak. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Giovanetti, Marta; do Rosario, Mateus Santana; Siqueira, Isadora Cristina; Alcantara Junior, Luiz Carlos] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Faria, Nuno Rodrigues; Lourenco, Jose; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 2JD, England.
   [Teixeira Nunes, Marcio Roberto; de Vasconcelos, Janaina Mota; Rodrigues, Sueli Guerreiro; Vianez, Joao Lidio, Jr.; Lemos, Poliana Silva; Tavares, Fernando Neto] Inst Evandro Chagas, Ananindeua, Para, Brazil.
   [Martin, Darren Patrick] Univ Cape Town, Fac Hlth Sci, Div Computat Biol, ZA-7925 Cape Town, South Africa.
   [do Rosario, Mateus Santana] Hosp Santa Isabel, Salvador, BA, Brazil.
   [Ciccozzi, Massimo] Natl Inst Hlth, Rome, Italy.
   [de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr, Durban, South Africa.
RP Giovanetti, M (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Hematol Genet & Biol Computac, BR-42296710 Salvador, BA, Brazil.
EM giovanetti.marta@gmail.com
RI Giovanetti, Marta/AAK-7408-2020; de Siqueira, Isadora
   Cristina/R-9953-2016; Faria, Nuno R/I-2975-2012; Pybus, Oliver
   G/B-2640-2012; CICCOZZI, MASSIMO/C-6484-2016; Vianez Junior, Joao
   Lidio/I-9547-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Faria, Nuno
   R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667; CICCOZZI,
   MASSIMO/0000-0003-3866-9239; do Rosario, Mateus/0000-0001-7404-6392;
   Vianez Junior, Joao Lidio/0000-0001-6226-9441; Giovanetti,
   Marta/0000-0002-5849-7326; Alcantara, Luiz/0000-0002-6769-9931;
   Lourenco, Jose/0000-0002-9318-2581
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O., 2014, PLOS NEGLECT TROP D, V9, P8
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Grard G, 2014, PLOS NEGLECT TROP D, P8
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlakar J, 2016, N ENGL J MED
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Rodrigues Faria N., 2016, PLOS CURR OUTBREAKS
   Ventura C. V., 2016, LANCET, V16
   Zamree I, 2005, Trop Biomed, V22, P217
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 17
Z9 17
U1 0
U2 112
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2016
VL 41
BP 142
EP 145
DI 10.1016/j.meegid.2016.03.030
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DL5BU
UT WOS:000375652800020
PM 27071531
OA Green Published
DA 2020-11-24
ER

PT J
AU Giovanetti, M
   Milano, T
   Alcantara, LC
   Carcangiu, L
   Cella, E
   Lai, A
   Lo Presti, A
   Pascarella, S
   Zehender, G
   Angeletti, S
   Ciccozzi, M
AF Giovanetti, Marta
   Milano, Teresa
   Alcantara, Luiz Carlos
   Carcangiu, Laura
   Cella, Eleonora
   Lai, Alessia
   Lo Presti, Alessandra
   Pascarella, Stefano
   Zehender, Gianguglielmo
   Angeletti, Silvia
   Ciccozzi, Massimo
TI Zika virus spreading in South America: evolutionary analysis of emerging
   neutralizing resistant Phe279Ser strains
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Phylogeny; Evolution
ID AMINO-ACID SITES; ENVELOPE PROTEIN; AEDES-AEGYPTI; SEQUENCE; PREDICTION;
   INFERENCE; ACCURACY; DYNAMICS; MODELS; POWER
AB Objective: To investigate the genetic diversity of Zika virus (ZIKV) and the relationships existing among these circulating viruses worldwide. To evaluate the genetic polymorphisms harboured from ZIKV that can have an influence on the virus circulation. Methods: Three different ZIKV dataset were built. The first dataset included 63 E gene sequences, the second one 22 NS3 sequences and the third dataset was composed of 108 NS5 gene sequences. Phylogenetic and selective pressure analysis was performed. The edited nucleic acid alignment from the Envelope dataset was used to generate a conceptual translation to the corresponding peptide sequences through UGene software. Results: The phylogeographic reconstruction was able to discriminate unambiguously that the Brazilian strains are belonged to the Asian lineage. The structural analysis reveals instead the presence of the Ser residue in the Brazilian sequences (however already observed in other previously reported ZIKV infections) that could suggest the presence of a neutralization-resistant population of viruses. Conclusions: Phylogenetic, evolutionary and selective pressure analysis contributed to improve the knowledge on the circulation of ZIKV.
C1 [Giovanetti, Marta; Carcangiu, Laura; Cella, Eleonora; Lo Presti, Alessandra; Ciccozzi, Massimo] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.
   [Giovanetti, Marta; Alcantara, Luiz Carlos] Oswaldo Cruz Fdn LHGB CPqGM FIOCRUZ, Goncalo Moniz Res Ctr, Lab Hematol Genet & Computat Biol, Salvador, BA, Brazil.
   [Milano, Teresa; Pascarella, Stefano] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy.
   [Cella, Eleonora] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy.
   [Lai, Alessia; Zehender, Gianguglielmo] Univ Milan, Lab Infect Dis & Trop Med, I-20122 Milan, Italy.
   [Angeletti, Silvia] Univ Hosp Campus Biomed Rome, Clin Pathol & Microbiol Lab, Rome, Italy.
   [Ciccozzi, Massimo] Univ Campus Biomed, Rome, Italy.
RP Ciccozzi, M (corresponding author), Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Epidemiol Unit, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Rome, Italy.
EM ciccozzi@iss.it
RI CICCOZZI, MASSIMO/C-6484-2016; Presti, Alessandra Lo/K-1451-2016; Cella,
   Eleonora/ABA-8333-2020; Cella, Eleonora/J-9961-2016; Giovanetti,
   Marta/AAK-7408-2020
OI CICCOZZI, MASSIMO/0000-0003-3866-9239; Presti, Alessandra
   Lo/0000-0001-7611-5021; Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Giovanetti, Marta/0000-0002-5849-7326;
   Alcantara, Luiz/0000-0002-6769-9931
CR Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152
   Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399
   Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721
   Bisset J A, 2001, Rev Cubana Med Trop, V53, P37
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Ciccozzi M, 2012, AIDS RES HUM RETROV, V28, P1280, DOI 10.1089/aid.2011.0138
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P921, DOI [10.1089/aid.2010.0323, 10.1089/AID.2010.0323]
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, PLOS NEGL TROP DIS, V201
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008
   Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nielsen R, 1998, GENETICS, V148, P929
   Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rodriguez MM, 2001, J MED ENTOMOL, V38, P623, DOI 10.1603/0022-2585-38.5.623
   Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schroedinger L., 2015, PYMOL MOL GRAPHICS S
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Yang ZH, 2000, GENETICS, V155, P431
   Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097
NR 47
TC 13
Z9 13
U1 0
U2 41
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD MAY
PY 2016
VL 9
IS 5
BP 445
EP 452
DI 10.1016/j.apjtm.2016.03.028
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DL0YS
UT WOS:000375359100006
PM 27261852
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Faria, NR
   Azevedo, RDD
   Kraemer, MUG
   Souza, R
   Cunha, MS
   Hill, SC
   Theze, J
   Bonsall, MB
   Bowden, TA
   Rissanen, I
   Rocco, IM
   Nogueira, JS
   Maeda, AY
   Vasami, FGD
   Macedo, FLD
   Suzuki, A
   Rodrigues, SG
   Cruz, ACR
   Nunes, BT
   Medeiros, DBD
   Rodrigues, DSG
   Queiroz, ALN
   da Silva, EVP
   Henriques, DF
   da Rosa, EST
   de Oliveira, CS
   Martins, LC
   Vasconcelos, HB
   Casseb, LMN
   Simith, DD
   Messina, JP
   Abade, L
   Loureno, J
   Alcantara, LCJ
   de Lima, MM
   Giovanetti, M
   Hay, SI
   de Oliveira, RS
   Lemos, PD
   de Oliveira, LF
   de Lima, CPS
   da Silva, SP
   de Vasconcelos, JM
   Franco, L
   Cardoso, JF
   Vianez, JLDG
   Mir, D
   Bello, G
   Delatorre, E
   Khan, K
   Creatore, M
   Coelho, GE
   de Oliveira, WK
   Tesh, R
   Pybus, OG
   Nunes, MRT
   Vasconcelos, PFC
AF Faria, Nuno Rodrigues
   da Silva Azevedo, Raimunda do Socorro
   Kraemer, Moritz U. G.
   Souza, Renato
   Cunha, Mariana Sequetin
   Hill, Sarah C.
   Theze, Julien
   Bonsall, Michael B.
   Bowden, Thomas A.
   Rissanen, Ilona
   Rocco, Iray Maria
   Nogueira, Juliana Silva
   Maeda, Adriana Yurika
   da Silva Vasami, Fernanda Giseli
   de Lima Macedo, Fernando Luiz
   Suzuki, Akemi
   Rodrigues, Sueli Guerreiro
   Ribeiro Cruz, Ana Cecilia
   Nunes, Bruno Tardeli
   de Almeida Medeiros, Daniele Barbosa
   Guerreiro Rodrigues, Daniela Sueli
   Nunes Queiroz, Alice Louize
   Pinto da Silva, Eliana Vieira
   Henriques, Daniele Freitas
   Travassos da Rosa, Elisabeth Salbe
   de Oliveira, Consuelo Silva
   Martins, Livia Caricio
   Vasconcelos, Helena Baldez
   Neves Casseb, Livia Medeiros
   Simith, Darlene de Brito
   Messina, Jane P.
   Abade, Leandro
   Loureno, Jose
   Junior Alcantara, Luiz Carlos
   de Lima, Maricelia Maia
   Giovanetti, Marta
   Hay, Simon I.
   de Oliveira, Rodrigo Santos
   Lemos, Poliana da Silva
   de Oliveira, Layanna Freitas
   Silva de Lima, Clayton Pereira
   da Silva, Sandro Patroca
   de Vasconcelos, Janaina Mota
   Franco, Luciano
   Cardoso, Jedson Ferreira
   da Silva Gonalves Vianez-Junior, Joao Lidio
   Mir, Daiana
   Bello, Gonzalo
   Delatorre, Edson
   Khan, Kamran
   Creatore, Marisa
   Coelho, Giovanini Evelim
   de Oliveira, Wanderson Kleber
   Tesh, Robert
   Pybus, Oliver G.
   Nunes, Marcio R. T.
   Vasconcelos, Pedro F. C.
TI Zika virus in the Americas: Early epidemiological and genetic findings
SO SCIENCE
LA English
DT Article
ID FRENCH-POLYNESIA; TRANSMISSION; INFECTION; BRAZIL; OUTBREAK; EVOLUTION;
   ISLAND; TRAVEL; CHILD
AB Brazil has experienced an unprecedented epidemic of Zika virus (ZIKV), with similar to 30,000 cases reported to date. ZIKV was first detected in Brazil in May 2015, and cases of microcephaly potentially associated with ZIKV infection were identified in November 2015. We performed next-generation sequencing to generate seven Brazilian ZIKV genomes sampled from four self-limited cases, one blood donor, one fatal adult case, and one newborn with microcephaly and congenital malformations. Results of phylogenetic and molecular clock analyses show a single introduction of ZIKV into the Americas, which we estimated to have occurred between May and December 2013, more than 12 months before the detection of ZIKV in Brazil. The estimated date of origin coincides with an increase in air passengers to Brazil from ZIKV-endemic areas, as well as with reported outbreaks in the Pacific Islands. ZIKV genomes from Brazil are phylogenetically interspersed with those from other South American and Caribbean countries. Mapping mutations onto existing structural models revealed the context of viral amino acid changes present in the outbreak lineage; however, no shared amino acid changes were found among the three currently available virus genomes from microcephaly cases. Municipality-level incidence data indicate that reports of suspected microcephaly in Brazil best correlate with ZIKV incidence around week 17 of pregnancy, although this correlation does not demonstrate causation. Our genetic description and analysis of ZIKV isolates in Brazil provide a baseline for future studies of the evolution and molecular epidemiology of this emerging virus in the Americas.
C1 [Faria, Nuno Rodrigues; de Oliveira, Rodrigo Santos; Lemos, Poliana da Silva; de Oliveira, Layanna Freitas; Silva de Lima, Clayton Pereira; da Silva, Sandro Patroca; de Vasconcelos, Janaina Mota; Franco, Luciano; Cardoso, Jedson Ferreira; da Silva Gonalves Vianez-Junior, Joao Lidio; Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.
   [Faria, Nuno Rodrigues; Kraemer, Moritz U. G.; Hill, Sarah C.; Theze, Julien; Bonsall, Michael B.; Messina, Jane P.; Abade, Leandro; Loureno, Jose; Pybus, Oliver G.] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
   [da Silva Azevedo, Raimunda do Socorro; Rodrigues, Sueli Guerreiro; Ribeiro Cruz, Ana Cecilia; Nunes, Bruno Tardeli; de Almeida Medeiros, Daniele Barbosa; Guerreiro Rodrigues, Daniela Sueli; Nunes Queiroz, Alice Louize; Pinto da Silva, Eliana Vieira; Henriques, Daniele Freitas; Travassos da Rosa, Elisabeth Salbe; de Oliveira, Consuelo Silva; Martins, Livia Caricio; Vasconcelos, Helena Baldez; Neves Casseb, Livia Medeiros; Simith, Darlene de Brito; Vasconcelos, Pedro F. C.] Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Para, Brazil.
   [Souza, Renato; Cunha, Mariana Sequetin; Rocco, Iray Maria; Nogueira, Juliana Silva; Maeda, Adriana Yurika; da Silva Vasami, Fernanda Giseli; de Lima Macedo, Fernando Luiz; Suzuki, Akemi] Univ Sao Paulo, Inst Adolfo Lutz, Sao Paulo, Brazil.
   [Bowden, Thomas A.; Rissanen, Ilona; Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Messina, Jane P.; Pybus, Oliver G.] Metabiota, San Francisco, CA 94104 USA.
   [Junior Alcantara, Luiz Carlos; Giovanetti, Marta] Oswaldo Cruz Fdn FIOCRUZ, Salvador, BA, Brazil.
   [de Lima, Maricelia Maia] Univ Estadual Feira de Santana, Ctr Post Grad Collect Hlth, Dept Hlth, Feira De Santana, BA, Brazil.
   [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.
   [Mir, Daiana; Bello, Gonzalo; Delatorre, Edson] Fiocruz MS, Lab AIDS & Imunol Mol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.
   [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
   [Creatore, Marisa] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Coelho, Giovanini Evelim; de Oliveira, Wanderson Kleber] Brazilian Minist Hlth, Brasilia, DF, Brazil.
   [Tesh, Robert; Nunes, Marcio R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Nunes, MRT (corresponding author), Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.; Vasconcelos, PFC (corresponding author), Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Para, Brazil.; Pybus, OG (corresponding author), Metabiota, San Francisco, CA 94104 USA.; Nunes, MRT (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM oliver.pybus@zoo.ox.ac.uk; marcionunesbrasil@yahoo.com.br;
   pedrovasconcelos@iec.pa.gov.br
RI Giovanetti, Marta/AAK-7408-2020; Cruz, Ana Cecilia Ribeiro/V-9276-2019;
   Bello, Gonzalo/E-6842-2013; Vasconcelos, Pedro/AAH-3142-2019; Delatorre,
   Edson/J-8330-2015; , daiana/J-5515-2019; Pybus, Oliver G/B-2640-2012;
   Faria, Nuno R/I-2975-2012; Azevedo, Raimunda/T-4656-2019; Hay, Simon
   I/F-8967-2015; Bentancor, Gonzalo Jose Bello/N-7377-2019; Oliveira,
   Wanderson/AAF-5182-2019; Vianez Junior, Joao Lidio/I-9547-2016
OI Delatorre, Edson/0000-0002-5746-0820; , daiana/0000-0002-3172-4867;
   Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   Azevedo, Raimunda/0000-0003-1932-9976; Hay, Simon I/0000-0002-0611-7272;
   Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Oliveira,
   Wanderson/0000-0002-9662-1930; Pereira de Souza,
   Renato/0000-0003-1315-7085; de Lima Macedo, Fernando
   Luiz/0000-0003-2097-0429; Theze, Julien/0000-0001-8188-9494; Rissanen,
   Ilona/0000-0003-4937-1825; Giovanetti, Marta/0000-0002-5849-7326;
   Bowden, Thomas/0000-0002-8066-8785; Hill, Sarah/0000-0002-2995-2596;
   Lourenco, Jose/0000-0002-9318-2581; Vianez Junior, Joao
   Lidio/0000-0001-6226-9441; Alcantara, Luiz/0000-0002-6769-9931
FU European Research Council (ERC) under the European UnionEuropean
   Research Council (ERC) [614725-PATHPHYLODYN]; ERC under the European
   Union [268904-DIVERSITY]; Metabiota; American people through the United
   States Agency for International Development (USAID) Emerging Pandemic
   Threats Program-PREDICTUnited States Agency for International
   Development (USAID); Wellcome TrustWellcome Trust [095066, 102427,
   090532/Z/09/Z]; Bill and Melinda Gates FoundationBill & Melinda Gates
   Foundation [OPP1119467, OPP1093011, OPP1106023, OPP1132415]; Evandro
   Chagas Institute; Brazilian Ministry of Health; CNPq (Brazilian National
   Council for Scientific and Technological Development)National Council
   for Scientific and Technological Development (CNPq) [302032/2011-8,
   200024/2015-9]; National Institute of Science and Technology for Viral
   Hemorrhagic Fevers; U.S. NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R24 AT 120942]; UK
   Medical Research CouncilMedical Research Council UK (MRC)
   [MR/L009528/1]; CNPq-National Agency for Scientific and Technologic
   Development [573739/2008-0, 301641/2010-2, 457664/2013-4]; Medical
   Research CouncilMedical Research Council UK (MRC) [MR/L009528/1] Funding
   Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R24AI120942, R24AI120942, R24AI120942,
   R24AI120942, R24AI120942, R24AI120942] Funding Source: NIH RePORTER
FX We thank X. de Lamballerie and J. Lednicky for permission to include
   their unpublished ZIKV genomes in our analysis. We thank the Death
   Verification Service (SVO); Central Laboratories of Public Health
   (LACEN); and health departments of the Ceara State and Maranhao State,
   Brazil, for collaboration. O.G.P. is supported by the European Research
   Council (ERC) under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant 614725-PATHPHYLODYN. J.L. is supported by the
   ERC under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant 268904-DIVERSITY. O.G.P. received consulting
   fees from Metabiota between 2015 and 2016. This study is made possible
   in part by the generous support of the American people through the
   United States Agency for International Development (USAID) Emerging
   Pandemic Threats Program-PREDICT. The contents are the responsibility of
   the authors and do not necessarily reflect the views of USAID or the
   U.S. government. S.I.H. is funded by a Senior Research Fellowship from
   the Wellcome Trust (095066) and grants from the Bill and Melinda Gates
   Foundation (OPP1119467, OPP1093011, OPP1106023, and OPP1132415).
   M.R.T.N. is funded as an associated researcher in public health by the
   Evandro Chagas Institute, Brazilian Ministry of Health, and as a
   researcher in scientific productivity by CNPq (Brazilian National
   Council for Scientific and Technological Development) grants
   302032/2011-8 and 200024/2015-9 and is also supported in part by the
   National Institute of Science and Technology for Viral Hemorrhagic
   Fevers. R.T. is funded by grant R24 AT 120942 from the U.S. NIH. S.C.H.
   is supported by a Wellcome Trust grant (102427). T.A.B. and I.R. are
   supported by grants from the UK Medical Research Council (MR/L009528/1)
   and the Wellcome Trust (090532/Z/09/Z). P.F.C.V. is supported by
   CNPq-National Agency for Scientific and Technologic Development (grants
   573739/2008-0, 301641/2010-2, and 457664/2013-4). All samples were
   obtained from persons visiting local clinics or hospitalized by the
   Brazilian Ministry of Health personnel as part of dengue, chikungunya,
   and Zika fever surveillance activities. In these cases, patient consent
   was oral and not recorded. The study was authorized by the Coordination
   of the National Program for Dengue, Chikungunya, and Zika Control
   coordinated by Brazil's Ministry of Health. The data are available at
   DRYAD (DOI: 10.5061/dryad.6kn23). The ZIKV genomes reported in this
   study are deposited in GenBank under accession numbers KU321639,
   KU365777 to KU365780, KU729217, and KU729218.
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   FAGBAMI A, 1988, AM J TROP MED HYG, V38, P205, DOI 10.4269/ajtmh.1988.38.205
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meyer AG, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev006
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   PAHO & WHO, 2015, EP AL NEUR SYNDR CON
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V47
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sorichetta A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.45
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   World Health Organization, 2016, ASS INF MICR CONT ZI
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 552
Z9 563
U1 3
U2 248
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 15
PY 2016
VL 352
IS 6283
BP 345
EP 349
DI 10.1126/science.aaf5036
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ1UK
UT WOS:000373990100041
PM 27013429
OA Bronze, Green Accepted
DA 2020-11-24
ER

PT J
AU Grifoni, A
   Lo Presti, A
   Giovanetti, M
   Montesano, C
   Amicosante, M
   Colizzi, V
   Lai, A
   Zehender, G
   Cella, E
   Angeletti, S
   Ciccozzi, M
AF Grifoni, Alba
   Lo Presti, Alessandra
   Giovanetti, Marta
   Montesano, Carla
   Amicosante, Massimo
   Colizzi, Vittorio
   Lai, Alessia
   Zehender, Gianguglielmo
   Cella, Eleonora
   Angeletti, Silvia
   Ciccozzi, Massimo
TI Genetic diversity in Ebola virus: Phylogenetic and in silico structural
   studies of Ebola viral proteins
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Ebola virus; Proteins; Evolutionary analysis
ID AMINO-ACID SITES; PROTECTION; PREDICTION; ANTIBODIES; SELECTION; MODELS;
   WEB
AB Objective: To explore the genetic diversity and the modification of antibody response in the recent outbreak of Ebola Virus. Methods: Sequences retrieved from public databases, the selective pressure analysis and the homology modelling based on the all protein (nucleoprotein, VP35, VP40, soluble glycoprotein, small soluble glycoprotein, VP30, VP24 and polymerase) were used. Results: Structural proteins VP24, VP30, VP35 and VP40 showed relative conserved sequences making them suitable target candidates for antiviral treatment. On the contrary, nucleoprotein, polymerase and soluble glycoprotein have high mutation frequency. Conclusions: Data from this study point out important aspects of Ebola virus sequence variability that for epitope and vaccine design should be considered for appropriate targeting of conserved protein regions.
C1 [Grifoni, Alba; Amicosante, Massimo] ProxAgen Ltd, Sofia, Bulgaria.
   [Lo Presti, Alessandra; Giovanetti, Marta; Cella, Eleonora; Ciccozzi, Massimo] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [Giovanetti, Marta; Montesano, Carla; Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.
   [Amicosante, Massimo] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy.
   [Lai, Alessia; Zehender, Gianguglielmo] Univ Milan, Lab Infect Dis & Trop Med, I-20122 Milan, Italy.
   [Cella, Eleonora] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Angeletti, Silvia] Univ Hosp Campus Biomed Rome, Clin Pathol & Microbiol Lab, Rome, Italy.
   [Ciccozzi, Massimo] Univ Campus Biomed Rome, Rome, Italy.
RP Ciccozzi, M (corresponding author), Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
EM ciccozzi@iss.it
RI Cella, Eleonora/J-9961-2016; Presti, Alessandra Lo/K-1451-2016; Cella,
   Eleonora/ABA-8333-2020; Giovanetti, Marta/AAK-7408-2020; CICCOZZI,
   MASSIMO/C-6484-2016
OI Cella, Eleonora/0000-0002-7870-9744; Presti, Alessandra
   Lo/0000-0001-7611-5021; Cella, Eleonora/0000-0002-7870-9744; CICCOZZI,
   MASSIMO/0000-0003-3866-9239; Giovanetti, Marta/0000-0002-5849-7326; ,
   Alba/0000-0002-2209-5966; Montesano, Carla/0000-0002-9865-6619
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; Proxagent Ltd;
   University of Rome 'Tor Vergata'
FX This work was supported by National Institute of Health and Proxagent
   Ltd in collaboration with University of Rome 'Tor Vergata'.
CR Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152
   Audet J, 2015, VIRAL IMMUNOL, V28, P10, DOI 10.1089/vim.2014.0066
   Audet J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06881
   Azarian T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10170
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Ciccozzi M, 2010, ARCH VIROL, V155, P1433, DOI 10.1007/s00705-010-0725-x
   Clinton TR, 2015, PROTEIN SCI, V24, P446, DOI 10.1002/pro.2578
   Dziubanska PJ, 2014, ACTA CRYSTALLOGR D, V70, P2420, DOI 10.1107/S1399004714014710
   Feldmann H, 2001, J GEN VIROL, V82, P2839, DOI 10.1099/0022-1317-82-12-2839
   Feldmann H, 1999, CURR TOP MICROBIOL, V235, P1
   Giovanetti M, 2015, J MED VIROL, V87, P893, DOI 10.1002/jmv.24133
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Gupta M, 2001, VIROLOGY, V284, P20, DOI 10.1006/viro.2001.0836
   Hernandez H, 2015, J INFECT DIS, V212, pS410, DOI 10.1093/infdis/jiv209
   Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kuhn JH, 2014, VIRUSES-BASEL, V6, P4760, DOI 10.3390/v6114760
   Matassov D, 2015, J INFECT DIS, V212, pS443, DOI 10.1093/infdis/jiv316
   Nielsen R, 1998, GENETICS, V148, P929
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006
   Raj U, 2016, INTERDISCIP SCI, V8, P132, DOI 10.1007/s12539-015-0109-8
   Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014
   Stahelin RV, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00300
   Takada A, 2007, VACCINE, V25, P993, DOI 10.1016/j.vaccine.2006.09.076
   Tsuda Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001275
   Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254
   Volchkova VA, 2015, J INFECT DIS, V212, pS226, DOI 10.1093/infdis/jiv309
   Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837
   Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00
   Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664
   Wong G, 2015, J INFECT DIS, V212, pS435, DOI 10.1093/infdis/jiv257
   Wong G, 2014, EXPERT REV CLIN IMMU, V10, P781, DOI 10.1586/1744666X.2014.908705
   World Health Organization, 2014, EB SIT REP
   World Health Organization, 2015, SEAS INFL VACC COMP
   Yang ZH, 2000, GENETICS, V155, P431
   Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097
   Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
NR 41
TC 5
Z9 5
U1 0
U2 23
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD APR
PY 2016
VL 9
IS 4
BP 329
EP 335
DI 10.1016/j.apjtm.2016.03.016
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DH4RW
UT WOS:000372774100006
PM 27086151
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Cella, E
   Gabrielli, I
   Zehender, G
   Giovanetti, M
   Lo Presti, A
   Lai, A
   Dicuonzo, G
   Angeletti, S
   Salemi, M
   Ciccozzi, M
AF Cella, Eleonora
   Gabrielli, Ivan
   Zehender, Gianguglielmo
   Giovanetti, Marta
   Lo Presti, Alessandra
   Lai, Alessia
   Dicuonzo, Giordano
   Angeletti, Silvia
   Salemi, Marco
   Ciccozzi, Massimo
TI Phylogeny of Murray Valley encephalitis virus in Australia and Papua New
   Guinea
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Murray Valley encephalitis virus; Phylogeny; Evolution
ID EPIDEMIOLOGY; JAPANESE
AB Objective: To study the genetic diversity of Murray Valley encephalitis virus (MVEV) in Australia and Papua New Guinea. Menzel:is: MVEV envelope gene sequences were aligned using Clustal X and manual editing was performed with Bioedit. ModelTest v. 3.7 was used to select the simplest evolutionary model that adequately fitted the sequence data. Maximum likelihood analysis was performed using PhyML. The phylogenetic signal of the dataset was investigated by the likelihood mapping analysis. The Bayesian phylogenetic tree was built using BEAST. Results: The phylogenetic trees showed two main Glades. The Glade I including eight strains isolated from West Australia. The Glade II was characterized by at least four epidemic entries, three of which localized in Northern West Australia and one in Papua New Guinea. The estimated mean evolutionary rate value of the MVEV envelope gene was 0.407 X 10(-3) substitution/site/year (95% HPD: 0.623 X 10(-4)-0.780 X 10(-3)). Population dynamics defines a relative constant population until the year 2000, when a reduction occurred, probably due to a bottleneck. Conchzsions: This study has been useful in supporting the probable connection between climate changes and viral evolution also by the vector point of view; multidisciplinary monitoring studies are important to prevent new viral epidemics inside and outside new endemic areas.
C1 [Cella, Eleonora; Giovanetti, Marta; Lo Presti, Alessandra; Ciccozzi, Massimo] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [Cella, Eleonora] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Gabrielli, Ivan] Univ Roma La Sapienza, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Zehender, Gianguglielmo; Lai, Alessia] Univ Milan, L Sacco Dept Biomed & Clin Sci, I-20122 Milan, Italy.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Dicuonzo, Giordano; Angeletti, Silvia] Univ Hosp Campus Biomed Rome, Clin Pathol & Microbiol Lab, Rome, Italy.
   [Salemi, Marco] Univ Florida, Dept Pathol & Lab Med, Gainesville, FL USA.
   [Ciccozzi, Massimo] Univ Hosp Campus Biomed, Rome, Italy.
RP Ciccozzi, M (corresponding author), Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Epidemiol Unit, Rome, Italy.
EM ciccozzi@iss.it
RI Presti, Alessandra Lo/K-1451-2016; Giovanetti, Marta/AAK-7408-2020;
   Cella, Eleonora/J-9961-2016; Cella, Eleonora/ABA-8333-2020; CICCOZZI,
   MASSIMO/C-6484-2016
OI Presti, Alessandra Lo/0000-0001-7611-5021; Cella,
   Eleonora/0000-0002-7870-9744; Cella, Eleonora/0000-0002-7870-9744;
   CICCOZZI, MASSIMO/0000-0003-3866-9239; Giovanetti,
   Marta/0000-0002-5849-7326
CR Bennett N, 2008, VIC INFECT DIS B, V11, P94
   Ciccozzi M, 2011, INFECT GENET EVOL, V11, P863, DOI 10.1016/j.meegid.2011.02.006
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Johansen CA, 2007, VIRUS GENES, V35, P147, DOI 10.1007/s11262-007-0091-2
   Kay BH, 2000, J MED ENTOMOL, V37, P797, DOI 10.1603/0022-2585-37.6.797
   Kingsford RT, 2002, EMU, V102, P47, DOI 10.1071/MU01030
   Kingsford RT, 2011, AERIAL SURVEY WETLAN
   Knox J, 2012, MED J AUSTRALIA, V196, P322, DOI 10.5694/mja11.11026
   MACKENZIE JS, 1995, VET MICROBIOL, V46, P79, DOI 10.1016/0378-1135(95)00074-K
   Marshall I, 1988, ARBOVIRUSES EPIDEMIO, P151
   Ritchie SA, 2001, EMERG INFECT DIS, V7, P900
   Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x
   Selvey LA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002656
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Zehender G, 2011, INFECT GENET EVOL, V11, P646, DOI 10.1016/j.meegid.2011.02.003
NR 16
TC 1
Z9 1
U1 0
U2 8
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD APR
PY 2016
VL 9
IS 4
BP 376
EP 380
DI 10.1016/j.apjtm.2016.03.006
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DH4RW
UT WOS:000372774100013
PM 27086158
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Rego, FFD
   de Oliveira, T
   Giovanetti, M
   Galvao-Castro, B
   Goncalves, MD
   Alcantara, LC
AF de Almeida Rego, Filipe Ferreira
   de Oliveira, Tulio
   Giovanetti, Marta
   Galvao-Castro, Bernardo
   Goncalves, Marilda de Souza
   Alcantara, Luiz Carlos
TI Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long
   Terminal Repeat 5' Region from Patients with Tropical Spastic
   Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy
   and Asymptomatic Carriers
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID LTR POINT MUTATIONS; LEUKEMIA
AB The aim of this study was to analyze patients by deep sequencing the human T cell lymphotropic virus type 1 (HTLV-1) long terminal repeat (LTR) region in order to determine if minor and/or major mutations in this promoter region might be associated with tropical spastic paraparesis (TSP)/human T cell lymphotropic virus type 1-associated myelopathy (HAM) outcome or proviral load or HTLV-1 expression. This study is a cross-sectional analyze of 29 HTLV-1-infected patients with TSP/HAM or asymptomatic carriers. Proviral DNA from those subjects was submitted to a nested PCR for the HTLV-1 LTR5 region. The HTLV-1 LTR5 purified products were submitted to deep sequencing using the Ion Torrent sequencing technology (Life Technologies, Carlsbad, CA). We found that samples with low proviral load showed more detected minor mutations than the samples with high proviral load. Mutations in 136 positions were found over the 520-bp analyzed fragment of HTLV-1 LTR5 with at least 1% frequency. Eleven mutations were present in the previously determined major transcription factor binding sites (TFBS) and in more than one patient, indicating that there might be a differential HTLV-1 expression comparing individuals or in comparing different cells from the same individual. Three mutations were statistically significant using the Fisher nonparametric test between the groups but were not present in previously determined TFBS (G126C/T, G306C, and C479T). Those mutations that were not present in previously determined TFBS were statistically significant in this study and were most frequent in patients with low proviral load or in asymptomatic carriers. Although those mutations were not present in previously determined TFBS, one of those mutations (G306C/A) was present in an Sp-1 binding site determined by in silico analysis, and its presence abrogated the site for Sp-1 binding and created a new possible ATF binding site.
C1 [de Almeida Rego, Filipe Ferreira; Giovanetti, Marta; Goncalves, Marilda de Souza; Alcantara, Luiz Carlos] Oswaldo Cruz Fdn LHGB CPqGM FIOCRUZ, Goncalo Moniz Res Ctr, Lab Hematol Genet & Computat Biol, Salvador, BA, Brazil.
   [de Almeida Rego, Filipe Ferreira; de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Study, Kwa Zulu, South Africa.
   [de Almeida Rego, Filipe Ferreira] Univ Catolica Salvador, Salvador, BA, Brazil.
   [Galvao-Castro, Bernardo] HTLV Ctr, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
RP Alcantara, LC (corresponding author), LHGB CPqGM FIOCRUZ, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM lalcan@bahia.fiocruz.br
RI Giovanetti, Marta/AAK-7408-2020
OI Alcantara, Luiz/0000-0002-6769-9931
FU Brazil Ciencia Sem Fronteiras project from CNPQ; CAPESCAPES
FX The authors are grateful to Ms. Prevashine Padayache for technical
   assistance and Justen Manasa M.Sc. for DNA Sanger sequencing support.
   This project was supported by Brazil Ciencia Sem Fronteiras project from
   CNPQ. F.F.A.R. was supported by CAPES.
CR Asquith B, 2007, P NATL ACAD SCI USA, V104, P8035, DOI 10.1073/pnas.0608832104
   GESSAIN A, 1985, LANCET, V2, P407
   GESSAIN A, 1992, ANN INTERN MED, V117, P933, DOI 10.7326/0003-4819-117-11-933
   Gillet NA, 2011, BLOOD, V117, P3113, DOI 10.1182/blood-2010-10-312926
   Grant C, 2002, J CELL PHYSIOL, V190, P133, DOI 10.1002/JCP.10053
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   LaGrenade L, 1996, J ACQ IMMUN DEF SYND, V13, pS46, DOI 10.1097/00042560-199600001-00009
   Magri MC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-184
   Mboudjeka I, 1997, JPN J CANCER RES, V88, P619, DOI 10.1111/j.1349-7006.1997.tb00427.x
   Mochizuki M, 1996, J ACQ IMMUN DEF SYND, V13, pS50, DOI 10.1097/00042560-199600001-00010
   Neto WK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-535
   Olavarria VN, 2013, BRAZ J INFECT DIS, V16, P357
   OSAME M, 1986, LANCET, V1, P1031
   SHERMAN MP, 1992, J VIROL, V66, P2556, DOI 10.1128/JVI.66.4.2556-2563.1992
   Switzer WM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-9
   Taniguchi Y, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-64
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
NR 18
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD MAR 1
PY 2016
VL 32
IS 3
BP 279
EP 283
DI 10.1089/aid.2015.0273
PG 5
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA DG1FY
UT WOS:000371812500010
PM 26472535
OA Green Published
DA 2020-11-24
ER

PT J
AU Montesano, C
   Giovanetti, M
   Ciotti, M
   Cella, E
   Lo Presti, A
   Grifoni, A
   Zehender, G
   Angeletti, S
   Ciccozzi, M
AF Montesano, Carla
   Giovanetti, Marta
   Ciotti, Marco
   Cella, Eleonora
   Lo Presti, Alessandra
   Grifoni, Alba
   Zehender, Gianguglielmo
   Angeletti, Silvia
   Ciccozzi, Massimo
TI Hepatitis E Virus Circulation in Italy: Phylogenetic and Evolutionary
   Analysis
SO HEPATITIS MONTHLY
LA English
DT Article
DE Hepatitis E Virus; Phylogeny; Evolution
ID AMINO-ACID SITES; POSITIVE SELECTION; HEV; GENOTYPE; PHYLOGEOGRAPHY;
   ACCURACY; SUBTYPES; GENOME; POWER
AB Background: Hepatitis E virus (HEV), a major cause of acute viral hepatitis in developing countries, has been classified into four main genotypes and a number of subtypes. New genotypes have been recently identified in various mammals, including HEV genotype 3, which has a worldwide distribution. It is widespread among pigs in developed countries.
   Objectives: This study investigated the genetic diversity of HEV among humans and swine in Italy. The date of origin and the demographic history of the HEV were also estimated.
   Materials and Methods: A total of 327 HEV sequences of swine and humans from Italy were downloaded from the national centre for biotechnology information. Three different data sets were constructed. The first and the second data set were used to confirm the genotype of the sequences analyzed. The third data set was used to estimate the mean evolutionary rate and to determine the time-scaled phylogeny and demographic history.
   Results: The Bayesian maximum clade credibility tree and the time of the most common recent ancestor estimates showed that the root of the tree dated back to the year 1907 (95% HPD: 1811 - 1975). Two main clades were found, divided into two subclades. Skyline plot analysis, performed separately for human and swine sequences, demonstrated the presence of a bottleneck only in the skyline plot from the swine sequences. Selective pressure analysis revealed only negatively selected sites.
   Conclusions: This study provides support for the hypothesis that humans are probably infected after contact with swine sources. The findings emphasize the importance of checking the country of origin of swine and of improving sanitary control measures from the veterinary standpoint to prevent the spread of HEV infection in Italy.
C1 [Montesano, Carla; Giovanetti, Marta] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.
   [Ciotti, Marco] Polyclin Tor Vergata Fdn, Mol Virol Lab, Rome, Italy.
   [Cella, Eleonora; Lo Presti, Alessandra; Ciccozzi, Massimo] Inst Super Sanita, Mol Epidemiol & Microbial Evolut FEMEM Epidemiol, Dept Infect Parasit & Immune Mediated Dis, Rome, Italy.
   [Cella, Eleonora] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Grifoni, Alba] ProxAgen Ltd, Sofia, Bulgaria.
   [Zehender, Gianguglielmo] Univ Milan, Lab Infect Dis & Trop Med, Milan, Italy.
   [Angeletti, Silvia; Ciccozzi, Massimo] Univ Hosp Campus Biomed, Clin Pathol & Microbiol Lab, Rome, Italy.
RP Ciccozzi, M (corresponding author), Natl Inst Hlth, Mol Epidemiol & Microbial Evolut FEMEM Epidemiol, Dept Infect Parasit & Immune Mediated Dis, Reference Ctr Phylogeny,Inst Super Sanita, Rome, Italy.
EM ciccozzi@iss.it
RI Presti, Alessandra Lo/K-1451-2016; CICCOZZI, MASSIMO/C-6484-2016;
   Giovanetti, Marta/AAK-7408-2020; Cella, Eleonora/ABA-8333-2020; Cella,
   Eleonora/J-9961-2016
OI Presti, Alessandra Lo/0000-0001-7611-5021; CICCOZZI,
   MASSIMO/0000-0003-3866-9239; Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Giovanetti, Marta/0000-0002-5849-7326;
   Montesano, Carla/0000-0002-9865-6619; , Alba/0000-0002-2209-5966
CR Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152
   Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945
   Buisson Y, 2000, J GEN VIROL, V81, P903, DOI 10.1099/0022-1317-81-4-903
   Caruso C, 2015, ARCH VIROL, V160, P153, DOI 10.1007/s00705-014-2246-5
   Ciccozzi M, 2014, INFECT GENET EVOL, V27, P395, DOI 10.1016/j.meegid.2014.08.010
   Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898
   Garbuglia AR, 2013, EMERG INFECT DIS, V19, P110, DOI 10.3201/eid1901.120983
   Giordani MT, 2013, EMERG INFECT DIS, V19, P2054, DOI 10.3201/eid1912.130521
   Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512
   Johne R, 2010, J GEN VIROL, V91, P750, DOI 10.1099/vir.0.016584-0
   Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7
   Panda SK, 2007, REV MED VIROL, V17, P151, DOI 10.1002/rmv.522
   Labrique AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061351
   Lo Presti A, 2013, NEW MICROBIOL, V36, P75
   Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015
   Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482
   Martelli F, 2008, VET MICROBIOL, V126, P74, DOI 10.1016/j.vetmic.2007.07.004
   Martinelli N, 2015, TRANSBOUND EMERG DIS, V62, P217, DOI 10.1111/tbed.12118
   Martinelli N., 2011, INFECT ECOL EPIDEMIO, V1, DOI DOI 10.3402/IEE.V1I0.7331
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Romano L, 2011, J HEPATOL, V54, P34, DOI 10.1016/j.jhep.2010.06.017
   Takahashi M, 2011, J GEN VIROL, V92, P902, DOI 10.1099/vir.0.029470-0
   TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9
   Tam AW, 1996, VIROLOGY, V215, P1, DOI 10.1006/viro.1996.0001
   Perez-Gracia MT, 2014, INFECT GENET EVOL, V22, P40, DOI 10.1016/j.meegid.2014.01.002
   vanCuyckGandre H, 1997, J MED VIROL, V53, P340, DOI 10.1002/(SICI)1096-9071(199712)53:4&lt;340::AID-JMV5&gt;3.0.CO;2-7
   Villano U, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1245-9
   Wedemeyer H, 2012, GASTROENTEROLOGY, V142, P1388, DOI 10.1053/j.gastro.2012.02.014
   Yang ZH, 2000, GENETICS, V155, P431
   Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097
   Zehender G, 2014, INFECT GENET EVOL, V25, P138, DOI 10.1016/j.meegid.2014.04.016
   Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536
NR 34
TC 12
Z9 12
U1 2
U2 4
PU KOWSAR PUBL
PI HOENSBROEK
PA PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS
SN 1735-143X
EI 1735-3408
J9 HEPAT MON
JI Hepat. Mon.
PD MAR
PY 2016
VL 16
IS 3
AR e31951
DI 10.5812/hepatmon.31951
PG 8
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA DO3HZ
UT WOS:000377673200008
PM 27226798
OA Green Published, Other Gold
DA 2020-11-24
ER

PT J
AU Lo Presti, A
   Cella, E
   Giovanetti, M
   Lai, A
   Angeletti, S
   Zehender, G
   Ciccozzi, M
AF Lo Presti, Alessandra
   Cella, Eleonora
   Giovanetti, Marta
   Lai, Alessia
   Angeletti, Silvia
   Zehender, Gianguglielmo
   Ciccozzi, Massimo
TI Origin and Evolution of Nipah Virus
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE Nipah virus; phylogeny; evolution
ID AMINO-ACID SITES; LONG-DISTANCE MOVEMENTS; ENCEPHALITIS; OUTBREAK;
   TRANSMISSION; MODELS; RISK; INFERENCE; ACCURACY; SILIGURI
AB Nipah virus, member of the Paramyxoviridae family, is classified as a Biosafety Level-4 agent and category C priority pathogen. Nipah virus disease is endemic in south Asia and outbreaks have been reported in Malaysia, Singapore, India, and Bangladesh. Bats of the genus Pteropus appear to be the natural reservoir of this virus. The aim of this study was to investigate the genetic diversity of Nipah virus, to estimate the date of origin and the spread of the infection. The mean value of Nipah virus N gene evolutionary rate, was 6.5 x 10(-4) substitution/site/year (95% HPD: 2.3 x 10(-4) -1.18 x 10(-3)). The time-scaled phylogenetic analysis showed that the root of the tree originated in 1947 (95% HPD: 1888-1988) as the virus entered in south eastern Asiatic regions. The segregation of sequences in two main clades (I and II) indicating that Nipah virus had two different introductions: one in 1995 (95% HPD: 1985-2002) which correspond to clade I, and the other in 1985 (95% HPD: 1971-1996) which correspond to clade II. The phylogeographic reconstruction indicated that the epidemic followed two different routes spreading to the other locations. The trade of infected pigs may have played a role in the spread of the virus. Bats of the Pteropus genus, that are able to travel to long distances, may have contributed to the spread of the infection. Negatively selected sites, statistically supported, could reflect the stability of the viral N protein. (C) 2015 Wiley Periodicals, Inc.
C1 [Lo Presti, Alessandra; Cella, Eleonora; Giovanetti, Marta; Ciccozzi, Massimo] Ist Super Sanita, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Dept Infect Parasit & Immunomediated Dis, Epidemiol Unit, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Cella, Eleonora] Univ Roma La Sapienza, Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.
   [Lai, Alessia; Zehender, Gianguglielmo] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Sect Infect Dis & Immonupathol, Milan, Italy.
   [Angeletti, Silvia] Univ Hosp Campus Biomed Rome, Clin Pathol & Microbiol Lab, Rome, Italy.
   [Ciccozzi, Massimo] Univ Hosp Campus Biomed, Rome, Italy.
RP Ciccozzi, M (corresponding author), Ist Super Sanita, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Dept Infect Parasit & Immunomediated Dis, Epidemiol Unit, Viale Regina Elena 299, I-00161 Rome, Italy.; Ciccozzi, M (corresponding author), Univ Hosp Campus Biomed, Rome, Italy.; Ciccozzi, M (corresponding author), Natl Inst Hlth, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Dept Infect Parasit & Immunomediated Dis, Epidemiol Unit, Rome, Italy.
EM ciccozzi@iss.it
RI Cella, Eleonora/J-9961-2016; Giovanetti, Marta/AAK-7408-2020; Cella,
   Eleonora/ABA-8333-2020; Presti, Alessandra Lo/K-1451-2016; CICCOZZI,
   MASSIMO/C-6484-2016
OI Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Presti, Alessandra Lo/0000-0001-7611-5021;
   CICCOZZI, MASSIMO/0000-0003-3866-9239; Giovanetti,
   Marta/0000-0002-5849-7326
CR Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152
   Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945
   [Anonymous], 1999, MMWR-MORBID MORTAL W, V48, P335
   [Anonymous], 2007, NIPAH VIRUS FATAL IN
   [Anonymous], 2005, COMMUN DIS REP WEEKL, V15
   [Anonymous], 2008, NIPAH VIRUS FATAL BA
   Breed AC, 2010, ECOHEALTH, V7, P204, DOI 10.1007/s10393-010-0332-z
   *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P265
   Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P335
   Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P265
   Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247
   Chan YP, 2004, J GEN VIROL, V85, P1675, DOI 10.1099/vir.0.19752-0
   Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432
   Chua KB, 2003, J CLIN VIROL, V26, P265, DOI 10.1016/S1386-6532(02)00268-8
   Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2
   Ciccozzi M, 2012, AIDS RES HUM RETROV, V28, P1280, DOI 10.1089/aid.2011.0138
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P921, DOI [10.1089/aid.2010.0323, 10.1089/AID.2010.0323]
   Colfer Carol J, 2013, PRACT POLICY
   de Wit E, 2015, J PATHOL, V235, P196, DOI 10.1002/path.4444
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   EBY P, 1991, WILDLIFE RES, V18, P547, DOI 10.1071/WR9910547
   Epstein Jonathan H, 2006, Curr Infect Dis Rep, V8, P59, DOI 10.1007/s11908-006-0036-2
   Epstein JH, 2006, EMERG INFECT DIS, V12, P1178, DOI 10.3201/eid1207.050799
   Epstein JH, 2009, J APPL ECOL, V46, P991, DOI 10.1111/j.1365-2664.2009.01699.x
   Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701
   Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128
   Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567
   Harit AK, 2006, INDIAN J MED RES, V123, P553
   Hondo Eiichi, 2010, Journal of Wildlife in Thailand, V17, P55
   Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Lam SK, 2003, ANTIVIR RES, V57, P113, DOI 10.1016/S0166-3542(02)00204-8
   Lee KE, 1999, ANN NEUROL, V46, P428, DOI 10.1002/1531-8249(199909)46:3<428::AID-ANA23>3.3.CO;2-9
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lo MK, 2012, EMERG INFECT DIS, V18, P248, DOI 10.3201/eid1802.111492
   Luby SP, 2006, EMERG INFECT DIS, V12, P1888
   Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951
   Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237
   Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836
   Nielsen R, 1998, GENETICS, V148, P929
   Parashar UD, 2000, J INFECT DIS, V181, P1755, DOI 10.1086/315457
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   Salemi M, 2008, PLOS ONE, V2, P3
   Sherrini B A, 2014, Med J Malaysia, V69 Suppl A, P103
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Tan CT, 2001, J INFECT DIS, V184, P1367, DOI 10.1086/323996
   Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960
   Wang LF, 2001, MICROBES INFECT, V3, P279, DOI 10.1016/S1286-4579(01)01381-8
   Wiles G. J., 1990, ATOLL RES B, V343, P1, DOI DOI 10.5479/SI.00775630.343.1
   Yang ZH, 2000, GENETICS, V155, P431
   Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097
   2004, HLTH SCI B, V2, P7
NR 56
TC 21
Z9 22
U1 0
U2 46
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAR
PY 2016
VL 88
IS 3
BP 380
EP 388
DI 10.1002/jmv.24345
PG 9
WC Virology
SC Virology
GA DC4II
UT WOS:000369184000004
PM 26252523
DA 2020-11-24
ER

PT J
AU Angeletti, S
   Lo Presti, A
   Giovanetti, M
   Grifoni, A
   Amicosante, M
   Ciotti, M
   Alcantara, LCJ
   Cella, E
   Ciccozzi, M
AF Angeletti, Silvia
   Lo Presti, Alessandra
   Giovanetti, Marta
   Grifoni, Alba
   Amicosante, Massimo
   Ciotti, Marco
   Alcantara, Luiz-Carlos J.
   Cella, Eleonora
   Ciccozzi, Massimo
TI Phylogenesys and homology modeling in Zika virus epidemic: food for
   thought
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article
DE Zika; Evolutionary analysis; Homology modeling; T-B cells epitope
   predictions
ID PREGNANT-WOMEN; PREDICTION; GENERATION; EVOLUTION; OUTBREAK
AB Zika virus (ZIKV) is an emerging Flavivirus that have recently caused an outbreak in Brazil and rapid spread in several countries. In this study, the consequences of ZIKV evolution on protein recognition by the host immune system have been analyzed. Evolutionary analysis was combined with homology modeling and T-B cells epitope predictions. Two separate clades, the African one with the Uganda sequence, as the most probable ancestor, and the second one containing all the most recent sequences from the equatorial belt were identified. Brazilian strains clustered all together and closely related to the French Polynesia isolates. A strong presence of a negatively selected site in the envelope gene (Env) protein was evidenced, suggesting a probable purging of deleterious polymorphisms in functionally important genes. Our results show relative conservancy of ZIKV sequences when envelope and other non-structural proteins (NS3 and NS5) are analyzed by homology modeling. However, some regions within the consensus sequence of NS5 protein and to a lesser extent in the envelope protein, show localized high mutation frequency corresponding to a considerable alteration in protein stability. In terms of viral immune escape, envelope protein is under a higher selective pressure than NS5 and NS3 proteins for HLA class I and II molecules. Moreover, envelope mutations that are not strictly related to T-cell immune responses are mostly located on the surface of the protein in putative B-cell epitopes, suggesting an important contribution of B cells in the immune response as well.
C1 [Angeletti, Silvia; Ciccozzi, Massimo] Univ Campus Biomed, Unit Clin Pathol & Microbiol, Rome, Italy.
   [Lo Presti, Alessandra; Cella, Eleonora; Ciccozzi, Massimo] Natl Inst Hlth, Dept Infect Parasit & Immune Mediated Dis, Epidemiol Unit, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Rome, Italy.
   [Giovanetti, Marta; Alcantara, Luiz-Carlos J.] Oswaldo Cruz Fdn FIOCRUZ, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Dept Biol, Rome, Italy.
   [Grifoni, Alba; Amicosante, Massimo] ProxAgen Ltd, Sofia, Bulgaria.
   [Amicosante, Massimo] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy.
   [Ciotti, Marco] Polyclin Tor Vergata Fdn, Lab Mol Virol, Rome, Italy.
   [Cella, Eleonora] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.
RP Ciccozzi, M (corresponding author), Natl Inst Hlth, Dept Infect Parasit & Immune Mediated Dis, Epidemiol Unit, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Rome, Italy.; Ciccozzi, M (corresponding author), Natl Inst Hlth, Viale Regina Elena 299, Rome, Italy.
EM ciccozzi@iss.it
RI Cella, Eleonora/J-9961-2016; Cella, Eleonora/ABA-8333-2020; Giovanetti,
   Marta/AAK-7408-2020; Lo Presti, Alessandra/K-1451-2016; ciccozzi,
   massimo/C-6484-2016
OI Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Lo Presti, Alessandra/0000-0001-7611-5021;
   , Alba/0000-0002-2209-5966; ciccozzi, massimo/0000-0003-3866-9239;
   Alcantara, Luiz/0000-0002-6769-9931
CR Ashfaq UA, 2016, VIRAL IMMUNOL
   Azarian T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10170
   Bell BP, 2016, AM J PUBLIC HEALTH, V106, P589, DOI 10.2105/AJPH.2016.303124
   Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P921, DOI [10.1089/aid.2010.0323, 10.1089/AID.2010.0323]
   Cox BD, 2016, ANTIVIR CHEM CHEMOTH
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015
   Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403
   Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238
   Nielsen R, 1998, GENETICS, V148, P929
   Patronov A, 2016, NEUTRACORP NEW TOOL
   Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Salimi N, 2012, IMMUNOLOGY, V137, P117, DOI 10.1111/j.1365-2567.2012.03611.x
   Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
NR 30
TC 3
Z9 3
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PY 2016
VL 110
IS 7-8
BP 269
EP 274
DI 10.1080/20477724.2016.1235337
PG 6
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA EI2NN
UT WOS:000392324300003
PM 27670692
OA Green Published
DA 2020-11-24
ER

PT J
AU Villano, U
   Lo Presti, A
   Equestre, M
   Cella, E
   Pisani, G
   Giovanetti, M
   Bruni, R
   Tritarelli, E
   Amicosante, M
   Grifoni, A
   Scarcella, C
   El-Hamad, I
   Pezzoli, MC
   Angeletti, S
   Ciccaglione, AR
   Ciccozzi, M
AF Villano, Umbertina
   Lo Presti, Alessandra
   Equestre, Michele
   Cella, Eleonora
   Pisani, Giulio
   Giovanetti, Marta
   Bruni, Roberto
   Tritarelli, Elena
   Amicosante, Massimo
   Grifoni, Alba
   Scarcella, Carmelo
   El-Hamad, Issa
   Pezzoli, Maria Chiara
   Angeletti, Silvia
   Ciccaglione, Anna Rita
   Ciccozzi, Massimo
TI Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in
   a group of migrants in Italy (vol 15, pg 287, 2015)
SO BMC INFECTIOUS DISEASES
LA English
DT Correction
C1 [Villano, Umbertina; Bruni, Roberto; Tritarelli, Elena; Ciccaglione, Anna Rita] Ist Super Sanita, Viral Hepatitis Unit, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy.
   [Lo Presti, Alessandra; Cella, Eleonora; Giovanetti, Marta; Ciccozzi, Massimo] Ist Super Sanita, Epidemiol Unit, Dept Infect Parasit & Immune Mediated Dis, Rome, Italy.
   [Equestre, Michele] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy.
   [Pisani, Giulio] Ist Super Sanita, Ctr Immunobiol Res & Evaluat, I-00161 Rome, Italy.
   [Amicosante, Massimo] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy.
   [Grifoni, Alba] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.
   [Scarcella, Carmelo; El-Hamad, Issa; Pezzoli, Maria Chiara] Spedali Civili Gen Hosp, Dept Infect Dis, Brescia, Italy.
   [El-Hamad, Issa] Brescia Local Hlth Author, Brescia, Italy.
   [Angeletti, Silvia; Ciccozzi, Massimo] Univ Hosp Campus Biomed, Clin Pathol & Microbiol Lab, Rome, Italy.
RP Ciccozzi, M (corresponding author), Ist Super Sanita, Epidemiol Unit, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, Rome, Italy.
EM massimo.ciccozzi@iss.it
RI Cella, Eleonora/ABA-8333-2020; Equestre, Michele/AAC-2129-2019;
   CICCOZZI, MASSIMO/C-6484-2016; Giovanetti, Marta/AAK-7408-2020;
   equestre, michele/AAV-4993-2020; Cella, Eleonora/J-9961-2016; Pisani,
   Giulio/M-9482-2017; BRUNI, ROBERTO/M-2957-2015; Presti, Alessandra
   Lo/K-1451-2016; Ciccaglione, Anna Rita/M-2956-2015
OI Cella, Eleonora/0000-0002-7870-9744; CICCOZZI,
   MASSIMO/0000-0003-3866-9239; equestre, michele/0000-0001-7883-1371;
   Cella, Eleonora/0000-0002-7870-9744; Pisani, Giulio/0000-0002-5569-8915;
   BRUNI, ROBERTO/0000-0002-3035-5510; Presti, Alessandra
   Lo/0000-0001-7611-5021; Ciccaglione, Anna Rita/0000-0002-3791-3781;
   Tritarelli, Elena/0000-0001-7600-7661; Grifoni, Alba/0000-0002-0369-1746
CR Villano U, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0994-9
NR 1
TC 3
Z9 3
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 17
PY 2015
VL 15
AR 531
DI 10.1186/s12879-015-1245-9
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA CW8ZG
UT WOS:000365287400002
PM 26578229
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Vaz, SN
   Giovanetti, M
   Rego, FFD
   de Oliveira, T
   Danaviah, S
   Goncalves, MLF
   Alcantara, LC
   Brites, C
AF Vaz, Sara Nunes
   Giovanetti, Marta
   de Almeida Rego, Filipe Ferreira
   de Oliveira, Tulio
   Danaviah, Siva
   Freire Goncalves, Maria Luiza
   Junior Alcantara, Luiz Carlos
   Brites, Carlos
TI Molecular Characterization of the Human Immunodeficiency Virus Type 1 in
   Women and Their Vertically Infected Children
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID HIV-1; RESISTANCE; POLYMORPHISMS; TRANSMISSION; PREVALENCE
AB Approximately 35 million people worldwide are infected with human immunodeficiency virus (HIV) around 3.2 million of whom are children under 15 years. Mother-to-child-transmission (MTCT) of HIV-1 accounts for 90% of all infections in children. Despite great advances in the prevention of MTCT in Brazil, children are still becoming infected. Samples from 19 HIV-1-infected families were collected. DNA was extracted and fragments from gag, pol, and env were amplified and sequenced directly. Phylogenetic reconstruction was performed. Drug resistance analyses were performed in pol and env sequences. We found 82.1% of subtype B and 17.9% of BF recombinants. A prevalence of 43.9% drug resistance-associated mutations in pol sequences was identified. Of the drug-naive children 33.3% presented at least one mutation related to protease inhibitor/nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor (PI/NRTI/NNRTI) resistance. The prevalence of transmitted drug resistance mutations was 4.9%. On env we found a low prevalence of HR1 (4.9%) and HR2 (14.6%) mutations.
C1 [Vaz, Sara Nunes; Brites, Carlos] Univ Fed Bahia, Retrovirol Lab, Salvador, BA, Brazil.
   [Vaz, Sara Nunes; Giovanetti, Marta; de Almeida Rego, Filipe Ferreira; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Lab Hematol Genet & Computat Biol, Salvador, BA, Brazil.
   [Giovanetti, Marta] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [de Oliveira, Tulio; Danaviah, Siva] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.
   [Freire Goncalves, Maria Luiza] Specialized Ctr Diag Care & Res, Salvador, BA, Brazil.
RP Brites, C (corresponding author), HUPES UFBA, Rua Augusto Viana Sn, BR-40110060 Salvador, BA, Brazil.
EM crbrites@gmail.com
RI Giovanetti, Marta/AAK-7408-2020; Brites, Carlos/D-1353-2013
OI Brites, Carlos/0000-0002-4673-6991; Giovanetti,
   Marta/0000-0002-5849-7326; Alcantara, Luiz/0000-0002-6769-9931
FU Wellcome TrustWellcome Trust [097410] Funding Source: Medline
CR Ahmad N, 2008, ADV PHARMACOL, V56, P453, DOI 10.1016/S1054-3589(07)56015-1
   Alencar CS, 2010, AIDS RES HUM RETROV, V26, P1267, DOI 10.1089/aid.2010.0057
   Araujo AF, 2010, AIDS RES HUM RETROV, V26, P1249, DOI 10.1089/aid.2010.0068
   Brazil Ministry of Health, 2014, B EP AIDS E DST, VIII, P1
   Reis MND, 2014, J MED VIROL, V86, P8, DOI 10.1002/jmv.23738
   da Silveira AA, 2012, AIDS RES HUM RETROV, V28, P304, DOI 10.1089/aid.2011.0128
   de Oliveira CM, 2008, ARCH VIROL, V153, P1799, DOI 10.1007/s00705-008-0178-7
   Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134
   Guimaraes PM, 2015, AIDS RES HUM RETROV, V31, P1
   Monteiro-Cunha JP, 2011, AIDS RES HUM RETROV, V27, P623, DOI [10.1089/AID.2010.0126, 10.1089/aid.2010.0126]
   MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569
   Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106
   Salminen MO, 1997, J VIROL, V71, P2647, DOI 10.1128/JVI.71.4.2647-2655.1997
   Sanabani SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062552
   Santos LA, 2011, J MED VIROL, V83, P2066, DOI 10.1002/jmv.22170
   Wensing Annemarie M, 2014, Top Antivir Med, V22, P642
   World Health Organization, AIDS EP 2013
NR 17
TC 5
Z9 5
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD OCT 1
PY 2015
VL 31
IS 10
BP 1046
EP 1051
DI 10.1089/aid.2015.0166
PG 6
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA CR5PL
UT WOS:000361395500015
PM 26200738
OA Green Published
DA 2020-11-24
ER

PT J
AU Mancini, F
   Ciccozzi, M
   Lo Presti, A
   Cella, E
   Giovanetti, M
   Di Luca, M
   Toma, L
   Bianchi, R
   Khoury, C
   Rezza, G
   Ciervo, A
AF Mancini, Fabiola
   Ciccozzi, Massimo
   Lo Presti, Alessandra
   Cella, Eleonora
   Giovanetti, Marta
   Di Luca, Marco
   Toma, Luciano
   Bianchi, Riccardo
   Khoury, Cristina
   Rezza, Giovanni
   Ciervo, Alessandra
TI Characterization of spotted fever group Rickettsiae in ticks from a city
   park of Rome, Italy
SO ANNALI DELL ISTITUTO SUPERIORE DI SANITA
LA English
DT Article
DE tick; urban park; Rickettsia SFG; molecular characterization
ID IXODES-RICINUS TICKS; DERMACENTOR-MARGINATUS; PHYLOGENETIC ANALYSIS;
   BORRELIA-BURGDORFERI; BORNE PATHOGENS; PUBLIC PARKS; BABESIA; ANAPLASMA;
   TUSCANY; PHAGOCYTOPHILUM
AB Background. Ticks are vectors and important reservoirs for microbial agents that cause disease in humans and animals. Among these pathogens, the members of Rickettsia species play an important role in public health.
   Aim and methods. One hundred twenty-nine ticks belonging to four tick species (Ixodes ricinus, Rhipicephalus turanicus, Dermacentor marginatus, and Haemaphysalis punctata) were collected at different sites of the Insugherata Natural Reserve, localized in the urban area of Rome, Italy. Questing ticks were tested by PCR for Rickettsia spp., amplifying partial gene of ompA.
   Results. Forty-six ticks were found to be infected with Rickettsia species. Five SFG rickettsiae were identified: three human pathogens Rickettsia conorii, Rickettsia massiliae and Rickettsia aeschlimannii, and two putative new strains Rickettsia sp. strain RM1 and Rickettsia sp. strain RM2. The phylogenetic analysis of partial gene sequences of ompA, gltA, and 17-kd antigen showed that they clustered with several rickettsiae with unidentified pathogenicity. However, Rickettsia sp. strain RM1 and Rickettsia sp. strain RM2 clustered in a statistically supported clade with R. massiliae, and R. monacensis, respectively.
   Conclusion. Our findings suggest that Rickettsia species other than R. conorii are implicated in human disease in Italy.
C1 [Mancini, Fabiola; Ciccozzi, Massimo; Lo Presti, Alessandra; Cella, Eleonora; Giovanetti, Marta; Di Luca, Marco; Toma, Luciano; Bianchi, Riccardo; Khoury, Cristina; Rezza, Giovanni; Ciervo, Alessandra] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Ciccozzi, Massimo] Univ Campus Biomed, Rome, Italy.
RP Ciervo, A (corresponding author), Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, Viale Regina Elena 299, I-00161 Rome, Italy.
EM alessandra.ciervo@iss.it
RI CICCOZZI, MASSIMO/C-6484-2016; CIERVO, ALESSANDRA/C-8812-2016; Di Luca,
   Marco/C-4966-2016; Giovanetti, Marta/AAK-7408-2020; rezza,
   giovanni/D-4393-2016; MANCINI, FABIOLA/C-8818-2016; Cella,
   Eleonora/J-9961-2016; Cella, Eleonora/ABA-8333-2020; Presti, Alessandra
   Lo/K-1451-2016
OI CICCOZZI, MASSIMO/0000-0003-3866-9239; Di Luca,
   Marco/0000-0003-1442-3672; rezza, giovanni/0000-0003-0268-6790; Cella,
   Eleonora/0000-0002-7870-9744; Cella, Eleonora/0000-0002-7870-9744;
   Presti, Alessandra Lo/0000-0001-7611-5021
FU Italian Ministry of Health (CCM :"Sorveglianza di laboratorio di
   infezioni batteriche sottoposte a sorveglianza europea e da agenti di
   bioterrorismo")
FX This study was partially supported by a research grant from the Italian
   Ministry of Health (CCM 2013-2014: "Sorveglianza di laboratorio di
   infezioni batteriche sottoposte a sorveglianza europea e da agenti di
   bioterrorismo").
CR Beninati T, 2005, EMERG INFECT DIS, V11, P509, DOI 10.3201/eid1103.040812
   Bertolotti L, 2006, J MED ENTOMOL, V43, P159, DOI 10.1603/0022-2585(2006)043[0159:BLASFG]2.0.CO;2
   Brouqui P, 2007, FEMS IMMUNOL MED MIC, V49, P2, DOI 10.1111/j.1574-695X.2006.00138.x
   Ciceroni L, 2006, ANN NY ACAD SCI, V1078, P143, DOI 10.1196/annals.1374.024
   Corrain R, 2012, ZOONOSES PUBLIC HLTH, V59, P468, DOI 10.1111/j.1863-2378.2012.01490.x
   Di Luca M, 2013, TICKS TICK-BORNE DIS, V4, P513, DOI 10.1016/j.ttbdis.2013.06.008
   Floris R, 2008, VECTOR-BORNE ZOONOT, V8, P777, DOI 10.1089/vbz.2008.0006
   Fournier PE, 1998, INT J SYST BACTERIOL, V48, P839, DOI 10.1099/00207713-48-3-839
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Lee JH, 2003, J CLIN MICROBIOL, V41, P2952, DOI 10.1128/JCM.41.7.2952-2960.2003
   Madeddu G, 2012, EMERG INFECT DIS, V18, P702, DOI 10.3201/eid1804.111583
   Manilla G, 1998, ACARI IXODIDA FAUNA, V36
   Movila A, 2011, VECTOR-BORNE ZOONOT, V11, P89, DOI 10.1089/vbz.2010.0043
   Mura A, 2008, CLIN MICROBIOL INFEC, V14, P1028, DOI 10.1111/j.1469-0691.2008.02082.x
   Piccolin G, 2006, VECTOR-BORNE ZOONOT, V6, P24, DOI 10.1089/vbz.2006.6.24
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991
   Reye AL, 2010, APPL ENVIRON MICROB, V76, P2923, DOI 10.1128/AEM.03061-09
   Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252
   Schorn S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-135
   Selmi M, 2008, EMERG INFECT DIS, V14, P817, DOI 10.3201/eid1405.070976
   Selmi M, 2009, J MED ENTOMOL, V46, P1490, DOI 10.1603/033.046.0636
   Stanczak J, 2004, ANN AGR ENV MED, V11, P109
   Stanczak J, 2006, ANN NY ACAD SCI, V1078, P512, DOI 10.1196/annals.1374.100
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Torina A, 2010, TRANSBOUND EMERG DIS, V57, P46, DOI 10.1111/j.1865-1682.2010.01101.x
   Tsui PY, 2007, AM J TROP MED HYG, V77, P883, DOI 10.4269/ajtmh.2007.77.883
   Vitale G, 2006, EMERG INFECT DIS, V12, P174, DOI 10.3201/eid1201.050850
   Wielinga PR, 2006, APPL ENVIRON MICROB, V72, P7594, DOI 10.1128/AEM.01851-06
NR 31
TC 9
Z9 9
U1 0
U2 2
PU PENSIERO SCIENTIFICO
PI ROME
PA VIA SAN GIOVANNI VALDARNO 8, ROME, 00198, ITALY
SN 0021-2571
J9 ANN I SUPER SANITA
JI Ann. Ist. Super. Sanita
PD OCT-DEC
PY 2015
VL 51
IS 4
BP 284
EP +
DI 10.4415/ANN_15_04_07
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DC4ZB
UT WOS:000369228400007
PM 26783214
OA DOAJ Gold
DA 2020-11-24
ER

PT J
AU Villano, U
   Lo Presti, A
   Equestre, M
   Cella, E
   Pisani, G
   Giovanetti, M
   Bruni, R
   Tritarelli, E
   Amicosante, M
   Grifoni, A
   Scarcella, C
   El-Hamad, I
   Pezzoli, MC
   Silvia, A
   Ciccaglione, AR
   Ciccozzi, M
AF Villano, Umbertina
   Lo Presti, Alessandra
   Equestre, Michele
   Cella, Eleonora
   Pisani, Giulio
   Giovanetti, Marta
   Bruni, Roberto
   Tritarelli, Elena
   Amicosante, Massimo
   Grifoni, Alba
   Scarcella, Carmelo
   El-Hamad, Issa
   Pezzoli, Maria Chiara
   Silvia, Angeletti
   Ciccaglione, Anna Rita
   Ciccozzi, Massimo
TI Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in
   a group of migrants in Italy
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE HBV; Phylogeny; Phylodynamics; Molecular epidemiology; Migrants
ID SUBGENOTYPES; GENOTYPES
AB Background: Hepatitis B virus infection (HBV) is widespread and it is considered a major health problem worldwide. The global distribution of HBV varies significantly between countries and between regions of the world. Among the many factors contributing to the changing epidemiology of viral hepatitis, the movement of people within and between countries is a potentially important one. In Italy, the number of migrant individuals has been increasing during the past 25 years. HBV genotype D has been found throughout the world, although its highest prevalence is in the Mediterranean area, the Middle East and southern Asia. We describe the molecular epidemiology of HBV in a chronically infected population of migrants (living in Italy), by using the phylogenetic analysis.
   Methods: HBV-DNA was amplified and sequenced from 43 HBV chronically infected patients. Phylogenetic and evolutionary analysis were performed using both maximum Likelihood and Bayesian methods.
   Results and conclusion: Of the 43 HBV S gene isolates from migrants, 25 (58.1 %) were classified as D genotype. Maximum Likelihood analysis showed an intermixing between Moldavian and foreigners sequences mostly respect to Italian ones. Italian sequences clustered mostly together in a main clade separately from all others. The estimation of the time of the tree's root gave a mean value of 17 years ago, suggesting the origin of the tree back to 1992 year. The skyline plot showed that the number of infections softly increased until the early 2005s, after which reached a plateau. Comparing phylogenetic data to the migrants date of arrival in Italy, it should be possible that migrants arrived in Italy yet infected from their country of origin. In conclusion, this is the first paper where phylogenetic analysis and genetic evolution has been used to characterize HBV sub genotypes D1 circulation in a selected and homogenous group of migrants coming from a restricted area of Balkans and to approximately define the period of infection besides the migration date.
C1 [Villano, Umbertina; Bruni, Roberto; Tritarelli, Elena; Ciccaglione, Anna Rita] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viral Hepatitis Unit, I-00161 Rome, Italy.
   [Lo Presti, Alessandra; Cella, Eleonora; Giovanetti, Marta; Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Epidemiol Unit, I-00161 Rome, Italy.
   [Equestre, Michele] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy.
   [Pisani, Giulio] Ist Super Sanita, Ctr Immunobiol Res & Evaluat, I-00161 Rome, Italy.
   [Amicosante, Massimo] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy.
   [Grifoni, Alba] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.
   [Scarcella, Carmelo; El-Hamad, Issa; Pezzoli, Maria Chiara] Spedali Civili Gen Hosp, Dept Infect Dis, Brescia, Italy.
   [El-Hamad, Issa] Brescia Local Hlth Author, Brescia, Italy.
   [Silvia, Angeletti; Ciccozzi, Massimo] Univ Hosp, Clin Pathol & Microbiol Lab, Rome, Italy.
RP Ciccozzi, M (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Epidemiol Unit, Viale Regina Elena 299, I-00161 Rome, Italy.
EM massimo.ciccozzi@iss.it
RI BRUNI, ROBERTO/M-2957-2015; equestre, michele/AAV-4993-2020; Giovanetti,
   Marta/AAK-7408-2020; CICCOZZI, MASSIMO/C-6484-2016; Pisani,
   Giulio/M-9482-2017; Presti, Alessandra Lo/K-1451-2016; TRITARELLI,
   ELENA/M-2966-2015; Equestre, Michele/AAC-2129-2019; Cella,
   Eleonora/ABA-8333-2020; Cella, Eleonora/J-9961-2016; Ciccaglione, Anna
   Rita/M-2956-2015
OI BRUNI, ROBERTO/0000-0002-3035-5510; equestre,
   michele/0000-0001-7883-1371; CICCOZZI, MASSIMO/0000-0003-3866-9239;
   Pisani, Giulio/0000-0002-5569-8915; Presti, Alessandra
   Lo/0000-0001-7611-5021; Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Grifoni, Alba/0000-0002-0369-1746;
   Amicosante, Massimo/0000-0002-2372-3311; Ciccaglione, Anna
   Rita/0000-0002-3791-3781; Giovanetti, Marta/0000-0002-5849-7326;
   Tritarelli, Elena/0000-0001-7600-7661; , Alba/0000-0002-2209-5966
CR Amini-Bavil-Olyaee S, 2005, J MED VIROL, V75, P227, DOI 10.1002/jmv.20261
   [Anonymous], 2004, Wkly Epidemiol Rec, V79, P255
   Carballo M, MIGRATION HEPATITIS
   Caritas & Migrantes, 2012, 22 CAR MIGR
   Ciccozzi M, 2014, INFECT GENET EVOL, V27, P395, DOI 10.1016/j.meegid.2014.08.010
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   El-Hamad I, 2015, J TRAVEL MED, V22, P78, DOI 10.1111/jtm.12176
   European Centre of Disease Prevention and control ECDC, 2010, TECHNICAL REPORT
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x
   Liang TJ, 2001, FIELDS VIROLOGY, V4, P2971
   Locarnini S, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-828672
   Murhekar MV, 2008, T ROY SOC TROP MED H, V102, P729, DOI 10.1016/j.trstmh.2008.04.044
   Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872
   Ozaras R., SEXUALLY TRANSMITTED
   Ozaras R, 2015, CLIN RES HEPATOL GAS, V39, P28, DOI 10.1016/j.clinre.2014.06.005
   Palumbo Emilio, 2007, Arq. Gastroenterol., V44, P54, DOI 10.1590/S0004-28032007000100012
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Schaefer S, 2007, WORLD J GASTROENTERO, V13, P14, DOI 10.3748/wjg.v13.i1.14
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Yousif M, 2013, HEPATOL RES, V43, P355, DOI 10.1111/j.1872-034X.2012.01090.x
   Zehender G, 2014, WORLD J GASTROENTERO, V20, P7622, DOI 10.3748/wjg.v20.i24.7622
NR 24
TC 9
Z9 9
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUL 25
PY 2015
VL 15
AR 287
DI 10.1186/s12879-015-0994-9
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA CN5PG
UT WOS:000358480700001
PM 26209519
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Zehender, G
   Svicher, V
   Gabanelli, E
   Ebranati, E
   Veo, C
   Lo Presti, A
   Cella, E
   Giovanetti, M
   Bussini, L
   Salpini, R
   Alteri, C
   Lai, A
   Tanzi, E
   Perno, CF
   Galli, M
   Ciccozzi, M
AF Zehender, Gianguglielmo
   Svicher, Valentina
   Gabanelli, Elena
   Ebranati, Erika
   Veo, Carla
   Lo Presti, Alessandra
   Cella, Eleonora
   Giovanetti, Marta
   Bussini, Linda
   Salpini, Romina
   Alteri, Claudia
   Lai, Alessia
   Tanzi, Elisabetta
   Perno, Carlo Federico
   Galli, Massimo
   Ciccozzi, Massimo
TI Reliable timescale inference of HBV genotype A origin and phylodynamics
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Hepatitis B virus; HBV genotype A; HBV subgenotype A2; HBV subgenotype
   A1; Phylogeography; Molecular clock calibration
ID HEPATITIS-B-VIRUS; GENETIC DIVERSITY; SEQUENCE ALIGNMENT; EVOLUTIONARY
   RATE; SOUTH-AFRICA; SLAVE-TRADE; INFECTION; EPIDEMIOLOGY; SUBGENOTYPES;
   INDIA
AB The worldwide distributed Hepatitis B virus (HBV) genotype A is classified into three subgenotypes, and one quasi-subgenotype. The majority of HBV-A subgenotypes are widespread in Africa and in ethnic groups that have relatively recently emigrated from African countries, whereas HBV-A2 is highly prevalent among subjects at high risk for sexual exposure to HBV in north-western Europe and the USA.
   The aim of this study was to reconstruct the origin and dispersion of HBV-A subgenotypes on a reliable timescale using short-term calibration based on heterochronous sampling for HBV-A2, and long-term calibration based on historical data for the other subgenotypes.
   To this aim, we analysed 113 newly characterised HBV-A isolates with 247 reference sequences retrieved from a public database. The phylodynamic reconstruction was performed by a Bayesian framework.
   The common ancestor of the currently circulating A subgenotypes was placed in west-central Africa a mean 1057 years ago. The genotype diverged into two main clades at the beginning of the 13th century: one including all of the west-central African quasi-subgenotypes and the other corresponding to subgenotype A1, originating in east Africa and further segregating into two main subclades: an "African" and a "cosmopolitan" clade.
   It is likely that the slave trade was the main source the spread of cosmopolitan HBV-A1, which was exported to Asia in the 17th century as a result of Arab or Portuguese trade, and to Latin America in the 18th centuries through the trans-Atlantic slave trade.
   The origin of the currently circulating A2 strains dates back to the first decades of the 20th century, and the evolutionary demography analysis suggests an exponential growth of infections, between 19705 and the mid-1990s.
   In conclusion, the very different epidemiological and evolutionary histories of HBV-A subgenotypes justify the use of different calibration approaches to reconstruct their reciprocal phylodynamics. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zehender, Gianguglielmo; Gabanelli, Elena; Ebranati, Erika; Veo, Carla; Bussini, Linda; Lai, Alessia; Galli, Massimo] Univ Milan, L Sacco Dept Biomed & Clin Sci, I-20157 Milan, Italy.
   [Svicher, Valentina; Salpini, Romina; Alteri, Claudia; Perno, Carlo Federico] Univ Roma Tor Vergata, Dept Expt Med & Surg, I-00100 Rome, Italy.
   [Lo Presti, Alessandra; Cella, Eleonora; Giovanetti, Marta; Ciccozzi, Massimo] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy.
   [Tanzi, Elisabetta] Univ Milan, Dept Biomed Sci Hlth, I-20157 Milan, Italy.
RP Zehender, G (corresponding author), Univ Milan, L Sacco Dept Biomed & Clin Sci, Via GB Grassi 74, I-20157 Milan, Italy.
EM gianguglielmo.zehender@unimi.it
RI CICCOZZI, MASSIMO/C-6484-2016; Tanzi, Elisabetta/M-9066-2016;
   Giovanetti, Marta/AAK-7408-2020; Alteri, Claudia/AAB-9956-2019; Presti,
   Alessandra Lo/K-1451-2016; Cella, Eleonora/J-9961-2016; Cella,
   Eleonora/ABA-8333-2020; Alteri, Claudia/J-9116-2016; Salpini,
   Romina/K-2170-2016; perno, carlo federico/O-1544-2016; GALLI,
   MASSIMO/L-7282-2017
OI CICCOZZI, MASSIMO/0000-0003-3866-9239; Tanzi,
   Elisabetta/0000-0002-4119-701X; Alteri, Claudia/0000-0003-4270-5079;
   Presti, Alessandra Lo/0000-0001-7611-5021; Cella,
   Eleonora/0000-0002-7870-9744; Cella, Eleonora/0000-0002-7870-9744;
   Alteri, Claudia/0000-0003-4270-5079; Salpini,
   Romina/0000-0002-2488-2082; GALLI, MASSIMO/0000-0001-8887-6215;
   Giovanetti, Marta/0000-0002-5849-7326; PERNO, CARLO
   FEDERICO/0000-0002-0825-5388
CR Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642
   Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618
   Araujo NM, 2011, INFECT GENET EVOL, V11, P1199, DOI 10.1016/j.meegid.2011.04.017
   Banerjee A, 2006, J MED VIROL, V78, P1164, DOI 10.1002/jmv.20677
   Bowyer SM, 1997, J GEN VIROL, V78, P1719, DOI 10.1099/0022-1317-78-7-1719
   Castilho MD, 2012, AM J TROP MED HYG, V87, P768, DOI 10.4269/ajtmh.2012.12-0083
   Chami F. A, 1998, AFR ARCHAEOL REV, V15, P199, DOI DOI 10.1023/A:1021612012892
   De Maddalena C, 2007, VIROLOGY, V365, P113, DOI 10.1016/j.virol.2007.03.015
   Devesa M, 2007, VIRUS RES, V127, P177, DOI 10.1016/j.virusres.2007.01.004
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615
   Fujisaki S, 2011, J CLIN MICROBIOL, V49, P1017, DOI 10.1128/JCM.02149-10
   Gauniyal M, 2008, HUM BIOL, V80, P251, DOI 10.3378/1534-6617-80.3.251
   Geggus D, 2001, WILLIAM MARY QUART, V58, P119, DOI 10.2307/2674421
   Godoy BA, 2013, ANTIVIR THER, V18, P505, DOI 10.3851/IMP2600
   Hahne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067866
   Hannoun C, 2005, J GEN VIROL, V86, P2163, DOI 10.1099/vir.0.80972-0
   Harrison A, 2011, VIRUSES-BASEL, V3, P83, DOI 10.3390/v3020083
   Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615
   Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Kramvis A, 2002, J GEN VIROL, V83, P835, DOI 10.1099/0022-1317-83-4-835
   Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x
   Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947
   Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657
   Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105317
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Locarnini S, 2013, SEMIN CANCER BIOL, V23, P561, DOI 10.1016/j.semcancer.2013.08.006
   MORTIMER PP, 1995, GENITOURIN MED, V71, P109
   Murhekar MV, 2008, T ROY SOC TROP MED H, V102, P729, DOI 10.1016/j.trstmh.2008.04.044
   Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872
   Oliver Roland, 2005, AFRICA SINCE 1800
   Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116
   Pakendorf B, 2011, LANG DYN CHANG, V1, P50, DOI 10.1163/221058211X570349
   Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079
   Pourkarim MR, 2010, J CLIN VIROL, V47, P93, DOI 10.1016/j.jcv.2009.09.032
   Rantala M., 2008, EURO SURVEILL, V13
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Sugauchi F, 2004, J GEN VIROL, V85, P811, DOI 10.1099/vir.0.79811-0
   Svicher V, 2012, ANTIVIR RES, V93, P86, DOI 10.1016/j.antiviral.2011.10.022
   Tamada Y, 2012, GUT, V61, P765, DOI 10.1136/gutjnl-2011-300832
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   van Houdt R, 2010, J VIRAL HEPATITIS, V17, P108, DOI 10.1111/j.1365-2893.2009.01158.x
   Vernet T., 2009, SLAVERY ISLAM DIASPO
   Vernet Thomas, 2013, ENCY GLOBAL HUMAN MI
   Zehender G, 2008, VIROLOGY, V380, P84, DOI 10.1016/j.virol.2008.07.009
   Zehender G, 2014, WORLD J GASTROENTERO, V20, P7622, DOI 10.3748/wjg.v20.i24.7622
   Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1
NR 50
TC 12
Z9 12
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUN
PY 2015
VL 32
BP 361
EP 369
DI 10.1016/j.meegid.2015.03.009
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA CI8MV
UT WOS:000355027300047
PM 25784568
DA 2020-11-24
ER

PT J
AU Giovanetti, M
   Grifoni, A
   Lo Presti, A
   Cella, E
   Montesano, C
   Zehender, G
   Colizzi, V
   Amicosante, M
   Ciccozzi, M
AF Giovanetti, Marta
   Grifoni, Alba
   Lo Presti, Alessandra
   Cella, Eleonora
   Montesano, Carla
   Zehender, Gianguglielmo
   Colizzi, Vittorio
   Amicosante, Massimo
   Ciccozzi, Massimo
TI Amino Acid Mutations in Ebola Virus Glycoprotein of the 2014 Epidemic
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE Ebola virus; glycoprotein; evolutionary analysis
ID SITES; PREDICTION; ACCURACY; ANTIBODY; MODELS; POWER
AB Zaire Ebola virus (EBOV) is an enveloped non-segmented negative strand RNA virus of 19kb in length belonging to the family Filoviridae. The virus was isolated and identified in 1976 during the epidemic of hemorrhagic fever in Zaire. The most recent outbreak of EBOV among humans, was that occurred in the forested areas of south eastern Guinea, that began in February 2014 and is still ongoing. The recent Ebola outbreak, is affecting other countries in West Africa, in addiction to Guinea: Liberia, Nigeria, and Sierra Leone. In this article, a selective pressure analysis and homology modeling based on the G Glycoprotein (GP) sequences retrieved from public databases were used to investigate the genetic diversity and modification of antibody response in the recent outbreak of Ebola Virus. Structural and the evolutionary analysis underline the 2014 epidemic virus being under negative selective pressure does not change with respect to the old epidemic in terms of genome adaptation. J. Med. Virol. 87:893-898, 2015. (c) 2015 Wiley Periodicals, Inc.
C1 [Giovanetti, Marta; Lo Presti, Alessandra; Cella, Eleonora; Ciccozzi, Massimo] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [Grifoni, Alba; Montesano, Carla; Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, Rome, Italy.
   [Zehender, Gianguglielmo] Univ Milan, Lab Infect Dis & Trop Med, I-20122 Milan, Italy.
   [Amicosante, Massimo] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy.
   [Amicosante, Massimo] ProxAgen Ltd, Sofia, Bulgaria.
   [Ciccozzi, Massimo] Univ Hosp Campus Biomed, Rome, Italy.
RP Ciccozzi, M (corresponding author), Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
EM ciccozzi@iss.it
RI Presti, Alessandra Lo/K-1451-2016; CICCOZZI, MASSIMO/C-6484-2016;
   Giovanetti, Marta/AAK-7408-2020; Cella, Eleonora/J-9961-2016; Cella,
   Eleonora/ABA-8333-2020
OI Presti, Alessandra Lo/0000-0001-7611-5021; CICCOZZI,
   MASSIMO/0000-0003-3866-9239; Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Giovanetti, Marta/0000-0002-5849-7326;
   Amicosante, Massimo/0000-0002-2372-3311; Grifoni,
   Alba/0000-0002-0369-1746; , Alba/0000-0002-2209-5966; Montesano,
   Carla/0000-0002-9865-6619
CR Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152
   Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945
   CDC, 2014, EB OUTBR W AFR
   Grifoni A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/283805
   Grifoni A, 2013, MOL IMMUNOL, V53, P410, DOI 10.1016/j.molimm.2012.09.009
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Kajihara M, 2013, J GEN VIROL, V94, P876, DOI 10.1099/vir.0.049114-0
   Kuhn JH, 2014, ARCH VIROL, V159, P1229, DOI 10.1007/s00705-013-1877-2
   Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082
   Lee JE, 2009, ACTA CRYSTALLOGR D, V65, P1162, DOI 10.1107/S0907444909032314
   Montieri S, 2007, J MED VIROL, V79, P1935, DOI 10.1002/jmv.21012
   Nielsen R, 1998, GENETICS, V148, P929
   Paessler S, 2013, ANNU REV PATHOL-MECH, V8, P411, DOI 10.1146/annurev-pathol-020712-164041
   Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006
   Sobarzo A, 2013, NEW ENGL J MED, V369, P492, DOI 10.1056/NEJMc1300266
   Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398
   Stahelin RV, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00300
   Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254
   Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837
   Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104
   Yang ZH, 2000, GENETICS, V155, P431
   Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097
   Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
NR 25
TC 4
Z9 6
U1 0
U2 48
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JUN
PY 2015
VL 87
IS 6
BP 893
EP 898
DI 10.1002/jmv.24133
PG 6
WC Virology
SC Virology
GA CF8ER
UT WOS:000352789200001
PM 25783989
DA 2020-11-24
ER

PT J
AU Azarian, T
   Lo Presti, A
   Giovanetti, M
   Cella, E
   Rife, B
   Lai, A
   Zehender, G
   Ciccozzi, M
   Salemi, M
AF Azarian, Taj
   Lo Presti, Alessandra
   Giovanetti, Marta
   Cella, Eleonora
   Rife, Brittany
   Lai, Alessia
   Zehender, Gianguglielmo
   Ciccozzi, Massimo
   Salemi, Marco
TI Impact of spatial dispersion, evolution, and selection on Ebola Zaire
   Virus epidemic waves
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; POPULATION-DYNAMICS; MAXIMUM-LIKELIHOOD;
   GLYCOPROTEIN; INFERENCE; TRANSMISSION; HISTORY; ORIGIN; MODEL; ANTIBODY
AB Ebola virus Zaire (EBOV) has reemerged in Africa, emphasizing the global importance of this pathogen. Amidst the response to the current epidemic, several gaps in our knowledge of EBOV evolution are evident. Specifically, uncertainty has been raised regarding the potential emergence of more virulent viral variants through amino acid substitutions. Glycoprotein (GP), an essential component of the EBOV genome, is highly variable and a potential site for the occurrence of advantageous mutations. For this study, we reconstructed the evolutionary history of EBOV by analyzing 65 GP sequences from humans and great apes over diverse locations across epidemic waves between 1976 and 2014. We show that, although patterns of spatial dispersion throughout Africa varied, the evolution of the virus has largely been characterized by neutral genetic drift. Therefore, the radical emergence of more transmissible variants is unlikely, a positive finding, which is increasingly important on the verge of vaccine deployment.
C1 [Azarian, Taj] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA.
   [Azarian, Taj] Univ Florida, Coll Med, Dept Epidemiol, Gainesville, FL USA.
   [Azarian, Taj; Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Lo Presti, Alessandra; Giovanetti, Marta; Cella, Eleonora; Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy.
   [Rife, Brittany; Salemi, Marco] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA.
   [Lai, Alessia; Zehender, Gianguglielmo] Univ Milan, L Sacco Hosp, Dept Biomed & Clin Sci, Infect Dis & Immunopathol Sect, Milan, Italy.
   [Ciccozzi, Massimo] Univ Hosp Campus Biomed, Rome, Italy.
RP Ciccozzi, M (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.
EM massimo.ciccozzi@iss.it; salemi@pathology.ufl.edu
RI CICCOZZI, MASSIMO/C-6484-2016; Azarian, Taj/H-5772-2019; Giovanetti,
   Marta/AAK-7408-2020; Presti, Alessandra Lo/K-1451-2016; Cella,
   Eleonora/J-9961-2016; Cella, Eleonora/ABA-8333-2020
OI CICCOZZI, MASSIMO/0000-0003-3866-9239; Azarian, Taj/0000-0002-8611-5241;
   Presti, Alessandra Lo/0000-0001-7611-5021; Cella,
   Eleonora/0000-0002-7870-9744; Cella, Eleonora/0000-0002-7870-9744; Rife
   Magalis, Brittany/0000-0001-6088-4651; Giovanetti,
   Marta/0000-0002-5849-7326
CR Baele G, 2013, BIOINFORMATICS, V29, P1970, DOI 10.1093/bioinformatics/btt340
   Baele G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-85
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Biek R, 2006, PLOS PATHOG, V2, P885, DOI 10.1371/journal.ppat.0020090
   Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110
   Chowell G, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0196-0
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Dudas G., 2014, PLOS CURR OUTBREAKS, V6, P1
   Feldmann H., 1993, UNCONV AGENTS UNCLAS, V7, P81
   Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082
   Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56
   Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lennemann NJ, 2014, MBIO, V5, DOI 10.1128/mBio.00862-13
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528
   Li YH, 2014, EPIDEMIOL INFECT, V142, P1138, DOI 10.1017/S0950268813002215
   Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015
   Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099
   Marzi A, 2007, J INFECT DIS, V196, pS237, DOI 10.1086/520607
   Matsuno K, 2010, BIOCHEM BIOPH RES CO, V403, P144, DOI 10.1016/j.bbrc.2010.10.136
   Medecins Sans Frontieres M. S, 2008, M S FIL HAEM FEV GUI, V1, P39
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   NEWTON MA, 1994, J R STAT SOC B, V56, P3
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006
   Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872
   Suzuki Y, 1997, MOL BIOL EVOL, V14, P800, DOI 10.1093/oxfordjournals.molbev.a025820
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371
   Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664
   Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104
   World Health Organisation, 2014, EB VIR DIS
   Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
   Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654
NR 52
TC 18
Z9 19
U1 0
U2 27
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 14
PY 2015
VL 5
AR 10170
DI 10.1038/srep10170
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ1EP
UT WOS:000355225300001
PM 25973685
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Vratnica, Z
   Zehender, G
   Ebranati, E
   Sorrentino, C
   Lai, A
   Vujosevic, D
   Veo, C
   Lo Presti, A
   Cella, E
   Giovanetti, M
   Lausevic, D
   Galli, M
   Ciccozzi, M
   Mugosa, B
AF Vratnica, Zoran
   Zehender, Gianguglielmo
   Ebranati, Erika
   Sorrentino, Chiara
   Lai, Alessia
   Vujosevic, Danijela
   Veo, Carla
   Lo Presti, Alessandra
   Cella, Eleonora
   Giovanetti, Marta
   Lausevic, Dragan
   Galli, Massimo
   Ciccozzi, Massimo
   Mugosa, Boban
TI Hepatitis B Virus Genotype and Subgenotype Prevalence and Distribution
   in Montenegro
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE Hepatitis B virus; HBV; phylogeny; Montenegro
ID RISK-FACTORS; PHYLOGENETIC ANALYSIS; GLOBAL EPIDEMIOLOGY; BLOOD-DONORS;
   INFECTION; SEQUENCE; SEROPREVALENCE; POPULATION; SUBTYPES; STRAINS
AB The Mediterranean area and the Balkans in particular show the highest level of genetic heterogeneity of HBV in Europe. Data about the circulation of HBV genotypes in Montenegro are lacking. It was studied the prevalence and distribution of HBV genot/subgenotypes in a total of 150 HBV infected patients living in Montenegro. Phylogenetic analysis of 136 successfully amplified P sequences showed a high degree of genetic heterogeneity of HBV in Montenegro. Subgenotype D2 (36.8%) and D3 (32.3%) were the most prevalent, followed by genotype A (subgenotype A2 in all of the cases-19.8%). Eight patients were infected with recombinant strains. HBV-D1 which is the most spread HBV subgenotype in the south-eastern Mediterranean countries, seems to be relatively rare in Montenegro, suggesting a penetration of HBV more probably from North-East or West than from Eastern Mediterranean countries. The relatively different prevalence of D3 and A2 among subjects infected through sexual route, seems to confirm the association of these subgenotypes with different route of transmissions (mainly parenteral for D3 and mainly sexual for A2) even in Montenegro. The low prevalence of D2 among children and its absence in perinatal transmission, suggests that this subgenotype circulated prevalently in the past. If this is due to changes in the most prevalent way of transmission and in the recent different contacts of Montenegro with other European countries, it remains to be established by other larger studies. J. Med. Virol. 87:807-813, 2015. (c) 2015 Wiley Periodicals, Inc.
C1 [Vratnica, Zoran; Vujosevic, Danijela; Lausevic, Dragan; Mugosa, Boban] Inst Publ Hlth, Podgorica, Montenegro.
   [Zehender, Gianguglielmo; Ebranati, Erika; Sorrentino, Chiara; Lai, Alessia; Veo, Carla; Galli, Massimo] Univ Milan, L Sacco Hosp, Dept Biomed & Clin Sci, Milan, Italy.
   [Lo Presti, Alessandra; Cella, Eleonora; Giovanetti, Marta; Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Epidemiol Unit, Reference Ctr Phylogeny Mol Epidemiol & Microbial, I-00161 Rome, Italy.
   [Ciccozzi, Massimo] Univ Campus Biomed, Rome, Italy.
RP Ciccozzi, M (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.
EM massimo.ciccozzi@iss.it
RI Giovanetti, Marta/AAK-7408-2020; Presti, Alessandra Lo/K-1451-2016;
   CICCOZZI, MASSIMO/C-6484-2016; Cella, Eleonora/ABA-8333-2020; Cella,
   Eleonora/J-9961-2016; GALLI, MASSIMO/L-7282-2017
OI Presti, Alessandra Lo/0000-0001-7611-5021; CICCOZZI,
   MASSIMO/0000-0003-3866-9239; Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Giovanetti, Marta/0000-0002-5849-7326;
   GALLI, MASSIMO/0000-0001-8887-6215
CR Amini-Bavil-Olyaee S, 2005, J MED VIROL, V75, P227, DOI 10.1002/jmv.20261
   Asimina F, 2011, J MED VIROL, V83, P245, DOI 10.1002/jmv.21969
   Bozdayi G, 2005, J MED VIROL, V76, P476, DOI 10.1002/jmv.20386
   Ciccozzi M, 2014, J MED VIROL, V86, P109, DOI 10.1002/jmv.23740
   Ciccozzi M, 2013, J MED VIROL, V85, P49, DOI 10.1002/jmv.23432
   Cox LE, 2011, J MED VIROL, V83, P1321, DOI 10.1002/jmv.22118
   Da Ros CT, 2008, ASIAN J ANDROL, V10, P110, DOI 10.1111/j.1745-7262.2008.00367.x
   Da Villa G, 2007, VACCINE, V25, P3133, DOI 10.1016/j.vaccine.2007.01.044
   De Maddalena C, 2007, VIROLOGY, V365, P113, DOI 10.1016/j.virol.2007.03.015
   European Centre for Disease prevention and Control, 2010, HEP B C EU NEIGHB PR
   Garmiri P, 2011, J MED VIROL, V83, P948, DOI 10.1002/jmv.21772
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0
   Koeppler TH, 2008, BMC EVOLUT BIOL, V8, P22
   Lazarevic I, 2007, ARCH VIROL, V152, P2017, DOI 10.1007/s00705-007-1031-0
   Lewis-Ximenez LL, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-26
   Medenica S, 2014, ANN REPORT COMMUNICA
   Meffre C, 2010, J MED VIROL, V82, P546, DOI 10.1002/jmv.21734
   Mugosa B, 2004, ANN REPORT COMMUNICA
   Mugosa B, 2011, SURVEY KNWLEDGE ATTI
   Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872
   OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575
   Olinger CM, 2008, CLIN MICROBIOL INFEC, V14, P575, DOI 10.1111/j.1469-0691.2008.01988.x
   Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116
   Ozer A, 2011, HEPAT MON, V11, P263
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Rantala M, 2008, EUROSURVEILLANCE, V13, P21
   Schaefer S, 2007, HEPATOL RES, V37, pS20, DOI 10.1111/j.1872-034X.2007.00099.x
   Schaefer S, 2007, WORLD J GASTROENTERO, V13, P14, DOI 10.3748/wjg.v13.i1.14
   Sheikh NS, 2011, SAUDI J GASTROENTERO, V17, P180, DOI 10.4103/1319-3767.80380
   Tallo T, 2008, J GEN VIROL, V89, P1829, DOI 10.1099/vir.0.83660-0
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Wang YB, 2011, EUR REV MED PHARMACO, V15, P592
   Zehender G, 2008, VIROLOGY, V380, P84, DOI 10.1016/j.virol.2008.07.009
   Zehender G, 2014, WORLD J GASTROENTERO, V20, P7622, DOI 10.3748/wjg.v20.i24.7622
   Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037198
   Zehender G, 2012, INFECT GENET EVOL, V12, P291, DOI [10.1016/j.meegid.2011.11.009, 10.101]
   Zhang H, 2011, INT J MED SCI, V8, P321, DOI 10.7150/ijms.8.321
NR 40
TC 4
Z9 4
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2015
VL 87
IS 5
BP 807
EP 813
DI 10.1002/jmv.24083
PG 7
WC Virology
SC Virology
GA CE0AW
UT WOS:000351465000011
PM 25712706
DA 2020-11-24
ER

PT J
AU Grifoni, A
   Montesano, C
   Palma, P
   Giovanetti, M
   Castelli-Gattinara, G
   Ciccozzi, M
   Mattei, M
   Mancino, G
   Salerno, A
   Colizzi, V
   Amicosante, M
AF Grifoni, A.
   Montesano, C.
   Palma, P.
   Giovanetti, M.
   Castelli-Gattinara, G.
   Ciccozzi, M.
   Mattei, M.
   Mancino, G.
   Salerno, A.
   Colizzi, V
   Amicosante, M.
TI Role of individual's T-cell immunome in controlling HIV-1 progression
   (vol 143, pg 631, 2014)
SO IMMUNOLOGY
LA English
DT Correction
RI Giovanetti, Marta/AAK-7408-2020; CICCOZZI, MASSIMO/C-6484-2016
OI CICCOZZI, MASSIMO/0000-0003-3866-9239
CR Grifoni A, 2014, IMMUNOLOGY, V143, P631, DOI 10.1111/imm.12344
NR 1
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD APR
PY 2015
VL 144
IS 4
BP 717
EP 717
DI 10.1111/imm.12455
PG 1
WC Immunology
SC Immunology
GA CD9DR
UT WOS:000351398200017
OA Green Published, Bronze
DA 2020-11-24
ER

PT J
AU De Luca, A
   Di Giambenedetto, S
   Lo Presti, A
   Sierra, S
   Prosperi, M
   Cella, E
   Giovanetti, M
   Torti, C
   Caudai, C
   Vicenti, I
   Saladini, F
   Almi, P
   Grima, P
   Blanc, P
   Fabbiani, M
   Rossetti, B
   Gagliardini, R
   Kaiser, R
   Ciccozzi, M
   Zazzi, M
AF De Luca, Andrea
   Di Giambenedetto, Simona
   Lo Presti, Alessandra
   Sierra, Saleta
   Prosperi, Mattia
   Cella, Eleonora
   Giovanetti, Marta
   Torti, Carlo
   Caudai, Cinzia
   Vicenti, Ilaria
   Saladini, Francesco
   Almi, Paolo
   Grima, Pierfrancesco
   Blanc, Pierluigi
   Fabbiani, Massimiliano
   Rossetti, Barbara
   Gagliardini, Roberta
   Kaiser, Rolf
   Ciccozzi, Massimo
   Zazzi, Maurizio
TI Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different
   Geographical Distribution and Association With Natural Resistance to NS3
   Protease Inhibitors
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE drug resistance; genotype 1a; HCV; protease; Q80K
ID TREATMENT-NAIVE PATIENTS; PEGYLATED INTERFERON; HCV INFECTION;
   SUBSTITUTION RATES; GENETIC DIVERSITY; DRUG-RESISTANCE; BI 207127; ALPHA
   2A; SIMEPREVIR; RIBAVIRIN
AB Background. Hepatitis C virus (HCV) genotype 1 is the most prevalent worldwide. Subtype 1a, compared with 1b, shows lower response rates and higher propensity to select for drug resistance to NS3 and selected NS5A and nonnucleoside NS5B inhibitors. Two distinct clades of subtype 1a have been described.
   Methods. Using Bayesian methodology, we performed a time-scaled phylogeny reconstruction of clade separation and characterized the geographic distribution, phylodynamics, and association with natural resistance variants of NS3 sequences from 362 patients carrying subtype 1a HCV.
   Results. All sequences segregated in 2 clearly distinct clades. Clade I showed an earlier origin from the common ancestor compared with clade II. Clade I virus was more prevalent in non-European countries, represented mostly by United States, compared with European (75.7% vs 49.3%; P < .001). The prevalence of the natural NS3 variant Q80K, associated with resistance to the macrocyclic protease inhibitor simeprevir, was detected in 51.6% of clade I and 0% of clade II (P < .001); clade I showed a lower genetic barrier for Q80K, whereas no sign of selective pressure at any protease inhibitor resistance-associated codon was detected.
   Conclusions. Hepatitis C virus subtype 1a clades have a clearly different distribution in Europe and the United States, and the natural resistance mutation Q80K is exclusively associated with clade I.
C1 [De Luca, Andrea; Rossetti, Barbara] Siena Univ Hosp, Unita Operat Complessa Malattie Infett Univ, Siena, Italy.
   [De Luca, Andrea; Di Giambenedetto, Simona; Fabbiani, Massimiliano; Gagliardini, Roberta] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, Rome, Italy.
   [Lo Presti, Alessandra; Cella, Eleonora; Giovanetti, Marta; Ciccozzi, Massimo] Natl Inst Hlth, Dept Infect Dis, Rome, Italy.
   [Sierra, Saleta; Kaiser, Rolf] Partner Site German Ctr Infect Res, Deutsch Zentrum Infekt Forsch, Berlin, Germany.
   [Sierra, Saleta; Kaiser, Rolf] Univ Cologne, Inst Virol, Cologne, Germany.
   [Prosperi, Mattia] Univ Florida, Dept Epidemiol, Gainesville, FL USA.
   [Cella, Eleonora] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Dept Biol, Rome, Italy.
   [Torti, Carlo] Univ Brescia, I-25121 Brescia, Italy.
   [Torti, Carlo] Magna Graecia Univ Catanzaro, Infect Dis Unit, Catanzaro, Italy.
   [Caudai, Cinzia; Vicenti, Ilaria; Saladini, Francesco; Zazzi, Maurizio] Univ Siena, Dept Med Biotechnol, I-53100 Siena, Italy.
   [Almi, Paolo] Siena Univ Hosp, Unita Operat Complessa Malattie Infett & Epatol, Siena, Italy.
   [Grima, Pierfrancesco] S Caterina Novella Hosp, Infect Dis Unit, Lecce, Italy.
   [Blanc, Pierluigi] Osped Santa Maria Annunziata Azienda Sanit Locale, Unita Operat Malattie Infett, Florence, Italy.
   [Ciccozzi, Massimo] Univ Campus Biomed, Rome, Italy.
RP De Luca, A (corresponding author), Azienda Osped Univ Senese, UOC Malattie Infett Univ, Viale M Bracci 16, I-53100 Siena, Italy.
EM deluca.andrea2308@icloud.com
RI Giovanetti, Marta/AAK-7408-2020; Vicenti, Ilaria/AAP-9663-2020; Zazzi,
   Maurizio/K-3422-2018; Gagliardini, Roberta/AAT-6951-2020; gagliardini,
   roberta/AAA-7253-2019; Fabbiani, Massimiliano/K-8842-2016; Saladini,
   Francesco/D-5837-2015; CICCOZZI, MASSIMO/C-6484-2016; digiambenedetto,
   simona/AAL-4429-2020; Cella, Eleonora/J-9961-2016; Presti, Alessandra
   Lo/K-1451-2016; Cella, Eleonora/ABA-8333-2020; Rossetti,
   Barbara/AAA-5989-2019; De Luca, Andrea/G-8810-2011; ,
   ilariavicenti/AAU-6986-2020
OI Zazzi, Maurizio/0000-0002-0344-6281; Fabbiani,
   Massimiliano/0000-0002-1343-812X; Saladini,
   Francesco/0000-0002-9934-377X; CICCOZZI, MASSIMO/0000-0003-3866-9239;
   Cella, Eleonora/0000-0002-7870-9744; Presti, Alessandra
   Lo/0000-0001-7611-5021; Cella, Eleonora/0000-0002-7870-9744; De Luca,
   Andrea/0000-0002-9561-9193; , ilariavicenti/0000-0002-4306-2960;
   Giovanetti, Marta/0000-0002-5849-7326; Gagliardini,
   Roberta/0000-0002-6351-2623
FU Bundesminster fur Bildung und Forschung (grant Deutsches Zentrum fur
   Infektionsforschung) [TTU05.805-PEPSI]; Bundesminister fur Gesundheit
   (HIV/HEPMASTER)
FX This study was supported by Bundesminster fur Bildung und Forschung
   (grant Deutsches Zentrum fur Infektionsforschung-TTU05.805-PEPSI) and
   from Bundesminister fur Gesundheit (HIV/HEPMASTER) (to R. K. and S. S.).
CR *AASLD IDSA IAS US, REC TEST MAN TREAT H
   Alves R, 2013, J VIRAL HEPATITIS, V20, P414, DOI 10.1111/jvh.12051
   Asselah T, 2014, LIVER INT, V34, P60, DOI 10.1111/liv.12424
   Bae A, 2010, ANTIMICROB AGENTS CH, V54, P5288, DOI 10.1128/AAC.00777-10
   Cento V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039652
   Chen Stephen L, 2006, Int J Med Sci, V3, P47
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P921, DOI [10.1089/aid.2010.0323, 10.1089/AID.2010.0323]
   De Luca A, 2014, CURR OPIN PHARMACOL, V18, P9, DOI 10.1016/j.coph.2014.07.016
   deLemos AS, 2014, TRENDS MOL MED, V20, P315, DOI 10.1016/j.molmed.2014.02.002
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Everson GT, 2014, 65 ANN M AM ASS STUD
   Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641
   HOLMES EC, 1995, PHILOS T R SOC B, V349, P33, DOI 10.1098/rstb.1995.0088
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Lambert SM, 2014, PROTEIN SCI, V23, P723, DOI 10.1002/pro.2456
   Larrey D, 2012, J HEPATOL, V57, P39, DOI 10.1016/j.jhep.2012.02.015
   Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x
   Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9
   Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09
   Li YP, 2014, GASTROENTEROLOGY, V146, P812, DOI 10.1053/j.gastro.2013.11.009
   Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015
   Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198
   Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9
   McCloskey RM, 2015, J INFECT DIS, V211, P1288, DOI 10.1093/infdis/jiu613
   Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259
   Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003
   Ng T, 2014, 21 C RETR OPP INF BO
   Nielsen R, 1998, GENETICS, V148, P929
   Olysio, 2014, EMACHMP1379692014
   Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003
   Peres-da-Silva A, 2012, MEM I OSWALDO CRUZ, V107, P254, DOI 10.1590/S0074-02762012000200016
   Pickett BE, 2011, J VIRAL HEPATITIS, V18, P608, DOI 10.1111/j.1365-2893.2010.01342.x
   Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232
   Pond SLK, 2005, MOL BIOL EVOL, V22, P223, DOI 10.1093/molbev/msi009
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011
   Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4
   SIERRA S, 2011, JOVE-J VIS EXP, V58, P3264
   Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744
   van de Vijver DA, 2006, JAIDS-J ACQ IMM DEF, V41, P352, DOI 10.1097/01.qai.0000209899.05126.e4
   Vicenti I, 2012, J ANTIMICROB CHEMOTH, V67, P984, DOI 10.1093/jac/dkr581
   Wyles DL, 2014, J VIRAL HEPATITIS, V21, P229, DOI 10.1111/jvh.12230
   Wyles David L, 2012, Top Antivir Med, V20, P139
   Zeuzem S, 2014, GASTROENTEROLOGY, V146, pe6
   Zeuzem S, 2014, GASTROENTEROLOGY, V146, P430, DOI 10.1053/j.gastro.2013.10.058
   Zeuzem S, 2011, GASTROENTEROLOGY, V141, P2047, DOI 10.1053/j.gastro.2011.08.051
   Zignego AL, 2003, TRANSPLANT P, V35, P1032, DOI 10.1016/S0041-1345(03)00257-4
NR 48
TC 26
Z9 26
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD SPR
PY 2015
VL 2
IS 2
DI 10.1093/ofid/ofv043
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CX6BM
UT WOS:000365786200010
PM 26213689
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Cordiali-Fei, P
   Trento, E
   Giovanetti, M
   Lo Presti, A
   Latini, A
   Giuliani, M
   D'Agosto, G
   Bordignon, V
   Cella, E
   Farchi, F
   Ferraro, C
   La Parola, IL
   Cota, C
   Sperduti, I
   Vento, A
   Cristaudo, A
   Ciccozzi, M
   Ensoli, F
AF Cordiali-Fei, Paola
   Trento, Elisabetta
   Giovanetti, Marta
   Lo Presti, Alessandra
   Latini, Alessandra
   Giuliani, Massimo
   D'Agosto, Giovanna
   Bordignon, Valentina
   Cella, Eleonora
   Farchi, Francesca
   Ferraro, Carmela
   La Parola, Ilaria Lesnoni
   Cota, Carlo
   Sperduti, Isabella
   Vento, Antonella
   Cristaudo, Antonio
   Ciccozzi, Massimo
   Ensoli, Fabrizio
TI Analysis of the ORFK1 hypervariable regions reveal distinct HHV-8
   clustering in Kaposi's sarcoma and non-Kaposi's cases
SO JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
LA English
DT Article
DE HHV-8; Kaposi's sarcoma; Phylogenesis; HHV-8 variants; Selective
   pressure
ID AMINO-ACID SITES; K1 PROTEIN; PHYLOGENETIC ANALYSIS; VIRUS SUBTYPES;
   RISK-FACTORS; HERPESVIRUS; HUMAN-HERPESVIRUS-8; VARIANTS; ACTIVATION;
   LESSONS
AB Background: Classical Kaposi's Sarcoma (cKS) is a rare vascular tumor, which develops in subjects infected with Human Herpesvirus-8 (HHV-8). Beside the host predisposing factors, viral genetic variants might possibly be related to disease development. The aim of this study was to identify HHV-8 variants in patients with cKS or in HHV-8 infected subjects either asymptomatic or with cKS-unrelated cutaneous lymphoproliferative disorders.
   Methods: The VR1 and VR2 regions of the ORF K1 sequence were analyzed in samples (peripheral blood and/or lesional tissue) collected between 2000 and 2010 from 27 subjects with HHV-8 infection, established by the presence of anti-HHV-8 antibodies. On the basis of viral genotyping, a phylogenetic analysis and a time-scaled evaluation were performed.
   Results: Two main clades of HHV-8, corresponding to A and C subtypes, were identified. Moreover, for each subtype, two main clusters were found distinctively associated to cKS or non-cKS subjects. Selective pressure analysis showed twelve sites of the K1 coding gene (VR1 and VR2 regions) under positive selective pressure and one site under negative pressure.
   Conclusion: Thus, present data suggest that HHV-8 genetic variants may influence the susceptibility to cKS in individuals with HHV-8 infection.
C1 [Cordiali-Fei, Paola; Trento, Elisabetta; Latini, Alessandra; Giuliani, Massimo; Ferraro, Carmela; La Parola, Ilaria Lesnoni; Cota, Carlo; Vento, Antonella; Ensoli, Fabrizio] San Gallicano Dermatol Inst, I-00144 Rome, Italy.
   [Giovanetti, Marta; Lo Presti, Alessandra; Cella, Eleonora; Farchi, Francesca; Ciccozzi, Massimo] NIH, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy.
   [Sperduti, Isabella] Regina Elena Inst Canc Res, I-00144 Rome, Italy.
   [Ciccozzi, Massimo] Univ Biomed Campus, I-00128 Rome, Italy.
RP Cordiali-Fei, P (corresponding author), San Gallicano Dermatol Inst, Via Elio Chianesi 53, I-00144 Rome, Italy.
EM cordiali-fei@ifo.it
RI Sperduti, Isabella/K-8902-2016; Giovanetti, Marta/AAK-7408-2020; Ensoli,
   Fabrizio/J-6540-2018; Giuliani, Massimo/J-2788-2018; CICCOZZI,
   MASSIMO/C-6484-2016; Cristaudo, Antonio/K-5944-2016; D'AGOSTO,
   GIOVANNA/K-3029-2016; Trento, Elisabetta/AAC-2085-2020; Presti,
   Alessandra Lo/K-1451-2016; Cella, Eleonora/ABA-8333-2020; Cella,
   Eleonora/J-9961-2016
OI Sperduti, Isabella/0000-0001-5115-3099; Ensoli,
   Fabrizio/0000-0003-4995-3067; Giuliani, Massimo/0000-0002-4523-8261;
   CICCOZZI, MASSIMO/0000-0003-3866-9239; Cristaudo,
   Antonio/0000-0002-0737-983X; D'AGOSTO, GIOVANNA/0000-0002-5737-8798;
   Trento, Elisabetta/0000-0003-2228-6292; Presti, Alessandra
   Lo/0000-0001-7611-5021; Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Giovanetti, Marta/0000-0002-5849-7326;
   Bordignon, Valentina/0000-0002-4225-8603; Latini,
   Alessandra/0000-0002-9421-6560; Cota, Carlo/0000-0001-6335-8649
CR Ablashi DV, 2002, CLIN MICROBIOL REV, V15, P439, DOI 10.1128/CMR.15.3.439-464.2002
   Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152
   Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945
   Betsem E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002851
   Biggar RJ, 2000, J INFECT DIS, V181, P1562, DOI 10.1086/315456
   Brown EE, 2006, CANCER, V107, P2282, DOI 10.1002/cncr.22236
   Brown EE, 2006, CANCER EPIDEM BIOMAR, V15, P926, DOI 10.1158/1055-9965.EPI-05-0791
   Calabro M L, 1998, J Hum Virol, V1, P207
   Ciccozzi M, 2014, J MED VIROL, V86, P454, DOI 10.1002/jmv.23787
   Cordiali-Fei P, 2014, EUR J DERMATOL, V24, P503, DOI 10.1684/ejd.2014.2375
   da Silva SR, 2011, CANCER LETT, V305, P175, DOI 10.1016/j.canlet.2011.02.007
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Ensoli B, 2001, EUR J CANCER, V37, P1251, DOI 10.1016/S0959-8049(01)00121-6
   Gazouli M, 2004, ANTICANCER RES, V24, P1311
   Giffin L, 2014, ADV VIRUS RES, V88, P111, DOI 10.1016/B978-0-12-800098-4.00002-7
   Gonnella R, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-79
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Jham BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019103
   Jham BC, 2010, J CELL BIOCHEM, V110, P1, DOI 10.1002/jcb.22524
   Kasolo FC, 1998, J GEN VIROL, V79, P3055, DOI 10.1099/0022-1317-79-12-3055
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Kreuter A, 2008, ARCH DERMATOL, V144, P1011, DOI 10.1001/archderm.144.8.1011
   Lagunoff M, 2001, J VIROL, V75, P5891, DOI 10.1128/JVI.75.13.5891-5898.2001
   Lee BS, 2000, J EXP MED, V192, P11, DOI 10.1084/jem.192.1.11
   Lee BS, 2005, J VIROL, V79, P12173, DOI 10.1128/JVI.79.19.12173-12184.2005
   Lee H, 1998, NAT MED, V4, P435, DOI 10.1038/nm0498-435
   Liang DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004253
   Mancuso R, 2008, J MED VIROL, V80, P2153, DOI 10.1002/jmv.21322
   Moss LAS, 2012, AM J PATHOL, V181, P1895, DOI 10.1016/j.ajpath.2012.08.044
   Nielsen R, 1998, GENETICS, V148, P929
   O'Brien TR, 1999, J INFECT DIS, V180, P1010, DOI 10.1086/315039
   Pileri A, 2015, HISTOPATHOLOGY, V66, P173, DOI 10.1111/his.12445
   Pimpinelli N, 2005, J AM ACAD DERMATOL, V53, P1053, DOI 10.1016/j.jaad.2005.08.057
   Polizzotto MN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00073
   Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Prakash O, 2005, BLOOD, V105, P3987, DOI 10.1182/blood-2004-07-2781
   Rohner E, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-11
   Roy D, 2013, CANCER RES, V73, P2235, DOI 10.1158/0008-5472.CAN-12-1851
   Samaniego F, 2001, J Natl Cancer Inst Monogr, P15
   Solivetti FM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-40
   Spadavecchia S, 2010, J VIROL, V84, P10488, DOI 10.1128/JVI.00894-10
   Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Tamburro KM, 2012, VIROLOGY, V433, P220, DOI 10.1016/j.virol.2012.08.014
   Taylor GS, 2011, CANCER LETT, V305, P263, DOI 10.1016/j.canlet.2010.08.019
   Tomkowicz B, 2005, DNA CELL BIOL, V24, P10, DOI 10.1089/dna.2005.24.10
   Tomlinson CC, 2008, J VIROL, V82, P6514, DOI 10.1128/JVI.02637-07
   Tornesello ML, 2011, BIOMARKERS, V16, P42, DOI 10.3109/1354750X.2010.525664
   Tornesello ML, 2010, VIROLOGY, V398, P280, DOI 10.1016/j.virol.2009.12.005
   Trento E, 2005, ARCH DERMATOL, V141, P1235, DOI 10.1001/archderm.141.10.1235
   Valdarchi C, 2007, INFECTION, V35, P22, DOI 10.1007/s15010-007-5123-2
   Wang L, 2006, CANCER RES, V66, P3658, DOI 10.1158/0008-5472.CAN-05-3680
   Wang L, 2004, CANCER RES, V64, P2774, DOI 10.1158/0008-5472.CAN-03-3653
   Whitby D, 1998, J NATL CANCER I, V90, P395, DOI 10.1093/jnci/90.5.395
   Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502
   Yang ZH, 2000, GENETICS, V155, P431
   Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097
   Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
   Zehender G, 2013, INFECT GENET EVOL, V17, P223, DOI 10.1016/j.meegid.2013.04.003
   Zehender G, 2011, INFECT GENET EVOL, V11, P646, DOI 10.1016/j.meegid.2011.02.003
   Zong JC, 2002, J CLIN VIROL, V23, P119, DOI 10.1016/S1386-6532(01)00205-0
   Zong JC, 1999, J VIROL, V73, P4156, DOI 10.1128/JVI.73.5.4156-4170.1999
NR 66
TC 8
Z9 9
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1756-9966
J9 J EXP CLIN CANC RES
JI J. Exp. Clin. Cancer Res.
PD JAN 16
PY 2015
VL 34
AR 1
DI 10.1186/s13046-014-0119-0
PG 12
WC Oncology
SC Oncology
GA CA7XH
UT WOS:000349130200001
PM 25592960
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Alshammari, AM
   El-Abd, E
   Ciccozzi, M
   Lo Presti, A
   Giovanetti, M
   Cella, E
AF Alshammari, Ahmed M.
   El-Abd, Eman
   Ciccozzi, Massimo
   Lo Presti, Alessandra
   Giovanetti, Marta
   Cella, Eleonora
TI Single-Gene Versus Double-Gene Tree Analyses in Molecular Classification
   of Saudi Venomous Snakes
SO ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING
LA English
DT Article
DE Molecular systematic; 12S rRNA; Phylogeny; Venomous snakes; Viperidae
ID MAXIMUM-LIKELIHOOD; PHYLOGENY; BIOGEOGRAPHY; SELECTION; ALIGNMENT;
   SQUAMATA; POSITION; ADULTS; BITES; PREY
AB Aiming to use DNA sequence for proper identification of venomous snakes in Saudi Arabia, mitochondrial 12S rRNA gene sequences of Bitis arietans, Cerastes cerastes, C. gasperettii, and Echis coloratus were investigated. Concatenated analysis of 16S and 12S rRNA gene sequences (as mosaic) was also performed to validate the usefulness of using more than one gene marker in molecular taxonomy of venomous snakes. DNA extracted from whole blood samples and 12S rRNA was amplified using PCR. Sequences submitted to GenBank were analyzed for similarity using BLAST and aligned using Clustal X followed by manual editing with BioEdit software. Phylogenetic analysis was generated using PAUP version 4, and the evolutionary distance among different groups was calculated using MEGA5 software for both 12S and 16S rRNA genes. Contrary to the morphological classification, phylogenetic analysis revealed that the collected isolates formed three different statistically supported clusters (B. arietans, C. cerastes, and E. coloratus). Although the combined analysis of 16S and 12S rRNA sequences improved the signal, the C. cerastes and C. gasperettii intermixing have not been resolved. Both single and combined genetic distance analyses showed that Echis is more distant from Cerastes than from Bitis. Further studies are mandatory to evaluate other gene markers in molecular classification.
C1 [Alshammari, Ahmed M.; El-Abd, Eman] Univ Hail, Dept Biol, Fac Sci, Hail, Saudi Arabia.
   [El-Abd, Eman] Univ Alexandria, Med Res Inst, Alexandria, Egypt.
   [Ciccozzi, Massimo; Lo Presti, Alessandra; Giovanetti, Marta; Cella, Eleonora] Ist Super Sanita, Fac Biomed Campus, I-00161 Rome, Italy.
RP El-Abd, E (corresponding author), Univ Hail, Dept Biol, Fac Sci, Hail, Saudi Arabia.
EM elabdeman@yahoo.com
RI El-Abd, Eman/A-2116-2017; Giovanetti, Marta/AAK-7408-2020; CICCOZZI,
   MASSIMO/C-6484-2016; Cella, Eleonora/ABA-8333-2020; Cella,
   Eleonora/J-9961-2016; Presti, Alessandra Lo/K-1451-2016
OI El-Abd, Eman/0000-0002-1195-7700; CICCOZZI, MASSIMO/0000-0003-3866-9239;
   Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Presti, Alessandra Lo/0000-0001-7611-5021
CR Adukauskiene D, 2011, MED LITH, V47, P461, DOI 10.3390/medicina47080061
   Al Harbi N, 1999, J ACCID EMERG MED, V16, P428
   Alshammari Ahmed M., 2011, International Journal of Biology, V3, P56
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Altschul SF, 2009, NUCLEIC ACIDS RES, V37, P815, DOI 10.1093/nar/gkn981
   Amr ZS, 2011, VERTEBR ZOOL, V61, P179
   Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048
   Busais S.M., 2003, THESIS SANAA U YEMEN
   Cruz LS, 2009, ETHNIC DIS, V19, P42
   de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002
   Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068
   Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009
   Douglas DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-14
   Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036
   EGAN D., 2007, SNAKES ARABIA, P208
   Gasperetti J., 1988, Fauna of Saudi Arabia, V9, P169
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Gunther A., 1878, P ZOOL SOC LOND, V1878, P977
   Gutierrez JM, 2009, J PROTEOMICS, V72, P165, DOI 10.1016/j.jprot.2009.01.008
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   HEISE PJ, 1995, MOL BIOL EVOL, V12, P259
   Ismail M, 2007, TOXICON, V49, P8, DOI 10.1016/j.toxicon.2006.08.015
   Joger Ulrich, 1999, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V8, P65
   Kornilios P, 2013, MOL PHYLOGENET EVOL, V68, P35, DOI 10.1016/j.ympev.2013.03.009
   Lenk P, 2001, MOL PHYLOGENET EVOL, V19, P94, DOI 10.1006/mpev.2001.0912
   Leviton A.E., 1967, P CALIFORNIA ACAD SC, V4, P157
   LINNAEUS C., 1758, SYSTEMA NATURAE REGN, V1
   MALIK GM, 1995, AM J TROP MED HYG, V52, P314, DOI 10.4269/ajtmh.1995.52.314
   Merrem B., 1820, VERSUCH SYSTEMS AMPH
   *NY AC SCI, 1988, INT PRINC GUID US AN
   Pook CE, 2009, MOL PHYLOGENET EVOL, V53, P792, DOI 10.1016/j.ympev.2009.08.002
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93
   Richards DP, 2012, TOXICON, V59, P110, DOI 10.1016/j.toxicon.2011.10.015
   Sant'Anna SS, 2013, J COMP PATHOL, V149, P503, DOI 10.1016/j.jcpa.2013.06.001
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Sharawy Sherif M., 2009, Australian Journal of Basic and Applied Sciences, V3, P2217
   Sindaco R., 2012, REPTILES W PALEARCTI
   Spawls S., 1995, DANGEROUS SNAKES AFR, P192
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Vidal N, 2010, CR BIOL, V333, P48, DOI 10.1016/j.crvi.2009.11.003
   Werner Yehudah L., 1999, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V8, P83
   Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00
   Wuster W, 2008, MOL PHYLOGENET EVOL, V49, P445, DOI 10.1016/j.ympev.2008.08.019
NR 46
TC 2
Z9 2
U1 0
U2 11
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2193-567X
EI 2191-4281
J9 ARAB J SCI ENG
JI Arab. J. Sci. Eng.
PD JAN
PY 2015
VL 40
IS 1
BP 37
EP 49
DI 10.1007/s13369-014-1491-y
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX8FZ
UT WOS:000347146800006
DA 2020-11-24
ER

PT J
AU Ciccozzi, M
   Cella, E
   Giovanetti, M
   Lo Presti, A
   Ciccaglione, AR
   Bon, I
   Gallo, P
   Musumeci, M
   Bonetti, M
   Picardi, A
   Riva, E
   Mottini, G
AF Ciccozzi, Massimo
   Cella, Eleonora
   Giovanetti, Marta
   Lo Presti, Alessandra
   Ciccaglione, Anna Rita
   Bon, Isabella
   Gallo, Paolo
   Musumeci, Maria
   Bonetti, Mario
   Picardi, Antonio
   Riva, Elisabetta
   Mottini, Giovanni
TI Hepatitis A virus in a medical setting in Madagascar: a lesson for
   public health
SO NEW MICROBIOLOGICA
LA English
DT Letter
ID AGE-SPECIFIC SEROPREVALENCE
C1 [Ciccozzi, Massimo; Cella, Eleonora; Giovanetti, Marta; Lo Presti, Alessandra] NIH, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [Ciccozzi, Massimo] Univ Campus Biomed, Rome, Italy.
   [Ciccaglione, Anna Rita] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viral Hepatitis Unit, Rome, Italy.
   [Bon, Isabella] Univ Bologna, Dept Expt Diagnost & Special Med, Microbiol Sect, I-40126 Bologna, Italy.
   [Gallo, Paolo; Picardi, Antonio] Univ Campus Biomed, Clin Med Hepatol, Rome, Italy.
   [Musumeci, Maria] Univ Campus Biomed, Dept Lab Med & Microbiol, Ctr Integrated Res, Rome, Italy.
   [Bonetti, Mario] Univ Campus Biomed, Int Hlth Cooperat Project, Rome, Italy.
   [Riva, Elisabetta] Univ Campus Biomed, Virol Lab, Rome, Italy.
   [Mottini, Giovanni] Univ Campus Biomed, Chief Int Hlth Cooperat Project, Rome, Italy.
RP Ciccozzi, M (corresponding author), NIH, Dept Infect Parasit & Immunomediated Dis, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Epidemiol Unit, Rome, Italy.
EM ciccozzi@iss.it
RI riva, elisabetta/H-7729-2016; Picardi, Antonio/C-2337-2012; Cella,
   Eleonora/ABA-8333-2020; Presti, Alessandra Lo/K-1451-2016; Cella,
   Eleonora/J-9961-2016; CICCOZZI, MASSIMO/C-6484-2016; Giovanetti,
   Marta/AAK-7408-2020; Gallo, Paolo/J-7941-2018; Ciccaglione, Anna
   Rita/M-2956-2015
OI riva, elisabetta/0000-0002-6870-8780; Picardi,
   Antonio/0000-0002-0230-218X; Cella, Eleonora/0000-0002-7870-9744;
   Presti, Alessandra Lo/0000-0001-7611-5021; Cella,
   Eleonora/0000-0002-7870-9744; CICCOZZI, MASSIMO/0000-0003-3866-9239;
   Gallo, Paolo/0000-0001-8292-1134; Alessandri Bonetti,
   Mario/0000-0002-5506-8323; Giovanetti, Marta/0000-0002-5849-7326;
   Ciccaglione, Anna Rita/0000-0002-3791-3781
CR de Paula VS, 2002, J MED VIROL, V66, P22, DOI 10.1002/jmv.2106
   Dentinger CM, 2001, J INFECT DIS, V183, P1273, DOI 10.1086/319688
   Franco E, 2012, WORLD J HEPATOL, V4, P68, DOI 10.4254/wjh.v4.i3.68
   Gharbi-Khelifi H, 2007, VIRUS GENES, V35, P155, DOI 10.1007/s11262-007-0093-0
   Legeay O, 2000, J VIROL METHODS, V90, P1, DOI 10.1016/S0166-0934(00)00174-9
   Letaief A, 2005, AM J TROP MED HYG, V73, P40, DOI 10.4269/ajtmh.2005.73.40
   Raharimanga V, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-78
   Robertson BH, 2000, J MED VIROL, V62, P144, DOI 10.1002/1096-9071(200010)62:2&lt;144::AID-JMV4&gt;3.0.CO;2-I
   Yokoi H, 2001, Kansenshogaku Zasshi, V75, P263
NR 9
TC 0
Z9 0
U1 0
U2 14
PU EDIZIONI INT SRL
PI MILANO
PA VIA SPADOLINI 7, MILANO, 20141, ITALY
SN 1121-7138
J9 NEW MICROBIOL
JI New Microbiol.
PD JAN
PY 2015
VL 38
IS 1
BP 119
EP 120
PG 2
WC Microbiology
SC Microbiology
GA CC7AU
UT WOS:000350520900016
PM 25742156
DA 2020-11-24
ER

PT J
AU Grifoni, A
   Montesano, C
   Palma, P
   Giovannetti, M
   Castelli-Gattinara, G
   Ciccozzi, M
   Mattei, M
   Mancino, G
   Salerno, A
   Colizzi, V
   Amicosante, M
AF Grifoni, Alba
   Montesano, Carla
   Palma, Paolo
   Giovannetti, Marta
   Castelli-Gattinara, Guido
   Ciccozzi, Massimo
   Mattei, Maurizio
   Mancino, Giorgio
   Salerno, Alfredo
   Colizzi, Vittorio
   Amicosante, Massimo
TI Role of individual's T-cell immunome in controlling HIV-1 progression
SO IMMUNOLOGY
LA English
DT Article
DE AIDS; antigens; epitopes; MHC; peptides; viral
ID DISEASE PROGRESSION; HLA-B; RESPONSES; EPITOPES; GENERATION; PREDICTION;
   AIDS
AB Viral and host factors can influence HIV-1 progression, among them human leucocyte antigen (HLA) has shown the strongest effect. However, studies on the functional contribution of HLA in controlling HIV progression toward AIDS are limited by multiple issues, including the viral strain variability within the study subjects. In this study, in a cohort of children infected with a monophyletic strain (CRF02_AG) during an outbreak, we evaluated the HIV-1 Gag, Vif, Vpr, Tat and hepatitis C virus E1/E2 (as control) proteins circulating in a cohort for the capability to be presented by the HLA molecules in the same population. A total of 70 Non-progressors and 37 Progressors to AIDS were evaluated. In the presence of a constant capability of HIV-1 to mutate in the region containing epitopes of Gag protein, the number of epitopes recognized in silico by the combination of the HLA alleles along the Gag consensus sequence is significantly higher in the Non-progressors compared with Progressors (HLA-A: Non-progressors=1532 +/- 1211, Progressors=07714 +/- 1031, P=00016; HLA-B: Non-progressors=1556 +/- 1298, Progressors=1000 +/- 0817, P=00319; HLA-DR: Non-progressors=1330 +/- 9488, Progressors=7294 +/- 6952, P=00006). Similar results were obtained for the other HIV-1 proteins Vif and Vpr, whereas no differences were obtained in the number of epitopes for the hepatitis C virus E1/E2 protein sequence or for the scrambled HIV-1 sequence. Finally, the results were confirmed also in a subgroup of subjects where both HLA typing and Gag sequence were available. In conclusion, in the absence of bias due to viral strain diversity, it is the overall fitting of the HLA molecules that are capable of better binding HIV-1 proteins in determining the major role in the control of HIV-1 replication and progression to AIDS.
C1 [Grifoni, Alba; Montesano, Carla; Mattei, Maurizio; Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy.
   [Palma, Paolo; Castelli-Gattinara, Guido] Bambino Gesu Pediat Hosp, Dept Immunol & Infect Dis, Rome, Italy.
   [Giovannetti, Marta; Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy.
   [Ciccozzi, Massimo] Campus Biomed Univ, Rome, Italy.
   [Mattei, Maurizio] Univ Roma Tor Vergata, Anim Technol Stn, I-00133 Rome, Italy.
   [Mancino, Giorgio] San Pietro Fatebenefratelli Hosp, Rome, Italy.
   [Salerno, Alfredo] Univ Palermo, Dept Biopathol & Biomed Methodol, Palermo, Italy.
   [Amicosante, Massimo] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy.
   [Amicosante, Massimo] ProxAgen Ltd, Sofia, Bulgaria.
RP Amicosante, M (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy.
EM amicosan@uniroma2.it
RI CICCOZZI, MASSIMO/C-6484-2016; Mattei, Maurizio/AAC-1303-2019;
   Giovanetti, Marta/AAK-7408-2020; Palma, Paolo/AAK-9275-2020
OI CICCOZZI, MASSIMO/0000-0003-3866-9239; Mattei,
   Maurizio/0000-0002-0814-8873; Palma, Paolo/0000-0002-3066-4719; Grifoni,
   Alba/0000-0002-0369-1746; Amicosante, Massimo/0000-0002-2372-3311; ,
   Alba/0000-0002-2209-5966; Castelli-Gattinara, Guido/0000-0002-3282-7462;
   Montesano, Carla/0000-0002-9865-6619; Giovanetti,
   Marta/0000-0002-5849-7326
FU University of Rome 'Tor Vergata' (MIUR)
FX We would like to thank Marco Pallante (University of Tor Vergata, Roma,
   IT) for assistance with the immunobioinformatic analysis and the helpful
   discussion. This study has been supported in part by a project at the
   University of Rome 'Tor Vergata' (ex 60% MIUR, 2006) to MA. We wish to
   thank to Prof. Graham Lord (Guy's and St Thomas' Hospitals and King's
   College London, UK) for the critical reading and editing of the
   manuscript.
CR BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.biochem.59.1.253
   Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094
   Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y
   CDC, 1994, MMWR CDC RECOMM REP, V1994, P43
   Chouquet C, 2002, AIDS, V16, P2399, DOI 10.1097/00002030-200212060-00004
   de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a
   GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0
   Grifoni A, 2013, MOL IMMUNOL, V53, P410, DOI 10.1016/j.molimm.2012.09.009
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Kaur G, 2009, TISSUE ANTIGENS, V74, P373, DOI 10.1111/j.1399-0039.2009.01337.x
   Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113
   Lundegaard C, 2010, IMMUNOLOGY, V130, P309, DOI 10.1111/j.1365-2567.2010.03300.x
   Montesano C., 2014, Journal of AIDS and Clinical Research, V5, P282
   Ngumbela KC, 2008, AIDS RES HUM RETROV, V24, P72, DOI 10.1089/aid.2007.0124
   Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403
   Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238
   O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1
   Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132
   Petrucci A, 1997, J ACQ IMMUN DEF SYND, V14, P243, DOI 10.1097/00042560-199703010-00008
   Pieters J, 1997, CURR OPIN IMMUNOL, V9, P89, DOI 10.1016/S0952-7915(97)80164-1
   Salimi N, 2012, IMMUNOLOGY, V137, P117, DOI 10.1111/j.1365-2567.2012.03611.x
   Scherer A, 2004, P NATL ACAD SCI USA, V101, P12266, DOI 10.1073/pnas.0404091101
   Schmid BV, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-184
   Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01
   Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893
   Trachtenberg EA, 2001, HIV MOL IMMUNOLOGY 2
   Turnbull EL, 2006, J IMMUNOL, V176, P6130, DOI 10.4049/jimmunol.176.10.6130
   Zhai S, 2008, CURR HIV RES, V6, P335, DOI 10.2174/157016208785132473
NR 30
TC 3
Z9 3
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 2014
VL 143
IS 4
BP 631
EP 639
DI 10.1111/imm.12344
PG 9
WC Immunology
SC Immunology
GA AT2RF
UT WOS:000344781200014
PM 24954875
OA Bronze, Green Published
DA 2020-11-24
ER

PT J
AU Ciccozzi, M
   Lo Presti, A
   Cell, E
   Giovanetti, M
   Lai, A
   El-Sawaf, G
   Faggioni, G
   Vescio, F
   Al Ameri, R
   De Santis, R
   Helaly, G
   Pomponi, A
   Metwally, D
   Fantini, M
   Qadi, H
   Zehender, G
   Lista, F
   Rezza, G
AF Ciccozzi, Massimo
   Lo Presti, Alessandra
   Cell, Eleonora
   Giovanetti, Marta
   Lai, Alessia
   El-Sawaf, Gamal
   Faggioni, Giovanni
   Vescio, Fenicia
   Al Ameri, Ranya
   De Santis, Riccardo
   Helaly, Ghada
   Pomponi, Alice
   Metwally, Dalia
   Fantini, Massimo
   Qadi, Hussein
   Zehender, Gianguglielmo
   Lista, Florigio
   Rezza, Giovanni
TI Phylogeny of Dengue and Chikungunya viruses in Al Hudayda governorate,
   Yemen
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE DENV; CHIKV; Phylogeny
ID FEVER; INFECTION; OUTBREAK
AB Yemen, which is located in the southwestern end of the Arabian Peninsula, is one of countries most affected by recurrent epidemics caused by emerging vector-borne viruses. Dengue virus (DENV) outbreaks have been reported with increasing frequency in several governorates since the year 2000, and the Chikungunya virus (CHIKV) has been also responsible of large outbreaks and it is now a major public health problem in Yemen. We report the results of the phylogenetic analysis of DENV-2 and CHII0/ isolates (NS1 and El genes, respectively) detected in an outbreak occurred in Al-Hudayda in 2012. Estimates of the introduction date of CHIKV and DENV-2, and the phylogeographic analysis of DENV-2 are also presented. Phylogenetic analysis showed that the Yemen isolates of DENV belonged to the lineage 2 Cosmopolitan subtype, whereas CHIKV isolates from Yemen belonged to the ECSA genotype. All the CHM/ isolates from Yemen were statistically supported and dated back to the year 2010 (95% HPD: 2009-2011); these sequences showed an alanine in the aminoacid position 226 of the El protein. Phylogeographic analysis of DENV-2 virus showed that cluster 1, which included Yemen isolates, dated back to 2003 Burkina Faso strains (95% HPD 1999-2007). The Yemen, cluster dated back to 2011 (95% HPD 2009-2012). Our study sheds light on the global spatiotemporal dynamics of DENV-2 and CHIKV in Yemen. This study reinforces both the need to monitor the spread of CHIKV and DENV, and to apply significant measures for vector control. (c) 2014 Elsevier B.V. All rights reserved.
C1 [Ciccozzi, Massimo; Lo Presti, Alessandra; Cell, Eleonora; Giovanetti, Marta; Vescio, Fenicia; Rezza, Giovanni] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy.
   [Ciccozzi, Massimo] Univ Hosp Campus Biomed, Rome, Italy.
   [Lai, Alessia; Zehender, Gianguglielmo] Univ Milan, L Sacco Hosp, Dept Biomed & Clin Sci, Infect Dis & Immunopathol Sect, Milan, Italy.
   [El-Sawaf, Gamal; Helaly, Ghada; Metwally, Dalia] Univ Alexandria, Med Res Inst, Alexandria, Egypt.
   [Faggioni, Giovanni; De Santis, Riccardo; Pomponi, Alice; Lista, Florigio] Army Med & Vet Res Ctr, Histol & Mol Biol Sect, Rome, Italy.
   [Al Ameri, Ranya; Qadi, Hussein] Sanaa Univ, Sanaa, Yemen.
   [Fantini, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy.
RP Ciccozzi, M (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.
EM ciccozzi@iss.it
RI CICCOZZI, MASSIMO/C-6484-2016; rezza, giovanni/D-4393-2016; Cella,
   Eleonora/J-9961-2016; Presti, Alessandra Lo/K-1451-2016; Giovanetti,
   Marta/AAK-7408-2020; Vescio, Fenicia/N-5776-2017
OI CICCOZZI, MASSIMO/0000-0003-3866-9239; rezza,
   giovanni/0000-0003-0268-6790; Cella, Eleonora/0000-0002-7870-9744;
   Presti, Alessandra Lo/0000-0001-7611-5021; Vescio,
   Fenicia/0000-0002-3285-919X; Helaly, Ghada/0000-0002-5118-5645;
   Giovanetti, Marta/0000-0002-5849-7326; Fantini,
   Massimo/0000-0002-8164-2587
CR Ahmed MM, 2010, J INFECT DEV COUNTR, V4, P503, DOI 10.3855/jidc.1038
   Bin Ghouth AS, 2012, AM J TROP MED HYG, V86, P1072, DOI 10.4269/ajtmh.2012.11-0723
   Ciccozzi M, 2013, NEW MICROBIOL, V36, P93
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   EpiSouth, 2011, EPISOUTHWEEKLY EPI B, V155
   Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001475
   JIMENEZLUCHO VE, 1984, AM J TROP MED HYG, V33, P650, DOI 10.4269/ajtmh.1984.33.650
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Kholedi A. A. N., 2012, Eastern Mediterranean Health Journal, V18, P15
   Madani TA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-136
   Nicoletti L, 2008, EMERG INFECT DIS, V14, P177, DOI 10.3201/eid1401.070618
   Ooi E. E., 2011, TROPICAL INFECT DIS
   Ravanini P, 2011, EMERG INFECT DIS, V17, P929, DOI 10.3201/eid1705.101626
   Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zayed A, 2012, ACTA TROP, V123, P62, DOI 10.1016/j.actatropica.2012.03.004
   Zehender G, 2011, INFECT GENET EVOL, V11, P646, DOI 10.1016/j.meegid.2011.02.003
NR 18
TC 14
Z9 15
U1 1
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD OCT
PY 2014
VL 27
BP 395
EP 401
DI 10.1016/j.meegid.2014.08.010
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA AS0EU
UT WOS:000343951900047
PM 25183027
DA 2020-11-24
ER

PT J
AU Pierangeli, A
   Ciccozzi, M
   Chiavelli, S
   Concato, C
   Giovanetti, M
   Cella, E
   Spano, L
   Scagnolari, C
   Moretti, C
   Papoff, P
   Muraca, M
   Midulla, F
   Antonelli, G
AF Pierangeli, Alessandra
   Ciccozzi, Massimo
   Chiavelli, Stefano
   Concato, Carlo
   Giovanetti, Marta
   Cella, Eleonora
   Spano, Lucia
   Scagnolari, Carolina
   Moretti, Corrado
   Papoff, Paola
   Muraca, Maurizio
   Midulla, Fabio
   Antonelli, Guido
TI Molecular epidemiology and genetic diversity of human rhinovirus
   affecting hospitalized children in Rome
SO MEDICAL MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
DE Rhinovirus; Genotyping; Phylogeny; Capsid protein
ID 5' NONCODING REGION; RESPIRATORY ILLNESSES; INFECTIONS; RECOMBINATION;
   PROPOSALS; SEVERITY; FEATURES; STRAINS; VIRUSES; ASTHMA
AB Human rhinoviruses (HRV) have been re-classified into three species (A-C), but the recently discovered HRV-C strains are not fully characterized yet. This study aimed to undertake a molecular and epidemiological characterization of HRV strains infecting children hospitalized over one year in two large research hospitals in Rome. Nasal washings from single HRV infections were retrospectively subjected to phylogenetic analysis on two genomic regions: the central part of the 5'Untranslated Region (5'UTR) and the Viral Protein (VP) 4 gene with the 5' portion of the VP2 gene (VP4/2). Forty-five different strains were identified in 73 HRV-positive children: 55 % of the cases were HRV-A, 38 % HRV-C and only 7 % HRV-B. HRV-C cases were less frequent than HRV-A during summer months and more frequent in cases presenting wheezing with respect to HRV-A. Species distribution was similar with respect to patient age, and seasonality differed during summer months with fewer HRV-C than HRV-A cases. On admission, a significantly higher number of HRV-C cases presented with wheezing with respect to HRV-A. The inter- and intra-genotype variability in VP4/2 was higher than in 5'UTR; in particular, HRV-A patient VP4/2 sequences were highly divergent (8-14 %) at the nucleotide level from those of their reference strains, but VP4 amino acid sequence was highly conserved. In HRV-C isolates, the region preceding the initiator AUG, the amino acids involved in VP4 myristoylation, the VP4-VP2 cleavage site and the cis-acting replication element were highly conserved. Differently, VP4 amino acid conservation was significantly lower in HRV-C than in HRV-A strains, especially in the transiently exposed VP4 N-terminus. This study confirmed the high number of different HRV genotypes infecting hospitalized children over one year and reveals a greater than expected variability in HRV-C VP4 protein, potentially suggestive of differences in replication.
C1 [Pierangeli, Alessandra; Spano, Lucia; Scagnolari, Carolina; Antonelli, Guido] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Lab Virol,Dept Mol Med, I-00185 Rome, Italy.
   [Ciccozzi, Massimo; Giovanetti, Marta; Cella, Eleonora] Ist Super Sanita, Dept Infect Dis, I-00161 Rome, Italy.
   [Chiavelli, Stefano; Concato, Carlo; Muraca, Maurizio] Bambino Gesu Children Hosp & Res Inst, I-00165 Rome, Italy.
   [Moretti, Corrado; Papoff, Paola; Midulla, Fabio] Univ Roma La Sapienza, Dept Paediat, Umberto Hosp 1, I-00161 Rome, Italy.
RP Pierangeli, A (corresponding author), Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Lab Virol,Dept Mol Med, Vle Porta Tiburtina 28, I-00185 Rome, Italy.
EM alessandra.pierangeli@uniroma1.it
RI Giovanetti, Marta/AAK-7408-2020; Concato, Carlo/AAA-5993-2020;
   Antonelli, Guido/K-7915-2016; Cella, Eleonora/J-9961-2016; Cella,
   Eleonora/ABA-8333-2020; Muraca, Maurizio/G-3063-2012; Midulla,
   Fabio/AAL-4391-2020; Pierangeli, Alessandra/A-6368-2008; CICCOZZI,
   MASSIMO/C-6484-2016; SCAGNOLARI, CAROLINA/G-3837-2011
OI Concato, Carlo/0000-0003-3995-9537; Cella, Eleonora/0000-0002-7870-9744;
   Cella, Eleonora/0000-0002-7870-9744; Pierangeli,
   Alessandra/0000-0003-0633-360X; CICCOZZI, MASSIMO/0000-0003-3866-9239;
   SCAGNOLARI, CAROLINA/0000-0003-1044-1478; Giovanetti,
   Marta/0000-0002-5849-7326; MURACA, MAURIZIO/0000-0003-1218-097X;
   Midulla, Fabio/0000-0001-7476-5266
FU Pasteur Institute; Sapienza University of Rome "Ricerche
   Universitarie''; Cenci Bolognetti FoundationIstituto Pasteur Italia
   Fondazione Cenci Bolognetti
FX This study was supported by grants from Pasteur Institute, Cenci
   Bolognetti Foundation to G.A and from Sapienza University of Rome
   "Ricerche Universitarie'' to C.S.
CR Arakawa M, 2012, J MED MICROBIOL, V61, P410, DOI 10.1099/jmm.0.035006-0
   Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689
   Arden KE, 2010, REV MED VIROL, V20, P156, DOI 10.1002/rmv.644
   Bizzintino J, 2011, EUR RESPIR J, V37, P1037, DOI 10.1183/09031936.00092410
   Bochkov YA, 2012, MICROBES INFECT, V14, P485, DOI 10.1016/j.micinf.2011.12.011
   Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358
   Calvo C, 2010, PEDIATR INFECT DIS J, V29, P717, DOI 10.1097/INF.0b013e3181d7a708
   Carstens EB, 2010, ARCH VIROL, V155, P133, DOI 10.1007/s00705-009-0547-x
   CHOW M, 1987, NATURE, V327, P482, DOI 10.1038/327482a0
   HAMPARIAN VV, 1987, VIROLOGY, V159, P191
   Henquell C, 2012, J CLIN VIROL, V53, P280, DOI 10.1016/j.jcv.2011.10.009
   Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355
   Iwane MK, 2011, J INFECT DIS, V204, P1702, DOI 10.1093/infdis/jir634
   Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC
   Katpally U, 2009, J VIROL, V83, P7040, DOI 10.1128/JVI.00557-09
   Kiang D, 2008, J CLIN MICROBIOL, V46, P3736, DOI 10.1128/JCM.00674-08
   Kiang D, 2007, J CLIN VIROL, V38, P227, DOI 10.1016/j.jcv.2006.12.016
   Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551
   Lau SKP, 2009, J INFECT DIS, V200, P1096, DOI 10.1086/605697
   Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966
   Lee WM, 2012, AM J RESP CRIT CARE, V186, P886, DOI 10.1164/rccm.201202-0330OC
   Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774
   Linder JE, 2013, J ALLERGY CLIN IMMUN, V131, P69, DOI 10.1016/j.jaci.2012.09.033
   Mackay IM, 2013, J INFECT DIS, V207, P1433, DOI 10.1093/infdis/jis476
   McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847
   McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10
   Midulla F, 2010, ARCH DIS CHILD, V95, P35, DOI 10.1136/adc.2008.153361
   Miller EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821
   Moreira LP, 2011, PEDIATR INFECT DIS J, V30, P612, DOI 10.1097/INF.0b013e31820d0de3
   Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557
   Peltola V, 2009, J MED VIROL, V81, P1831, DOI 10.1002/jmv.21590
   Pierangeli A, 2007, J MED VIROL, V79, P463, DOI 10.1002/jmv.20832
   Piralla A, 2009, J CLIN VIROL, V45, P311, DOI 10.1016/j.jcv.2009.04.016
   Piralla A, 2011, J CLIN MICROBIOL, V49, P373, DOI 10.1128/JCM.01814-10
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Regamey N, 2008, EUR RESPIR J, V32, P249, DOI 10.1183/09031936.00076508
   Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333
   Savolainen-Kopra C, 2009, J CLIN MICROBIOL, V47, P1278, DOI 10.1128/JCM.02130-08
   Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0
   SWOFFORD D, 2003, PHYLOGENETIC HDB PRA, P160
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Tapparel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021163
   Tuthill TJ, 2010, CURR TOP MICROBIOL, V343, P43, DOI 10.1007/82_2010_37
NR 43
TC 16
Z9 18
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0300-8584
EI 1432-1831
J9 MED MICROBIOL IMMUN
JI Med. Microbiol. Immunol.
PD AUG
PY 2013
VL 202
IS 4
BP 303
EP 311
DI 10.1007/s00430-013-0296-z
PG 9
WC Immunology; Microbiology
SC Immunology; Microbiology
GA 195MJ
UT WOS:000322706500007
PM 23625169
DA 2020-11-24
ER

PT J
AU Ciccozzi, M
   Peletto, S
   Cella, E
   Giovanetti, M
   Lai, A
   Gabanelli, E
   Acutis, PL
   Modesto, P
   Rezza, G
   Platonov, AE
   Lo Presti, A
   Zehender, G
AF Ciccozzi, Massimo
   Peletto, Simone
   Cella, Eleonora
   Giovanetti, Marta
   Lai, Alessia
   Gabanelli, Elena
   Acutis, Pier Luigi
   Modesto, Paola
   Rezza, Giovanni
   Platonov, Alexander E.
   Lo Presti, Alessandra
   Zehender, Gianguglielmo
TI Epidemiological history and phylogeography of West Nile virus lineage 2
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE West Nile virus; Phylogeography; Epidemiology
ID MEDITERRANEAN BASIN; STRAINS; SOUTHERN; DYNAMICS; RUSSIA; EUROPE
AB West Nile virus (WNV) was first isolated in Uganda. In Europe WNV was sporadically detected until 1996, since then the virus has been regularly isolated from birds and mosquitoes and caused several outbreaks in horses and humans. Phylogenetic analysis showed two main different WNV lineages. The lineage 1 is widespread and segregates into different subclades (1a-c). WNV-1a includes numerous strains from Africa, America, and Eurasia. The spatio-temporal history of WNV-1a in Europe was recently described, identifying two main routes of dispersion, one in Eastern and the second in Western Europe. The West Nile lineage 2 (WNV-2) is mainly present in sub-Saharan Africa but has been recently emerged in Eastern and Western European countries. In this study we reconstruct the phylogeny of WNV-2 on a spatio-temporal scale in order to estimate the time of origin and patterns of geographical dispersal of the different isolates, particularly in Europe. Phylogeography findings obtained from E and NS5 gene analyses suggest that there were at least two separate introductions of WNV-2 from the African continent dated back approximately to the year 1999 (Central Europe) and 2000 (Russia), respectively. The epidemiological implications and clinical consequences of lineage 1 and 2 cocirculation deserve further investigations. (c) 2013 Elsevier B.V. All rights reserved.
C1 [Ciccozzi, Massimo; Cella, Eleonora; Giovanetti, Marta; Rezza, Giovanni; Lo Presti, Alessandra] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [Peletto, Simone; Acutis, Pier Luigi; Modesto, Paola] Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy.
   [Lai, Alessia; Gabanelli, Elena; Zehender, Gianguglielmo] Univ Milan, Dept Clin Sci Luigi Sacco, Infect Dis Sect, Milan, Italy.
   [Platonov, Alexander E.] Minist Publ Hlth Russia, Cent Res Inst Epidemiol, Moscow, Russia.
RP Ciccozzi, M (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.
EM massimo.ciccozzi@iss.it
RI Giovanetti, Marta/AAK-7408-2020; Modesto, Paola/AAW-3642-2020; Peletto,
   Simone/K-2005-2016; Cella, Eleonora/ABA-8333-2020; Cella,
   Eleonora/J-9961-2016; Presti, Alessandra Lo/K-1451-2016; Acutis, Pier
   Luigi/G-4802-2013; CICCOZZI, MASSIMO/C-6484-2016; Platonov, Alexander
   E/I-4906-2014; rezza, giovanni/D-4393-2016
OI Peletto, Simone/0000-0002-8684-898X; Cella,
   Eleonora/0000-0002-7870-9744; Cella, Eleonora/0000-0002-7870-9744;
   Presti, Alessandra Lo/0000-0001-7611-5021; Acutis, Pier
   Luigi/0000-0003-4814-2924; CICCOZZI, MASSIMO/0000-0003-3866-9239; rezza,
   giovanni/0000-0003-0268-6790; Platonov, Alexander/0000-0001-7450-0081;
   Giovanetti, Marta/0000-0002-5849-7326
FU European Commission EuroWestNile FP7 Project [261391]
FX A.E.P. was supported in part by the European Commission EuroWestNile FP7
   Project (261391).
CR Bagnarelli P, 2011, EURO SURVEILL, V16
   Bakonyi T, 2006, EMERG INFECT DIS, V12, P618
   Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028
   Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0
   Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654
   Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029
   Chaskopoulou A, 2011, EURO SURVEILL, V16
   Danis K, 2011, EURO SURVEILL, V16
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Hayes CG, 2001, ANN NY ACAD SCI, V951, P25
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lvov DK, 2004, ARCH VIROL, P85
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   Murgue B, 2001, ANN NY ACAD SCI, V951, P117
   Papa A, 2010, EUROSURVEILLANCE, V15
   Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759
   Platonov A. E., 2011, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P29
   Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Rizzo C, 2012, EURO SURVEILL, V17
   Savini G, 2012, VET MICROBIOL, V158, P267, DOI 10.1016/j.vetmic.2012.02.018
   Shopenskaya TA, 2008, EPID INF BOL, V5, P38
   Sirbu A, 2011, EURO SURVEILL, V16, P19762
   Thompson JD, 1994, NUCLEIC ACIDS RES, V25, P4876, DOI DOI 10.1093/NAR/25.24.4876
   Valiakos G, 2010, EURO SURVEILL, V16
   Vazquez A, 2010, EMERG INFECT DIS, V16, P549, DOI 10.3201/eid1603.091033
   Wodak E, 2011, VET MICROBIOL, V149, P358, DOI 10.1016/j.vetmic.2010.12.012
   Zehender G, 2011, INFECT GENET EVOL, V11, P646, DOI 10.1016/j.meegid.2011.02.003
   Zeller HG, 2004, EUR J CLIN MICROBIOL, V23, P147, DOI 10.1007/s10096-003-1085-1
NR 35
TC 41
Z9 42
U1 0
U2 32
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2013
VL 17
BP 46
EP 50
DI 10.1016/j.meegid.2013.03.034
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA 175MS
UT WOS:000321235400007
PM 23542457
DA 2020-11-24
ER

PT J
AU Delogu, R
   Lo Presti, A
   Ruggeri, FM
   Cella, E
   Giovanetti, M
   Ciccozzi, M
   Ljubin-Sternak, S
   Bukovski-Simonoski, S
   Lukic-Grlic, A
   Ianiro, G
   Fiore, L
AF Delogu, Roberto
   Lo Presti, Alessandra
   Ruggeri, Franco Maria
   Cella, Eleonora
   Giovanetti, Marta
   Ciccozzi, Massimo
   Ljubin-Sternak, Suncanica
   Bukovski-Simonoski, Suzana
   Lukic-Grlic, Amarela
   Ianiro, Giovanni
   Fiore, Lucia
TI Full-Genome Characterization of a G8P[8] Rotavirus That Emerged among
   Children with Diarrhea in Croatia in 2006
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID GROUP-A ROTAVIRUS; MOLECULAR CHARACTERIZATION; CLOSE RELATIONSHIP; G8
   STRAINS; WA-LIKE; SEROTYPE; BOVINE; DIVERSITY; PORCINE; CLASSIFICATION
AB The whole genome of a G8P[8] rotavirus from the 2006 epidemic in Croatia was sequenced and showed a Wa-like genotype constellation. Its VP7 gene clustered with DS-1-like G8 African rotaviruses and a G8P[4] German strain. Remaining genes clustered with contemporary Belgian G1P[8] rotaviruses, suggesting reassortment between human G8 and G1P[8] rotaviruses in Croatia or other European countries.
C1 [Delogu, Roberto; Ianiro, Giovanni; Fiore, Lucia] Ist Super Sanita, Natl Ctr Immunobiol Res & Evaluat, I-00161 Rome, Italy.
   [Lo Presti, Alessandra; Cella, Eleonora; Giovanetti, Marta; Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy.
   [Ruggeri, Franco Maria] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy.
   [Ljubin-Sternak, Suncanica] Univ Zagreb, Croatian Natl Inst Publ Hlth, Zagreb 41000, Croatia.
   [Ljubin-Sternak, Suncanica; Lukic-Grlic, Amarela] Univ Zagreb, Sch Med, Zagreb 41001, Croatia.
   [Bukovski-Simonoski, Suzana] Univ Hosp Infect Dis Dr Fran Mihaljevic, Zagreb, Croatia.
   [Lukic-Grlic, Amarela] Univ Zagreb, Childrens Hosp, Zagreb 41000, Croatia.
RP Ruggeri, FM (corresponding author), Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, Viale Regina Elena 299, I-00161 Rome, Italy.
EM franco.ruggeri@iss.it
RI Cella, Eleonora/J-9961-2016; Ianiro, Giovanni/H-9259-2016; Giovanetti,
   Marta/AAK-7408-2020; Presti, Alessandra Lo/K-1451-2016; Ruggeri, Franco
   M/B-5707-2013; CICCOZZI, MASSIMO/C-6484-2016; Cella,
   Eleonora/ABA-8333-2020
OI Cella, Eleonora/0000-0002-7870-9744; Ianiro,
   Giovanni/0000-0002-8053-4904; Presti, Alessandra Lo/0000-0001-7611-5021;
   CICCOZZI, MASSIMO/0000-0003-3866-9239; Cella,
   Eleonora/0000-0002-7870-9744; Delogu, Roberto/0000-0003-0951-6655
FU Ministry of Health, Italy (CCM Epidemiologia Molecolare di Rotavirus in
   Eta Pediatrica in Italia); Ministry of Health, Italy (Creazione di una
   Rete di Sorveglianza per Monitorare la Diffusione e l'Evoluzione di
   Genotipi Virali); Strategic Program: Preparedness and Response to
   Emerging Zoonoses and Exotic Viral Infection through an Integrated
   Medical and Veterinary Approach; ISS/NIH (Molecular and Antigenic
   Evolution of Rotavirus Strains of Human and Animal Origin)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA; EuroRotaNet
FX This study was sponsored by the Ministry of Health, Italy (CCM
   Epidemiologia Molecolare di Rotavirus in Eta Pediatrica in Italia;
   Creazione di una Rete di Sorveglianza per Monitorare la Diffusione e
   l'Evoluzione di Genotipi Virali [to L. F.] and Strategic Program:
   Preparedness and Response to Emerging Zoonoses and Exotic Viral
   Infection through an Integrated Medical and Veterinary Approach [to F.
   M. R.]), ISS/NIH (Molecular and Antigenic Evolution of Rotavirus Strains
   of Human and Animal Origin to F. M. R.), and EuroRotaNet
   (http://www.eurorota.net).
CR Adah MI, 2003, J CLIN MICROBIOL, V41, P3945, DOI 10.1128/JCM.41.8.3945-3950.2003
   Armah GE, 2001, J MED VIROL, V63, P67, DOI 10.1002/1096-9071(200101)63:1&lt;67::AID-JMV1010&gt;3.0.CO;2-T
   BROWNING GF, 1992, ARCH VIROL, V125, P121, DOI 10.1007/BF01309632
   Ciccozzi M, 2011, OPEN VIROL J, V5, P22
   CLEMENS J, 1993, PEDIATRICS, V92, P680
   Cunliffe NA, 2000, VIROLOGY, V274, P309, DOI 10.1006/viro.2000.0456
   DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994
   De Grazia S, 2009, J MED VIROL, V81, P2089, DOI 10.1002/jmv.21615
   Dennehy PH, 2006, PEDIATR INFECT DIS J, V25, P1123, DOI 10.1097/01.inf.0000243777.01375.5b
   Dhama K, 2009, VET RES COMMUN, V33, P1, DOI 10.1007/s11259-008-9070-x
   Esona MD, 2009, J MED VIROL, V81, P937, DOI 10.1002/jmv.21468
   Esona MD, 2009, EMERG INFECT DIS, V15, P83, DOI 10.3201/eid1501.080899
   Estes MK, 2007, FIELDS VIROLOGY, V5, P1917, DOI DOI 10.1007/978-3-642-69159-1_3
   Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499
   GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992
   HASEGAWA A, 1984, MICROBIOL IMMUNOL, V28, P719, DOI 10.1111/j.1348-0421.1984.tb00726.x
   Holmes JL, 1999, ARCH VIROL, V144, P1381, DOI 10.1007/s007050050594
   Iturriza-Gomara M, 2001, J VIROL, V75, P3696, DOI 10.1128/JVI.75.8.3696-3705.2001
   Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278
   Kirkwood CD, 2010, J INFECT DIS, V202, pS43, DOI 10.1086/653548
   Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238
   Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028
   MATSUNO S, 1985, J VIROL, V54, P623, DOI 10.1128/JVI.54.2.623-624.1985
   Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1
   Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07
   Matthijnssens J, 2006, J CLIN MICROBIOL, V44, P1801, DOI 10.1128/JCM.44.5.1801-1809.2006
   Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z
   Maunula L, 2002, J VIROL, V76, P11793, DOI 10.1128/JVI.76.23.11793-11800.2002
   Monini M, 2008, VET MICROBIOL, V129, P384, DOI 10.1016/j.vetmic.2007.11.036
   Montenegro FMU, 2007, J MED VIROL, V79, P335, DOI 10.1002/jmv.20803
   OFFIT PA, 1986, J VIROL, V58, P700, DOI 10.1128/JVI.58.2.700-703.1986
   Palombo EA, 2000, J MED VIROL, V60, P56, DOI 10.1002/(SICI)1096-9071(200001)60:1&lt;56::AID-JMV10&gt;3.0.CO;2-7
   Pietsch C, 2009, J CLIN MICROBIOL, V47, P3569, DOI 10.1128/JCM.01471-09
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06
   Ramachandran M, 1998, J CLIN MICROBIOL, V36, P3223, DOI 10.1128/JCM.36.11.3223-3229.1998
   Santos N, 1999, J CLIN MICROBIOL, V37, P2734, DOI 10.1128/JCM.37.8.2734-2736.1999
   Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448
   Santos N, 1998, J CLIN MICROBIOL, V36, P2727, DOI 10.1128/JCM.36.9.2727-2729.1998
   Steele AD, 1999, J GEN VIROL, V80, P3029, DOI 10.1099/0022-1317-80-11-3029
   Steyer A, 2008, J GEN VIROL, V89, P1690, DOI 10.1099/vir.0.2008/001206-0
   Steyer A, 2007, J MED VIROL, V79, P626, DOI 10.1002/jmv.20811
   Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5
   Tcheremenskaia O, 2007, J CLIN MICROBIOL, V45, P2197, DOI 10.1128/JCM.00484-07
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0
   Volotao EM, 2006, J MED VIROL, V78, P263, DOI 10.1002/jmv.20535
   Ward R, 2009, PEDIATR INFECT DIS J, V28, pS57, DOI 10.1097/INF.0b013e3181967c16
   Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002
NR 49
TC 14
Z9 14
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAY
PY 2013
VL 51
IS 5
BP 1583
EP 1588
DI 10.1128/JCM.00396-13
PG 6
WC Microbiology
SC Microbiology
GA 126GT
UT WOS:000317602100040
PM 23426928
OA Bronze, Green Published
DA 2020-11-24
ER

PT J
AU Ciccozzi, M
   Madeddu, G
   Lo Presti, A
   Cella, E
   Giovanetti, M
   Budroni, C
   Babudieri, S
   Mura, MS
   Zehender, G
   Salemi, M
AF Ciccozzi, Massimo
   Madeddu, Giordano
   Lo Presti, Alessandra
   Cella, Eleonora
   Giovanetti, Marta
   Budroni, Carla
   Babudieri, Sergio
   Mura, Maria Stella
   Zehender, Gianguglielmo
   Salemi, Marco
TI HIV Type 1 Origin and Transmission Dynamics Among Different Risk Groups
   in Sardinia: Molecular Epidemiology Within the Close Boundaries of an
   Italian Island
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID INJECTING DRUG-USERS; GENETIC DIVERSITY; VIRUS
AB In Italy, the HIV-1 epidemic is still mainly sustained by the subtype B genetic form, although other and novel subtypes and circulating recombinant forms (CRFs) have been reported. A total of 215 HIV-1 pol gene sequences were collected between 1992 and 2010. Multiple alignments spanning subtype-specific HIV-1 B pol sequences were analyzed by Bayesian phylogenetic methods. Subtype B represented 90.7% (n = 195) of the sequences. Three main clusters were detected. The root of the tree dated to 1987. Most of the observed viral gene flow events occurred from heterosexual to intravenous drug users (IDUs). Phylogenetic and molecular clock analysis showed an early HIV-1 subtype B introduction in the mid-1980s and dissemination within local risk-specific clusters. This is the first study to describe in detail the HIV-1 molecular epidemiology in one of the largest islands in the European basin. The future potential of the Sardinian epidemic as a hub between Southern and Northern Europe has to been considered.
C1 [Ciccozzi, Massimo; Lo Presti, Alessandra; Cella, Eleonora; Giovanetti, Marta] Italian Inst Hlth, Dept Infect Parasite & Immune Mediated Dis, Epidemiol Unit, Rome, Italy.
   [Madeddu, Giordano; Budroni, Carla; Babudieri, Sergio; Mura, Maria Stella] Univ Sassari, Dept Clin & Expt Med, Infect Dis Unit, I-07100 Sassari, Italy.
   [Zehender, Gianguglielmo] Univ Milan, L Sacco Hosp, Sect Infect Dis & Immunopathol, Dept Clin Sci, Milan, Italy.
   [Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.
RP Salemi, M (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, 2055 Mowry Rd, Gainesville, FL 32610 USA.
EM salemi@pathology.ufl.edu
RI CICCOZZI, MASSIMO/C-6484-2016; Giovanetti, Marta/AAK-7408-2020; Cella,
   Eleonora/ABA-8333-2020; Presti, Alessandra Lo/K-1451-2016; MADEDDU,
   Giordano/AAP-4342-2020; Cella, Eleonora/J-9961-2016
OI CICCOZZI, MASSIMO/0000-0003-3866-9239; Cella,
   Eleonora/0000-0002-7870-9744; Presti, Alessandra Lo/0000-0001-7611-5021;
   MADEDDU, Giordano/0000-0001-6099-2273; Cella,
   Eleonora/0000-0002-7870-9744; BABUDIERI, SERGIO/0000-0001-7291-8687;
   Giovanetti, Marta/0000-0002-5849-7326
CR Buonaguro L., 2008, INFECT AGENTS CANCER, V10, P3
   Castelnuovo B, 2003, EUR J CLIN MICROBIOL, V22, P663, DOI 10.1007/s10096-003-1038-8
   Ciccozzi M, 2005, J INFECT DIS, V192, P475, DOI 10.1086/431599
   Ciccozzi M, 2007, AIDS, V21, P1213, DOI 10.1097/QAD.0b013e32813aee1a
   Ciccozzi M, 2012, AIDS RES HUM RETROV, V28, P1280, DOI 10.1089/aid.2011.0138
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P921, DOI [10.1089/aid.2010.0323, 10.1089/AID.2010.0323]
   Ciccozzi M, 2011, J MED VIROL, V83, P1565, DOI 10.1002/jmv.22154
   Veras NMC, 2011, AIDS RES HUM RETROV, V27, P1173, DOI [10.1089/aid.2010.0333, 10.1089/AID.2010.0333]
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Italian AIDS Operational Center C, 2010, NOTIZIAR I SUPER SAN, V4, P3
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   McCutchan FE, 2000, AIDS, V14, pS31
   Peeters M, 2000, AIDS, V14, pS129
   SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423
   SEILLIERMOISEIWITSCH F, 1994, ANNU REV GENET, V28, P559
   Slatikin M, 1989, GENETICS, V123, P401
   Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872
   Swofford DL, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P267
NR 19
TC 8
Z9 8
U1 1
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD FEB
PY 2013
VL 29
IS 2
BP 404
EP 410
DI 10.1089/aid.2012.0209
PG 7
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 074JZ
UT WOS:000313810100030
PM 22985362
DA 2020-11-24
ER

PT J
AU Lo Presti, A
   Ciccozzi, M
   Cella, E
   Giovanetti, M
   Zehender, G
   Valenti, D
   Iannotti, N
   Malfatto, E
   Bernardini, C
   Maggiolo, F
   Callegaro, A
AF Lo Presti, Alessandra
   Ciccozzi, Massimo
   Cella, Eleonora
   Giovanetti, Marta
   Zehender, Gianguglielmo
   Valenti, Daniela
   Iannotti, Nathalie
   Malfatto, Emanuele
   Bernardini, Claudia
   Maggiolo, Franco
   Callegaro, Annapaola
TI Migration patterns of HIV-1 subtype B virus in Northern Italy
SO NEW MICROBIOLOGICA
LA English
DT Article
DE HIV-1 subtype B epidemic; Phylogenetic analysis; Migration patterns
   analysis
ID STRAINS; TYPE-1
AB Gene flow analysis is used to identify the migration patterns of viruses within a geographical area and/or in different populations. 883 HIV-1 B subtype pot gene sequences were analyzed. The gene analysis among different geographical areas of the Bergamo district and from different transmission risk groups showed 25% of the observed gene flow was from people living in the north valleys to lowland and 40.5% from a heterosexual risk group to injecting drug users. Injecting drug users seem to be the central link, mercenary sex being the common route of transmission (and gene flow) between this group and both heterosexual and homosexual individuals.
C1 [Lo Presti, Alessandra; Ciccozzi, Massimo; Cella, Eleonora; Giovanetti, Marta] NIH, Dept Infect Parasit & Immunomed Dis, I-00161 Rome, Italy.
   [Zehender, Gianguglielmo] Univ Milan, Dept Clin Sci L Sacco, I-20122 Milan, Italy.
   [Valenti, Daniela; Iannotti, Nathalie; Malfatto, Emanuele; Bernardini, Claudia; Maggiolo, Franco] Osped Riuniti Bergamo, Div Infect Dis, Bergamo, Italy.
   [Callegaro, Annapaola] Osped Riuniti Bergamo, Bergamo, Italy.
RP Ciccozzi, M (corresponding author), NIH, Dept Infect Parasit & Immunomed Dis, Viale Regina Elena 299, I-00161 Rome, Italy.
EM massimo.ciccozzi@iss.it
RI Cella, Eleonora/J-9961-2016; Cella, Eleonora/ABA-8333-2020; Giovanetti,
   Marta/AAK-7408-2020; Presti, Alessandra Lo/K-1451-2016; CICCOZZI,
   MASSIMO/C-6484-2016
OI Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Presti, Alessandra Lo/0000-0001-7611-5021;
   CICCOZZI, MASSIMO/0000-0003-3866-9239; Giovanetti,
   Marta/0000-0002-5849-7326
CR Baldanti F, 2008, J MED VIROL, V80, P947, DOI 10.1002/jmv.21163
   Balotta C, 2001, J ACQ IMMUN DEF SYND, V27, P499, DOI 10.1097/00126334-200108150-00012
   Buonaguro L., 2008, INFECT AGENTS CANCER, V10, P3
   Callegaro A, 2011, INFECT GENET EVOL, V11, P624, DOI 10.1016/j.meegid.2011.01.019
   Ciccozzi M, 2007, AIDS, V21, P1213, DOI 10.1097/QAD.0b013e32813aee1a
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P921, DOI [10.1089/aid.2010.0323, 10.1089/AID.2010.0323]
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390
   Salemi M, 2008, AIDS RES HUM RETROV, V24, P771, DOI 10.1089/aid.2007.0181
   SLATKIN M, 1989, GENETICS, V123, P603
   Suligoi B., 2010, NOTIZIARIO I SUPE S1, V24, P3
NR 11
TC 7
Z9 7
U1 0
U2 0
PU EDIZIONI INT SRL
PI MILANO
PA VIA SPADOLINI 7, MILANO, 20141, ITALY
SN 1121-7138
J9 NEW MICROBIOL
JI New Microbiol.
PD JAN
PY 2013
VL 36
IS 1
BP 75
EP 79
PG 5
WC Microbiology
SC Microbiology
GA AQ4QS
UT WOS:000342783800007
PM 23435818
DA 2020-11-24
ER

PT J
AU Ciccozzi, M
   Callegaro, A
   Lo Presti, A
   Cella, E
   Giovanetti, M
   Salpini, R
   Babakir-Mina, M
   Farina, C
   Maggiolo, F
   Perno, CF
   Ciotti, M
AF Ciccozzi, Massimo
   Callegaro, Annapaola
   Lo Presti, Alessandra
   Cella, Eleonora
   Giovanetti, Marta
   Salpini, Romina
   Babakir-Mina, Muhammed
   Farina, Claudio
   Maggiolo, Franco
   Perno, Carlo Federico
   Ciotti, Marco
TI When phylogenetic analysis complements the epidemiological
   investigation: a case of HIV-2 infection, Italy
SO NEW MICROBIOLOGICA
LA English
DT Article
DE HIV-2; Italian patient; Phylogenesis
ID VIRUS TYPE-2 HIV-2; MAXIMUM-LIKELIHOOD; RETROVIRUS
AB Human immunodeficiency virus type 2 (HIV-2) infection is geographically restricted, affecting West African countries such as Guinea- Bissau and Cape Verde. We describe a recent case of HIV-2 infection in an Italian patient. Phylogenetic analysis of the V3 region of HIV-2 indicated that the Italian patient was infected by HIV-2 subtype A2. The sequence obtained from the Italian patient clustered significantly with a sequence isolated from Senegal. A phylogenetic doubt may arise from a Guinea Bissau sequence because it was in a major clade with the Italian and Senegal sequences, but was not statistically significant. The discovery of another Italian case over a short time frame stresses the importance of strengthening the surveillance system for HIV-2 because of the increase in migration from endemic areas to Italy.
C1 [Ciccozzi, Massimo; Lo Presti, Alessandra; Cella, Eleonora; Giovanetti, Marta] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy.
   [Callegaro, Annapaola] Osped Riuniti Bergamo, Bergamo, Italy.
   [Salpini, Romina; Perno, Carlo Federico] Univ Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy.
   [Babakir-Mina, Muhammed; Perno, Carlo Federico; Ciotti, Marco] Fdn Polyclin Tor Vergata, Mol Virol Lab, Rome, Italy.
   [Farina, Claudio; Maggiolo, Franco] Osped Riuniti Bergamo, Div Infect Dis, Bergamo, Italy.
RP Ciccozzi, M (corresponding author), Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.
EM massimo.ciccozzi@iss.it
RI CICCOZZI, MASSIMO/C-6484-2016; Presti, Alessandra Lo/K-1451-2016; Cella,
   Eleonora/ABA-8333-2020; Cella, Eleonora/J-9961-2016; perno, carlo
   federico/O-1544-2016; Giovanetti, Marta/AAK-7408-2020; Salpini,
   Romina/K-2170-2016; Farina, Claudio/U-7175-2017
OI CICCOZZI, MASSIMO/0000-0003-3866-9239; Presti, Alessandra
   Lo/0000-0001-7611-5021; Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Salpini, Romina/0000-0002-2488-2082;
   PERNO, CARLO FEDERICO/0000-0002-0825-5388; Farina,
   Claudio/0000-0003-2298-4293; Giovanetti, Marta/0000-0002-5849-7326
CR BARIN F, 1985, LANCET, V2, P1387
   Ciccaglione AR, 2010, J CLIN MICROBIOL, V48, P2902, DOI 10.1128/JCM.00121-10
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P1333, DOI 10.1089/aid.2011.0055
   CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430
   Costarelli S, 2008, AIDS PATIENT CARE ST, V22, P489, DOI 10.1089/apc.2007.0149
   Damond F, 2001, VIROLOGY, V280, P19, DOI 10.1006/viro.2000.0685
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   Gomes P, 2003, LANCET INFECT DIS, V3, P683, DOI 10.1016/S1473-3099(03)00797-7
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Quiros-Roldan E, 2001, INFECTION, V29, P362, DOI 10.1007/s15010-001-2025-6
   Soriano V, 2000, J MED VIROL, V61, P111, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;111::AID-JMV18&gt;3.0.CO;2-W
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
NR 13
TC 3
Z9 3
U1 0
U2 3
PU EDIZIONI INT SRL
PI MILANO
PA VIA SPADOLINI 7, MILANO, 20141, ITALY
SN 1121-7138
J9 NEW MICROBIOL
JI New Microbiol.
PD JAN
PY 2013
VL 36
IS 1
BP 93
EP 96
PG 4
WC Microbiology
SC Microbiology
GA AQ4QS
UT WOS:000342783800011
PM 23435822
DA 2020-11-24
ER

PT J
AU Vettoretto, N
   Bartoli, M
   Montori, G
   Giovanetti, M
AF Vettoretto, N.
   Bartoli, M.
   Montori, G.
   Giovanetti, M.
TI Combined laparoscopic cholecystectomy and incisional hernia repair: a
   proposal for standardised technique
SO ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND
LA English
DT Letter
C1 [Vettoretto, N.; Giovanetti, M.] Mellino Mellini Hosp, Chiari, Italy.
   [Bartoli, M.; Montori, G.] Univ Brescia, I-25121 Brescia, Italy.
RP Vettoretto, N (corresponding author), Mellino Mellini Hosp, Chiari, Italy.
EM nereovet@gmail.com
RI Giovanetti, Marta/AAK-7408-2020
CR Ergul Z, 2009, G CHIR, V30, P437
   IKARD RW, 1995, AM SURGEON, V61, P304
   Kamer E, 2007, J POSTGRAD MED, V53, P176, DOI 10.4103/0022-3859.33859
   Ok E, 2000, SURG TODAY, V30, P1046, DOI 10.1007/s005950070032
NR 4
TC 1
Z9 1
U1 0
U2 2
PU ROYAL COLL SURGEONS ENGLAND
PI LONDON
PA 35-43 LINCOLN'S INN FIELDS, LONDON WC2A 3PN, ENGLAND
SN 0035-8843
J9 ANN ROY COLL SURG
JI Ann. R. Coll. Surg. Engl.
PD NOV
PY 2012
VL 94
IS 8
BP 606
EP 606
DI 10.1308/003588412X13373405387096i
PG 1
WC Surgery
SC Surgery
GA 038NO
UT WOS:000311181600024
PM 23131242
OA Green Published, Other Gold
DA 2020-11-24
ER

PT J
AU Ciccozzi, M
   Santoro, MM
   Giovanetti, M
   Andrissi, L
   Bertoli, A
   Ciotti, M
AF Ciccozzi, Massimo
   Santoro, Maria Mercedes
   Giovanetti, Marta
   Andrissi, Laura
   Bertoli, Ada
   Ciotti, Marco
TI HIV-1 Non-B subtypes in Italy: a growing trend
SO NEW MICROBIOLOGICA
LA English
DT Review
DE Phylogeny; HIV-1 non-B subtypes in Italy; Genotypic resistance test
ID RESISTANCE-ASSOCIATED MUTATIONS; TYPE-1 DRUG-RESISTANCE; MOLECULAR
   EPIDEMIOLOGY; REVERSE-TRANSCRIPTASE; GENETIC DIVERSITY; INFECTED
   PATIENTS; HIV-1-INFECTED PATIENTS; INCREASING PREVALENCE;
   ANTIRETROVIRAL-NAIVE; PROTEASE INHIBITORS
AB Sequence analysis plays an important role in the management of patients chronically infected with HIV-1. Knowledge of the viral genotype and drug resistance mutations is crucial for the correct management of these patients. From this point of view, the experience of researchers in the HIV-1 field and the introduction of the HIV-1 genotyping resistance test has been fundamental. Several molecular tools are available to assist the provider in interpreting genotypic test results including phylogenetics. However, it should be remembered that antiretroviral drug designs, resistance studies and interpretation systems have been largely based on HIV-1 subtype B, which has been historically the most prevalent subtype in Western countries. Due to increased migration towards Europe, especially from Africa and South-East Asia, the molecular epidemiology of HIV-1 in Western Europe, including Italy is changing. HIV-1 non-B subtypes have entered Europe and their prevalence has increased over the last years. In Italy the estimated percentage of infection with non-B subtypes ranges from 2.4 % to 19.4%. However, the true prevalence of HIV-1 non-B subtypes in this count!), is still not well known and probably underestimated. This may have important clinical and diagnostic implications. A strict molecular epidemiological survey and a reinforced sequencing strategy are required.
C1 [Ciccozzi, Massimo; Giovanetti, Marta] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [Santoro, Maria Mercedes; Bertoli, Ada] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy.
   [Bertoli, Ada; Ciotti, Marco] Tor Vergata Fdn Hosp, Rome, Italy.
   [Andrissi, Laura] Univ Rome, Rome, Italy.
RP Ciccozzi, M (corresponding author), Ist Super Sanita, Dept Infect Dis, Viale Regina Elena 299, I-00161 Rome, Italy.
EM ciccozzi@iss.it
RI Torres, Ricardo A/K-4063-2014; CICCOZZI, MASSIMO/C-6484-2016;
   Giovanetti, Marta/AAK-7408-2020; SANTORO, MARIA/K-3250-2018; Andrissi,
   LAURA/S-9919-2019
OI Torres, Ricardo A/0000-0003-4583-9849; CICCOZZI,
   MASSIMO/0000-0003-3866-9239; SANTORO, MARIA/0000-0002-6228-1114;
   Giovanetti, Marta/0000-0002-5849-7326; BERTOLI, ADA/0000-0003-0663-2503
CR Abecasis AB, 2005, AIDS, V19, P1799, DOI 10.1097/01.aids.0000188422.95162.b7
   Baldanti F, 2008, J MED VIROL, V80, P947, DOI 10.1002/jmv.21163
   Balotta C, 2001, J ACQ IMMUN DEF SYND, V27, P499, DOI 10.1097/00126334-200108150-00012
   Bon I, 2010, J CLIN VIROL, V48, P212, DOI 10.1016/j.jcv.2010.03.021
   Bracciale L, 2009, J ANTIMICROB CHEMOTH, V64, P607, DOI 10.1093/jac/dkp246
   Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001
   Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b
   Brenner BG, 2011, J MED VIROL, V83, P751, DOI 10.1002/jmv.22047
   Buonaguro L, 2004, JAIDS-J ACQ IMM DEF, V37, P1295, DOI 10.1097/01.qai.0000123273.76723.04
   BUONAGURO L., 2007, RETROVIR, V21, P4
   Buonaguro L., 2008, INFECT AGENTS CANCER, V10, P3
   BUTLER J., 2010, UNIVERSAL PRINCIPLES
   Calazans A, 2005, J INFECT DIS, V191, P1961, DOI 10.1086/430002
   Callegaro A, 2011, INFECT GENET EVOL, V11, P624, DOI 10.1016/j.meegid.2011.01.019
   Cane PA, 2001, J CLIN MICROBIOL, V39, P2652, DOI 10.1128/JCM.39.7.2652-2654.2001
   Chaix ML, 2003, AIDS, V17, P2635, DOI 10.1097/00002030-200312050-00011
   Chilton DN, 2010, ANTIVIR THER, V15, P985, DOI 10.3851/IMP1658
   CICCOZZI M., 2012, AIDS RES HUM RETROVI
   Ciccozzi M, 2007, AIDS, V21, P1213, DOI 10.1097/QAD.0b013e32813aee1a
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P921, DOI [10.1089/aid.2010.0323, 10.1089/AID.2010.0323]
   Ciccozzi M, 2010, NEW MICROBIOL, V33, P179
   Colafigli M, 2012, CLIN MICROBIOL INFEC, V18, pE299, DOI 10.1111/j.1469-0691.2012.03847.x
   Veras NMC, 2011, AIDS RES HUM RETROV, V27, P1173, DOI [10.1089/aid.2010.0333, 10.1089/AID.2010.0333]
   Coutsinos D, 2009, J VIROL, V83, P2029, DOI 10.1128/JVI.01349-08
   de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a
   De Paschale M, 2011, CLIN MICROBIOL INFEC, V17, P935, DOI 10.1111/j.1469-0691.2010.03382.x
   Descamps D, 2010, J ANTIMICROB CHEMOTH, V65, P2620, DOI 10.1093/jac/dkq380
   Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06
   EUROPEAN AIDS CLINICAL SOCIETY GUIDELINES (EACS), 2011, GUID CLIN MAN TREATM
   Felsenstein J, 2004, INFERRING PHYLOGENIE
   FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279
   Franzetti M, 2012, CLIN MICROBIOL INFEC, V18, pE66, DOI 10.1111/j.1469-0691.2011.03740.x
   Franzetti M, 2012, J ANTIMICROB CHEMOTH, V67, P1250, DOI 10.1093/jac/dks013
   Garcia-Lerma JG, 2003, J VIROL, V77, P5685, DOI 10.1128/JVI.77.10.5685-5693.2003
   Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07
   Giuliani M, 2009, AIDS RES HUM RETROV, V25, P157, DOI 10.1089/aid.2008.0175
   Gonzalez LMF, 2008, J ANTIMICROB CHEMOTH, V61, P1201, DOI 10.1093/jac/dkn099
   Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008
   Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc
   Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93
   Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297
   Invernizzi CF, 2009, J INFECT DIS, V200, P1202, DOI 10.1086/605894
   ISTITUTO SUPERIORE DI SANITA, 2011, EP HIV AIDS IT DAT C
   KANTOR R., 2005, MED GEN MED, V23, P7
   Lai A, 2010, HIV MED, V11, P593, DOI 10.1111/j.1468-1293.2010.00832.x
   Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P1
   Longo B, 2008, J MED VIROL, V80, P1689, DOI 10.1002/jmv.21275
   Lospitao E, 2005, HIV MED, V6, P313, DOI 10.1111/j.1468-1293.2005.00313.x
   Maiga AI, 2009, ANTIVIR THER, V14, P123
   Miller MD, 2007, AIDS, V21, P265, DOI 10.1097/QAD.0b013e32801199ee
   Monno L, 2005, J MED VIROL, V75, P483, DOI 10.1002/jmv.20300
   Monno L, 2009, ANTIVIR RES, V83, P118, DOI 10.1016/j.antiviral.2009.04.001
   Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009
   Palma AC, 2012, J ANTIMICROB CHEMOTH, V67, P1075, DOI 10.1093/jac/dks010
   Peeters M, 2010, CLIN MICROBIOL INFEC, V16, P1525, DOI 10.1111/j.1469-0691.2010.03300.x
   Piralla A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-149
   Pol D, 2004, SYST BIOL, V53, P949, DOI 10.1080/10635150490888868
   Riva C, 2010, AIDS RES HUM RETROV, V26, P41, DOI 10.1089/aid.2009.0057
   Rossotti R, 2011, J MED VIROL, V83, P1493, DOI 10.1002/jmv.22142
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Saladini F, 2012, AIDS RES HUM RETROV, V28, P299, DOI 10.1089/aid.2011.0002
   Salemi M, 2008, AIDS RES HUM RETROV, V24, P771, DOI 10.1089/aid.2007.0181
   SALPINI R., 2011, 6 IAS C HIV PATH TRE
   SANTORO M.M., 2012, AIDS RES HUM RETROVI
   Snoeck J, 2004, JAIDS-J ACQ IMM DEF, V35, P279, DOI 10.1097/00126334-200403010-00009
   Sonnerborg A, 1997, AIDS RES HUM RETROV, V13, P343, DOI 10.1089/aid.1997.13.343
   Sugiura W, 2002, ANTIMICROB AGENTS CH, V46, P708, DOI 10.1128/AAC.46.3.708-715.2002
   Tagliamonte M, 2006, AIDS RES HUM RETROV, V22, P1045, DOI 10.1089/aid.2006.22.1045
   Torti C, 2010, EPIDEMIOL INFECT, V138, P1298, DOI 10.1017/S0950268810000166
   Tramuto F, 2004, AIDS RES HUM RETROV, V20, P251, DOI 10.1089/088922204773004987
   U.S. Department of Health and Human Services, 2012, PROF OLD AM 2012, P1
   van de Vijver DA, 2006, JAIDS-J ACQ IMM DEF, V41, P352, DOI 10.1097/01.qai.0000209899.05126.e4
   Vandamme AM, 2011, AIDS REV, V13, P77
   Visco-Comandini U, 2003, SCAND J INFECT DIS, V35, P75, DOI 10.1080/03008870310009777
   Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811
   Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685
   Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002
NR 77
TC 16
Z9 16
U1 0
U2 4
PU EDIZIONI INT SRL
PI MILANO
PA VIA SPADOLINI 7, MILANO, 20141, ITALY
SN 1121-7138
J9 NEW MICROBIOL
JI New Microbiol.
PD OCT
PY 2012
VL 35
IS 4
BP 377
EP 386
PG 10
WC Microbiology
SC Microbiology
GA 042KG
UT WOS:000311469500002
PM 23109005
DA 2020-11-24
ER

PT J
AU Paganelli, M
   Taglietti, L
   Di Flumeri, G
   Giovanetti, M
AF Paganelli, M.
   Taglietti, L.
   Di Flumeri, G.
   Giovanetti, M.
TI BILIARY ASCARIASIS ASSOCIATED WITH CHOLEDOCOLITHIASIS AND
   CHOLELITHIASIS: A RARE CAUSE OF BILIARY OBSTRUCTION IN WESTERN
   COUNTRIES. A CASE REPORT
SO DIGESTIVE AND LIVER DISEASE
LA English
DT Meeting Abstract
C1 [Paganelli, M.; Taglietti, L.; Di Flumeri, G.; Giovanetti, M.] AO Mellino Mellini, Chiari, BS, Italy.
RI Giovanetti, Marta/AAK-7408-2020
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1590-8658
EI 1878-3562
J9 DIGEST LIVER DIS
JI Dig. Liver Dis.
PD MAR
PY 2008
VL 40
SU 1
MA PA.235
BP S161
EP S162
DI 10.1016/S1590-8658(08)60430-2
PG 2
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA VG2YM
UT WOS:000446236900431
DA 2020-11-24
ER

PT J
AU Giulini, SM
   Bonardelli, S
   Portolani, N
   Giovanetti, M
   Galvani, G
   Maffeis, R
   Coniglio, A
   Tiberio, GAM
   Nodari, F
   De Lucia, M
   Lussardi, L
   Regina, P
   Scolari, F
   Tomasoni, G
AF Giulini, SM
   Bonardelli, S
   Portolani, N
   Giovanetti, M
   Galvani, G
   Maffeis, R
   Coniglio, A
   Tiberio, GAM
   Nodari, F
   De Lucia, M
   Lussardi, L
   Regina, P
   Scolari, F
   Tomasoni, G
TI Suprarenal aortic cross-clamping in elective abdominal aortic aneurysm
   surgery
SO EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
LA English
DT Article
DE abdominal aorta; aneurysms; aortic cross-clamping; juxtarenal aneurysms;
   renal artery; pararenal aneurysms; endovascular exclusion
ID REPAIR; MANAGEMENT; ANGIOGRAPHY; CT
AB Introduction: this retrospective study was undertaken to evaluate whether suprarenal aortic cross-clamping increased the perioperative mortality and morbidity as compared to infrarenal clamping, in order to create the rationale for a more extensive application of this apparently more traumatic manoeuvre.
   Materials and methods: in a series of 734 elective aortic substitutions for abdominal aneurysm (AA), performed consecutively from January 1992 to June 1999, aortic cross-clamping was performed at a suprarenal level in 56 performed aneurysms, i.e. aneurysms extending to the lower edge of the renal arteries (8%, Group 1), and at atl infrarenal level in 634 subrenal aneurysms (92%, Group 2). When analysing preoperative data, the diameter of aneurysms was larger in Group 1 than in Group 2 (p<0.005). No significant differences were found between the two groups as regards age, sex, postinfarction cardiomyopathy, chronic obstructive pulmonary disease, chronic renal insufficiency and ASA classification of operative risks.
   Results: the average time of venal exclusion? in the juxtarenal aneurysms was 20 min (range 12-35 min). There is Ilo difference between the two groups as regards the time of aortic clamping (mean 50 vs. 60 min) or the need for homologous blood transfusion (7% vs. 11% of patients). Perioperative (30 days) mortality did not differ: 3.6% vs. 1.9% (n.s.); nor did the incidence of acute myocardial infarction (3.6% vs. 2.3%). Renal function deteriorated in 8 (14%) vs. 0 (0%) (p<0.001) and 1 patient (2%) required permanent dialysis, as compared to 0% in Group 2. The incidence of ischaemic colitis was also significantly higher in Group 1 (7%) than ill Group 2 (2%, p<0.01).
   Conclusion: this data shows that suprarenal clamping, which is necessary for the radical treatment of juxtarenal aortic aneurysms, can be performed with a low risk.
C1 Univ Brescia, Dept Surg, Brescia, Italy.
   Univ Brescia, Chair Nephrol, Brescia, Italy.
   Univ Brescia, Chair Anaesthesiol & Intens Care, Brescia, Italy.
RP Bonardelli, S (corresponding author), Via Aperta 21, I-25075 Brescia, Italy.
RI bonardelli, stefano/A-6961-2011; Giovanetti, Marta/AAK-7408-2020
CR ABURAHMA AF, 1991, SURG GYNECOL OBSTET, V14, P83
   ALLEN BT, 1993, J VASC SURG, V17, P948, DOI 10.1016/0741-5214(93)90045-N
   BRECKWOLDT WL, 1992, ARCH SURG-CHICAGO, V127, P520
   Broeders IAMJ, 1997, J ENDOVASC SURG, V4, P252, DOI 10.1583/1074-6218(1997)004<0252:PSOGFT>2.0.CO;2
   CRAWFORD ES, 1986, ANN SURG, V203, P661, DOI 10.1097/00000658-198606000-00011
   CURL GR, 1992, J VASC SURG, V16, P855
   Darling R C 3rd, 1997, Adv Surg, V31, P237
   EDWARDS JM, 1992, J VASC SURG, V15, P344, DOI 10.1016/0741-5214(92)90256-8
   ETIENNE G, 1991, J CHIR-PARIS, V128, P395
   Faggioli G, 1998, EUR J VASC ENDOVASC, V15, P205, DOI 10.1016/S1078-5884(98)80177-9
   GUINET C, 1992, J COMPUT ASSIST TOMO, V16, P182, DOI 10.1097/00004728-199203000-00003
   Hines GL, 1998, ANN VASC SURG, V12, P335, DOI 10.1007/s100169900164
   Illig KA, 1997, J VASC SURG, V26, P492, DOI 10.1016/S0741-5214(97)70042-9
   Jean-Claude JM, 1999, J VASC SURG, V29, P902, DOI 10.1016/S0741-5214(99)70218-1
   LACROIX H, 1994, J MAL VASCUL, V19, P78
   Lipski DA, 1998, J VASC SURG, V27, P805, DOI 10.1016/S0741-5214(98)70259-9
   May J, 1999, EUR J VASC ENDOVASC, V18, P284, DOI 10.1053/ejvs.1999.0898
   NYPAVER TJ, 1993, ARCH SURG-CHICAGO, V128, P803
   OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003
   POULIAS GE, 1992, J CARDIOVASC SURG, V33, P324
   QVARFORDT PG, 1986, J VASC SURG, V3, P84
   Rozenblit A, 1997, Semin Vasc Surg, V10, P222
   Schneider J R, 1997, Cardiovasc Surg, V5, P279, DOI 10.1016/S0967-2109(97)00021-5
   Scolari F, 1996, NEPHROL DIAL TRANSPL, V11, P1607
   SHEPARD AD, 1991, J VASC SURG, V14, P283, DOI 10.1016/0741-5214(91)90078-9
   SICARD GA, 1987, J VASC SURG, V5, P9
   STONEY RJ, 1989, AORTIC SURG, P161
   TREIMAN GS, 1988, J VASC SURG, V8, P268, DOI 10.1067/mva.1988.avs0080268
   VANDENAKKER PJ, 1989, ANN SURG, V210, P658, DOI 10.1097/00000658-198911000-00015
   White RA, 1997, J ENDOVASC SURG, V4, P45, DOI 10.1583/1074-6218(1997)004<0045:IUTUTF>2.0.CO;2
NR 30
TC 42
Z9 43
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1078-5884
J9 EUR J VASC ENDOVASC
JI Eur. J. Vasc. Endovasc. Surg.
PD SEP
PY 2000
VL 20
IS 3
BP 286
EP 289
DI 10.1053/ejvs.2000.1171
PG 4
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 359HT
UT WOS:000089606000012
PM 10986028
DA 2020-11-24
ER

PT J
AU Giovanetti, M
   Brotto, AC
   Tiberio, GAM
   Campedelli, L
   Vettoretto, N
   Ronconi, M
   Di Flumeri, G
   Giulini, SM
AF Giovanetti, M
   Brotto, AC
   Tiberio, GAM
   Campedelli, L
   Vettoretto, N
   Ronconi, M
   Di Flumeri, G
   Giulini, SM
TI D2 lymphectomy in the treatment of gastric cancer: A retrospective view
   on our experience (1990-1997)
SO JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
LA English
DT Article
DE gastric cancer surgery; lymphadenectomy; post operative complications
ID LYMPH-NODE DISSECTION; CARCINOMA; SPLENECTOMY; AGE; GASTRECTOMY;
   MANAGEMENT; SURVIVAL
AB From 1990 to 1997 we observed, in our departement, 267 patients affected by gastric cancer. In the first four years of our experience (1990-93) we resected 87 patients out of 136 gastric cancers observed (63.9%): 56 pts. (64.4%) were classified as ASA I-II, 21 (24.1%) as ASA III, 10 (11.5%) as ASA TV. In 2 cases (2.3%), operated in emergency, a D0-1 lymphectomy was performed, with a mean of 4 nodes resected; 67 pts. (77.0%) had a D2, with a mean of 36.5 nodes resected; in 18 pts. (20.7%) we performed a D3, with a mean of 64.3 nodes resected. Post-operative technical complications were 13 (14.9%). We observed 5 post-operatory deaths (5.7%), 3 due to technical complications. Absolutely and relatively curative resections have been 62 (71.3%). In the second period (1994-97) we resected 89/131 patients (67.9%): in this group 50 pts. (56.2%) were classified as ASA I-II, 24 (26.9%) as ASA III, 15 (16.9%) as ASA TV. With the exception of 3 patients (3.4%) who were operated in emergency (D0-1 procedures, with a mean number of 2.3 nodes resected) we adopted D2 lymphadenectomy plus hepatic peduncle as the procedure of choice, performed in 86 pts. (96.6%), with a mean of 34.1 nodes resected. Post-operative technical complications were 5 (5.6%). We observed 5 post-operatory deaths (5.6%), 1 due to technical problems. Absolutely and relatively curative resections have been 76 (85.4%), Morbidity and mortality due to technical complications in the second period are lower than observed in the first period, without any difference in the curability rate. D2 lymphectomy seems to be an effective procedure, safe even in high anesthesiological risk patients. Increasing experience and standardization of the technique reduced risk of surgical complications and mortality.
C1 Univ Brescia, Clin Chirurg, Div Chirurg Gen 3, Dept Med & Surg Sci, Brescia, Italy.
RP Giovanetti, M (corresponding author), Univ Brescia, Clin Chirurg, Div Chirurg Gen 3, Dept Med & Surg Sci, Brescia, Italy.
RI Giovanetti, Marta/AAK-7408-2020
CR AKOH JA, 1992, BRIT J SURG, V79, P293, DOI 10.1002/bjs.1800790404
   BANDOH T, 1991, SURGERY, V109, P136
   BOLLSCHWEILER E, 1992, BRIT J SURG, V79, P156, DOI 10.1002/bjs.1800790221
   BRADY MS, 1991, ARCH SURG-CHICAGO, V126, P359
   DAMHUIS RAM, 1995, EUR J CANCER, V31A, P928, DOI 10.1016/0959-8049(95)00075-5
   DENT DM, 1988, BRIT J SURG, V75, P110, DOI 10.1002/bjs.1800750206
   DRIPPS RD, 1961, JAMA-J AM MED ASSOC, V178, P261, DOI 10.1001/jama.1961.03040420001001
   ELLISON FC, 1983, SURG CLIN N AM, V63, P1313
   HABU H, 1989, HEPATO-GASTROENTEROL, V36, P71
   HIROSHI I, 1994, DIGEST SURG, V11, P78
   *JRSGC, 1995, JAP CLASS GASTR CARC
   Kodama Y, 1981, World J Surg, V5, P241
   MAEHARA Y, 1995, BRIT J SURG, V82, P102, DOI 10.1002/bjs.1800820134
   Meyer Hans-Joachim, 1994, Digestive Surgery, V11, P72, DOI 10.1159/000172228
   MITSUDOMI T, 1989, WORLD J SURG, V13, P225, DOI 10.1007/BF01658407
   OKAJIMA K, 1995, WORLD J SURG, V19, P537, DOI 10.1007/BF00294715
   RODER JD, 1995, WORLD J SURG, V19, P546, DOI 10.1007/BF00294718
   SIEWERT JR, 1993, BRIT J SURG, V80, P1015, DOI 10.1002/bjs.1800800829
   TAKEDA J, 1994, HEPATO-GASTROENTEROL, V41, P516
   Tsujitani S, 1996, BRIT J SURG, V83, P836, DOI 10.1002/bjs.1800830634
   *UICC, 1987, TNM CLASS MAL TUM
   Winslet MC, 1996, EUR J SURG ONCOL, V22, P220, DOI 10.1016/S0748-7983(96)80006-0
NR 22
TC 7
Z9 8
U1 0
U2 0
PU APSIT ASSOC PROM STUD IMMUNOL TUMOR
PI ROME
PA VIALE REGINA ELENA 291, 00161 ROME, ITALY
SN 0392-9078
J9 J EXP CLIN CANC RES
JI J. Exp. Clin. Cancer Res.
PD DEC
PY 1999
VL 18
IS 4
BP 455
EP 458
PG 4
WC Oncology
SC Oncology
GA 285QX
UT WOS:000085400700002
PM 10746969
DA 2020-11-24
ER

PT B
AU Bonardelli, S
   Benetti, A
   Brotto, AC
   Piardi, T
   Portolani, N
   Campedelli, L
   Giovanetti, M
   Coniglio, A
   Tiberio, GAM
   Gaverini, G
   Giulini, SM
AF Bonardelli, S
   Benetti, A
   Brotto, AC
   Piardi, T
   Portolani, N
   Campedelli, L
   Giovanetti, M
   Coniglio, A
   Tiberio, GAM
   Gaverini, G
   Giulini, SM
BE Bismuth, H
   Galmiche, JP
   Huguier, M
   Jaeck, D
TI Endolymphatic, endovenular and perineural invasion in T1m and sm and T2
   gastric cancer
SO 8TH WORLD CONGRESS OF THE INTERNATIONAL GASTRO-SURGICAL CLUB
LA English
DT Proceedings Paper
CT 8th World Congress of the International Gastro-Surgical Club
CY APR 15-18, 1998
CL STRASBOURG, FRANCE
SP Int Gastro-Surg Club
AB In 19 T1m. 28 T1sm and 30 T2 gastric cancers with and without nodal involvement. lymphatic-vessels invasion (LVI). blood-vessels invasion (BVI) and perineural invasion (RNI) were studied by haematoxylin-eosin and immunohistochemical techniques (CD34. UEA. FVIII. S100). Nodal metastasis were present in 5.26% T1m. 21.42% T1sm and 46.66% T2 cancers.
   LVI was present in 5.26% T1m. 39.28% T1sm and 46.66% T2. BVI was present in no T1m. 32.14% T1sm and 26.66% in T2 cancers. PNI was present in no T1m. 10.71% T1sm and 40% T2 cancers. Conclusions: T1m. T1sm and T2 cancers show a different rate of nodal metastasis and perineural invasion. T1sm cancers demonstrate an incidence of LVI and BVI significantly higher T1m anti not different from T2 cancers. Early sm cancers show an invading aptitude more similar to advanced T2 cancers than to early in cancers.
C1 Univ Brescia, Dept Surg Sci, I-25121 Brescia, Italy.
RP Bonardelli, S (corresponding author), Univ Brescia, Dept Surg Sci, I-25121 Brescia, Italy.
RI Giovanetti, Marta/AAK-7408-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
PY 1998
BP 109
EP 112
PG 4
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA BL07T
UT WOS:000074187400021
DA 2020-11-24
ER

PT B
AU Giulini, SM
   Giovanetti, M
   Brotto, AC
   Portolani, N
   Pelizzari, A
   Chiametti, G
   Campedelli, L
   Schiavi, G
   Bonardelli, S
   Tiberio, GAM
AF Giulini, SM
   Giovanetti, M
   Brotto, AC
   Portolani, N
   Pelizzari, A
   Chiametti, G
   Campedelli, L
   Schiavi, G
   Bonardelli, S
   Tiberio, GAM
BE Bismuth, H
   Galmiche, JP
   Huguier, M
   Jaeck, D
TI D2 lymphectomy for gastric cancer is a safe procedure in over 70 years
   old patients
SO 8TH WORLD CONGRESS OF THE INTERNATIONAL GASTRO-SURGICAL CLUB
LA English
DT Proceedings Paper
CT 8th World Congress of the International Gastro-Surgical Club
CY APR 15-18, 1998
CL STRASBOURG, FRANCE
SP Int Gastro-Surg Club
AB From 1990 to 1997 110 gastric carcinomas in over 70 years old patients were observed: 72 (65.8%) were resected. Among them 35 were resected during the first period. 1990-1993: 9 patients presented surgical risk ASA I-II. 18 ASA III. 8 ASA IV; lymphectomy of extension D0 was performed in 1 case. D2 non complete. with mean number of node resected 27.3. in 13 cases. completed D2 resection with mean number of nodes 40.46 in 15 cases. D3 resection with mean number of nodes 57.6 in 6 cases: postoperation deaths were 5. consequent to technical complications in 3 cases. with surgical mortality of 14.28%: 24 (68.5%) were the absolutely or relatively curative resections. During the second period. 1994 - 1997. 37 old patients were resected: 8 of them presented surgical risk ASA I-II. 15 ASA III. 14 ASA IV: lymphectomy of extension D0 was performed in 2 casts. D2 non complete. with mean number of nodes 32.6. in 13 cases. completed D2 resection with mean number of nodes 31.4 in 22 cases: postoperation deaths were 2 (5.4%). both for pulmonary embolism without technical complications: 30 (81.1%) were the absolutely or relatively curative resections. We conclude that with increasing experience and standardization of the technique also in old and high risk patients D2 lymphadenectomy with an high number of nodes resected and high curativity rate. can be safely performed. In fact the 5.4% surgical mortality observed during the more recent experience is similar to the 2.9% mortality observed in the 104 young patients resected.
C1 Univ Brescia, Dept Surg Sci, I-25121 Brescia, Italy.
RP Giulini, SM (corresponding author), Univ Brescia, Dept Surg Sci, I-25121 Brescia, Italy.
RI Giovanetti, Marta/AAK-7408-2020
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
PY 1998
BP 569
EP 573
PG 5
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA BL07T
UT WOS:000074187400102
DA 2020-11-24
ER

EF